data_1sjq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1sjq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 2.2 m . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.845 0.355 . . . . 3.1400000000000001 110.898 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -108.15 -40.74 5.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 3.4100000000000001 110.887 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.444 HG11 ' N ' ' A' ' 19' ' ' ILE . 77.3 t -93.56 135.86 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 1.77 111.149 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.504 ' CG2' HG23 ' A' ' 86' ' ' ILE . 36.5 mm -107.97 109.83 29.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 1.27 111.146 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.671 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 6.4 t-160 -83.08 109.14 16.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 2.0099999999999998 110.865 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.526 ' CD1' HG11 ' A' ' 33' ' ' VAL . 4.3 mt -83.44 122.26 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 1.6200000000000001 111.194 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -103.61 174.82 5.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 3.2799999999999998 110.735 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 42.85 41.36 2.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 3.1200000000000001 110.74 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 3.6 tp -128.19 127.02 23.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 1.8700000000000001 110.705 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.518 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 72.0 Cg_endo -75.58 71.66 5.28 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.504 2.136 . . . . 1.4199999999999999 112.036 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.607 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 15.9 mm -27.22 110.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.1 0.476 . . . . 2.6800000000000002 110.876 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 4.0 t70 146.07 -18.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.291 -0.868 . . . . 2.1600000000000001 109.451 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.518 HG11 ' N ' ' A' ' 29' ' ' THR . 1.8 p -52.41 -167.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 115.628 -0.714 . . . . 2.1899999999999999 109.842 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.518 ' N ' HG11 ' A' ' 28' ' ' VAL . 45.9 p -99.36 145.21 27.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.069 0.461 . . . . 1.3 111.773 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.6 mp0 -70.32 -46.77 63.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.761 -0.654 . . . . 2.0099999999999998 110.504 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.04 -28.64 0.16 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.543 -0.837 . . . . 0.58999999999999997 111.936 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.52 ' HG2' ' CD1' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -83.96 -57.26 3.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.319 . . . . 2.48 110.491 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.526 HG11 ' CD1' ' A' ' 21' ' ' ILE . 61.5 t -51.5 -49.96 31.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.953 0.406 . . . . 1.26 110.575 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.48 HD12 ' CD2' ' A' ' 46' ' ' LEU . 1.2 mp -69.97 -38.23 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.056 -0.52 . . . . 1.3999999999999999 110.558 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -49.1 -38.76 25.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 1.8400000000000001 110.373 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.519 HD12 ' CB ' ' A' ' 77' ' ' PRO . 12.1 mt -72.7 -38.55 67.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.946 -0.57 . . . . 2.2000000000000002 110.358 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.595 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -71.54 -20.34 78.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 0.52000000000000002 112.305 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.493 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -41.65 -60.52 1.86 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.852 0.358 . . . . 2.1400000000000001 110.775 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 30.1 Cg_endo -63.29 -34.63 66.64 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.714 2.276 . . . . 0.81000000000000005 111.939 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.595 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 22.8 m-30 -60.22 -32.62 71.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.974 -0.557 . . . . 2.2000000000000002 110.678 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 64' ' ' ALA . . . 157.85 -102.29 0.21 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.86 -0.686 . . . . 0.56000000000000005 112.231 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.59 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 28.5 mttt -150.4 137.31 19.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.762 0.315 . . . . 2.8300000000000001 111.023 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.5 t -87.83 121.72 38.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 1.1699999999999999 110.468 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.58 ' CG2' ' CG ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -96.27 -2.0 46.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 1.6799999999999999 111.459 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 170.98 152.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 1.8300000000000001 111.056 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.52 HD13 ' CG2' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -145.38 100.52 3.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 2.1099999999999999 110.89 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.493 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 2.8 tt -108.33 113.74 27.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 2.0099999999999998 110.918 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.468 ' HB3' HD11 ' A' ' 26' ' ' ILE . 2.8 mmm -90.79 94.91 9.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 1.3500000000000001 110.865 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.488 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -74.53 93.05 2.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 2.4300000000000002 110.843 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.549 ' CD ' HG21 ' A' ' 26' ' ' ILE . 3.4 mmtp -51.95 -18.74 1.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 2.0299999999999998 111.09 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -33.71 -95.21 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.798 -0.715 . . . . 2.0299999999999998 112.622 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 26.5 mttt -107.9 55.88 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 3.8100000000000001 110.975 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.518 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 14.8 m120 40.56 68.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 1.75 110.948 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.524 ' CG ' ' O ' ' A' ' 52' ' ' LYS . 10.7 mt-30 -146.99 129.35 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 1.8600000000000001 110.747 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.555 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.7 160.21 16.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 1.0900000000000001 110.891 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.671 ' CE2' ' CD2' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -142.77 115.86 8.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.307 -0.406 . . . . 2.3199999999999998 111.187 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.52 ' CG2' HD13 ' A' ' 46' ' ' LEU . 6.1 pt -114.64 146.82 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 1.3500000000000001 110.771 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.472 ' O ' HG23 ' A' ' 44' ' ' THR . 1.6 mt-10 -111.8 123.18 49.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.289 -0.414 . . . . 1.96 111.222 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.492 ' CE ' ' HB1' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -90.77 137.41 32.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 1.1100000000000001 110.251 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.59 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 1.2 m-80 -68.4 -20.74 64.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.418 -0.356 . . . . 1.5700000000000001 111.484 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.4 t -129.84 146.88 51.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 1.75 111.326 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.48 -46.09 89.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.088 -0.505 . . . . 1.95 110.779 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.64 -23.42 17.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 2.1299999999999999 110.721 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB1' ' CE ' ' A' ' 59' ' ' MET . . . -78.21 -54.84 5.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 1.1200000000000001 111.029 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -52.72 -52.61 55.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 1.05 111.138 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -54.18 -67.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 2.4100000000000001 110.986 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.585 HG21 ' CD1' ' A' ' 40' ' ' PHE . 22.7 m -40.97 -38.25 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 1.1299999999999999 111.277 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.581 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -52.12 -65.18 0.6 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 1.3600000000000001 111.024 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.572 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 99.8 t -75.08 -49.85 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 1.1799999999999999 111.128 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.453 ' O ' ' OG1' ' A' ' 73' ' ' THR . 13.0 t-20 -43.39 -60.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 2.0800000000000001 110.997 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -55.97 -42.26 76.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 2.23 110.965 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' A' ' 68' ' ' MET . 16.3 m-85 -74.5 0.2 15.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 2.0800000000000001 111.073 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 32.0 m -50.11 -29.04 8.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.355 -0.384 . . . . 1.3799999999999999 110.952 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.25 -57.19 1.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 1.78 110.779 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 40.8 t -80.28 124.69 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 1.97 110.979 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.5 HG22 ' HD2' ' A' ' 77' ' ' PRO . 1.2 m -102.41 144.22 28.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 1.3799999999999999 111.241 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.532 ' HG2' ' CD1' ' A' ' 86' ' ' ILE . 22.6 Cg_endo -94.56 135.02 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.199 2.599 . . . . 0.82999999999999996 111.961 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.531 ' HB ' ' N ' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -114.6 177.73 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 1.99 111.222 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.52 ' CD1' ' HG2' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -131.99 112.56 12.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 3.0699999999999998 110.927 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 46.58 23.37 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 5.2199999999999998 110.725 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.09 9.17 20.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.875 -0.679 . . . . 1.0900000000000001 112.649 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.46 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -117.0 97.64 51.02 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.97 0.414 . . . . 2.5299999999999998 110.819 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.531 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 36.6 Cg_exo -57.64 117.12 3.77 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.852 2.368 . . . . 1.01 112.615 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 3.3 pt -118.64 107.73 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 1.1299999999999999 110.67 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.456 ' O ' HG22 ' A' ' 21' ' ' ILE . 20.6 m-85 -65.42 148.4 51.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 2.6699999999999999 111.648 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.551 HD11 ' CE2' ' A' ' 72' ' ' TYR . 4.2 mt -126.23 103.87 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.809 -0.632 . . . . 1.27 110.556 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' HIS . 11.8 mt-30 -112.67 170.79 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.395 . . . . 2.6400000000000001 111.147 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.572 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 37.4 m-85 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 2.3700000000000001 110.885 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.798 0.332 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -76.72 -20.03 57.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.943 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 t -90.11 107.51 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.122 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.463 ' HB ' HG12 ' A' ' 57' ' ' ILE . 24.9 mm -94.39 108.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.184 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.624 ' NE2' ' CE2' ' A' ' 56' ' ' PHE . 4.7 t-160 -79.32 109.62 13.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.744 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 86' ' ' ILE . 16.4 mt -83.99 131.1 34.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.363 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -109.29 168.27 9.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.635 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.5 OUTLIER 46.43 44.22 12.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.0 110.377 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 26' ' ' ILE . 0.4 OUTLIER -129.44 95.72 29.42 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.972 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.512 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 50.5 Cg_exo -53.32 78.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.699 2.266 . . . . 0.0 111.932 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.562 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 29.6 mm -34.62 118.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.084 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.4 t0 149.76 -19.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.06 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.505 HG21 ' N ' ' A' ' 29' ' ' THR . 6.1 m -55.44 -155.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.783 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.505 ' N ' HG21 ' A' ' 28' ' ' VAL . 71.2 p -114.0 145.69 41.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.923 0.392 . . . . 0.0 111.64 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.522 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 9.5 mp0 -63.47 -34.19 77.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.602 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.12 -38.18 65.94 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.182 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.515 ' OE1' ' CD1' ' A' ' 79' ' ' LEU . 3.6 mm-40 -68.59 -58.97 3.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.785 0.326 . . . . 0.0 110.608 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.0 t -53.28 -45.5 55.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.743 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.523 ' CD1' HD22 ' A' ' 46' ' ' LEU . 1.4 mp -66.63 -39.58 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.395 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.36 -43.37 5.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.144 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.46 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 8.5 mt -77.71 -25.35 49.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.291 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -81.43 -16.33 74.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.405 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.487 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -58.9 -54.73 53.51 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.738 0.304 . . . . 0.0 110.725 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 31.6 Cg_exo -58.19 -50.08 10.85 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.569 2.179 . . . . 0.0 111.828 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.569 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 27.2 m-85 -53.68 -32.61 52.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.783 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 64' ' ' ALA . . . 161.71 -104.08 0.23 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.186 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.541 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 8.8 mttm -150.45 143.77 24.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 111.007 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 49.9 t -86.92 114.59 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.518 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.521 ' CG2' ' CG ' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -89.26 -4.5 58.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.458 -179.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 176.4 151.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.523 HD22 ' CD1' ' A' ' 34' ' ' ILE . 3.9 tp -137.63 125.76 22.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.007 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 tp -134.09 123.74 24.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.462 ' HB3' HD13 ' A' ' 26' ' ' ILE . 2.5 mmm -109.66 121.82 46.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HG ' ' CE1' ' A' ' 56' ' ' PHE . 12.8 mt -98.89 91.62 5.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.976 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.509 ' CD ' HG23 ' A' ' 26' ' ' ILE . 13.6 mmtp -41.22 -27.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.966 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -81.24 129.6 9.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.545 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 0.9 OUTLIER 67.28 16.37 10.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 110.997 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 21.8 m120 36.35 78.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.509 ' N ' HG12 ' A' ' 26' ' ' ILE . 2.4 mt-30 -150.21 132.91 15.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.993 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.548 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.7 167.81 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.767 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.624 ' CE2' ' NE2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -148.09 115.99 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.305 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.463 HG12 ' HB ' ' A' ' 19' ' ' ILE . 6.5 pt -108.71 155.09 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.768 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.47 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 0.0 OUTLIER -119.51 119.28 33.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.525 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 38.7 mmm -89.98 141.47 28.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.632 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.541 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -73.76 -27.03 60.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.909 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 4.5 t -123.92 137.94 54.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.234 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -51.27 -38.2 51.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.687 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -59.08 -27.88 65.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.689 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 59' ' ' MET . . . -75.81 -47.24 26.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 68' ' ' MET . . . -60.4 -57.09 14.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.993 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -51.82 -70.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.504 ' O ' ' CE1' ' A' ' 40' ' ' PHE . 12.7 m -41.8 -27.48 0.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.569 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -59.62 -65.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.558 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 72.0 t -74.92 -37.61 41.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.469 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 8.2 t30 -59.23 -63.66 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.994 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 67' ' ' THR . 2.8 t80 -49.31 -45.72 45.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.11 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.559 ' CD2' ' HG3' ' A' ' 77' ' ' PRO . 22.4 m-30 -83.83 11.57 7.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.106 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.469 ' OG1' ' HA ' ' A' ' 70' ' ' ASN . 21.5 m -62.29 -30.24 70.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.2 t -113.66 -39.19 4.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.5 p -106.18 129.95 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.144 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.528 HG21 ' CD ' ' A' ' 77' ' ' PRO . 1.3 m -98.61 142.48 24.67 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.85 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.559 ' HG3' ' CD2' ' A' ' 72' ' ' TYR . 26.8 Cg_endo -95.01 137.67 0.84 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 123.028 2.485 . . . . 0.0 112.214 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -123.65 -179.87 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 111.21 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.515 ' CD1' ' OE1' ' A' ' 32' ' ' GLU . 1.9 mm? -137.97 107.43 6.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.963 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 56.88 16.67 2.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.935 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.46 8.63 14.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.655 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.456 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -116.01 97.67 49.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.008 0.432 . . . . 0.0 110.95 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.481 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 74.3 Cg_endo -75.84 135.93 18.16 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.894 2.396 . . . . 0.0 112.853 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.525 ' CG2' HD23 ' A' ' 24' ' ' LEU . 9.2 pt -136.97 110.11 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.497 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.446 ' O ' HG22 ' A' ' 21' ' ' ILE . 8.1 m-85 -60.47 143.55 53.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.587 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.509 ' CG2' ' SD ' ' A' ' 68' ' ' MET . 7.1 mt -125.85 104.07 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.528 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' HIS . 3.9 mt-30 -115.13 172.83 6.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.1 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.558 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 45.5 m-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.84 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.827 0.346 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -68.06 -7.27 27.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.033 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 t -87.99 122.49 39.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.031 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.514 HD13 ' CA ' ' A' ' 65' ' ' ALA . 3.9 mm -119.28 116.85 52.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.211 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.467 ' HB3' ' O ' ' A' ' 88' ' ' PHE . 6.9 t-80 -88.28 153.59 21.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.721 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.48 HG12 ' CG1' ' A' ' 86' ' ' ILE . 2.3 mp -133.37 110.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.478 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' LYS . 2.8 ttm180 -88.09 167.4 13.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.827 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 43.77 90.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.521 ' CD1' HD13 ' A' ' 84' ' ' ILE . 4.7 tp -167.66 115.42 0.65 Allowed Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.447 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 26' ' ' ILE . 37.4 Cg_exo -59.08 73.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.466 2.111 . . . . 0.0 111.062 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.551 ' CG1' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -30.01 153.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.989 -178.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER 87.46 9.43 0.16 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.983 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.518 ' N ' ' CE ' ' A' ' 48' ' ' MET . 1.4 t -57.86 -149.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.806 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.455 ' OG1' ' HB2' ' A' ' 32' ' ' GLU . 17.9 p -124.52 149.81 46.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.16 0.505 . . . . 0.0 111.899 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.458 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 2.1 mt-10 -68.75 -47.11 67.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.789 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 35' ' ' SER . . . -51.34 -37.27 39.02 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.348 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.466 ' N ' ' OE1' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -78.63 -64.93 1.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.753 0.311 . . . . 0.0 110.768 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.9 t -45.59 -52.72 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.529 HG12 ' CG2' ' A' ' 43' ' ' VAL . 1.5 mp -65.7 -40.17 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.315 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -39.17 -42.42 0.96 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.924 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.525 ' CD2' ' OH ' ' A' ' 72' ' ' TYR . 11.1 mt -73.21 -40.63 64.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.02 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -77.22 -3.97 82.9 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.399 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.524 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 9.3 mt -61.44 -58.3 19.53 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.182 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 19.7 Cg_endo -58.3 -32.02 95.07 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.511 2.141 . . . . 0.0 112.105 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.582 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 22.0 m-30 -58.04 -28.51 64.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.683 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.76 -98.03 0.17 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.18 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.569 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 19.3 mmtp -150.47 146.01 26.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 0.0 111.022 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.529 ' CG2' HG12 ' A' ' 34' ' ' ILE . 67.0 t -89.73 116.43 31.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.763 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.526 ' CG2' ' N ' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -92.82 -9.71 39.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.244 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.417 ' HB2' ' OE1' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -176.88 146.95 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.725 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.486 ' C ' ' CD1' ' A' ' 46' ' ' LEU . 2.1 tm? -132.59 124.83 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.024 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.525 ' CD1' HD23 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -141.23 141.4 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.708 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.518 ' CE ' ' N ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -129.3 103.08 6.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.784 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.525 HD23 ' CD1' ' A' ' 47' ' ' LEU . 3.4 mm? -70.18 107.82 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.832 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.459 ' HA ' HG21 ' A' ' 26' ' ' ILE . 5.9 mttp -91.68 81.13 5.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.943 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.23 -56.43 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.284 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -123.17 18.29 9.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.919 0.39 . . . . 0.0 110.544 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.551 ' HA ' ' CG1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 68.81 86.47 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.953 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 53' ' ' ASN . 26.6 mt-30 -160.12 129.52 5.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 111.431 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.546 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -113.75 163.27 15.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.241 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 55' ' ' ALA . 5.8 m-85 -148.1 118.59 7.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.839 0.352 . . . . 0.0 111.599 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 57' ' ' ILE . 7.0 pt -118.53 140.85 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.527 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.517 ' CB ' ' OG1' ' A' ' 44' ' ' THR . 61.6 mt-10 -103.34 123.65 47.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.292 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.529 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 23.4 mmm -98.81 134.49 41.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.569 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -72.28 -20.56 61.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.27 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.464 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 11.9 t -134.67 129.14 34.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.909 0.385 . . . . 0.0 111.231 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -38.99 -49.55 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -46.06 -32.23 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 59' ' ' MET . . . -75.29 -48.88 21.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.514 ' CA ' HD13 ' A' ' 19' ' ' ILE . . . -66.58 -59.23 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -50.59 -65.82 0.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.075 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.7 m -40.7 -46.78 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.27 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -44.98 -65.11 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.275 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.575 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 24.7 t -71.89 -51.54 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.297 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -49.96 -26.51 4.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.186 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -85.53 -64.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.169 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.525 ' OH ' ' CD2' ' A' ' 36' ' ' LEU . 27.2 m-85 -56.46 -16.54 6.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.989 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 72' ' ' TYR . 69.7 m -35.54 -31.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.023 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 72' ' ' TYR . 7.7 t -112.4 -62.94 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 75' ' ' VAL . 6.2 p -82.15 121.71 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.054 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.502 HG23 ' CE1' ' A' ' 85' ' ' TYR . 2.5 m -95.59 145.85 30.28 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.032 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.471 ' HD2' HG21 ' A' ' 76' ' ' THR . 37.1 Cg_endo -97.23 163.61 0.96 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.299 2.666 . . . . 0.0 112.032 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.524 ' HB ' ' N ' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -153.24 152.41 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.899 0.381 . . . . 0.0 111.105 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 0.9 OUTLIER -98.78 100.83 12.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.406 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 28.6 mmt180 67.27 -59.51 0.39 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.469 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -159.44 22.92 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.404 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.437 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 26.1 mp0 -126.1 97.8 34.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.392 . . . . 0.0 110.936 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.524 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 19.9 Cg_exo -66.19 129.47 21.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 123.047 2.498 . . . . 0.0 112.714 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.521 HD13 ' CD1' ' A' ' 24' ' ' LEU . 6.1 pt -134.47 118.52 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.57 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CE1' HG23 ' A' ' 76' ' ' THR . 4.6 m-85 -78.66 148.88 33.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.847 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.523 HG21 ' CG ' ' A' ' 68' ' ' MET . 4.0 mt -126.26 109.09 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.473 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 20' ' ' HIS . 70.8 mm-40 -120.87 173.79 7.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.013 0.435 . . . . 0.0 111.149 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.575 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 30.1 m-85 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.886 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.5 p . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.53 -53.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.73 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.26 143.59 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.806 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.517 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 20.9 mm -118.41 103.07 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.376 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.549 ' NE2' ' CZ ' ' A' ' 56' ' ' PHE . 4.5 t-160 -79.03 144.95 34.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.338 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.519 ' CG2' ' O ' ' A' ' 85' ' ' TYR . 9.5 mt -133.05 138.68 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.918 0.39 . . . . 0.0 111.457 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.526 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 12.2 ptm180 -123.42 170.35 10.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.467 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER 52.2 38.98 25.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.216 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.525 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 2.7 tp -125.22 119.85 25.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.466 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 26' ' ' ILE . 20.2 Cg_endo -60.49 80.15 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.274 1.982 . . . . 0.0 110.716 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.577 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -32.18 154.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.733 -178.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 28' ' ' VAL . 22.3 t0 79.23 2.37 2.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.171 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.522 HG11 ' N ' ' A' ' 29' ' ' THR . 2.0 p -54.81 -165.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.522 ' N ' HG11 ' A' ' 28' ' ' VAL . 55.1 p -104.26 144.72 31.23 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.904 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -62.06 -46.66 88.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.487 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.3 -29.45 0.12 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.64 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.526 ' HG2' ' CD2' ' A' ' 79' ' ' LEU . 2.7 tp10 -83.34 -60.96 1.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 0.0 110.259 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 t -55.45 -58.87 3.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.597 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.3 mt -53.24 -53.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.489 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.5 m -39.29 -50.2 1.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.571 ' O ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -61.09 -32.39 72.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.747 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -83.03 -25.77 47.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.608 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.457 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -39.21 -60.65 1.16 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.709 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 43.1 Cg_endo -67.8 -22.88 42.4 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.548 2.165 . . . . 0.0 111.651 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.573 ' CD2' ' HA ' ' A' ' 68' ' ' MET . 16.1 m-30 -76.34 -6.47 51.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.043 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.19 -103.23 0.44 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.334 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.493 ' HB3' ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -150.4 138.23 19.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.154 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.453 HG22 HG23 ' A' ' 34' ' ' ILE . 43.2 t -92.53 89.96 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 110.328 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -74.82 1.9 11.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.867 -179.068 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 44' ' ' THR . 0.7 OUTLIER 170.69 158.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.939 0.4 . . . . 0.0 111.456 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.532 HD11 ' CG2' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -152.58 102.25 2.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.582 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.485 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -95.6 104.5 16.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.481 ' CE ' ' N ' ' A' ' 28' ' ' VAL . 46.9 mmm -78.19 107.95 11.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.553 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.532 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -88.91 101.58 14.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.862 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.53 ' CD ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -74.3 -168.39 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.072 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.42 -100.68 2.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.429 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -74.13 -69.87 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.736 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.577 ' ND2' ' CD1' ' A' ' 26' ' ' ILE . 0.6 OUTLIER 159.97 77.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 49' ' ' LEU . 0.8 OUTLIER -159.33 161.83 35.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.863 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.536 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -151.38 163.98 37.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.705 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -143.0 115.77 8.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.871 0.367 . . . . 0.0 111.242 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CG2' HD11 ' A' ' 46' ' ' LEU . 31.2 pt -105.17 133.01 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.552 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.66 102.64 14.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.84 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.46 ' SD ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -64.46 157.21 27.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.489 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.543 ' N ' ' OG1' ' A' ' 44' ' ' THR . 2.6 m-80 -68.79 -39.42 80.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.647 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -133.18 169.81 16.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.168 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.429 ' N ' ' OG1' ' A' ' 61' ' ' THR . 2.4 mp0 -73.31 -36.2 66.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.773 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -60.91 -40.08 91.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.719 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 40' ' ' PHE . . . -64.45 -49.09 72.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.459 ' HA ' ' SD ' ' A' ' 59' ' ' MET . . . -50.44 -53.23 31.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.221 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -46.49 -63.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.114 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.572 HG21 ' CD1' ' A' ' 40' ' ' PHE . 24.8 m -40.91 -46.77 2.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.309 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.573 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 0.9 OUTLIER -46.64 -65.01 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 -179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 46.1 t -70.61 -54.2 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.452 ' O ' ' OG1' ' A' ' 73' ' ' THR . 5.7 t-20 -38.75 -64.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -59.18 -31.2 68.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.013 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.464 ' OH ' ' HG ' ' A' ' 36' ' ' LEU . 14.0 m-30 -89.22 20.11 3.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.048 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.453 ' O ' HG22 ' A' ' 73' ' ' THR . 32.5 m -78.57 -22.64 46.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.841 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.1 m -124.34 -41.08 2.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.683 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.8 t -89.96 130.12 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.454 HG22 ' HD2' ' A' ' 77' ' ' PRO . 2.8 m -91.82 146.14 32.41 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.025 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.468 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 26.8 Cg_endo -95.97 138.5 0.72 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 123.262 2.641 . . . . 0.0 112.165 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.51 HG11 ' N ' ' A' ' 83' ' ' PRO . 16.9 t -125.02 154.51 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.127 0.489 . . . . 0.0 111.402 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.593 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -114.18 99.89 7.96 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.188 178.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.482 ' HB2' HD21 ' A' ' 79' ' ' LEU . 0.0 OUTLIER 62.24 -62.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.029 0.443 . . . . 0.0 110.182 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -159.45 23.86 0.3 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.371 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.79 97.77 26.32 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 110.693 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.51 ' N ' HG11 ' A' ' 78' ' ' VAL . 52.9 Cg_exo -55.3 106.01 0.17 Allowed 'Trans proline' 0 C--O 1.23 0.125 0 C-N-CA 122.833 2.355 . . . . 0.0 112.707 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 2.6 pt -107.28 107.71 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.465 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.526 ' HB2' ' CG ' ' A' ' 22' ' ' ARG . 8.9 m-30 -65.12 142.18 58.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.63 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.456 HG13 HG22 ' A' ' 21' ' ' ILE . 13.5 mt -126.14 134.24 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.372 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -149.78 172.17 15.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 0.0 111.04 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 39.4 m-85 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 23.4 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.825 0.345 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -11.7 61.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 19' ' ' ILE . 12.6 p -114.12 142.79 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CG2' HG21 ' A' ' 86' ' ' ILE . 11.4 mm -127.04 143.18 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.488 ' CD2' ' HB3' ' A' ' 54' ' ' GLN . 7.2 t-80 -110.86 156.28 21.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.672 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.472 ' CD1' HG12 ' A' ' 86' ' ' ILE . 2.5 mm -128.31 106.93 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.425 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -83.61 171.22 13.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.646 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER 39.32 31.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.947 0.403 . . . . 0.0 110.354 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -102.07 107.41 52.55 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.288 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 26' ' ' ILE . 53.2 Cg_exo -51.98 82.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.484 2.122 . . . . 0.0 111.534 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.578 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -34.24 155.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.022 -179.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 25.1 t0 80.88 -3.05 1.8 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.223 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 29' ' ' THR . 2.0 p -54.64 -166.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.516 ' N ' HG13 ' A' ' 28' ' ' VAL . 69.8 p -100.2 144.19 29.51 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.862 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -63.74 -40.63 97.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.312 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -58.39 -28.09 61.56 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.982 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.471 ' HG2' HD22 ' A' ' 79' ' ' LEU . 30.5 mt-10 -70.71 -64.59 0.87 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.361 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.432 HG11 ' CG2' ' A' ' 57' ' ' ILE . 46.8 t -55.2 -43.07 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.555 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.528 ' CG2' ' CD2' ' A' ' 38' ' ' LEU . 1.6 mp -70.1 -42.81 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.5 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 3.4 t -40.3 -42.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.027 0.441 . . . . 0.0 110.138 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.503 HD13 ' CB ' ' A' ' 77' ' ' PRO . 81.5 mt -73.03 -37.89 66.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.101 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -76.49 -11.69 84.95 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.332 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.528 ' CD2' ' CG2' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -55.93 -61.04 7.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.818 0.342 . . . . 0.0 110.794 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.6 Cg_endo -66.12 -21.14 56.16 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.649 2.233 . . . . 0.0 111.772 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 16.3 m-30 -70.04 -28.78 65.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.626 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.3 -99.14 0.18 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.13 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.555 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 14.3 mtpt -150.63 135.89 17.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.826 0.346 . . . . 0.0 111.079 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.478 HG12 ' CG1' ' A' ' 34' ' ' ILE . 42.4 t -86.6 118.13 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.27 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.534 ' CG2' ' OD1' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -88.78 -8.61 54.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.698 -179.039 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 44' ' ' THR . 1.3 t-20 170.85 165.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.885 0.374 . . . . 0.0 111.275 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.525 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -139.85 113.9 8.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.883 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.58 ' CD1' ' CD2' ' A' ' 49' ' ' LEU . 1.3 tm? -122.75 120.44 33.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.417 ' CE ' ' N ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -108.43 145.09 35.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.91 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.58 ' CD2' ' CD1' ' A' ' 47' ' ' LEU . 2.1 mt -117.09 102.69 9.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.795 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.51 ' N ' HG21 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -72.71 136.71 45.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.4 -80.0 0.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.693 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.49 8.16 14.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 111.079 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.578 ' ND2' ' CD1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 56.89 84.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.068 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 51.8 mt-30 -159.25 123.45 3.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.398 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.538 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.7 170.12 8.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.527 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.538 ' CD1' ' C ' ' A' ' 55' ' ' ALA . 28.1 m-85 -148.23 143.22 26.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.01 0.433 . . . . 0.0 111.383 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.513 ' CD1' ' SD ' ' A' ' 68' ' ' MET . 1.0 OUTLIER -144.33 125.18 8.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.494 179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.469 ' O ' HG21 ' A' ' 44' ' ' THR . 38.3 mt-10 -93.74 127.13 39.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.258 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.514 ' CE ' ' HB3' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -99.98 146.44 26.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.164 179.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.555 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -88.78 -9.22 52.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.716 0.293 . . . . 0.0 110.69 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.55 160.55 21.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.138 0.494 . . . . 0.0 111.785 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -80.84 -37.8 29.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.305 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.461 ' O ' ' HB ' ' A' ' 67' ' ' THR . 1.1 tp10 -71.09 -23.02 62.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.061 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.514 ' HB3' ' CE ' ' A' ' 59' ' ' MET . . . -74.27 -43.29 57.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.692 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 16' ' ' SER . . . -65.46 -66.06 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.211 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -52.22 -63.2 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 63' ' ' GLU . 77.3 m -40.73 -47.72 2.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.371 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.583 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -46.36 -65.26 0.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.068 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 68.0 t -68.51 -54.83 18.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.233 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 73' ' ' THR . 8.9 t-20 -46.52 -62.2 1.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.07 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.459 ' HB3' ' O ' ' A' ' 67' ' ' THR . 4.0 t80 -43.42 -48.81 7.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.153 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.448 ' OH ' HD23 ' A' ' 36' ' ' LEU . 39.6 m-85 -80.52 7.37 10.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.242 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 70' ' ' ASN . 20.4 m -49.03 -32.39 9.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.96 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.3 m -115.36 -56.06 2.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -81.1 134.64 26.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.189 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.499 ' CG2' ' CD ' ' A' ' 77' ' ' PRO . 8.1 m -92.17 152.19 42.37 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.886 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.507 ' CG ' HD13 ' A' ' 86' ' ' ILE . 9.6 Cg_endo -91.4 94.05 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.194 2.596 . . . . 0.0 112.315 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.465 ' O ' HD12 ' A' ' 79' ' ' LEU . 3.5 t -86.3 154.51 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.471 HD22 ' HG2' ' A' ' 32' ' ' GLU . 9.5 mp -144.29 100.96 3.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 59.92 14.6 4.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.724 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.438 ' O ' ' HD3' ' A' ' 83' ' ' PRO . . . 115.33 -3.23 22.1 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -102.71 97.72 9.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.329 . . . . 0.0 110.77 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 89.5 Cg_endo -79.11 96.78 1.09 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.8 2.333 . . . . 0.0 112.511 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.52 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 2.0 pt -100.81 107.74 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.738 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 12.1 m-85 -66.29 148.84 51.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.546 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.507 HD13 ' CG ' ' A' ' 77' ' ' PRO . 4.6 mt -126.27 111.88 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.473 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.412 ' OE1' ' HB3' ' A' ' 85' ' ' TYR . 3.1 mp0 -128.25 173.11 10.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.909 0.385 . . . . 0.0 111.155 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 72.7 m-85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.819 0.342 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.11 -53.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.98 103.92 14.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.995 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -87.25 134.03 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.544 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 9.3 t-160 -97.19 114.38 26.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 85' ' ' TYR . 11.2 mt -89.31 123.69 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -107.68 168.68 9.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 5.9 tmtt? 49.02 37.16 9.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.634 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 2.5 tp -120.83 126.95 26.47 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.003 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 26' ' ' ILE . 58.1 Cg_endo -71.74 76.5 1.96 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.45 2.1 . . . . 0.0 111.449 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.526 HG22 ' CE ' ' A' ' 50' ' ' LYS . 34.2 mm -34.42 155.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.837 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 24.7 t0 86.64 -4.97 0.72 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.776 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 29' ' ' THR . 1.8 p -59.95 -154.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.744 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.478 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 43.8 p -105.99 144.79 32.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.184 0.516 . . . . 0.0 112.082 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.461 ' O ' HD13 ' A' ' 34' ' ' ILE . 11.2 mp0 -69.66 -35.25 74.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.517 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 35' ' ' SER . . . -53.58 -30.72 43.15 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.913 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.459 ' OE2' HD23 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -77.26 -57.88 3.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.447 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.5 t -53.1 -43.14 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.5 mp -72.45 -46.87 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.589 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -38.62 -34.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.355 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.492 ' CD1' ' CB ' ' A' ' 77' ' ' PRO . 18.3 mt -82.38 -39.26 22.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.51 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -72.32 -17.51 77.61 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.38 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.48 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -46.81 -60.67 3.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.876 0.369 . . . . 0.0 110.806 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.6 Cg_endo -66.05 -30.78 47.18 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.716 2.277 . . . . 0.0 112.11 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.584 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 22.1 m-30 -63.73 -40.44 96.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.597 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 64' ' ' ALA . . . 168.57 -98.78 0.14 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.395 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.437 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -151.09 142.5 23.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.719 0.295 . . . . 0.0 110.923 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.498 ' CG2' ' CG1' ' A' ' 34' ' ' ILE . 42.8 t -88.76 82.54 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.213 0.53 . . . . 0.0 110.687 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.542 ' CG2' ' CG ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -66.57 -7.3 19.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.42 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 176.68 145.74 0.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.914 0.388 . . . . 0.0 111.249 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.524 HD12 ' CG2' ' A' ' 57' ' ' ILE . 4.9 tp -136.4 103.07 5.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.53 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.87 105.17 15.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.3 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.6 mmm -90.5 99.61 12.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.302 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -85.64 110.92 19.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.306 -179.513 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.526 ' CE ' HG22 ' A' ' 26' ' ' ILE . 10.1 mmtp -62.34 -172.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.349 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . 55.22 114.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.029 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER 88.87 -21.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.914 0.387 . . . . 0.0 110.669 -179.446 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 0.8 OUTLIER 68.11 63.73 0.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.494 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.483 ' C ' ' CD1' ' A' ' 26' ' ' ILE . 7.2 mm-40 -136.07 126.5 26.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.758 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.542 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.75 160.12 16.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -142.32 115.91 9.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.033 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.524 ' CD1' ' SD ' ' A' ' 59' ' ' MET . 13.8 pt -113.42 140.91 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -96.22 102.73 14.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.632 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.524 ' SD ' ' CD1' ' A' ' 57' ' ' ILE . 7.1 mmm -66.34 116.07 6.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.0 110.779 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.542 ' CG ' ' CG2' ' A' ' 44' ' ' THR . 4.9 m120 -33.68 -49.72 0.32 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.328 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.76 -173.01 2.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.125 0.488 . . . . 0.0 112.079 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 64' ' ' ALA . 2.1 mt-10 -72.39 -57.45 4.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.177 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -38.92 -30.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.065 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 59' ' ' MET . . . -76.63 -56.29 4.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -54.34 -55.47 28.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.382 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -56.0 -70.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.575 HG21 ' CD1' ' A' ' 40' ' ' PHE . 21.1 m -42.47 -39.34 2.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.215 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.584 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -49.17 -62.84 1.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 72.2 t -80.79 -50.42 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.308 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -45.37 -39.03 6.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.195 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' A' ' 67' ' ' THR . 4.3 t80 -78.01 -57.94 3.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.19 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.464 ' CZ ' HD11 ' A' ' 36' ' ' LEU . 14.5 m-85 -62.14 -12.03 17.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.14 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 69' ' ' VAL . 4.2 m -39.66 -29.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.011 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 72' ' ' TYR . 10.7 t -116.81 -45.9 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.795 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.39 131.83 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.566 ' OG1' ' CE2' ' A' ' 85' ' ' TYR . 1.3 m -97.62 142.41 24.52 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.979 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.529 ' CD ' HG21 ' A' ' 76' ' ' THR . 19.1 Cg_endo -93.86 128.93 0.62 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.022 2.481 . . . . 0.0 112.076 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 83' ' ' PRO . 3.3 t -115.89 149.18 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.192 0.52 . . . . 0.0 111.427 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.583 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -114.09 107.98 16.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.371 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.448 ' HB2' HD22 ' A' ' 79' ' ' LEU . 5.2 mtt180 62.93 -61.33 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 0.0 110.517 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -163.64 24.84 0.19 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.455 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.456 ' O ' HG23 ' A' ' 84' ' ' ILE . 1.2 tp60 -128.05 110.04 19.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.515 ' N ' HG12 ' A' ' 78' ' ' VAL . 37.8 Cg_endo -66.73 96.79 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.61 2.207 . . . . 0.0 112.385 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.3 pt -100.63 107.94 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.767 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.566 ' CE2' ' OG1' ' A' ' 76' ' ' THR . 6.4 m-85 -75.28 153.64 37.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.525 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.527 HG22 ' CG ' ' A' ' 68' ' ' MET . 5.7 mt -126.01 112.12 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.561 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 20' ' ' HIS . 9.1 mt-30 -125.45 166.27 16.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 111.1 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.571 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 74.6 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.832 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.5 ' CB ' ' CD2' ' A' ' 88' ' ' PHE . 64.9 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.851 0.358 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -123.75 -47.99 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.91 97.92 7.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.982 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.527 ' CG2' HG22 ' A' ' 86' ' ' ILE . 37.3 mm -82.41 110.52 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.292 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' GLN . 11.1 t-80 -80.59 156.51 26.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.487 ' CG2' HD13 ' A' ' 24' ' ' LEU . 1.4 mt -131.13 107.84 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.404 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 85' ' ' TYR . 2.4 ptm180 -96.38 176.03 6.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.503 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 43.52 32.94 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.975 0.416 . . . . 0.0 110.252 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.526 ' HG ' ' CD1' ' A' ' 84' ' ' ILE . 1.4 tt -118.08 99.72 51.9 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.94 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.523 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 29.4 Cg_endo -63.25 67.15 0.16 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.178 1.919 . . . . 0.0 111.163 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.572 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 47.7 mm -15.28 112.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 123.987 0.805 . . . . 0.0 112.085 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.6 t70 149.41 -10.71 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.51 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.52 ' O ' ' CG2' ' A' ' 29' ' ' THR . 6.0 m -60.96 -11.91 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.287 0.565 . . . . 0.0 111.809 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 28' ' ' VAL . 3.0 p 90.64 154.16 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.991 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -70.38 -41.39 73.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.512 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -42.35 -35.4 1.86 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.039 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.462 ' OE2' ' HB3' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -80.51 -45.28 17.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.865 0.364 . . . . 0.0 110.581 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.414 HG12 HG22 ' A' ' 57' ' ' ILE . 16.6 t -59.32 -58.2 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.969 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.5 mp -64.8 -40.68 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.661 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -41.58 -43.5 2.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.988 0.423 . . . . 0.0 110.292 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.519 ' CG ' ' OH ' ' A' ' 72' ' ' TYR . 7.4 mp -72.21 -36.71 69.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.5 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -70.82 -21.31 78.03 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.43 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.448 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -44.87 -61.31 2.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.74 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 36' ' ' LEU . 39.8 Cg_endo -67.05 -41.16 10.27 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.609 2.206 . . . . 0.0 111.648 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.577 ' CE2' ' HG2' ' A' ' 68' ' ' MET . 22.1 m-30 -54.39 -28.43 43.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.687 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 154.0 -106.92 0.31 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.191 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.572 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 17.3 mtpt -150.78 142.17 23.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.0 111.002 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 42.0 t -86.71 117.82 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.5 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -91.75 -6.01 52.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.437 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -172.46 155.32 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.877 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.526 ' CD2' ' CG2' ' A' ' 57' ' ' ILE . 2.7 tm? -151.14 113.81 4.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.433 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 6.6 tt -136.5 116.81 13.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.45 ' HB3' HG23 ' A' ' 26' ' ' ILE . 4.2 mtp -95.44 139.64 31.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -125.48 91.42 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.945 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.527 ' HD2' ' CG2' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -45.02 -26.18 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.938 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.35 127.82 10.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.53 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.7 OUTLIER 66.89 8.3 5.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.79 0.329 . . . . 0.0 110.901 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 16.7 m120 45.88 84.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.496 ' C ' ' CD1' ' A' ' 26' ' ' ILE . 67.5 mt-30 -159.2 135.71 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.595 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.537 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.29 166.6 10.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.794 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.537 ' CD1' ' C ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -139.72 117.45 11.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.478 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.526 ' CG2' ' CD2' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -127.37 152.07 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.618 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 35.7 mt-10 -120.05 142.06 49.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.41 . . . . 0.0 111.295 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.527 ' CE ' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -110.74 130.39 55.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.174 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.572 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 1.5 m-80 -68.56 -15.47 63.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.64 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.467 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 12.3 t -132.21 125.34 30.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 111.271 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -43.46 -41.94 4.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.692 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.464 ' O ' ' OG1' ' A' ' 67' ' ' THR . 8.3 tt0 -57.12 -20.82 27.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.815 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.527 ' HB3' ' CE ' ' A' ' 59' ' ' MET . . . -84.47 -46.93 11.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.968 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 16' ' ' SER . . . -64.25 -49.44 71.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.042 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -44.28 90.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.494 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.573 HG21 ' CD1' ' A' ' 40' ' ' PHE . 18.2 m -60.34 -32.74 71.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.577 ' HG2' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -58.36 -63.13 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.577 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 8.4 t -70.31 -51.06 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.07 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.459 ' O ' ' OG1' ' A' ' 73' ' ' THR . 6.8 t30 -44.06 -63.96 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.964 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -55.59 -35.69 66.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.574 ' CD2' ' O ' ' A' ' 68' ' ' MET . 17.8 m-85 -83.23 9.86 9.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 53.6 m -59.52 -28.37 67.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.13 -45.73 1.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.8 t -83.43 110.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.467 HG23 ' HD2' ' A' ' 77' ' ' PRO . 4.1 m -88.17 149.18 44.57 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.845 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 76' ' ' THR . 18.3 Cg_endo -95.28 113.43 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.226 2.617 . . . . 0.0 112.3 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.1 t -100.26 160.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.988 0.423 . . . . 0.0 111.167 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -156.27 133.91 10.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.713 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 79' ' ' LEU . 2.0 ttt-85 37.24 30.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.94 0.4 . . . . 0.0 110.423 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 80.53 50.19 5.45 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.803 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.525 ' CB ' HD11 ' A' ' 79' ' ' LEU . 1.7 mm-40 -155.2 97.68 2.41 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.05 96.56 0.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.585 2.19 . . . . 0.0 112.496 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.526 ' CD1' ' HG ' ' A' ' 24' ' ' LEU . 4.4 pt -95.15 111.14 25.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.67 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 4.6 m-30 -72.52 152.94 41.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.521 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.527 HG22 ' CG2' ' A' ' 19' ' ' ILE . 6.5 mt -126.14 104.77 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.519 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -131.6 171.49 13.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 111.097 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.577 ' CZ ' ' CG2' ' A' ' 69' ' ' VAL . 1.4 m-85 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 6.5 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.767 0.318 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.89 -49.06 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.848 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.05 126.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.069 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 48.0 mm -101.88 112.82 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.234 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.467 ' HB3' ' O ' ' A' ' 88' ' ' PHE . 4.9 t-80 -87.49 112.89 22.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.515 HG22 HD13 ' A' ' 21' ' ' ILE . 4.8 mt -82.78 127.9 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.303 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HG2' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -114.03 151.83 31.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.66 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.486 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 64.4 34.86 10.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.553 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.517 ' CD1' HD12 ' A' ' 84' ' ' ILE . 4.8 tp -119.84 129.23 25.46 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.891 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 26' ' ' ILE . 73.6 Cg_endo -76.63 69.64 6.67 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.484 2.123 . . . . 0.0 111.79 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.561 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 6.1 mm -30.64 108.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.236 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 2.2 t70 148.69 -19.48 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.673 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' ASP . 1.9 p -54.69 -162.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.857 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.8 p -107.91 145.79 33.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.104 0.478 . . . . 0.0 111.885 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 34' ' ' ILE . 7.8 mp0 -63.07 -46.7 86.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.635 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' OG ' ' A' ' 35' ' ' SER . . . -39.85 -29.36 0.17 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.782 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 30' ' ' GLU . 12.8 mm-40 -81.32 -55.03 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.254 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.1 t -61.26 -57.91 9.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.64 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -53.76 -50.26 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.066 179.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 31' ' ' GLY . 1.8 m -42.12 -43.43 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.39 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.509 HD21 ' CB ' ' A' ' 77' ' ' PRO . 19.9 mt -63.99 -33.91 76.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.36 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -81.62 -23.12 58.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.521 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.517 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -40.49 -58.47 2.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.826 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.1 Cg_endo -66.18 -40.28 15.83 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.616 2.21 . . . . 0.0 111.947 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 22.5 m-30 -55.23 -30.45 60.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.575 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 156.9 -104.41 0.25 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.094 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.577 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -150.43 137.95 19.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 111.03 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 34' ' ' ILE . 51.4 t -86.99 121.47 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.403 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.567 ' CG2' ' N ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -96.76 -0.73 47.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.574 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 44' ' ' THR . 44.4 t30 178.06 149.44 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.982 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.528 HD13 ' CG2' ' A' ' 57' ' ' ILE . 1.5 tp -139.91 103.17 4.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.47 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -115.5 113.85 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.935 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.449 ' HB3' HD13 ' A' ' 26' ' ' ILE . 2.4 mmm -99.65 99.58 10.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.51 ' N ' HD11 ' A' ' 26' ' ' ILE . 14.8 tp -82.04 97.41 8.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.524 ' CD ' HG23 ' A' ' 26' ' ' ILE . 3.4 mmtp -49.0 -21.5 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.303 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -79.34 126.07 7.29 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.698 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.507 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 1.8 mttt 71.36 7.19 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 111.314 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 8.2 m120 49.98 62.09 2.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.035 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 52' ' ' LYS . 14.0 mm-40 -139.98 134.9 32.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.54 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.77 166.82 10.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.81 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -146.85 115.92 6.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.244 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.528 ' CG2' HD13 ' A' ' 46' ' ' LEU . 6.8 pt -118.03 143.04 29.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.698 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.467 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 0.5 OUTLIER -109.64 124.38 51.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.23 -179.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.507 ' CE ' ' HB1' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -91.66 138.68 31.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.351 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.577 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 1.2 m-80 -67.25 -27.05 66.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.326 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 3.6 t -123.85 140.26 53.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.921 0.391 . . . . 0.0 111.377 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -54.43 -42.11 70.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.773 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -56.65 -29.28 62.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.632 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.507 ' HB1' ' CE ' ' A' ' 59' ' ' MET . . . -72.04 -52.35 17.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.874 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 68' ' ' MET . . . -51.88 -60.97 2.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.08 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -44.99 -68.49 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.565 HG22 ' CD1' ' A' ' 40' ' ' PHE . 86.3 m -40.91 -36.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.979 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.566 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -51.67 -65.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.833 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.577 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 78.9 t -79.7 -49.26 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.172 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -41.99 -57.16 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.027 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -61.25 -50.37 73.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.053 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.47 ' OH ' ' HB3' ' A' ' 36' ' ' LEU . 20.2 m-30 -73.76 -0.42 15.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.259 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 69' ' ' VAL . 95.0 m -51.82 -20.68 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.931 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 t -127.21 -51.87 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.83 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.4 p -89.73 123.41 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.03 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.526 HG23 ' CD ' ' A' ' 77' ' ' PRO . 1.4 m -99.02 142.2 24.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.986 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.526 ' CD ' HG23 ' A' ' 76' ' ' THR . 45.6 Cg_endo -96.94 109.63 0.1 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.271 2.647 . . . . 0.0 112.292 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.514 HG22 ' N ' ' A' ' 79' ' ' LEU . 1.4 m -100.86 -179.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.514 ' N ' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -154.95 122.97 5.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.684 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 80' ' ' ARG . 2.8 ttp180 63.32 11.82 5.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.715 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.81 19.97 15.89 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.5 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.43 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 4.5 mm-40 -116.59 97.61 50.43 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.82 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.441 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 17.2 Cg_exo -67.24 115.41 3.65 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.969 2.446 . . . . 0.0 112.55 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.517 HD12 ' CD1' ' A' ' 24' ' ' LEU . 3.3 pt -122.01 107.82 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.446 ' O ' HG23 ' A' ' 21' ' ' ILE . 3.5 m-85 -76.03 150.75 37.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.661 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 5.6 mt -126.11 109.67 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 20' ' ' HIS . 2.5 mt-30 -117.13 173.29 6.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.128 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.577 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 47.9 m-85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.95 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.569 ' OG ' ' CD1' ' A' ' 88' ' ' PHE . 42.2 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -166.44 -42.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.94 107.94 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.109 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.521 ' CG2' HG23 ' A' ' 86' ' ' ILE . 1.4 mp -93.58 113.38 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.577 ' CD2' ' HB3' ' A' ' 54' ' ' GLN . 4.5 t-80 -84.24 117.5 23.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.361 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.524 ' CD1' HG11 ' A' ' 33' ' ' VAL . 9.9 mt -87.76 98.32 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.501 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -77.57 177.29 8.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.452 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER 37.19 38.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 110.555 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -123.65 99.94 38.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.934 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.518 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 34.6 Cg_exo -57.33 74.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.569 2.179 . . . . 0.0 111.771 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.555 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 16.2 mm -33.23 119.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.1 t0 150.95 -19.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.952 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.513 HG23 ' N ' ' A' ' 29' ' ' THR . 6.1 m -54.99 -153.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.797 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.513 ' N ' HG23 ' A' ' 28' ' ' VAL . 40.6 p -112.05 145.7 39.23 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.06 0.457 . . . . 0.0 111.815 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' CD ' ' CD1' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -65.28 -56.16 14.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.545 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.89 -33.15 0.4 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.999 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.526 ' HG2' ' CG ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -68.63 -58.33 4.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.476 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.524 HG11 ' CD1' ' A' ' 21' ' ' ILE . 75.9 t -59.02 -48.52 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.622 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.44 ' CD1' ' CG ' ' A' ' 30' ' ' GLU . 1.6 mp -65.08 -38.2 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.513 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -47.51 -41.44 20.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.525 ' CD2' ' OH ' ' A' ' 72' ' ' TYR . 8.5 mp -71.5 -33.53 69.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.2 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -69.92 -25.25 75.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.346 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.51 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -41.76 -59.77 2.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 110.856 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 28.5 Cg_endo -62.87 -23.06 74.27 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.67 2.247 . . . . 0.0 111.883 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.588 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 13.7 m-30 -76.64 -38.69 54.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.507 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.4 ' HA3' ' HB1' ' A' ' 64' ' ' ALA . . . 161.13 -102.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.158 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.525 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 3.4 mtmm -150.52 146.55 26.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.777 0.323 . . . . 0.0 110.987 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -86.86 112.55 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.525 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.52 ' CG2' ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -88.19 -13.64 40.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.202 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.5 OUTLIER 170.93 119.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.857 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.524 ' CD2' HG22 ' A' ' 57' ' ' ILE . 1.2 tm? -123.83 117.41 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.999 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.457 ' N ' HD22 ' A' ' 46' ' ' LEU . 8.9 tt -117.84 128.55 54.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.848 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.464 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 9.1 mtp -106.16 139.05 41.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.509 ' N ' HG23 ' A' ' 26' ' ' ILE . 37.3 mt -120.22 103.85 9.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.521 ' N ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -55.51 -17.37 5.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . -84.08 116.52 4.27 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.439 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER 82.65 -8.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 111.059 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.518 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 25.6 m120 61.29 77.53 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.968 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.577 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 48.8 mt-30 -155.06 130.8 9.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.54 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.72 162.54 14.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.779 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.604 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -144.9 116.11 7.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.367 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.524 HG22 ' CD2' ' A' ' 46' ' ' LEU . 8.0 pt -110.19 155.04 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.815 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.467 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 0.0 OUTLIER -122.04 119.11 30.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.534 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 32.7 mmm -90.77 142.54 27.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.698 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.525 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 0.9 OUTLIER -72.88 -23.87 60.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.912 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 8.5 t -130.35 137.39 49.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.229 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -48.29 -42.85 32.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.46 ' O ' ' OG1' ' A' ' 67' ' ' THR . 10.8 mp0 -53.03 -30.07 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.749 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 59' ' ' MET . . . -77.25 -47.28 20.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.988 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -65.75 -58.94 4.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.045 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -54.68 -59.5 4.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.813 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 63' ' ' GLU . 18.6 m -40.93 -49.0 3.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.977 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 40' ' ' PHE . 2.1 ttm -46.18 -63.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.82 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 39.1 t -68.91 -15.97 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.136 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.462 ' O ' ' OG1' ' A' ' 73' ' ' THR . 1.2 t-20 -72.82 -64.12 1.03 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 5.0 t80 -60.86 -24.4 65.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.525 ' OH ' ' CD2' ' A' ' 36' ' ' LEU . 24.5 m-85 -93.07 19.99 7.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.059 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 91.6 m -72.03 -31.1 65.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -118.79 -50.55 2.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.789 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.8 t -82.48 119.92 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.982 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.524 HG23 ' CD ' ' A' ' 77' ' ' PRO . 1.5 m -87.59 141.93 32.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.921 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.524 ' CD ' HG23 ' A' ' 76' ' ' THR . 35.5 Cg_endo -95.81 142.88 1.08 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.081 2.52 . . . . 0.0 112.255 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 83' ' ' PRO . 2.0 m -129.21 -179.69 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.165 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.526 ' CG ' ' HG2' ' A' ' 32' ' ' GLU . 0.4 OUTLIER -141.75 108.5 5.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.467 ' HG3' HD23 ' A' ' 79' ' ' LEU . 21.1 mtm-85 61.26 14.02 5.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.502 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.29 7.78 20.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.361 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.445 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 6.3 tp60 -113.54 103.75 55.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.974 0.416 . . . . 0.0 110.896 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.521 ' HA ' ' CG1' ' A' ' 78' ' ' VAL . 24.6 Cg_exo -63.01 121.02 8.74 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.943 2.429 . . . . 0.0 112.617 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.524 HG21 ' CD2' ' A' ' 24' ' ' LEU . 2.4 pt -122.34 107.56 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.513 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.456 ' O ' HG22 ' A' ' 21' ' ' ILE . 20.4 m-85 -62.08 141.54 58.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.036 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.524 ' CG2' ' HG2' ' A' ' 68' ' ' MET . 6.5 mt -126.55 107.92 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.466 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 20' ' ' HIS . 1.0 OUTLIER -152.88 169.55 22.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 111.192 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 1.1 m-85 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.885 0.374 . . . . 0.0 111.061 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.23 -24.64 25.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.887 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.7 t -87.86 144.27 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.035 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.478 ' CG2' HG22 ' A' ' 86' ' ' ILE . 34.8 mm -122.4 107.89 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.213 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' GLN . 5.4 t-160 -78.82 121.9 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.806 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.512 ' CD1' HG12 ' A' ' 86' ' ' ILE . 4.3 mm -100.45 112.65 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.241 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 174.16 6.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.795 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER 45.06 44.01 7.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.675 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.522 ' CD1' HG22 ' A' ' 84' ' ' ILE . 3.2 tp -134.46 109.34 11.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.52 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 33.0 Cg_endo -64.51 74.84 0.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.401 2.067 . . . . 0.0 111.729 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 15.3 mm -31.83 117.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.052 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 3.6 t70 151.16 -19.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.162 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 29' ' ' THR . 5.7 m -54.86 -155.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.881 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.504 ' N ' HG22 ' A' ' 28' ' ' VAL . 81.2 p -112.38 145.03 40.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 111.674 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 34' ' ' ILE . 32.6 mt-10 -65.36 -50.6 64.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.438 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.99 -28.33 0.23 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.036 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.457 ' OE1' HD21 ' A' ' 79' ' ' LEU . 37.5 mt-10 -78.46 -52.15 8.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.403 . . . . 0.0 110.494 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.54 -57.47 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.729 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -53.14 -40.74 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 8.0 t -54.94 -43.07 73.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.698 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 6.3 mp -74.87 -11.27 60.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.761 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.65 -22.13 8.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.769 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.43 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -50.73 -52.54 55.77 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.66 0.267 . . . . 0.0 110.985 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 39.7 Cg_exo -60.01 -24.2 75.7 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.484 2.123 . . . . 0.0 111.668 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.588 ' CD2' ' HA ' ' A' ' 68' ' ' MET . 79.0 m-85 -82.03 7.24 13.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.035 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.13 -108.67 1.0 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.292 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.521 ' HB3' ' ND2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -150.55 146.05 26.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.101 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.2 t -99.81 97.04 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -87.8 22.23 2.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.302 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.9 OUTLIER 171.67 147.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.069 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.456 HD12 HG23 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -155.05 97.26 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.828 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.476 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 2.3 tm? -105.36 122.29 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.011 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.494 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 6.9 mtt -102.17 116.82 33.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -88.88 101.06 13.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.499 ' CD ' HG21 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -82.03 48.13 1.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.98 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -129.57 -60.49 0.1 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.249 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -108.32 12.3 26.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 24.8 m120 62.72 64.89 0.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.914 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.51 ' N ' HG12 ' A' ' 26' ' ' ILE . 78.3 mt-30 -148.0 134.17 19.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.843 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.538 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.66 157.68 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.735 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -140.95 115.85 9.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.239 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.468 ' O ' HG13 ' A' ' 57' ' ' ILE . 22.5 pt -114.91 138.18 45.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.797 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -104.6 102.7 12.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.993 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.457 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -62.9 128.31 35.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.408 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -48.13 -39.81 21.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.31 -179.312 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.11 163.43 16.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.872 0.367 . . . . 0.0 111.238 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -71.68 -44.75 63.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.828 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -55.13 -30.51 59.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.423 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 40' ' ' PHE . . . -69.15 -46.51 67.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.643 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 16' ' ' SER . . . -58.12 -60.0 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.255 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -42.01 -58.28 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.962 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.558 HG21 ' CE2' ' A' ' 40' ' ' PHE . 22.3 m -50.81 -51.84 46.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.326 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.588 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 6.3 tpt -36.3 -60.15 0.59 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.071 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 76.3 t -79.41 -26.43 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.424 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.459 ' O ' ' OG1' ' A' ' 73' ' ' THR . 1.5 t-20 -58.69 -64.12 1.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.079 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.62 -36.22 83.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.054 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CE1' ' HG3' ' A' ' 77' ' ' PRO . 22.4 m-85 -87.93 20.06 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.983 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 69' ' ' VAL . 87.7 m -68.7 -44.57 73.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.024 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.6 t -113.62 -39.82 3.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.769 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.54 108.91 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.474 ' OG1' ' CE2' ' A' ' 85' ' ' TYR . 2.2 m -93.81 122.3 62.53 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.065 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.568 ' HG3' ' CE1' ' A' ' 72' ' ' TYR . 74.2 Cg_endo -96.79 120.17 0.18 Allowed 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 123.064 2.509 . . . . 0.0 112.215 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.483 ' CG1' ' HA ' ' A' ' 83' ' ' PRO . 1.4 m -89.34 -179.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.235 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.552 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -141.71 133.53 27.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.688 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.525 ' HB2' ' CD2' ' A' ' 79' ' ' LEU . 0.5 OUTLIER 36.25 30.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.443 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 85.57 51.98 3.5 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.871 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.529 ' HB3' ' CD1' ' A' ' 79' ' ' LEU . 1.5 tt0 -155.2 97.74 2.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.984 0.421 . . . . 0.0 110.799 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.483 ' HA ' ' CG1' ' A' ' 78' ' ' VAL . 52.1 Cg_exo -54.8 107.28 0.22 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.866 2.377 . . . . 0.0 112.658 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.522 HG22 ' CD1' ' A' ' 24' ' ' LEU . 7.1 pt -116.83 107.75 23.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.701 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CE2' ' OG1' ' A' ' 76' ' ' THR . 27.7 m-85 -71.28 149.08 46.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.317 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.512 HG12 ' CD1' ' A' ' 21' ' ' ILE . 4.5 mt -124.68 103.81 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.631 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 20' ' ' HIS . 2.8 mt-30 -125.16 172.05 9.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.883 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.574 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 59.9 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.409 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.856 0.36 . . . . 0.0 110.986 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HG3' ' OE1' ' A' ' 58' ' ' GLU . 15.1 ptp180 -72.04 -16.98 62.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 87.5 t -87.92 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.497 HG21 ' CG2' ' A' ' 86' ' ' ILE . 24.1 mm -127.07 109.24 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.642 ' CD2' ' CZ ' ' A' ' 56' ' ' PHE . 11.5 t-160 -78.93 110.55 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.795 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.535 HG23 ' CD2' ' A' ' 24' ' ' LEU . 25.7 mt -82.91 130.44 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.524 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 3.0 ptt180 -112.4 177.24 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 44.15 30.93 0.48 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.684 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.535 ' CD2' HG23 ' A' ' 21' ' ' ILE . 5.8 tp -117.59 112.85 38.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 21.9 Cg_exo -64.48 69.55 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.399 2.066 . . . . 0.0 111.391 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.572 ' CG2' ' CD ' ' A' ' 50' ' ' LYS . 5.1 mm -33.97 111.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.371 0.605 . . . . 0.0 110.717 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 4.4 t70 150.7 -22.9 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.98 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 27' ' ' ASP . 2.1 p -56.79 -157.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.608 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.421 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 38.1 p -98.73 144.16 28.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.217 0.532 . . . . 0.0 112.035 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.65 -48.3 27.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.36 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.61 -31.4 0.4 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.706 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.51 ' HG2' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -79.22 -51.9 8.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 110.398 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 t -56.08 -51.09 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.775 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.441 HG21 HG21 ' A' ' 43' ' ' VAL . 1.5 mp -66.51 -50.4 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.506 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 14.9 t -44.76 -40.57 6.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.378 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.511 ' CD1' ' HB2' ' A' ' 77' ' ' PRO . 13.4 mt -63.26 -42.0 99.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.43 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -82.09 -8.99 85.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.387 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.517 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 1.3 tp -55.06 -60.05 9.16 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 110.724 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 19.7 Cg_endo -60.46 -17.85 50.34 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.611 2.208 . . . . 0.0 111.833 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 28.0 m-85 -76.99 -5.65 49.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.886 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.429 ' O ' ' HG2' ' A' ' 42' ' ' LYS . . . 141.1 -103.21 0.33 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.134 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.581 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 1.5 mmtp -150.46 138.88 20.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 111.067 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.441 HG21 HG21 ' A' ' 34' ' ' ILE . 54.0 t -89.2 120.23 37.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -95.17 -11.98 27.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.157 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 8.7 t30 174.08 146.53 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.839 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -144.6 125.03 13.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.818 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.516 ' N ' HD23 ' A' ' 46' ' ' LEU . 7.2 tt -131.33 123.05 27.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.039 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.515 ' CA ' HD12 ' A' ' 26' ' ' ILE . 3.3 mmm -89.18 109.77 20.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.749 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 26' ' ' ILE . 13.6 tp -84.14 109.46 17.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.081 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.572 ' CD ' ' CG2' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -86.84 44.7 1.19 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.819 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -115.84 -42.47 0.72 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.554 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 28.12 2.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 110.963 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 18.9 m120 57.93 49.18 12.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.522 ' HB3' ' NE2' ' A' ' 20' ' ' HIS . 47.8 mt-30 -134.4 140.08 46.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.363 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.54 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.9 172.55 6.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.65 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.642 ' CZ ' ' CD2' ' A' ' 20' ' ' HIS . 11.9 m-85 -148.01 115.71 6.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.355 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 45' ' ' ASN . 6.6 pt -114.41 155.13 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.662 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.525 ' CB ' ' OG1' ' A' ' 44' ' ' THR . 6.7 mm-40 -118.36 122.9 43.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.992 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.527 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 24.3 mmm -94.26 133.47 37.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.515 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.581 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 0.9 OUTLIER -71.77 -24.82 61.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 110.924 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 9.0 t -125.0 129.0 49.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.17 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -44.68 -38.56 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -59.01 -26.45 64.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 59' ' ' MET . . . -76.38 -51.35 12.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.059 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.442 ' N ' ' HG3' ' A' ' 59' ' ' MET . . . -57.05 -64.12 0.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.058 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -44.73 -60.06 2.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.756 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.8 m -48.06 -35.88 12.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.034 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.58 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 9.4 tpt -51.52 -62.26 1.73 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.959 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.574 HG21 ' CG ' ' A' ' 88' ' ' PHE . 46.1 t -77.53 -15.91 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.366 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.464 ' O ' ' OG1' ' A' ' 73' ' ' THR . 11.5 t-20 -76.46 -64.19 1.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.131 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -56.66 -38.47 72.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.128 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.526 ' CE2' ' CZ ' ' A' ' 40' ' ' PHE . 24.7 m-85 -84.72 12.78 6.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.07 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 89.0 m -67.88 -34.73 77.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.22 -40.71 3.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.08 156.93 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.009 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.466 HG22 ' HD2' ' A' ' 77' ' ' PRO . 2.5 m -122.64 147.3 50.16 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.776 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.511 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 28.9 Cg_endo -96.39 75.73 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.338 2.692 . . . . 0.0 112.386 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.46 ' O ' HD21 ' A' ' 79' ' ' LEU . 12.3 t -70.91 158.08 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.227 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.51 ' CD1' ' HG2' ' A' ' 32' ' ' GLU . 53.5 mt -137.63 113.44 9.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.108 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 51.64 20.23 1.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 83' ' ' PRO . . . 105.99 8.74 33.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.668 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.436 ' C ' HG13 ' A' ' 78' ' ' VAL . 5.5 tp-100 -109.27 97.5 26.44 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.829 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 81' ' ' GLY . 13.5 Cg_exo -69.93 126.75 13.55 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 123.045 2.496 . . . . 0.0 112.434 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.526 HG22 ' CD1' ' A' ' 24' ' ' LEU . 8.0 pt -135.35 107.45 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.524 ' HB2' ' CG ' ' A' ' 22' ' ' ARG . 3.3 m-85 -75.03 151.08 38.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.397 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.497 ' CG2' HG21 ' A' ' 19' ' ' ILE . 4.4 mt -125.91 122.05 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.562 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.471 ' NE2' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -130.91 169.98 15.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.149 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.574 ' CG ' HG21 ' A' ' 69' ' ' VAL . 58.8 m-85 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.021 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.46 ' OG ' ' ND2' ' A' ' 66' ' ' ASN . 87.6 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.742 0.306 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -170.54 -45.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.917 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.464 HG22 ' N ' ' A' ' 19' ' ' ILE . 7.5 p -87.94 138.59 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.511 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 47.2 mm -119.14 105.52 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 87' ' ' GLN . 5.0 t-160 -78.98 107.59 11.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.718 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.446 HG21 ' O ' ' A' ' 85' ' ' TYR . 9.5 mt -85.22 118.52 32.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.402 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.465 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -100.73 170.08 8.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.483 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.08 32.4 2.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.981 0.42 . . . . 0.0 110.253 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.527 ' CD1' HD13 ' A' ' 84' ' ' ILE . 4.2 tp -116.99 123.34 30.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.172 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' ILE . 57.1 Cg_endo -71.05 75.6 1.74 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.426 2.084 . . . . 0.0 111.597 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.577 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 17.9 mm -30.91 148.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.117 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 96.43 7.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.788 -178.394 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.491 ' N ' ' CE ' ' A' ' 48' ' ' MET . 0.9 OUTLIER -63.25 -151.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.027 179.341 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 32' ' ' GLU . 71.8 p -120.26 148.9 43.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.007 0.432 . . . . 0.0 111.749 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -66.28 -66.0 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.756 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.05 -29.53 0.2 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.154 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.51 ' N ' ' OE1' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -82.51 -61.21 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.713 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.9 t -55.21 -53.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.851 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.506 HD13 ' CD2' ' A' ' 46' ' ' LEU . 1.4 mp -62.66 -33.99 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.279 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -51.07 -36.23 39.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.054 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.528 ' CD2' ' OH ' ' A' ' 72' ' ' TYR . 2.0 mt -70.64 -46.9 62.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.21 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.83 -13.6 82.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.281 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.515 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -48.79 -60.28 4.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.78 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 20.2 Cg_endo -60.77 -34.95 91.01 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.636 2.224 . . . . 0.0 111.731 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.584 ' CD2' ' HA ' ' A' ' 68' ' ' MET . 39.7 m-85 -63.25 -12.39 28.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.999 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.73 -106.86 0.36 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.122 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.472 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -150.61 150.22 30.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.909 0.385 . . . . 0.0 111.139 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.4 HG11 HG12 ' A' ' 34' ' ' ILE . 55.0 t -102.58 121.19 53.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.307 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.518 ' CG2' ' N ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -102.64 8.24 39.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.513 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.95 153.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.52 ' CD1' HG21 ' A' ' 57' ' ' ILE . 17.1 tp -140.53 131.2 25.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.949 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 tp -136.18 137.28 40.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.491 ' CE ' ' N ' ' A' ' 28' ' ' VAL . 4.9 mmm -125.09 94.77 4.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.776 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.477 ' O ' HG13 ' A' ' 26' ' ' ILE . 27.6 tp -76.43 92.9 3.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.505 ' HE3' ' CA ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -60.65 159.23 11.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.011 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.71 -73.49 0.24 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.482 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -83.07 -8.87 59.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.788 0.327 . . . . 0.0 111.018 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER 68.65 47.43 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.483 ' C ' ' CD1' ' A' ' 26' ' ' ILE . 17.2 mt-30 -129.54 126.96 39.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.728 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.541 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.15 161.41 15.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.784 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -140.94 115.89 9.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.396 -179.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.52 HG21 ' CD1' ' A' ' 46' ' ' LEU . 7.1 pt -112.75 140.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.579 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -103.53 102.97 12.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.27 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 2.7 mtp -74.64 147.39 41.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.122 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.518 ' N ' ' CG2' ' A' ' 44' ' ' THR . 0.2 OUTLIER -64.2 -55.13 23.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.399 -178.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -108.03 169.81 8.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 111.451 -179.094 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' N ' ' OG1' ' A' ' 61' ' ' THR . 24.1 mt-10 -71.33 -47.75 54.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.64 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.463 ' O ' ' OG1' ' A' ' 67' ' ' THR . 5.7 mt-10 -49.33 -31.6 9.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.262 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 40' ' ' PHE . . . -70.62 -51.6 27.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.769 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HA ' ' SD ' ' A' ' 59' ' ' MET . . . -67.14 -66.1 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.315 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.46 ' ND2' ' OG ' ' A' ' 16' ' ' SER . 53.4 m-80 -37.92 -45.32 0.85 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.989 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.567 HG21 ' CD2' ' A' ' 40' ' ' PHE . 43.7 m -64.68 -53.44 47.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.141 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.584 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -35.36 -64.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.041 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.577 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 75.1 t -68.47 -46.69 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.286 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -46.47 -64.41 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.174 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -62.11 -38.1 87.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.562 ' CE1' ' HB3' ' A' ' 77' ' ' PRO . 18.1 m-85 -87.73 19.66 3.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 69' ' ' VAL . 20.3 m -83.78 -35.36 24.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.923 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 t -113.29 -40.51 3.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.49 HG11 ' N ' ' A' ' 76' ' ' THR . 68.9 t -75.53 138.63 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.49 ' N ' HG11 ' A' ' 75' ' ' VAL . 2.4 m -90.42 112.11 51.07 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.275 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.562 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 58.8 Cg_endo -98.05 109.62 0.08 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 123.24 2.627 . . . . 0.0 112.299 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.446 ' HB ' ' C ' ' A' ' 82' ' ' GLN . 0.7 OUTLIER -110.71 157.62 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 111.002 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.452 HD23 ' HG3' ' A' ' 32' ' ' GLU . 3.4 tm? -107.26 100.92 10.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.523 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.75 -58.72 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.997 0.427 . . . . 0.0 110.493 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.39 24.65 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.417 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.446 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -129.64 104.57 17.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.717 0.294 . . . . 0.0 110.584 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HA ' ' CB ' ' A' ' 78' ' ' VAL . 28.0 Cg_endo -63.45 117.79 4.73 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.563 2.175 . . . . 0.0 112.634 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.4 pt -131.63 111.28 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.628 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.466 ' OH ' ' OG1' ' A' ' 76' ' ' THR . 19.8 m-85 -77.9 165.68 23.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.442 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 87' ' ' GLN . 39.6 mm -119.54 142.56 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.827 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.517 ' N ' HG23 ' A' ' 86' ' ' ILE . 2.1 mm-40 -141.98 170.72 15.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.06 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.577 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 32.7 m-85 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.815 0.34 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -138.87 -57.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 18' ' ' VAL . 7.3 p -88.63 104.94 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.093 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.505 ' CG2' ' HG2' ' A' ' 68' ' ' MET . 47.3 mm -84.04 117.94 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.552 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 3.2 t-160 -82.59 153.0 25.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.525 ' CD1' HG12 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -123.31 110.54 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.083 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.46 171.0 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER 44.22 40.19 3.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.892 0.377 . . . . 0.0 110.297 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.534 HD12 ' CD1' ' A' ' 84' ' ' ILE . 8.1 tp -123.73 117.39 27.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.34 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.465 ' O ' ' C ' ' A' ' 26' ' ' ILE . 39.2 Cg_endo -67.03 74.09 0.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.299 1.999 . . . . 0.0 111.209 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.58 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 29.1 mm -30.06 148.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.208 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER 100.81 10.59 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.657 -178.192 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -151.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.877 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 32' ' ' GLU . 71.7 p -124.76 145.14 49.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.978 0.418 . . . . 0.0 111.613 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.473 ' O ' HG13 ' A' ' 34' ' ' ILE . 79.0 mt-10 -62.78 -63.73 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.57 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.69 -31.11 0.23 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.785 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.458 ' HB2' ' OG1' ' A' ' 29' ' ' THR . 7.3 mm-40 -79.45 -63.73 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 110.248 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.7 t -56.77 -63.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.408 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.524 HG23 ' CG2' ' A' ' 43' ' ' VAL . 1.6 mt -46.8 -47.62 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.964 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -42.7 -50.68 5.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.376 179.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.509 ' O ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 mp -57.47 -31.48 66.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.263 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -90.45 -16.42 55.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.333 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.534 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 19.8 mt -48.96 -56.42 15.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.66 0.267 . . . . 0.0 110.986 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 31.8 Cg_endo -63.88 -18.63 64.65 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.526 2.15 . . . . 0.0 112.11 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 37.0 m-85 -77.26 -14.67 59.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.718 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.94 -101.66 0.24 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.124 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -150.62 149.43 29.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.825 0.345 . . . . 0.0 111.09 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.524 ' CG2' HG23 ' A' ' 34' ' ' ILE . 55.0 t -100.08 115.85 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.343 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.505 ' CG2' ' N ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -96.56 2.11 52.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.522 -178.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.6 OUTLIER 170.83 142.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.937 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.486 ' CD1' HG23 ' A' ' 57' ' ' ILE . 39.7 tp -144.4 115.4 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.021 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.62 138.3 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.476 ' HB3' HG23 ' A' ' 26' ' ' ILE . 5.3 mmm -116.14 103.79 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -89.55 91.48 8.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.812 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.517 ' HE2' ' CB ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -45.63 -26.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.887 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . -77.79 118.93 5.12 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.458 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 6.6 mtmm 85.09 -10.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 0.0 111.013 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.49 ' HA ' ' CG1' ' A' ' 26' ' ' ILE . 0.6 OUTLIER 61.89 58.75 1.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.053 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.466 ' C ' ' CD1' ' A' ' 26' ' ' ILE . 3.4 mm-40 -137.72 133.15 33.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.734 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.546 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.16 161.75 14.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.655 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -143.76 115.86 8.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.528 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.486 HG23 ' CD1' ' A' ' 46' ' ' LEU . 5.9 pt -109.9 154.93 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.259 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.465 ' O ' HG23 ' A' ' 44' ' ' THR . 0.7 OUTLIER -116.33 111.18 19.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.807 0.337 . . . . 0.0 111.536 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.522 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 8.5 mmm -80.14 137.42 36.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.023 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.505 ' N ' ' CG2' ' A' ' 44' ' ' THR . 0.2 OUTLIER -65.49 -41.3 93.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.419 . . . . 0.0 110.633 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -119.23 176.61 5.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.095 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.52 ' N ' ' OG1' ' A' ' 61' ' ' THR . 1.6 mp0 -73.73 -50.38 21.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.838 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -46.02 -29.32 1.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.643 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 59' ' ' MET . . . -75.94 -51.08 13.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.016 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.504 ' CA ' HD11 ' A' ' 19' ' ' ILE . . . -64.09 -61.03 2.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.099 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -44.78 -62.09 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.665 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.57 ' CG2' ' CD2' ' A' ' 40' ' ' PHE . 88.9 m -46.22 -51.83 13.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.98 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.578 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 7.1 tpt -34.63 -61.17 0.41 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.98 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.62 ' CG1' ' CE2' ' A' ' 88' ' ' PHE . 68.9 t -79.75 -54.59 10.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.246 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.405 ' O ' ' HB ' ' A' ' 73' ' ' THR . 20.5 m-20 -38.33 -64.18 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.305 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -60.97 -45.52 94.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.192 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 68' ' ' MET . 13.1 m-30 -73.42 -1.0 16.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.249 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 69' ' ' VAL . 46.8 m -59.16 -36.77 75.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 110.817 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.7 m -112.71 -44.08 3.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.6 t -80.92 126.69 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.571 ' OG1' ' CZ ' ' A' ' 85' ' ' TYR . 3.0 m -89.31 134.94 31.9 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.07 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.467 ' O ' HG12 ' A' ' 84' ' ' ILE . 46.5 Cg_endo -97.69 80.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.982 2.455 . . . . 0.0 112.292 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.509 HG21 ' N ' ' A' ' 79' ' ' LEU . 1.4 p -92.21 158.73 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.509 ' N ' HG21 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -148.6 132.09 16.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.229 -179.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.9 18.8 1.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.18 15.3 52.03 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.66 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.445 ' C ' HG23 ' A' ' 78' ' ' VAL . 74.0 mt-30 -113.68 96.78 41.95 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.054 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 14.9 Cg_exo -69.29 108.7 2.05 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.903 2.402 . . . . 0.0 112.608 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.534 ' CD1' HD12 ' A' ' 24' ' ' LEU . 3.7 pt -117.24 110.21 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.521 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.571 ' CZ ' ' OG1' ' A' ' 76' ' ' THR . 2.4 m-85 -86.02 152.3 23.02 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.879 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.525 HG12 ' CD1' ' A' ' 21' ' ' ILE . 3.8 mt -126.59 140.46 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.466 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -157.14 172.71 18.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 111.166 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.62 ' CE2' ' CG1' ' A' ' 69' ' ' VAL . 6.0 m-85 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.02 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 1.3 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.797 0.332 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.33 -24.98 22.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.7 t -87.9 111.66 22.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.122 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.432 HG23 ' CG ' ' A' ' 68' ' ' MET . 48.7 mm -97.08 105.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.22 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 87' ' ' GLN . 6.6 t-160 -79.02 119.74 22.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 85' ' ' TYR . 10.2 mt -96.72 124.53 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.292 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -107.69 171.2 7.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.605 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 49.01 39.36 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.167 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.529 ' CD1' HG21 ' A' ' 84' ' ' ILE . 9.5 tp -129.16 98.27 24.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.515 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 39.9 Cg_exo -56.14 77.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.518 2.146 . . . . 0.0 111.519 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.565 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 19.4 mm -31.54 125.45 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.065 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 2.1 t70 146.31 -15.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.144 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.52 ' CG1' ' HG ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -55.15 -154.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.4 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 p -124.41 146.93 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.985 0.421 . . . . 0.0 111.683 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.458 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 3.2 mp0 -66.67 -49.35 66.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.62 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -45.41 -36.0 5.6 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.981 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.52 ' HG2' ' CD1' ' A' ' 79' ' ' LEU . 2.8 tp10 -81.96 -61.05 2.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.791 0.329 . . . . 0.0 110.606 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.7 t -52.76 -59.88 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.553 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.465 HD13 HD22 ' A' ' 46' ' ' LEU . 33.7 mt -54.07 -40.79 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.544 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -50.92 -40.56 57.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.147 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.524 ' CD1' ' OH ' ' A' ' 72' ' ' TYR . 2.1 mm? -65.9 -28.34 68.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.068 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.577 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -81.22 -20.65 64.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.375 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.501 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -46.11 -56.42 10.69 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.702 0.287 . . . . 0.0 110.575 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 35.4 Cg_exo -59.56 -19.98 55.07 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.385 2.057 . . . . 0.0 111.061 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.577 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 6.2 m-30 -92.02 16.16 11.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.655 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.18 -111.14 3.02 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.034 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.463 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -150.79 154.59 37.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 0.0 111.209 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.0 t -101.82 116.92 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.509 ' CG2' ' CG ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -98.89 9.38 43.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.448 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' THR . 8.4 t-20 175.61 144.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.465 HD22 HD13 ' A' ' 34' ' ' ILE . 5.2 tp -151.91 126.69 9.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -141.01 107.56 5.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.463 ' HB3' HD13 ' A' ' 26' ' ' ILE . 2.7 mmm -86.29 118.87 26.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.79 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.459 ' O ' HG13 ' A' ' 26' ' ' ILE . 14.7 tp -102.02 100.36 10.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.084 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.462 ' CE ' ' HA ' ' A' ' 27' ' ' ASP . 1.4 mmtp -53.83 -19.05 3.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -37.68 -96.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.696 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -100.94 48.1 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.328 . . . . 0.0 110.981 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 25.6 m120 39.93 73.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 52' ' ' LYS . 5.0 mt-30 -151.05 133.24 15.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.64 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.53 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.6 165.33 11.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.744 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.542 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -143.87 115.9 8.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.308 -179.543 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 57' ' ' ILE . 15.0 pt -119.52 139.26 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.675 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.0 103.84 13.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.256 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.459 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -69.84 146.21 51.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.248 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.509 ' CG ' ' CG2' ' A' ' 44' ' ' THR . 0.2 OUTLIER -66.22 -47.0 75.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.329 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.95 168.94 9.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.426 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -72.05 -47.21 53.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.682 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -50.53 -26.93 5.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.408 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 40' ' ' PHE . . . -74.39 -52.41 12.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.852 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.456 ' HA ' ' SD ' ' A' ' 59' ' ' MET . . . -53.89 -58.43 7.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.197 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 70' ' ' ASN . 1.7 m-20 -46.54 -64.71 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.568 HG21 ' CD1' ' A' ' 40' ' ' PHE . 19.9 m -40.83 -55.43 2.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.569 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -36.12 -63.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.037 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 65.2 t -83.37 -58.47 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.257 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 66' ' ' ASN . 21.1 t-20 -37.6 -36.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 67' ' ' THR . 2.1 t80 -78.19 -52.73 8.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.991 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.524 ' OH ' ' CD1' ' A' ' 36' ' ' LEU . 13.4 m-85 -65.89 -9.1 26.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.054 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 72' ' ' TYR . 28.6 m -38.1 -36.66 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.936 0.398 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 t -110.32 -56.62 2.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.739 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.43 120.91 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.581 HG21 ' CD1' ' A' ' 85' ' ' TYR . 1.5 m -94.3 141.47 23.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.263 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.523 ' CD ' HG22 ' A' ' 76' ' ' THR . 58.2 Cg_endo -98.43 137.6 0.36 Allowed 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.436 2.757 . . . . 0.0 112.311 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.521 ' CB ' ' HA ' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -122.91 179.94 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.948 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.52 ' CD1' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -140.92 118.73 11.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.85 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 47.33 24.28 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.536 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.51 15.38 23.11 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.412 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.441 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -120.3 97.9 48.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.521 ' HA ' ' CB ' ' A' ' 78' ' ' VAL . 39.6 Cg_exo -57.3 129.06 32.13 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.976 2.45 . . . . 0.0 112.802 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.529 HG21 ' CD1' ' A' ' 24' ' ' LEU . 5.3 pt -133.45 109.33 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.203 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.602 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -80.4 146.57 31.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.086 -178.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.523 ' CG2' ' HG3' ' A' ' 68' ' ' MET . 5.9 mt -126.4 108.75 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.412 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.527 ' HA ' ' CG1' ' A' ' 69' ' ' VAL . 30.0 mt-30 -140.39 166.09 25.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 111.366 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.571 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.656 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.577 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . 3.1 m . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.847 0.356 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.07 -49.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.85 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 t -88.03 100.43 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.04 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.523 HG23 ' CD1' ' A' ' 21' ' ' ILE . 37.4 mm -81.21 105.7 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.239 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.692 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 10.2 t-160 -84.65 107.58 16.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.837 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.523 ' CD1' HG23 ' A' ' 19' ' ' ILE . 1.7 mm -82.86 119.35 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.187 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.97 173.42 6.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.685 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 3.1 tmtt? 43.22 41.99 3.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.536 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.454 HD11 HG23 ' A' ' 84' ' ' ILE . 6.3 tp -127.79 130.45 23.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.46 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 73.6 Cg_endo -76.49 74.75 4.62 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.592 2.194 . . . . 0.0 111.742 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.567 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 15.0 mm -32.83 110.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.143 0.497 . . . . 0.0 110.659 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.567 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 6.3 t70 146.69 -17.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.539 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.493 HG11 ' N ' ' A' ' 29' ' ' THR . 1.7 p -51.19 -168.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.373 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.493 ' N ' HG11 ' A' ' 28' ' ' VAL . 45.2 p -105.77 145.91 30.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.12 0.486 . . . . 0.0 111.808 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.9 mp0 -62.08 -46.12 90.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.672 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.64 -36.77 0.76 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.085 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.428 ' OE1' ' HB2' ' A' ' 79' ' ' LEU . 91.9 mt-10 -75.12 -51.18 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 110.454 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.3 t -64.07 -61.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.523 HG21 ' CG2' ' A' ' 43' ' ' VAL . 1.1 mt -50.82 -46.82 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.097 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 3.7 t -45.62 -45.12 13.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.583 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.462 ' HB3' ' OH ' ' A' ' 72' ' ' TYR . 68.6 mt -69.16 -21.27 64.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.539 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -87.1 -28.37 25.76 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.526 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.489 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -40.86 -53.14 6.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.698 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.489 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 19.6 Cg_exo -65.71 -34.33 41.27 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.718 2.279 . . . . 0.0 111.786 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.585 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 15.6 m-30 -65.83 -39.3 90.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.833 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.521 ' O ' ' CD ' ' A' ' 42' ' ' LYS . . . 165.68 -98.52 0.15 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.42 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -150.48 141.64 23.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.79 0.328 . . . . 0.0 110.94 179.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.523 ' CG2' HG21 ' A' ' 34' ' ' ILE . 55.5 t -88.68 86.49 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -80.62 7.44 10.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.322 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 170.75 137.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.027 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.518 HD21 ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -147.92 98.4 2.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 48' ' ' MET . 6.5 tt -97.88 149.16 22.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.816 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.47 ' HB3' HG22 ' A' ' 26' ' ' ILE . 8.2 mtt -125.21 110.65 14.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.148 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.48 ' O ' HG13 ' A' ' 26' ' ' ILE . 6.0 tp -88.42 96.4 10.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.751 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.531 ' CD ' HG23 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -74.73 0.56 14.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.255 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.63 -9.03 36.07 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.404 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -160.46 -64.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.778 0.323 . . . . 0.0 111.001 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER 155.08 43.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.551 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.497 ' HB3' ' NE2' ' A' ' 20' ' ' HIS . 63.8 mt-30 -130.44 133.09 46.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.11 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.81 163.06 13.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.715 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.692 ' CE2' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -148.0 115.78 6.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.134 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.524 ' CD1' ' SD ' ' A' ' 59' ' ' MET . 22.0 pt -112.18 137.18 45.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.78 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.73 102.67 14.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.731 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.526 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 17.7 mmm -67.02 124.02 21.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.645 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.555 ' N ' ' OG1' ' A' ' 44' ' ' THR . 2.8 m120 -35.69 -33.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.78 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -144.67 176.78 9.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.971 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.512 ' N ' ' OG1' ' A' ' 61' ' ' THR . 1.2 mp0 -72.88 -44.76 60.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.95 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -50.25 -24.55 2.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.947 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 59' ' ' MET . . . -83.47 -49.72 9.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.465 ' O ' HD12 ' A' ' 19' ' ' ILE . . . -65.41 -31.2 72.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.369 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -70.09 -54.49 12.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.494 HG21 ' CD1' ' A' ' 40' ' ' PHE . 24.1 m -56.62 -22.63 35.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.269 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.576 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -69.03 -65.01 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.066 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 21.6 t -67.97 -48.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.277 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -52.77 -40.47 63.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.037 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.428 ' CB ' ' O ' ' A' ' 67' ' ' THR . 3.5 t80 -67.81 -44.53 77.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.462 ' OH ' ' HB3' ' A' ' 36' ' ' LEU . 41.0 m-85 -85.84 12.48 9.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' A' ' 70' ' ' ASN . 54.1 m -66.26 -13.84 61.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.2 m -127.77 -39.8 1.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.832 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.76 138.74 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.529 HG22 ' CD ' ' A' ' 77' ' ' PRO . 1.3 m -103.33 142.56 24.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.01 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.529 ' CD ' HG22 ' A' ' 76' ' ' THR . 30.2 Cg_endo -95.24 145.08 1.4 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 123.103 2.535 . . . . 0.0 112.097 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.46 ' HB ' ' C ' ' A' ' 82' ' ' GLN . 0.7 OUTLIER -133.29 166.28 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 0.0 110.994 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.596 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -107.88 107.63 18.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.406 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER 28.92 34.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.327 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 115.93 36.24 1.16 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.559 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.541 ' CB ' ' HG ' ' A' ' 79' ' ' LEU . 2.5 tt0 -151.34 97.18 3.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.076 0.465 . . . . 0.0 110.613 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.4 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 38.7 Cg_exo -61.16 126.2 18.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.004 2.47 . . . . 0.0 112.959 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 84' ' ' ILE . 9.4 pt -137.73 107.7 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.273 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.452 ' O ' HG22 ' A' ' 21' ' ' ILE . 2.6 m-85 -68.85 146.88 52.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.99 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.529 ' CG2' ' HG2' ' A' ' 68' ' ' MET . 6.5 mt -126.31 103.75 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.203 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' HIS . 4.1 mt-30 -126.64 174.27 8.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.899 0.381 . . . . 0.0 111.142 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 16' ' ' SER . 71.4 m-85 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.415 ' O ' ' OG ' ' A' ' 16' ' ' SER . 10.0 p . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.89 0.376 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 58' ' ' GLU . 3.5 mtm180 -137.22 -42.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 t -87.91 133.81 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.544 ' HB ' ' CG2' ' A' ' 57' ' ' ILE . 4.8 mm -115.61 102.42 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.395 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 87' ' ' GLN . 4.7 t-160 -79.08 113.98 17.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.598 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.523 ' CG1' ' HB3' ' A' ' 55' ' ' ALA . 4.1 mm -82.83 127.03 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.347 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -108.79 171.33 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.671 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HG2' ' CZ ' ' A' ' 85' ' ' TYR . 1.9 tptp 43.66 33.17 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.27 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 2.2 tp -115.46 110.66 44.74 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.103 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.516 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 43.8 Cg_endo -68.22 61.69 1.04 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.277 1.985 . . . . 0.0 110.991 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.622 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 37.5 mm -8.5 105.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.468 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.622 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 24.6 t70 129.18 24.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 O-C-N 124.408 1.067 . . . . 0.0 111.325 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.51 ' O ' ' CG2' ' A' ' 29' ' ' THR . 5.2 p -85.23 8.38 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.376 0.607 . . . . 0.0 111.031 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 28' ' ' VAL . 3.0 p 90.29 146.82 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.976 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' HD13 ' A' ' 34' ' ' ILE . 37.2 mp0 -74.92 -40.19 60.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.228 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -53.86 -25.9 31.65 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.96 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.549 ' CG ' ' CD1' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -80.39 -50.31 10.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 110.551 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.451 HG12 HD22 ' A' ' 46' ' ' LEU . 12.4 t -62.29 -51.26 74.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.748 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 30' ' ' GLU . 1.5 mp -64.32 -41.51 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.442 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.9 t -49.74 -33.3 15.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.181 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.449 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 6.6 mt -75.43 -34.9 61.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.547 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -70.03 -26.09 74.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.457 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -37.87 -61.23 0.81 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.367 . . . . 0.0 110.723 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.2 Cg_endo -65.87 -22.51 56.16 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.57 2.18 . . . . 0.0 111.626 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 13.1 m-30 -80.77 0.45 34.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.976 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.8 -101.69 0.85 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.375 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.448 ' O ' ' HE3' ' A' ' 59' ' ' MET . 5.7 mtpm? -150.32 145.56 26.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 111.481 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.51 122.58 41.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.651 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.579 ' CG2' ' N ' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -99.15 -14.32 19.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.211 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.1 t-20 172.88 142.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.676 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' PHE . 5.3 tp -148.52 95.93 2.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.998 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.434 HD21 ' O ' ' A' ' 48' ' ' MET . 7.1 tt -95.33 127.48 41.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.434 ' O ' HD21 ' A' ' 47' ' ' LEU . 27.9 mtp -94.59 137.03 34.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.971 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.2 tp -124.06 101.82 7.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.784 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.529 ' CD ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -59.6 -13.86 11.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.21 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -35.15 -95.36 0.01 OUTLIER Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.619 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 63.8 mmtt -104.03 44.11 1.04 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.914 0.388 . . . . 0.0 110.774 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 4.9 m120 48.76 75.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.912 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.499 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 21.8 mt-30 -157.65 138.42 13.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.619 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.534 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.28 167.97 9.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -139.55 115.66 10.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.283 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.544 ' CG2' ' HB ' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -127.56 144.03 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.655 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.504 ' N ' HG12 ' A' ' 57' ' ' ILE . 15.5 mt-10 -121.53 133.14 55.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.895 0.379 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.519 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 27.9 mmm -92.09 151.28 20.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.589 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.579 ' N ' ' CG2' ' A' ' 44' ' ' THR . 0.4 OUTLIER -68.65 -26.73 65.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.952 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.8 t -131.17 138.22 49.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.091 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.39 -21.02 2.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.821 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -73.59 -36.59 65.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 40' ' ' PHE . . . -67.43 -49.87 61.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.489 ' N ' ' HG3' ' A' ' 59' ' ' MET . . . -55.78 -56.91 14.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -41.97 -68.48 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.986 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.558 HG22 ' CD1' ' A' ' 40' ' ' PHE . 19.4 m -40.93 -49.83 3.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.114 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.578 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -38.4 -64.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.977 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 54.1 t -77.09 -59.0 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -41.88 -27.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.056 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.423 ' CB ' ' O ' ' A' ' 67' ' ' THR . 10.7 t80 -85.46 -45.43 11.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.948 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.577 ' CE1' ' HG3' ' A' ' 77' ' ' PRO . 19.2 m-85 -82.9 9.12 10.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 m -70.13 -23.63 63.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.05 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.9 t -116.65 -34.2 4.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.788 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.7 p -113.8 126.82 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.989 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.496 HG21 ' CE1' ' A' ' 85' ' ' TYR . 2.0 m -97.6 131.26 27.37 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.151 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.577 ' HG3' ' CE1' ' A' ' 72' ' ' TYR . 72.5 Cg_endo -98.33 120.87 0.14 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 123.178 2.585 . . . . 0.0 112.411 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.51 HG23 ' N ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -95.07 -179.96 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.856 179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.549 ' CD1' ' CG ' ' A' ' 32' ' ' GLU . 2.4 mm? -139.96 115.53 10.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.951 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.07 21.41 1.02 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.728 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.42 15.72 16.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.465 ' O ' HG22 ' A' ' 84' ' ' ILE . 18.7 mm100 -122.83 97.98 43.33 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.027 0.441 . . . . 0.0 110.956 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.481 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 22.2 Cg_exo -64.91 105.9 0.71 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.974 2.449 . . . . 0.0 112.746 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.519 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 1.6 pt -119.9 112.39 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.641 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -76.71 156.03 32.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.94 -178.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.528 ' CG2' HG23 ' A' ' 19' ' ' ILE . 7.7 mt -126.15 104.27 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.327 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -113.84 175.3 5.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 111.346 -179.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 44.3 m-85 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.041 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.5 p . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.765 0.317 . . . . 6.6699999999999999 111.194 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -37.64 151.82 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 3.9700000000000002 112.434 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.1 OUTLIER -122.08 121.23 28.02 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.357 . . . . 3.7400000000000002 111.062 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.04 86.12 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.739 2.292 . . . . 4.1699999999999999 112.265 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 14' ' ' VAL . 2.2 m -138.63 101.47 4.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 3.1400000000000001 110.898 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -108.15 -40.74 5.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 3.4100000000000001 110.887 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.52 ' HB ' ' CB ' ' A' ' 89' ' ' SER . 77.3 t -93.56 135.86 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 1.77 111.149 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.504 ' CG2' HG23 ' A' ' 86' ' ' ILE . 36.5 mm -107.97 109.83 29.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 1.27 111.146 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.671 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 6.4 t-160 -83.08 109.14 16.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 2.0099999999999998 110.865 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.526 ' CD1' HG11 ' A' ' 33' ' ' VAL . 4.3 mt -83.44 122.26 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 1.6200000000000001 111.194 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -103.61 174.82 5.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 3.2799999999999998 110.735 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 42.85 41.36 2.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 3.1200000000000001 110.74 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 3.6 tp -128.19 127.02 23.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 1.8700000000000001 110.705 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.518 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 72.0 Cg_endo -75.58 71.66 5.28 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.504 2.136 . . . . 1.4199999999999999 112.036 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.607 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 15.9 mm -27.22 110.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.1 0.476 . . . . 2.6800000000000002 110.876 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 4.0 t70 146.07 -18.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.291 -0.868 . . . . 2.1600000000000001 109.451 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.518 HG11 ' N ' ' A' ' 29' ' ' THR . 1.8 p -52.41 -167.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 115.628 -0.714 . . . . 2.1899999999999999 109.842 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.518 ' N ' HG11 ' A' ' 28' ' ' VAL . 45.9 p -99.36 145.21 27.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.069 0.461 . . . . 1.3 111.773 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.6 mp0 -70.32 -46.77 63.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.761 -0.654 . . . . 2.0099999999999998 110.504 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.04 -28.64 0.16 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.543 -0.837 . . . . 0.58999999999999997 111.936 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.52 ' HG2' ' CD1' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -83.96 -57.26 3.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.319 . . . . 2.48 110.491 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.526 HG11 ' CD1' ' A' ' 21' ' ' ILE . 61.5 t -51.5 -49.96 31.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.953 0.406 . . . . 1.26 110.575 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.48 HD12 ' CD2' ' A' ' 46' ' ' LEU . 1.2 mp -69.97 -38.23 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.056 -0.52 . . . . 1.3999999999999999 110.558 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -49.1 -38.76 25.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 1.8400000000000001 110.373 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.519 HD12 ' CB ' ' A' ' 77' ' ' PRO . 12.1 mt -72.7 -38.55 67.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.946 -0.57 . . . . 2.2000000000000002 110.358 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.595 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -71.54 -20.34 78.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 0.52000000000000002 112.305 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.493 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -41.65 -60.52 1.86 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.852 0.358 . . . . 2.1400000000000001 110.775 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 30.1 Cg_endo -63.29 -34.63 66.64 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.714 2.276 . . . . 0.81000000000000005 111.939 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.595 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 22.8 m-30 -60.22 -32.62 71.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.974 -0.557 . . . . 2.2000000000000002 110.678 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 64' ' ' ALA . . . 157.85 -102.29 0.21 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.86 -0.686 . . . . 0.56000000000000005 112.231 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.59 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 28.5 mttt -150.4 137.31 19.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.762 0.315 . . . . 2.8300000000000001 111.023 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.5 t -87.83 121.72 38.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 1.1699999999999999 110.468 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.58 ' CG2' ' CG ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -96.27 -2.0 46.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 1.6799999999999999 111.459 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 170.98 152.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 1.8300000000000001 111.056 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.52 HD13 ' CG2' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -145.38 100.52 3.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 2.1099999999999999 110.89 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.493 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 2.8 tt -108.33 113.74 27.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 2.0099999999999998 110.918 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.468 ' HB3' HD11 ' A' ' 26' ' ' ILE . 2.8 mmm -90.79 94.91 9.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 1.3500000000000001 110.865 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.488 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -74.53 93.05 2.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 2.4300000000000002 110.843 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.549 ' CD ' HG21 ' A' ' 26' ' ' ILE . 3.4 mmtp -51.95 -18.74 1.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 2.0299999999999998 111.09 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -33.71 -95.21 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.798 -0.715 . . . . 2.0299999999999998 112.622 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 26.5 mttt -107.9 55.88 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 3.8100000000000001 110.975 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.518 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 14.8 m120 40.56 68.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 1.75 110.948 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.524 ' CG ' ' O ' ' A' ' 52' ' ' LYS . 10.7 mt-30 -146.99 129.35 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 1.8600000000000001 110.747 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.555 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.7 160.21 16.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 1.0900000000000001 110.891 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.671 ' CE2' ' CD2' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -142.77 115.86 8.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.307 -0.406 . . . . 2.3199999999999998 111.187 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.52 ' CG2' HD13 ' A' ' 46' ' ' LEU . 6.1 pt -114.64 146.82 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 1.3500000000000001 110.771 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.472 ' O ' HG23 ' A' ' 44' ' ' THR . 1.6 mt-10 -111.8 123.18 49.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.289 -0.414 . . . . 1.96 111.222 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.492 ' CE ' ' HB1' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -90.77 137.41 32.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 1.1100000000000001 110.251 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.59 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 1.2 m-80 -68.4 -20.74 64.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.418 -0.356 . . . . 1.5700000000000001 111.484 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.4 t -129.84 146.88 51.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 1.75 111.326 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.48 -46.09 89.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.088 -0.505 . . . . 1.95 110.779 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.64 -23.42 17.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 2.1299999999999999 110.721 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB1' ' CE ' ' A' ' 59' ' ' MET . . . -78.21 -54.84 5.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 1.1200000000000001 111.029 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -52.72 -52.61 55.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 1.05 111.138 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -54.18 -67.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 2.4100000000000001 110.986 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.585 HG21 ' CD1' ' A' ' 40' ' ' PHE . 22.7 m -40.97 -38.25 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 1.1299999999999999 111.277 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.581 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -52.12 -65.18 0.6 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 1.3600000000000001 111.024 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.572 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 99.8 t -75.08 -49.85 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 1.1799999999999999 111.128 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.453 ' O ' ' OG1' ' A' ' 73' ' ' THR . 13.0 t-20 -43.39 -60.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 2.0800000000000001 110.997 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -55.97 -42.26 76.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 2.23 110.965 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' A' ' 68' ' ' MET . 16.3 m-85 -74.5 0.2 15.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 2.0800000000000001 111.073 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 32.0 m -50.11 -29.04 8.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.355 -0.384 . . . . 1.3799999999999999 110.952 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.25 -57.19 1.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 1.78 110.779 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 40.8 t -80.28 124.69 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 1.97 110.979 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.5 HG22 ' HD2' ' A' ' 77' ' ' PRO . 1.2 m -102.41 144.22 28.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 1.3799999999999999 111.241 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.532 ' HG2' ' CD1' ' A' ' 86' ' ' ILE . 22.6 Cg_endo -94.56 135.02 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.199 2.599 . . . . 0.82999999999999996 111.961 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.531 ' HB ' ' N ' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -114.6 177.73 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 1.99 111.222 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.52 ' CD1' ' HG2' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -131.99 112.56 12.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 3.0699999999999998 110.927 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 46.58 23.37 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 5.2199999999999998 110.725 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.09 9.17 20.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.875 -0.679 . . . . 1.0900000000000001 112.649 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.46 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -117.0 97.64 51.02 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.97 0.414 . . . . 2.5299999999999998 110.819 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.531 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 36.6 Cg_exo -57.64 117.12 3.77 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.852 2.368 . . . . 1.01 112.615 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 3.3 pt -118.64 107.73 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 1.1299999999999999 110.67 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.456 ' O ' HG22 ' A' ' 21' ' ' ILE . 20.6 m-85 -65.42 148.4 51.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 2.6699999999999999 111.648 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.551 HD11 ' CE2' ' A' ' 72' ' ' TYR . 4.2 mt -126.23 103.87 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.809 -0.632 . . . . 1.27 110.556 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' HIS . 11.8 mt-30 -112.67 170.79 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.395 . . . . 2.6400000000000001 111.147 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.572 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 37.4 m-85 -71.21 -175.89 1.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 2.3700000000000001 110.885 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.52 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 28.9 t -96.1 174.05 7.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 2.6899999999999999 110.887 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -126.92 27.33 6.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 4.5199999999999996 110.89 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -158.46 159.38 35.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 6.25 110.904 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.54 -88.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 7.5199999999999996 110.901 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -135.11 164.67 27.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 3.4100000000000001 110.913 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.6 tp -74.63 123.31 24.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 2.3599999999999999 110.907 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -88.62 131.38 35.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 6.8200000000000003 110.845 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 98' ' ' SER . 0.1 OUTLIER -84.65 97.02 9.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 5.8200000000000003 111.133 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.4 t0 40.77 -91.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 8.3000000000000007 110.949 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 96' ' ' THR . 3.1 p -157.83 37.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 9.6600000000000001 110.845 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.214 -0.898 . . . . 10.859999999999999 110.919 -179.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.816 0.341 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.03 -81.17 1.58 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.482 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.86 130.24 17.58 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.371 . . . . 0.0 111.138 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.575 ' HG3' ' CZ ' ' A' ' 88' ' ' PHE . 35.2 Cg_endo -65.79 -86.03 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.725 2.283 . . . . 0.0 112.308 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 p -178.6 162.19 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.856 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -76.72 -20.03 57.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.943 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 89' ' ' SER . 4.0 t -90.11 107.51 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.122 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.463 ' HB ' HG12 ' A' ' 57' ' ' ILE . 24.9 mm -94.39 108.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.184 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.624 ' NE2' ' CE2' ' A' ' 56' ' ' PHE . 4.7 t-160 -79.32 109.62 13.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.744 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 86' ' ' ILE . 16.4 mt -83.99 131.1 34.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.363 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -109.29 168.27 9.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.635 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.5 OUTLIER 46.43 44.22 12.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.0 110.377 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 26' ' ' ILE . 0.4 OUTLIER -129.44 95.72 29.42 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.972 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.512 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 50.5 Cg_exo -53.32 78.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.699 2.266 . . . . 0.0 111.932 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.562 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 29.6 mm -34.62 118.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.084 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.4 t0 149.76 -19.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.06 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.505 HG21 ' N ' ' A' ' 29' ' ' THR . 6.1 m -55.44 -155.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.783 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.505 ' N ' HG21 ' A' ' 28' ' ' VAL . 71.2 p -114.0 145.69 41.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.923 0.392 . . . . 0.0 111.64 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.522 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 9.5 mp0 -63.47 -34.19 77.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.602 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.12 -38.18 65.94 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.182 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.515 ' OE1' ' CD1' ' A' ' 79' ' ' LEU . 3.6 mm-40 -68.59 -58.97 3.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.785 0.326 . . . . 0.0 110.608 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.0 t -53.28 -45.5 55.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.743 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.523 ' CD1' HD22 ' A' ' 46' ' ' LEU . 1.4 mp -66.63 -39.58 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.395 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.36 -43.37 5.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.144 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.46 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 8.5 mt -77.71 -25.35 49.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.291 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -81.43 -16.33 74.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.405 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.487 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -58.9 -54.73 53.51 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.738 0.304 . . . . 0.0 110.725 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 31.6 Cg_exo -58.19 -50.08 10.85 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.569 2.179 . . . . 0.0 111.828 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.569 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 27.2 m-85 -53.68 -32.61 52.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.783 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 64' ' ' ALA . . . 161.71 -104.08 0.23 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.186 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.541 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 8.8 mttm -150.45 143.77 24.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 111.007 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 49.9 t -86.92 114.59 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.518 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.521 ' CG2' ' CG ' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -89.26 -4.5 58.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.458 -179.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 176.4 151.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.523 HD22 ' CD1' ' A' ' 34' ' ' ILE . 3.9 tp -137.63 125.76 22.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.007 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 tp -134.09 123.74 24.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.462 ' HB3' HD13 ' A' ' 26' ' ' ILE . 2.5 mmm -109.66 121.82 46.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HG ' ' CE1' ' A' ' 56' ' ' PHE . 12.8 mt -98.89 91.62 5.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.976 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.509 ' CD ' HG23 ' A' ' 26' ' ' ILE . 13.6 mmtp -41.22 -27.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.966 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -81.24 129.6 9.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.545 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 0.9 OUTLIER 67.28 16.37 10.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 110.997 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 21.8 m120 36.35 78.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.509 ' N ' HG12 ' A' ' 26' ' ' ILE . 2.4 mt-30 -150.21 132.91 15.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.993 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.548 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.7 167.81 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.767 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.624 ' CE2' ' NE2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -148.09 115.99 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.305 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.463 HG12 ' HB ' ' A' ' 19' ' ' ILE . 6.5 pt -108.71 155.09 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.768 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.47 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 0.0 OUTLIER -119.51 119.28 33.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.525 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 38.7 mmm -89.98 141.47 28.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.632 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.541 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 0.8 OUTLIER -73.76 -27.03 60.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.909 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 4.5 t -123.92 137.94 54.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.234 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -51.27 -38.2 51.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.687 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -59.08 -27.88 65.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.689 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 59' ' ' MET . . . -75.81 -47.24 26.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 68' ' ' MET . . . -60.4 -57.09 14.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.993 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.514 ' ND2' ' HD2' ' A' ' 15' ' ' PRO . 1.6 m-20 -51.82 -70.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.504 ' O ' ' CE1' ' A' ' 40' ' ' PHE . 12.7 m -41.8 -27.48 0.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.569 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -59.62 -65.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.558 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 72.0 t -74.92 -37.61 41.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.469 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 8.2 t30 -59.23 -63.66 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.994 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 67' ' ' THR . 2.8 t80 -49.31 -45.72 45.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.11 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.559 ' CD2' ' HG3' ' A' ' 77' ' ' PRO . 22.4 m-30 -83.83 11.57 7.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.106 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.469 ' OG1' ' HA ' ' A' ' 70' ' ' ASN . 21.5 m -62.29 -30.24 70.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.2 t -113.66 -39.19 4.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.5 p -106.18 129.95 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.144 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.528 HG21 ' CD ' ' A' ' 77' ' ' PRO . 1.3 m -98.61 142.48 24.67 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.85 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.559 ' HG3' ' CD2' ' A' ' 72' ' ' TYR . 26.8 Cg_endo -95.01 137.67 0.84 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 123.028 2.485 . . . . 0.0 112.214 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -123.65 -179.87 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 111.21 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.515 ' CD1' ' OE1' ' A' ' 32' ' ' GLU . 1.9 mm? -137.97 107.43 6.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.963 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 56.88 16.67 2.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.935 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.46 8.63 14.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.655 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.456 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -116.01 97.67 49.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.008 0.432 . . . . 0.0 110.95 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.481 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 74.3 Cg_endo -75.84 135.93 18.16 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.894 2.396 . . . . 0.0 112.853 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.525 ' CG2' HD23 ' A' ' 24' ' ' LEU . 9.2 pt -136.97 110.11 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.497 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.446 ' O ' HG22 ' A' ' 21' ' ' ILE . 8.1 m-85 -60.47 143.55 53.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.587 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.509 ' CG2' ' SD ' ' A' ' 68' ' ' MET . 7.1 mt -125.85 104.07 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.528 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' HIS . 3.9 mt-30 -115.13 172.83 6.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.1 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.575 ' CZ ' ' HG3' ' A' ' 15' ' ' PRO . 45.5 m-85 -71.73 179.97 2.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.84 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 20' ' ' HIS . 70.4 m -114.33 144.95 42.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -94.47 31.32 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.988 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -127.61 176.27 7.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.73 -36.77 6.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.68 164.56 29.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.938 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.34 110.0 18.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -105.03 136.21 44.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.8 p -81.34 129.56 34.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.104 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -114.88 -39.52 3.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.0 t -178.87 169.87 1.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.97 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.1 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.847 -179.954 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.777 0.323 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.493 ' C ' ' CG2' ' A' ' 14' ' ' VAL . . . 40.85 77.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.456 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.493 ' CG2' ' C ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER 51.57 112.07 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.847 0.356 . . . . 0.0 111.207 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 35.0 Cg_endo -65.35 -86.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.609 2.206 . . . . 0.0 112.349 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 1.4 m 167.08 172.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.982 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -68.06 -7.27 27.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.033 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG11 ' CB ' ' A' ' 89' ' ' SER . 7.2 t -87.99 122.49 39.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.514 HD13 ' CA ' ' A' ' 65' ' ' ALA . 3.9 mm -119.28 116.85 52.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.211 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.467 ' HB3' ' O ' ' A' ' 88' ' ' PHE . 6.9 t-80 -88.28 153.59 21.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.721 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.48 HG12 ' CG1' ' A' ' 86' ' ' ILE . 2.3 mp -133.37 110.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.478 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' LYS . 2.8 ttm180 -88.09 167.4 13.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.827 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 43.77 90.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.521 ' CD1' HD13 ' A' ' 84' ' ' ILE . 4.7 tp -167.66 115.42 0.65 Allowed Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.447 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 26' ' ' ILE . 37.4 Cg_exo -59.08 73.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.466 2.111 . . . . 0.0 111.062 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.551 ' CG1' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -30.01 153.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.989 -178.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER 87.46 9.43 0.16 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.983 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.518 ' N ' ' CE ' ' A' ' 48' ' ' MET . 1.4 t -57.86 -149.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.806 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.455 ' OG1' ' HB2' ' A' ' 32' ' ' GLU . 17.9 p -124.52 149.81 46.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.16 0.505 . . . . 0.0 111.899 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.458 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 2.1 mt-10 -68.75 -47.11 67.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.789 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 35' ' ' SER . . . -51.34 -37.27 39.02 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.348 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.466 ' N ' ' OE1' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -78.63 -64.93 1.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.753 0.311 . . . . 0.0 110.768 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.9 t -45.59 -52.72 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.529 HG12 ' CG2' ' A' ' 43' ' ' VAL . 1.5 mp -65.7 -40.17 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.315 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -39.17 -42.42 0.96 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.924 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.525 ' CD2' ' OH ' ' A' ' 72' ' ' TYR . 11.1 mt -73.21 -40.63 64.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.02 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -77.22 -3.97 82.9 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.399 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.524 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 9.3 mt -61.44 -58.3 19.53 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.182 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 19.7 Cg_endo -58.3 -32.02 95.07 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.511 2.141 . . . . 0.0 112.105 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.582 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 22.0 m-30 -58.04 -28.51 64.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.683 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.76 -98.03 0.17 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.18 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.569 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 19.3 mmtp -150.47 146.01 26.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 0.0 111.022 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.529 ' CG2' HG12 ' A' ' 34' ' ' ILE . 67.0 t -89.73 116.43 31.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.763 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.526 ' CG2' ' N ' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -92.82 -9.71 39.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.244 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.417 ' HB2' ' OE1' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -176.88 146.95 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.725 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.486 ' C ' ' CD1' ' A' ' 46' ' ' LEU . 2.1 tm? -132.59 124.83 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.024 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' CD1' HD23 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -141.23 141.4 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.708 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.518 ' CE ' ' N ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -129.3 103.08 6.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.784 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.525 HD23 ' CD1' ' A' ' 47' ' ' LEU . 3.4 mm? -70.18 107.82 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.832 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.459 ' HA ' HG21 ' A' ' 26' ' ' ILE . 5.9 mttp -91.68 81.13 5.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.943 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.23 -56.43 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.284 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -123.17 18.29 9.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.919 0.39 . . . . 0.0 110.544 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.551 ' HA ' ' CG1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 68.81 86.47 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.953 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 53' ' ' ASN . 26.6 mt-30 -160.12 129.52 5.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 111.431 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.546 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -113.75 163.27 15.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.241 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 55' ' ' ALA . 5.8 m-85 -148.1 118.59 7.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.839 0.352 . . . . 0.0 111.599 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 57' ' ' ILE . 7.0 pt -118.53 140.85 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.527 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.517 ' CB ' ' OG1' ' A' ' 44' ' ' THR . 61.6 mt-10 -103.34 123.65 47.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.292 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.529 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 23.4 mmm -98.81 134.49 41.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.569 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 0.5 OUTLIER -72.28 -20.56 61.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.27 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.464 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 11.9 t -134.67 129.14 34.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.909 0.385 . . . . 0.0 111.231 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -38.99 -49.55 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -46.06 -32.23 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 59' ' ' MET . . . -75.29 -48.88 21.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.514 ' CA ' HD13 ' A' ' 19' ' ' ILE . . . -66.58 -59.23 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -50.59 -65.82 0.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.075 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.7 m -40.7 -46.78 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.27 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -44.98 -65.11 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.275 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.575 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 24.7 t -71.89 -51.54 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.297 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -49.96 -26.51 4.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.186 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -85.53 -64.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.169 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.525 ' OH ' ' CD2' ' A' ' 36' ' ' LEU . 27.2 m-85 -56.46 -16.54 6.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.989 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 72' ' ' TYR . 69.7 m -35.54 -31.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.023 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 72' ' ' TYR . 7.7 t -112.4 -62.94 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 75' ' ' VAL . 6.2 p -82.15 121.71 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.054 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.502 HG23 ' CE1' ' A' ' 85' ' ' TYR . 2.5 m -95.59 145.85 30.28 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.032 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.471 ' HD2' HG21 ' A' ' 76' ' ' THR . 37.1 Cg_endo -97.23 163.61 0.96 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.299 2.666 . . . . 0.0 112.032 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.524 ' HB ' ' N ' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -153.24 152.41 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.899 0.381 . . . . 0.0 111.105 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 0.9 OUTLIER -98.78 100.83 12.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.406 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 28.6 mmt180 67.27 -59.51 0.39 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.469 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -159.44 22.92 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.404 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.437 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 26.1 mp0 -126.1 97.8 34.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.392 . . . . 0.0 110.936 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.524 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 19.9 Cg_exo -66.19 129.47 21.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 123.047 2.498 . . . . 0.0 112.714 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.521 HD13 ' CD1' ' A' ' 24' ' ' LEU . 6.1 pt -134.47 118.52 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.57 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CE1' HG23 ' A' ' 76' ' ' THR . 4.6 m-85 -78.66 148.88 33.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.847 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.523 HG21 ' CG ' ' A' ' 68' ' ' MET . 4.0 mt -126.26 109.09 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.473 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 20' ' ' HIS . 70.8 mm-40 -120.87 173.79 7.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.013 0.435 . . . . 0.0 111.149 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.575 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 30.1 m-85 -68.36 167.77 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.886 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.52 ' CB ' HG11 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -104.61 153.28 21.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.908 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -96.38 34.35 1.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.489 ' CB ' ' HD2' ' A' ' 95' ' ' LYS . 1.3 t60 -148.13 148.82 31.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.417 ' O ' HG21 ' A' ' 18' ' ' VAL . 8.3 mmtt -66.54 -72.34 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.992 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -102.85 168.58 9.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.5 tp -52.34 142.66 16.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.489 ' HD2' ' CB ' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -106.99 132.78 52.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.68 100.42 8.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.122 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -49.27 -32.61 11.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 99' ' ' SER . 19.6 m -120.01 125.89 49.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 98' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.978 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.52 164.02 52.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.498 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.09 142.65 38.97 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 111.151 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -51.66 130.19 32.76 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.704 2.269 . . . . 0.0 112.31 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.5 p -150.8 151.48 32.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.53 -53.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.73 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.426 ' HB ' ' HB3' ' A' ' 89' ' ' SER . 21.8 t -90.26 143.59 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.806 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.517 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 20.9 mm -118.41 103.07 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.376 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.549 ' NE2' ' CZ ' ' A' ' 56' ' ' PHE . 4.5 t-160 -79.03 144.95 34.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.338 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.519 ' CG2' ' O ' ' A' ' 85' ' ' TYR . 9.5 mt -133.05 138.68 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.918 0.39 . . . . 0.0 111.457 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.526 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 12.2 ptm180 -123.42 170.35 10.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.467 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER 52.2 38.98 25.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.216 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.525 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 2.7 tp -125.22 119.85 25.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.466 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 26' ' ' ILE . 20.2 Cg_endo -60.49 80.15 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.274 1.982 . . . . 0.0 110.716 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.577 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -32.18 154.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.733 -178.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 28' ' ' VAL . 22.3 t0 79.23 2.37 2.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.171 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.522 HG11 ' N ' ' A' ' 29' ' ' THR . 2.0 p -54.81 -165.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.522 ' N ' HG11 ' A' ' 28' ' ' VAL . 55.1 p -104.26 144.72 31.23 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.904 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -62.06 -46.66 88.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.487 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.3 -29.45 0.12 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.64 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.526 ' HG2' ' CD2' ' A' ' 79' ' ' LEU . 2.7 tp10 -83.34 -60.96 1.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 0.0 110.259 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 t -55.45 -58.87 3.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.597 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.3 mt -53.24 -53.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.489 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.5 m -39.29 -50.2 1.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.571 ' O ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -61.09 -32.39 72.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.747 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -83.03 -25.77 47.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.608 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.457 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -39.21 -60.65 1.16 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.709 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 43.1 Cg_endo -67.8 -22.88 42.4 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.548 2.165 . . . . 0.0 111.651 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.573 ' CD2' ' HA ' ' A' ' 68' ' ' MET . 16.1 m-30 -76.34 -6.47 51.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.043 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.19 -103.23 0.44 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.334 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.493 ' HB3' ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -150.4 138.23 19.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.154 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.453 HG22 HG23 ' A' ' 34' ' ' ILE . 43.2 t -92.53 89.96 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 110.328 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -74.82 1.9 11.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.867 -179.068 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 44' ' ' THR . 0.7 OUTLIER 170.69 158.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.939 0.4 . . . . 0.0 111.456 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.532 HD11 ' CG2' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -152.58 102.25 2.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.582 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.485 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -95.6 104.5 16.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.481 ' CE ' ' N ' ' A' ' 28' ' ' VAL . 46.9 mmm -78.19 107.95 11.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.553 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.532 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -88.91 101.58 14.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.862 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.53 ' CD ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -74.3 -168.39 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.072 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.42 -100.68 2.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.429 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -74.13 -69.87 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.736 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.577 ' ND2' ' CD1' ' A' ' 26' ' ' ILE . 0.6 OUTLIER 159.97 77.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 49' ' ' LEU . 0.8 OUTLIER -159.33 161.83 35.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.863 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.536 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -151.38 163.98 37.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.705 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -143.0 115.77 8.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.871 0.367 . . . . 0.0 111.242 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CG2' HD11 ' A' ' 46' ' ' LEU . 31.2 pt -105.17 133.01 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.552 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.66 102.64 14.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.84 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.46 ' SD ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -64.46 157.21 27.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.489 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.543 ' N ' ' OG1' ' A' ' 44' ' ' THR . 2.6 m-80 -68.79 -39.42 80.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.647 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -133.18 169.81 16.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.168 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.429 ' N ' ' OG1' ' A' ' 61' ' ' THR . 2.4 mp0 -73.31 -36.2 66.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.773 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -60.91 -40.08 91.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.719 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 40' ' ' PHE . . . -64.45 -49.09 72.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.459 ' HA ' ' SD ' ' A' ' 59' ' ' MET . . . -50.44 -53.23 31.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.221 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -46.49 -63.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.114 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.572 HG21 ' CD1' ' A' ' 40' ' ' PHE . 24.8 m -40.91 -46.77 2.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.309 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.573 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 0.9 OUTLIER -46.64 -65.01 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 -179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 46.1 t -70.61 -54.2 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.452 ' O ' ' OG1' ' A' ' 73' ' ' THR . 5.7 t-20 -38.75 -64.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -59.18 -31.2 68.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.013 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.464 ' OH ' ' HG ' ' A' ' 36' ' ' LEU . 14.0 m-30 -89.22 20.11 3.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.048 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.453 ' O ' HG22 ' A' ' 73' ' ' THR . 32.5 m -78.57 -22.64 46.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.841 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.1 m -124.34 -41.08 2.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.683 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.8 t -89.96 130.12 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.454 HG22 ' HD2' ' A' ' 77' ' ' PRO . 2.8 m -91.82 146.14 32.41 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.025 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.468 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 26.8 Cg_endo -95.97 138.5 0.72 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 123.262 2.641 . . . . 0.0 112.165 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.51 HG11 ' N ' ' A' ' 83' ' ' PRO . 16.9 t -125.02 154.51 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.127 0.489 . . . . 0.0 111.402 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.593 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -114.18 99.89 7.96 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.188 178.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.482 ' HB2' HD21 ' A' ' 79' ' ' LEU . 0.0 OUTLIER 62.24 -62.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.029 0.443 . . . . 0.0 110.182 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -159.45 23.86 0.3 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.371 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.79 97.77 26.32 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 110.693 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.51 ' N ' HG11 ' A' ' 78' ' ' VAL . 52.9 Cg_exo -55.3 106.01 0.17 Allowed 'Trans proline' 0 C--O 1.23 0.125 0 C-N-CA 122.833 2.355 . . . . 0.0 112.707 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 2.6 pt -107.28 107.71 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.465 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.526 ' HB2' ' CG ' ' A' ' 22' ' ' ARG . 8.9 m-30 -65.12 142.18 58.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.63 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.456 HG13 HG22 ' A' ' 21' ' ' ILE . 13.5 mt -126.14 134.24 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.372 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -149.78 172.17 15.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 0.0 111.04 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 39.4 m-85 -65.48 -173.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.893 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.426 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 1.7 t -142.37 139.9 31.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.503 ' O ' ' CB ' ' A' ' 91' ' ' HIS . 0.1 OUTLIER -36.34 -60.93 0.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.503 ' CB ' ' O ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER 159.37 45.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.957 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.407 ' O ' HD12 ' A' ' 94' ' ' LEU . 15.0 mmmt -88.09 73.43 9.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.929 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -65.47 138.63 58.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.548 ' N ' ' CD1' ' A' ' 94' ' ' LEU . 2.3 mp -98.12 147.64 24.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 145.0 25.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.915 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.34 123.59 28.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.078 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.5 t0 57.15 111.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -101.6 111.21 23.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.899 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.806 0.336 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.429 ' C ' ' HD2' ' A' ' 15' ' ' PRO . . . 82.36 102.03 0.44 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.565 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.763 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 29.3 m -124.32 24.63 0.11 Allowed Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.763 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 90.3 Cg_exo -35.43 -63.11 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.261 2.641 . . . . 0.0 112.45 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 23.4 m 36.17 63.64 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -11.7 61.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 89' ' ' SER . 12.6 p -114.12 142.79 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CG2' HG21 ' A' ' 86' ' ' ILE . 11.4 mm -127.04 143.18 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.488 ' CD2' ' HB3' ' A' ' 54' ' ' GLN . 7.2 t-80 -110.86 156.28 21.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.672 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.472 ' CD1' HG12 ' A' ' 86' ' ' ILE . 2.5 mm -128.31 106.93 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.425 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -83.61 171.22 13.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.646 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER 39.32 31.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.947 0.403 . . . . 0.0 110.354 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -102.07 107.41 52.55 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.288 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 26' ' ' ILE . 53.2 Cg_exo -51.98 82.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.484 2.122 . . . . 0.0 111.534 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.578 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -34.24 155.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.022 -179.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 25.1 t0 80.88 -3.05 1.8 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.223 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 29' ' ' THR . 2.0 p -54.64 -166.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.516 ' N ' HG13 ' A' ' 28' ' ' VAL . 69.8 p -100.2 144.19 29.51 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.862 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -63.74 -40.63 97.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.312 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -58.39 -28.09 61.56 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.982 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.471 ' HG2' HD22 ' A' ' 79' ' ' LEU . 30.5 mt-10 -70.71 -64.59 0.87 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.361 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.432 HG11 ' CG2' ' A' ' 57' ' ' ILE . 46.8 t -55.2 -43.07 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.555 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.528 ' CG2' ' CD2' ' A' ' 38' ' ' LEU . 1.6 mp -70.1 -42.81 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.5 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 3.4 t -40.3 -42.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.027 0.441 . . . . 0.0 110.138 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.503 HD13 ' CB ' ' A' ' 77' ' ' PRO . 81.5 mt -73.03 -37.89 66.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.101 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.581 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -76.49 -11.69 84.95 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.332 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.528 ' CD2' ' CG2' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -55.93 -61.04 7.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.818 0.342 . . . . 0.0 110.794 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.6 Cg_endo -66.12 -21.14 56.16 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.649 2.233 . . . . 0.0 111.772 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.583 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 16.3 m-30 -70.04 -28.78 65.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.626 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.3 -99.14 0.18 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.13 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.555 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 14.3 mtpt -150.63 135.89 17.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.826 0.346 . . . . 0.0 111.079 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.478 HG12 ' CG1' ' A' ' 34' ' ' ILE . 42.4 t -86.6 118.13 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.27 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.534 ' CG2' ' OD1' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -88.78 -8.61 54.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.698 -179.039 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 44' ' ' THR . 1.3 t-20 170.85 165.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.885 0.374 . . . . 0.0 111.275 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.525 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -139.85 113.9 8.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.883 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.58 ' CD1' ' CD2' ' A' ' 49' ' ' LEU . 1.3 tm? -122.75 120.44 33.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.417 ' CE ' ' N ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -108.43 145.09 35.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.91 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.58 ' CD2' ' CD1' ' A' ' 47' ' ' LEU . 2.1 mt -117.09 102.69 9.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.795 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.51 ' N ' HG21 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -72.71 136.71 45.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.4 -80.0 0.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.693 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.49 8.16 14.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 111.079 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.578 ' ND2' ' CD1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 56.89 84.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.068 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 51.8 mt-30 -159.25 123.45 3.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.398 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.538 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.7 170.12 8.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.527 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.538 ' CD1' ' C ' ' A' ' 55' ' ' ALA . 28.1 m-85 -148.23 143.22 26.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.01 0.433 . . . . 0.0 111.383 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.513 ' CD1' ' SD ' ' A' ' 68' ' ' MET . 1.0 OUTLIER -144.33 125.18 8.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.494 179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.469 ' O ' HG21 ' A' ' 44' ' ' THR . 38.3 mt-10 -93.74 127.13 39.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.258 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.514 ' CE ' ' HB3' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -99.98 146.44 26.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.164 179.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.555 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -88.78 -9.22 52.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.716 0.293 . . . . 0.0 110.69 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.55 160.55 21.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.138 0.494 . . . . 0.0 111.785 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -80.84 -37.8 29.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.305 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.461 ' O ' ' HB ' ' A' ' 67' ' ' THR . 1.1 tp10 -71.09 -23.02 62.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.061 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.514 ' HB3' ' CE ' ' A' ' 59' ' ' MET . . . -74.27 -43.29 57.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.692 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 16' ' ' SER . . . -65.46 -66.06 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.211 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -52.22 -63.2 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 63' ' ' GLU . 77.3 m -40.73 -47.72 2.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.371 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.583 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -46.36 -65.26 0.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.068 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 68.0 t -68.51 -54.83 18.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.233 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 73' ' ' THR . 8.9 t-20 -46.52 -62.2 1.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.07 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.459 ' HB3' ' O ' ' A' ' 67' ' ' THR . 4.0 t80 -43.42 -48.81 7.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.153 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.448 ' OH ' HD23 ' A' ' 36' ' ' LEU . 39.6 m-85 -80.52 7.37 10.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.242 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 70' ' ' ASN . 20.4 m -49.03 -32.39 9.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.96 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.3 m -115.36 -56.06 2.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -81.1 134.64 26.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.189 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.499 ' CG2' ' CD ' ' A' ' 77' ' ' PRO . 8.1 m -92.17 152.19 42.37 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.886 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.507 ' CG ' HD13 ' A' ' 86' ' ' ILE . 9.6 Cg_endo -91.4 94.05 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.194 2.596 . . . . 0.0 112.315 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.465 ' O ' HD12 ' A' ' 79' ' ' LEU . 3.5 t -86.3 154.51 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.471 HD22 ' HG2' ' A' ' 32' ' ' GLU . 9.5 mp -144.29 100.96 3.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 59.92 14.6 4.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.724 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.438 ' O ' ' HD3' ' A' ' 83' ' ' PRO . . . 115.33 -3.23 22.1 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -102.71 97.72 9.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.329 . . . . 0.0 110.77 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 89.5 Cg_endo -79.11 96.78 1.09 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.8 2.333 . . . . 0.0 112.511 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.52 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 2.0 pt -100.81 107.74 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.738 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 12.1 m-85 -66.29 148.84 51.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.546 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.507 HD13 ' CG ' ' A' ' 77' ' ' PRO . 4.6 mt -126.27 111.88 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.473 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.412 ' OE1' ' HB3' ' A' ' 85' ' ' TYR . 3.1 mp0 -128.25 173.11 10.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.909 0.385 . . . . 0.0 111.155 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 72.7 m-85 -72.84 152.26 41.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.523 ' O ' ' CG1' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -152.13 -174.97 5.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.506 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . 0.9 OUTLIER 38.4 -162.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.955 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 92' ' ' LYS . 1.3 t-80 -105.03 -153.04 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 91' ' ' HIS . 6.1 mmtt -35.69 -64.07 0.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.4 ' OE2' ' CB ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER -136.58 154.71 50.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.452 ' O ' ' OE2' ' A' ' 58' ' ' GLU . 9.3 tp -93.85 99.88 12.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.902 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.99 142.38 38.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.982 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.45 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -126.97 97.24 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 96' ' ' THR . 3.7 p30 164.57 178.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 99' ' ' SER . 12.5 m -153.31 34.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 98' ' ' SER . 2.0 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.866 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.781 0.324 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.447 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -115.29 -70.57 0.48 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.464 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -167.02 156.24 9.58 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.369 . . . . 0.0 111.153 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.7 105.45 1.11 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.77 2.313 . . . . 0.0 112.288 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.8 m -147.21 102.38 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.11 -53.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' A' ' 89' ' ' SER . 98.2 t -87.98 103.92 14.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.995 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -87.25 134.03 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.544 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 9.3 t-160 -97.19 114.38 26.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 85' ' ' TYR . 11.2 mt -89.31 123.69 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -107.68 168.68 9.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 5.9 tmtt? 49.02 37.16 9.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.634 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.463 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 2.5 tp -120.83 126.95 26.47 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.003 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 26' ' ' ILE . 58.1 Cg_endo -71.74 76.5 1.96 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.45 2.1 . . . . 0.0 111.449 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.526 HG22 ' CE ' ' A' ' 50' ' ' LYS . 34.2 mm -34.42 155.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.837 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 24.7 t0 86.64 -4.97 0.72 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.776 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 29' ' ' THR . 1.8 p -59.95 -154.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.744 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.478 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 43.8 p -105.99 144.79 32.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.184 0.516 . . . . 0.0 112.082 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.461 ' O ' HD13 ' A' ' 34' ' ' ILE . 11.2 mp0 -69.66 -35.25 74.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.517 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 35' ' ' SER . . . -53.58 -30.72 43.15 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.913 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.459 ' OE2' HD23 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -77.26 -57.88 3.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.447 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.5 t -53.1 -43.14 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.5 mp -72.45 -46.87 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.589 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -38.62 -34.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.355 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.492 ' CD1' ' CB ' ' A' ' 77' ' ' PRO . 18.3 mt -82.38 -39.26 22.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.51 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -72.32 -17.51 77.61 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.38 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.48 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -46.81 -60.67 3.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.876 0.369 . . . . 0.0 110.806 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.6 Cg_endo -66.05 -30.78 47.18 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.716 2.277 . . . . 0.0 112.11 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.584 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 22.1 m-30 -63.73 -40.44 96.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.597 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 64' ' ' ALA . . . 168.57 -98.78 0.14 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.395 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -151.09 142.5 23.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.719 0.295 . . . . 0.0 110.923 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.498 ' CG2' ' CG1' ' A' ' 34' ' ' ILE . 42.8 t -88.76 82.54 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.213 0.53 . . . . 0.0 110.687 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.542 ' CG2' ' CG ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -66.57 -7.3 19.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.42 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 176.68 145.74 0.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.914 0.388 . . . . 0.0 111.249 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.524 HD12 ' CG2' ' A' ' 57' ' ' ILE . 4.9 tp -136.4 103.07 5.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.53 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.87 105.17 15.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.3 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.6 mmm -90.5 99.61 12.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.302 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -85.64 110.92 19.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.306 -179.513 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.526 ' CE ' HG22 ' A' ' 26' ' ' ILE . 10.1 mmtp -62.34 -172.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.349 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . 55.22 114.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.029 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER 88.87 -21.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.914 0.387 . . . . 0.0 110.669 -179.446 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 25' ' ' PRO . 0.8 OUTLIER 68.11 63.73 0.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.494 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.483 ' C ' ' CD1' ' A' ' 26' ' ' ILE . 7.2 mm-40 -136.07 126.5 26.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.758 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.542 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.75 160.12 16.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -142.32 115.91 9.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.033 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.524 ' CD1' ' SD ' ' A' ' 59' ' ' MET . 13.8 pt -113.42 140.91 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -96.22 102.73 14.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.632 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.524 ' SD ' ' CD1' ' A' ' 57' ' ' ILE . 7.1 mmm -66.34 116.07 6.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.0 110.779 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.542 ' CG ' ' CG2' ' A' ' 44' ' ' THR . 4.9 m120 -33.68 -49.72 0.32 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.328 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.76 -173.01 2.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.125 0.488 . . . . 0.0 112.079 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 64' ' ' ALA . 2.1 mt-10 -72.39 -57.45 4.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.177 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -38.92 -30.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.065 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 59' ' ' MET . . . -76.63 -56.29 4.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -54.34 -55.47 28.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.382 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -56.0 -70.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.575 HG21 ' CD1' ' A' ' 40' ' ' PHE . 21.1 m -42.47 -39.34 2.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.215 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.584 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -49.17 -62.84 1.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 72.2 t -80.79 -50.42 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.308 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -45.37 -39.03 6.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.195 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' A' ' 67' ' ' THR . 4.3 t80 -78.01 -57.94 3.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.19 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.464 ' CZ ' HD11 ' A' ' 36' ' ' LEU . 14.5 m-85 -62.14 -12.03 17.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.14 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 69' ' ' VAL . 4.2 m -39.66 -29.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.011 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 72' ' ' TYR . 10.7 t -116.81 -45.9 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.795 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.39 131.83 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.566 ' OG1' ' CE2' ' A' ' 85' ' ' TYR . 1.3 m -97.62 142.41 24.52 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.979 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.529 ' CD ' HG21 ' A' ' 76' ' ' THR . 19.1 Cg_endo -93.86 128.93 0.62 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.022 2.481 . . . . 0.0 112.076 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 83' ' ' PRO . 3.3 t -115.89 149.18 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.192 0.52 . . . . 0.0 111.427 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.583 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -114.09 107.98 16.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.371 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.448 ' HB2' HD22 ' A' ' 79' ' ' LEU . 5.2 mtt180 62.93 -61.33 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 0.0 110.517 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -163.64 24.84 0.19 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.455 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.456 ' O ' HG23 ' A' ' 84' ' ' ILE . 1.2 tp60 -128.05 110.04 19.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.515 ' N ' HG12 ' A' ' 78' ' ' VAL . 37.8 Cg_endo -66.73 96.79 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.61 2.207 . . . . 0.0 112.385 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.3 pt -100.63 107.94 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.767 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.566 ' CE2' ' OG1' ' A' ' 76' ' ' THR . 6.4 m-85 -75.28 153.64 37.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.525 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.527 HG22 ' CG ' ' A' ' 68' ' ' MET . 5.7 mt -126.01 112.12 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.561 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 20' ' ' HIS . 9.1 mt-30 -125.45 166.27 16.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 111.1 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.571 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 74.6 m-85 -61.72 177.53 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.832 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -133.84 148.09 51.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.99 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.19 17.65 2.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.71 -153.74 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -73.49 76.23 1.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.872 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 92' ' ' LYS . 77.1 mt-10 -38.99 160.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.43 137.85 32.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -109.35 128.87 55.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.405 ' O ' ' CG ' ' A' ' 97' ' ' ASP . 0.9 OUTLIER -110.42 109.55 19.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.097 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.435 ' OD1' ' OG ' ' A' ' 98' ' ' SER . 3.4 p30 47.16 -165.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.435 ' OG ' ' OD1' ' A' ' 97' ' ' ASP . 0.3 OUTLIER 65.29 112.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.25 -147.94 5.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.459 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -128.52 114.53 19.54 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 0.0 111.064 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.64 120.73 7.32 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.675 2.25 . . . . 0.0 112.317 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.5 ' CB ' ' CD2' ' A' ' 88' ' ' PHE . 64.9 m -151.12 158.62 44.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.942 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -123.75 -47.99 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 91' ' ' HIS . 3.4 t -87.91 97.92 7.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.982 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.527 ' CG2' HG22 ' A' ' 86' ' ' ILE . 37.3 mm -82.41 110.52 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.292 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' GLN . 11.1 t-80 -80.59 156.51 26.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.487 ' CG2' HD13 ' A' ' 24' ' ' LEU . 1.4 mt -131.13 107.84 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.404 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 85' ' ' TYR . 2.4 ptm180 -96.38 176.03 6.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.503 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 43.52 32.94 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.975 0.416 . . . . 0.0 110.252 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.526 ' HG ' ' CD1' ' A' ' 84' ' ' ILE . 1.4 tt -118.08 99.72 51.9 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.94 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.523 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 29.4 Cg_endo -63.25 67.15 0.16 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.178 1.919 . . . . 0.0 111.163 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.572 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 47.7 mm -15.28 112.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 123.987 0.805 . . . . 0.0 112.085 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.6 t70 149.41 -10.71 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.51 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.52 ' O ' ' CG2' ' A' ' 29' ' ' THR . 6.0 m -60.96 -11.91 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.287 0.565 . . . . 0.0 111.809 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 28' ' ' VAL . 3.0 p 90.64 154.16 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.991 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -70.38 -41.39 73.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.512 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -42.35 -35.4 1.86 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.039 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.462 ' OE2' ' HB3' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -80.51 -45.28 17.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.865 0.364 . . . . 0.0 110.581 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.414 HG12 HG22 ' A' ' 57' ' ' ILE . 16.6 t -59.32 -58.2 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.969 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.5 mp -64.8 -40.68 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.661 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -41.58 -43.5 2.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.988 0.423 . . . . 0.0 110.292 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.519 ' CG ' ' OH ' ' A' ' 72' ' ' TYR . 7.4 mp -72.21 -36.71 69.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.5 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -70.82 -21.31 78.03 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.43 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.448 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -44.87 -61.31 2.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.74 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 36' ' ' LEU . 39.8 Cg_endo -67.05 -41.16 10.27 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.609 2.206 . . . . 0.0 111.648 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.577 ' CE2' ' HG2' ' A' ' 68' ' ' MET . 22.1 m-30 -54.39 -28.43 43.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.687 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 154.0 -106.92 0.31 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.191 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.572 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 17.3 mtpt -150.78 142.17 23.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.0 111.002 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 42.0 t -86.71 117.82 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.5 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -91.75 -6.01 52.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.437 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -172.46 155.32 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.877 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.526 ' CD2' ' CG2' ' A' ' 57' ' ' ILE . 2.7 tm? -151.14 113.81 4.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 6.6 tt -136.5 116.81 13.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.45 ' HB3' HG23 ' A' ' 26' ' ' ILE . 4.2 mtp -95.44 139.64 31.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -125.48 91.42 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.945 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.527 ' HD2' ' CG2' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -45.02 -26.18 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.938 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.35 127.82 10.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.53 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.7 OUTLIER 66.89 8.3 5.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.79 0.329 . . . . 0.0 110.901 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 16.7 m120 45.88 84.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.496 ' C ' ' CD1' ' A' ' 26' ' ' ILE . 67.5 mt-30 -159.2 135.71 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.595 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.537 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.29 166.6 10.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.794 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.537 ' CD1' ' C ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -139.72 117.45 11.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.478 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.526 ' CG2' ' CD2' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -127.37 152.07 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.618 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 35.7 mt-10 -120.05 142.06 49.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.41 . . . . 0.0 111.295 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.527 ' CE ' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -110.74 130.39 55.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.174 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.572 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 1.5 m-80 -68.56 -15.47 63.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.64 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.467 ' O ' ' HB1' ' A' ' 64' ' ' ALA . 12.3 t -132.21 125.34 30.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 111.271 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -43.46 -41.94 4.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.692 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.464 ' O ' ' OG1' ' A' ' 67' ' ' THR . 8.3 tt0 -57.12 -20.82 27.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.815 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.527 ' HB3' ' CE ' ' A' ' 59' ' ' MET . . . -84.47 -46.93 11.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.968 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 16' ' ' SER . . . -64.25 -49.44 71.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.042 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -64.77 -44.28 90.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.494 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.573 HG21 ' CD1' ' A' ' 40' ' ' PHE . 18.2 m -60.34 -32.74 71.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.577 ' HG2' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -58.36 -63.13 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.577 ' CG2' ' CZ ' ' A' ' 88' ' ' PHE . 8.4 t -70.31 -51.06 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.07 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' O ' ' OG1' ' A' ' 73' ' ' THR . 6.8 t30 -44.06 -63.96 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.964 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -55.59 -35.69 66.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.574 ' CD2' ' O ' ' A' ' 68' ' ' MET . 17.8 m-85 -83.23 9.86 9.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 53.6 m -59.52 -28.37 67.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.13 -45.73 1.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.8 t -83.43 110.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.467 HG23 ' HD2' ' A' ' 77' ' ' PRO . 4.1 m -88.17 149.18 44.57 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.845 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 76' ' ' THR . 18.3 Cg_endo -95.28 113.43 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.226 2.617 . . . . 0.0 112.3 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.1 t -100.26 160.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.988 0.423 . . . . 0.0 111.167 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -156.27 133.91 10.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.713 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 79' ' ' LEU . 2.0 ttt-85 37.24 30.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.94 0.4 . . . . 0.0 110.423 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 80.53 50.19 5.45 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.803 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.525 ' CB ' HD11 ' A' ' 79' ' ' LEU . 1.7 mm-40 -155.2 97.68 2.41 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.05 96.56 0.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.585 2.19 . . . . 0.0 112.496 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.526 ' CD1' ' HG ' ' A' ' 24' ' ' LEU . 4.4 pt -95.15 111.14 25.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.67 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 4.6 m-30 -72.52 152.94 41.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.521 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.527 HG22 ' CG2' ' A' ' 19' ' ' ILE . 6.5 mt -126.14 104.77 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.519 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -131.6 171.49 13.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 111.097 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.577 ' CZ ' ' CG2' ' A' ' 69' ' ' VAL . 1.4 m-85 -84.41 155.56 22.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.1 t -152.03 81.01 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.939 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 54.66 70.8 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.975 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.43 ' HA ' ' HB ' ' A' ' 18' ' ' VAL . 2.6 p-80 -44.77 96.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -128.79 90.31 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -39.42 137.34 0.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -78.34 111.55 14.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.38 154.09 19.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 3.8 p -81.51 106.28 13.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.148 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 96' ' ' THR . 15.7 m-20 66.07 175.0 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -54.54 9.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.838 0.351 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.439 ' C ' ' HD2' ' A' ' 15' ' ' PRO . . . 74.57 93.54 0.14 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.501 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.766 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 7.1 p -126.73 22.66 0.1 Allowed Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.766 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 35.0 Cg_endo -65.83 157.15 60.5 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.964 2.443 . . . . 0.0 112.264 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 6.5 t -175.4 146.8 0.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.89 -49.06 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.848 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 91' ' ' HIS . 52.2 t -88.05 126.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.069 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 48.0 mm -101.88 112.82 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.234 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.524 ' HB2' ' CB ' ' A' ' 89' ' ' SER . 4.9 t-80 -87.49 112.89 22.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.515 HG22 HD13 ' A' ' 21' ' ' ILE . 4.8 mt -82.78 127.9 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.303 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HG2' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -114.03 151.83 31.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.66 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 64.4 34.86 10.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.553 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.517 ' CD1' HD12 ' A' ' 84' ' ' ILE . 4.8 tp -119.84 129.23 25.46 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.891 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 26' ' ' ILE . 73.6 Cg_endo -76.63 69.64 6.67 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.484 2.123 . . . . 0.0 111.79 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.561 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 6.1 mm -30.64 108.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.236 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 2.2 t70 148.69 -19.48 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.673 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' ASP . 1.9 p -54.69 -162.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.857 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.8 p -107.91 145.79 33.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.104 0.478 . . . . 0.0 111.885 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 34' ' ' ILE . 7.8 mp0 -63.07 -46.7 86.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.635 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' OG ' ' A' ' 35' ' ' SER . . . -39.85 -29.36 0.17 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.782 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 30' ' ' GLU . 12.8 mm-40 -81.32 -55.03 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.254 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.1 t -61.26 -57.91 9.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.64 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -53.76 -50.26 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.066 179.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 31' ' ' GLY . 1.8 m -42.12 -43.43 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.39 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.509 HD21 ' CB ' ' A' ' 77' ' ' PRO . 19.9 mt -63.99 -33.91 76.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.36 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -81.62 -23.12 58.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.521 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.517 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -40.49 -58.47 2.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.826 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.1 Cg_endo -66.18 -40.28 15.83 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.616 2.21 . . . . 0.0 111.947 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 22.5 m-30 -55.23 -30.45 60.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.575 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 156.9 -104.41 0.25 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.094 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.577 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -150.43 137.95 19.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 111.03 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 34' ' ' ILE . 51.4 t -86.99 121.47 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.403 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.567 ' CG2' ' N ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -96.76 -0.73 47.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.574 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 44' ' ' THR . 44.4 t30 178.06 149.44 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.982 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.528 HD13 ' CG2' ' A' ' 57' ' ' ILE . 1.5 tp -139.91 103.17 4.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.47 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -115.5 113.85 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.935 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.449 ' HB3' HD13 ' A' ' 26' ' ' ILE . 2.4 mmm -99.65 99.58 10.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.51 ' N ' HD11 ' A' ' 26' ' ' ILE . 14.8 tp -82.04 97.41 8.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.524 ' CD ' HG23 ' A' ' 26' ' ' ILE . 3.4 mmtp -49.0 -21.5 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.303 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -79.34 126.07 7.29 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.698 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.507 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 1.8 mttt 71.36 7.19 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 111.314 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 8.2 m120 49.98 62.09 2.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.035 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 52' ' ' LYS . 14.0 mm-40 -139.98 134.9 32.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.54 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.77 166.82 10.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.81 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -146.85 115.92 6.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.244 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.528 ' CG2' HD13 ' A' ' 46' ' ' LEU . 6.8 pt -118.03 143.04 29.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.698 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.467 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 0.5 OUTLIER -109.64 124.38 51.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.23 -179.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.507 ' CE ' ' HB1' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -91.66 138.68 31.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.351 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.577 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 1.2 m-80 -67.25 -27.05 66.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.326 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 3.6 t -123.85 140.26 53.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.921 0.391 . . . . 0.0 111.377 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -54.43 -42.11 70.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.773 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -56.65 -29.28 62.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.632 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.507 ' HB1' ' CE ' ' A' ' 59' ' ' MET . . . -72.04 -52.35 17.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.874 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 68' ' ' MET . . . -51.88 -60.97 2.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.08 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -44.99 -68.49 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.565 HG22 ' CD1' ' A' ' 40' ' ' PHE . 86.3 m -40.91 -36.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.979 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.566 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -51.67 -65.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.833 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.577 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 78.9 t -79.7 -49.26 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.172 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -41.99 -57.16 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.027 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -61.25 -50.37 73.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.053 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.47 ' OH ' ' HB3' ' A' ' 36' ' ' LEU . 20.2 m-30 -73.76 -0.42 15.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.259 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 69' ' ' VAL . 95.0 m -51.82 -20.68 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.931 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 t -127.21 -51.87 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.83 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.4 p -89.73 123.41 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.03 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.526 HG23 ' CD ' ' A' ' 77' ' ' PRO . 1.4 m -99.02 142.2 24.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.986 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.526 ' CD ' HG23 ' A' ' 76' ' ' THR . 45.6 Cg_endo -96.94 109.63 0.1 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.271 2.647 . . . . 0.0 112.292 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.514 HG22 ' N ' ' A' ' 79' ' ' LEU . 1.4 m -100.86 -179.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.514 ' N ' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -154.95 122.97 5.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.684 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 80' ' ' ARG . 2.8 ttp180 63.32 11.82 5.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.715 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.81 19.97 15.89 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.5 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.43 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 4.5 mm-40 -116.59 97.61 50.43 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.82 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.441 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 17.2 Cg_exo -67.24 115.41 3.65 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.969 2.446 . . . . 0.0 112.55 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.517 HD12 ' CD1' ' A' ' 24' ' ' LEU . 3.3 pt -122.01 107.82 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.446 ' O ' HG23 ' A' ' 21' ' ' ILE . 3.5 m-85 -76.03 150.75 37.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.661 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 5.6 mt -126.11 109.67 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 20' ' ' HIS . 2.5 mt-30 -117.13 173.29 6.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.128 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.577 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 47.9 m-85 -71.73 156.12 39.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.95 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.524 ' CB ' ' HB2' ' A' ' 20' ' ' HIS . 4.0 t -120.08 145.76 46.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 92' ' ' LYS . 1.9 m-20 -64.48 64.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.767 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.506 ' NE2' ' HG2' ' A' ' 93' ' ' GLU . 81.8 t60 38.04 -92.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.996 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.545 ' O ' ' CG ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER 51.83 80.47 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.08 0.467 . . . . 0.0 110.137 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.506 ' HG2' ' NE2' ' A' ' 91' ' ' HIS . 0.9 OUTLIER -48.4 118.43 2.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.911 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.9 mt -72.67 149.33 43.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.02 137.08 39.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.038 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 85.6 m -127.19 133.32 50.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.101 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -57.57 175.3 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 47.59 81.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.898 0.38 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.64 171.05 33.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.495 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.69 161.8 28.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 111.141 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 16' ' ' SER . 51.4 Cg_exo -52.71 -62.58 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.738 2.292 . . . . 0.0 112.316 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.569 ' OG ' ' CD1' ' A' ' 88' ' ' PHE . 42.2 t 68.53 159.01 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.943 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -166.44 -42.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.94 107.94 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.109 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.521 ' CG2' HG23 ' A' ' 86' ' ' ILE . 1.4 mp -93.58 113.38 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.577 ' CD2' ' HB3' ' A' ' 54' ' ' GLN . 4.5 t-80 -84.24 117.5 23.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.361 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.524 ' CD1' HG11 ' A' ' 33' ' ' VAL . 9.9 mt -87.76 98.32 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.501 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -77.57 177.29 8.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.452 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER 37.19 38.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 110.555 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -123.65 99.94 38.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.934 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.518 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 34.6 Cg_exo -57.33 74.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.569 2.179 . . . . 0.0 111.771 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.555 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 16.2 mm -33.23 119.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.1 t0 150.95 -19.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.952 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.513 HG23 ' N ' ' A' ' 29' ' ' THR . 6.1 m -54.99 -153.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.797 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.513 ' N ' HG23 ' A' ' 28' ' ' VAL . 40.6 p -112.05 145.7 39.23 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.06 0.457 . . . . 0.0 111.815 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' CD ' ' CD1' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -65.28 -56.16 14.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.545 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.89 -33.15 0.4 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.999 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.526 ' HG2' ' CG ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -68.63 -58.33 4.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.476 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.524 HG11 ' CD1' ' A' ' 21' ' ' ILE . 75.9 t -59.02 -48.52 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.622 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.44 ' CD1' ' CG ' ' A' ' 30' ' ' GLU . 1.6 mp -65.08 -38.2 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.513 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -47.51 -41.44 20.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.525 ' CD2' ' OH ' ' A' ' 72' ' ' TYR . 8.5 mp -71.5 -33.53 69.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.2 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -69.92 -25.25 75.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.346 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.51 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -41.76 -59.77 2.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 110.856 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 28.5 Cg_endo -62.87 -23.06 74.27 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.67 2.247 . . . . 0.0 111.883 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.588 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 13.7 m-30 -76.64 -38.69 54.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.507 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.4 ' HA3' ' HB1' ' A' ' 64' ' ' ALA . . . 161.13 -102.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.158 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.525 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 3.4 mtmm -150.52 146.55 26.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.777 0.323 . . . . 0.0 110.987 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -86.86 112.55 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.525 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.52 ' CG2' ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -88.19 -13.64 40.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.202 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.5 OUTLIER 170.93 119.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.857 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.524 ' CD2' HG22 ' A' ' 57' ' ' ILE . 1.2 tm? -123.83 117.41 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.999 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.457 ' N ' HD22 ' A' ' 46' ' ' LEU . 8.9 tt -117.84 128.55 54.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.848 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.464 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 9.1 mtp -106.16 139.05 41.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.509 ' N ' HG23 ' A' ' 26' ' ' ILE . 37.3 mt -120.22 103.85 9.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.521 ' N ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -55.51 -17.37 5.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . -84.08 116.52 4.27 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.439 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER 82.65 -8.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 111.059 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.518 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 25.6 m120 61.29 77.53 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.968 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.577 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 48.8 mt-30 -155.06 130.8 9.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.54 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.72 162.54 14.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.779 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.604 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -144.9 116.11 7.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.367 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.524 HG22 ' CD2' ' A' ' 46' ' ' LEU . 8.0 pt -110.19 155.04 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.815 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.467 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 0.0 OUTLIER -122.04 119.11 30.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.534 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 32.7 mmm -90.77 142.54 27.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.698 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 0.9 OUTLIER -72.88 -23.87 60.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.912 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 8.5 t -130.35 137.39 49.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.229 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -48.29 -42.85 32.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.46 ' O ' ' OG1' ' A' ' 67' ' ' THR . 10.8 mp0 -53.03 -30.07 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.749 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 59' ' ' MET . . . -77.25 -47.28 20.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.988 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -65.75 -58.94 4.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.045 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 6.4 m-20 -54.68 -59.5 4.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.813 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 63' ' ' GLU . 18.6 m -40.93 -49.0 3.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.977 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 40' ' ' PHE . 2.1 ttm -46.18 -63.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.82 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 39.1 t -68.91 -15.97 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.136 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.462 ' O ' ' OG1' ' A' ' 73' ' ' THR . 1.2 t-20 -72.82 -64.12 1.03 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 5.0 t80 -60.86 -24.4 65.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.525 ' OH ' ' CD2' ' A' ' 36' ' ' LEU . 24.5 m-85 -93.07 19.99 7.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.059 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 91.6 m -72.03 -31.1 65.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -118.79 -50.55 2.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.789 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.8 t -82.48 119.92 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.982 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.524 HG23 ' CD ' ' A' ' 77' ' ' PRO . 1.5 m -87.59 141.93 32.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.921 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.524 ' CD ' HG23 ' A' ' 76' ' ' THR . 35.5 Cg_endo -95.81 142.88 1.08 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.081 2.52 . . . . 0.0 112.255 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 83' ' ' PRO . 2.0 m -129.21 -179.69 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.165 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.526 ' CG ' ' HG2' ' A' ' 32' ' ' GLU . 0.4 OUTLIER -141.75 108.5 5.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.467 ' HG3' HD23 ' A' ' 79' ' ' LEU . 21.1 mtm-85 61.26 14.02 5.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.502 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.29 7.78 20.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.361 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.445 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 6.3 tp60 -113.54 103.75 55.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.974 0.416 . . . . 0.0 110.896 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.521 ' HA ' ' CG1' ' A' ' 78' ' ' VAL . 24.6 Cg_exo -63.01 121.02 8.74 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.943 2.429 . . . . 0.0 112.617 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.524 HG21 ' CD2' ' A' ' 24' ' ' LEU . 2.4 pt -122.34 107.56 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.513 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.456 ' O ' HG22 ' A' ' 21' ' ' ILE . 20.4 m-85 -62.08 141.54 58.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.036 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.524 ' CG2' ' HG2' ' A' ' 68' ' ' MET . 6.5 mt -126.55 107.92 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.466 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 20' ' ' HIS . 1.0 OUTLIER -152.88 169.55 22.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 111.192 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 1.1 m-85 -74.8 137.74 42.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 20' ' ' HIS . 3.9 t -152.39 82.56 1.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.882 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 89' ' ' SER . 11.5 m-80 82.51 -152.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.54 -58.98 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.931 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt 38.88 64.6 0.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -39.06 139.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -88.0 110.27 20.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.84 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -105.53 109.47 21.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.818 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.5 p -115.13 131.25 56.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.147 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 98' ' ' SER . 0.2 OUTLIER -72.69 90.32 1.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 59.1 p 173.74 53.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.429 ' O ' HG11 ' A' ' 14' ' ' VAL . 71.0 m . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.88 0.371 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 53.04 -98.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.464 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.521 HG23 ' CA ' ' A' ' 62' ' ' GLU . 7.6 p -37.11 111.98 0.55 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.18 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.578 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 55.5 Cg_endo -70.24 -47.99 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.714 2.276 . . . . 0.0 112.395 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -157.96 159.45 36.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.061 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.23 -24.64 25.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.887 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.7 t -87.86 144.27 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.035 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.478 ' CG2' HG22 ' A' ' 86' ' ' ILE . 34.8 mm -122.4 107.89 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.213 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' GLN . 5.4 t-160 -78.82 121.9 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.806 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.512 ' CD1' HG12 ' A' ' 86' ' ' ILE . 4.3 mm -100.45 112.65 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.241 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 174.16 6.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.795 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER 45.06 44.01 7.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.675 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.522 ' CD1' HG22 ' A' ' 84' ' ' ILE . 3.2 tp -134.46 109.34 11.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.52 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 33.0 Cg_endo -64.51 74.84 0.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.401 2.067 . . . . 0.0 111.729 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 15.3 mm -31.83 117.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.052 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 3.6 t70 151.16 -19.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.162 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 29' ' ' THR . 5.7 m -54.86 -155.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.881 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.504 ' N ' HG22 ' A' ' 28' ' ' VAL . 81.2 p -112.38 145.03 40.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 111.674 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 34' ' ' ILE . 32.6 mt-10 -65.36 -50.6 64.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.438 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.99 -28.33 0.23 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.036 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.457 ' OE1' HD21 ' A' ' 79' ' ' LEU . 37.5 mt-10 -78.46 -52.15 8.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.403 . . . . 0.0 110.494 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.54 -57.47 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.729 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -53.14 -40.74 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 8.0 t -54.94 -43.07 73.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.698 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 6.3 mp -74.87 -11.27 60.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.761 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.65 -22.13 8.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.769 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.43 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -50.73 -52.54 55.77 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.66 0.267 . . . . 0.0 110.985 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 39.7 Cg_exo -60.01 -24.2 75.7 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.484 2.123 . . . . 0.0 111.668 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.588 ' CD2' ' HA ' ' A' ' 68' ' ' MET . 79.0 m-85 -82.03 7.24 13.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.035 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.13 -108.67 1.0 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.292 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.521 ' HB3' ' ND2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -150.55 146.05 26.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.101 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.2 t -99.81 97.04 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -87.8 22.23 2.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.302 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.9 OUTLIER 171.67 147.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.069 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.456 HD12 HG23 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -155.05 97.26 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.828 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.476 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 2.3 tm? -105.36 122.29 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.011 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.494 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 6.9 mtt -102.17 116.82 33.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -88.88 101.06 13.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.499 ' CD ' HG21 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -82.03 48.13 1.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.98 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -129.57 -60.49 0.1 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.249 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -108.32 12.3 26.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 24.8 m120 62.72 64.89 0.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.914 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.51 ' N ' HG12 ' A' ' 26' ' ' ILE . 78.3 mt-30 -148.0 134.17 19.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.843 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.538 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.66 157.68 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.735 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -140.95 115.85 9.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.239 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.468 ' O ' HG13 ' A' ' 57' ' ' ILE . 22.5 pt -114.91 138.18 45.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.797 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -104.6 102.7 12.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.993 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.457 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -62.9 128.31 35.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.408 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -48.13 -39.81 21.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.31 -179.312 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.11 163.43 16.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.872 0.367 . . . . 0.0 111.238 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.521 ' CA ' HG23 ' A' ' 14' ' ' VAL . 5.6 mp0 -71.68 -44.75 63.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.828 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -55.13 -30.51 59.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.423 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 40' ' ' PHE . . . -69.15 -46.51 67.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.643 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 16' ' ' SER . . . -58.12 -60.0 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.255 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -42.01 -58.28 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.962 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.558 HG21 ' CE2' ' A' ' 40' ' ' PHE . 22.3 m -50.81 -51.84 46.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.326 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.588 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 6.3 tpt -36.3 -60.15 0.59 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.071 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 76.3 t -79.41 -26.43 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.424 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' O ' ' OG1' ' A' ' 73' ' ' THR . 1.5 t-20 -58.69 -64.12 1.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.079 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.62 -36.22 83.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.054 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CE1' ' HG3' ' A' ' 77' ' ' PRO . 22.4 m-85 -87.93 20.06 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.983 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 69' ' ' VAL . 87.7 m -68.7 -44.57 73.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.024 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.6 t -113.62 -39.82 3.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.769 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.54 108.91 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.474 ' OG1' ' CE2' ' A' ' 85' ' ' TYR . 2.2 m -93.81 122.3 62.53 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.065 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.568 ' HG3' ' CE1' ' A' ' 72' ' ' TYR . 74.2 Cg_endo -96.79 120.17 0.18 Allowed 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 123.064 2.509 . . . . 0.0 112.215 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.483 ' CG1' ' HA ' ' A' ' 83' ' ' PRO . 1.4 m -89.34 -179.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.235 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.552 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -141.71 133.53 27.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.688 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.525 ' HB2' ' CD2' ' A' ' 79' ' ' LEU . 0.5 OUTLIER 36.25 30.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.443 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 85.57 51.98 3.5 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.871 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.529 ' HB3' ' CD1' ' A' ' 79' ' ' LEU . 1.5 tt0 -155.2 97.74 2.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.984 0.421 . . . . 0.0 110.799 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.483 ' HA ' ' CG1' ' A' ' 78' ' ' VAL . 52.1 Cg_exo -54.8 107.28 0.22 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.866 2.377 . . . . 0.0 112.658 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.522 HG22 ' CD1' ' A' ' 24' ' ' LEU . 7.1 pt -116.83 107.75 23.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.701 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CE2' ' OG1' ' A' ' 76' ' ' THR . 27.7 m-85 -71.28 149.08 46.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.317 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.512 HG12 ' CD1' ' A' ' 21' ' ' ILE . 4.5 mt -124.68 103.81 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.631 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 20' ' ' HIS . 2.8 mt-30 -125.16 172.05 9.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.883 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.578 ' CZ ' ' CG ' ' A' ' 15' ' ' PRO . 59.9 m-85 -68.88 -174.88 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.5 170.4 15.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.33 43.63 1.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -118.36 -177.83 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.57 -82.25 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.31 136.86 28.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.973 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mp -75.25 135.48 40.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.97 125.15 51.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 97' ' ' ASP . 0.9 OUTLIER -124.48 120.05 30.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.123 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER 42.99 -170.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.927 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 p -139.82 111.46 7.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.865 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.802 0.334 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 47.08 91.05 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.457 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 62' ' ' GLU . 1.9 t -63.86 130.19 94.3 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.888 0.375 . . . . 0.0 111.194 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HG2' ' CZ ' ' A' ' 88' ' ' PHE . 75.1 Cg_exo -49.45 -64.68 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.731 2.287 . . . . 0.0 112.328 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 0.3 OUTLIER 165.36 156.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.986 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HG3' ' OE1' ' A' ' 58' ' ' GLU . 15.1 ptp180 -72.04 -16.98 62.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 87.5 t -87.92 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.497 HG21 ' CG2' ' A' ' 86' ' ' ILE . 24.1 mm -127.07 109.24 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.642 ' CD2' ' CZ ' ' A' ' 56' ' ' PHE . 11.5 t-160 -78.93 110.55 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.795 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.535 HG23 ' CD2' ' A' ' 24' ' ' LEU . 25.7 mt -82.91 130.44 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.524 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 3.0 ptt180 -112.4 177.24 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 44.15 30.93 0.48 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.684 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.535 ' CD2' HG23 ' A' ' 21' ' ' ILE . 5.8 tp -117.59 112.85 38.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 21.9 Cg_exo -64.48 69.55 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.399 2.066 . . . . 0.0 111.391 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.572 ' CG2' ' CD ' ' A' ' 50' ' ' LYS . 5.1 mm -33.97 111.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.371 0.605 . . . . 0.0 110.717 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 4.4 t70 150.7 -22.9 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.98 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 27' ' ' ASP . 2.1 p -56.79 -157.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.608 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.421 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 38.1 p -98.73 144.16 28.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.217 0.532 . . . . 0.0 112.035 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.65 -48.3 27.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.36 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.61 -31.4 0.4 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.706 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.51 ' HG2' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -79.22 -51.9 8.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 110.398 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 t -56.08 -51.09 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.775 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.441 HG21 HG21 ' A' ' 43' ' ' VAL . 1.5 mp -66.51 -50.4 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.506 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 14.9 t -44.76 -40.57 6.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.378 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.511 ' CD1' ' HB2' ' A' ' 77' ' ' PRO . 13.4 mt -63.26 -42.0 99.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.43 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -82.09 -8.99 85.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.387 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.517 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 1.3 tp -55.06 -60.05 9.16 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 110.724 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 19.7 Cg_endo -60.46 -17.85 50.34 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.611 2.208 . . . . 0.0 111.833 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 28.0 m-85 -76.99 -5.65 49.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.886 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.429 ' O ' ' HG2' ' A' ' 42' ' ' LYS . . . 141.1 -103.21 0.33 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.134 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.581 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 1.5 mmtp -150.46 138.88 20.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 111.067 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.441 HG21 HG21 ' A' ' 34' ' ' ILE . 54.0 t -89.2 120.23 37.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -95.17 -11.98 27.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.157 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 8.7 t30 174.08 146.53 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.839 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -144.6 125.03 13.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.818 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.516 ' N ' HD23 ' A' ' 46' ' ' LEU . 7.2 tt -131.33 123.05 27.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.039 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.515 ' CA ' HD12 ' A' ' 26' ' ' ILE . 3.3 mmm -89.18 109.77 20.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.749 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 26' ' ' ILE . 13.6 tp -84.14 109.46 17.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.081 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.572 ' CD ' ' CG2' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -86.84 44.7 1.19 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.819 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -115.84 -42.47 0.72 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.554 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 28.12 2.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 110.963 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 18.9 m120 57.93 49.18 12.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.522 ' HB3' ' NE2' ' A' ' 20' ' ' HIS . 47.8 mt-30 -134.4 140.08 46.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.363 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.54 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.9 172.55 6.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.65 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.642 ' CZ ' ' CD2' ' A' ' 20' ' ' HIS . 11.9 m-85 -148.01 115.71 6.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.355 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 45' ' ' ASN . 6.6 pt -114.41 155.13 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.662 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.525 ' CB ' ' OG1' ' A' ' 44' ' ' THR . 6.7 mm-40 -118.36 122.9 43.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.992 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.527 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 24.3 mmm -94.26 133.47 37.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.515 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.581 ' ND2' ' CB ' ' A' ' 42' ' ' LYS . 0.9 OUTLIER -71.77 -24.82 61.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 110.924 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 9.0 t -125.0 129.0 49.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.17 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.46 ' HB3' HG13 ' A' ' 14' ' ' VAL . 2.0 mp0 -44.68 -38.56 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.846 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -59.01 -26.45 64.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 59' ' ' MET . . . -76.38 -51.35 12.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.059 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.442 ' N ' ' HG3' ' A' ' 59' ' ' MET . . . -57.05 -64.12 0.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.058 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.442 ' OD1' ' HG2' ' A' ' 15' ' ' PRO . 2.3 m-20 -44.73 -60.06 2.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.756 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.8 m -48.06 -35.88 12.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.034 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.58 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 9.4 tpt -51.52 -62.26 1.73 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.959 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.574 HG21 ' CG ' ' A' ' 88' ' ' PHE . 46.1 t -77.53 -15.91 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.366 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.464 ' O ' ' OG1' ' A' ' 73' ' ' THR . 11.5 t-20 -76.46 -64.19 1.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.131 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -56.66 -38.47 72.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.128 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.526 ' CE2' ' CZ ' ' A' ' 40' ' ' PHE . 24.7 m-85 -84.72 12.78 6.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.07 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 89.0 m -67.88 -34.73 77.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.22 -40.71 3.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.08 156.93 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.009 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.466 HG22 ' HD2' ' A' ' 77' ' ' PRO . 2.5 m -122.64 147.3 50.16 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.776 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.511 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 28.9 Cg_endo -96.39 75.73 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.338 2.692 . . . . 0.0 112.386 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.46 ' O ' HD21 ' A' ' 79' ' ' LEU . 12.3 t -70.91 158.08 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.227 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.51 ' CD1' ' HG2' ' A' ' 32' ' ' GLU . 53.5 mt -137.63 113.44 9.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.108 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 51.64 20.23 1.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 83' ' ' PRO . . . 105.99 8.74 33.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.668 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.436 ' C ' HG13 ' A' ' 78' ' ' VAL . 5.5 tp-100 -109.27 97.5 26.44 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.829 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 81' ' ' GLY . 13.5 Cg_exo -69.93 126.75 13.55 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 123.045 2.496 . . . . 0.0 112.434 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.526 HG22 ' CD1' ' A' ' 24' ' ' LEU . 8.0 pt -135.35 107.45 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.524 ' HB2' ' CG ' ' A' ' 22' ' ' ARG . 3.3 m-85 -75.03 151.08 38.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.397 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.497 ' CG2' HG21 ' A' ' 19' ' ' ILE . 4.4 mt -125.91 122.05 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.562 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.471 ' NE2' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -130.91 169.98 15.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.149 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.574 ' CG ' HG21 ' A' ' 69' ' ' VAL . 58.8 m-85 -64.09 -179.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.021 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 20' ' ' HIS . 87.9 p -113.76 -171.38 1.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -125.74 -39.6 2.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -68.13 -172.81 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 -43.69 3.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.5 163.28 27.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.98 118.41 20.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -63.44 120.58 11.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.28 135.39 54.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.112 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -101.09 51.64 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -133.23 95.74 3.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.849 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 98' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.942 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.796 0.331 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.08 63.48 0.61 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 14' ' ' VAL . 8.4 p -51.61 118.84 12.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.796 0.331 . . . . 0.0 111.123 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.48 115.89 2.5 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.704 2.269 . . . . 0.0 112.352 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.46 ' OG ' ' ND2' ' A' ' 66' ' ' ASN . 87.6 p -140.17 159.86 41.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.922 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -170.54 -45.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.917 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.498 ' CG1' ' HB3' ' A' ' 89' ' ' SER . 7.5 p -87.94 138.59 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.511 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 47.2 mm -119.14 105.52 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 87' ' ' GLN . 5.0 t-160 -78.98 107.59 11.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.718 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.446 HG21 ' O ' ' A' ' 85' ' ' TYR . 9.5 mt -85.22 118.52 32.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.402 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -100.73 170.08 8.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.483 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.08 32.4 2.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.981 0.42 . . . . 0.0 110.253 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.527 ' CD1' HD13 ' A' ' 84' ' ' ILE . 4.2 tp -116.99 123.34 30.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.172 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' ILE . 57.1 Cg_endo -71.05 75.6 1.74 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.426 2.084 . . . . 0.0 111.597 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.577 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 17.9 mm -30.91 148.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.117 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 96.43 7.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.788 -178.394 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.491 ' N ' ' CE ' ' A' ' 48' ' ' MET . 0.9 OUTLIER -63.25 -151.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.027 179.341 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 32' ' ' GLU . 71.8 p -120.26 148.9 43.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.007 0.432 . . . . 0.0 111.749 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -66.28 -66.0 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.756 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.05 -29.53 0.2 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.154 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.51 ' N ' ' OE1' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -82.51 -61.21 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.713 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.9 t -55.21 -53.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.851 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.506 HD13 ' CD2' ' A' ' 46' ' ' LEU . 1.4 mp -62.66 -33.99 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.279 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -51.07 -36.23 39.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.054 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.528 ' CD2' ' OH ' ' A' ' 72' ' ' TYR . 2.0 mt -70.64 -46.9 62.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.21 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.83 -13.6 82.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.281 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.515 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -48.79 -60.28 4.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.78 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 20.2 Cg_endo -60.77 -34.95 91.01 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.636 2.224 . . . . 0.0 111.731 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.584 ' CD2' ' HA ' ' A' ' 68' ' ' MET . 39.7 m-85 -63.25 -12.39 28.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.999 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.73 -106.86 0.36 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.122 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.472 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -150.61 150.22 30.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.909 0.385 . . . . 0.0 111.139 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.4 HG11 HG12 ' A' ' 34' ' ' ILE . 55.0 t -102.58 121.19 53.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.307 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.518 ' CG2' ' N ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -102.64 8.24 39.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.513 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.95 153.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.52 ' CD1' HG21 ' A' ' 57' ' ' ILE . 17.1 tp -140.53 131.2 25.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.949 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 tp -136.18 137.28 40.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.491 ' CE ' ' N ' ' A' ' 28' ' ' VAL . 4.9 mmm -125.09 94.77 4.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.776 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.477 ' O ' HG13 ' A' ' 26' ' ' ILE . 27.6 tp -76.43 92.9 3.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.505 ' HE3' ' CA ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -60.65 159.23 11.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.011 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.71 -73.49 0.24 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.482 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -83.07 -8.87 59.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.788 0.327 . . . . 0.0 111.018 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER 68.65 47.43 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.483 ' C ' ' CD1' ' A' ' 26' ' ' ILE . 17.2 mt-30 -129.54 126.96 39.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.728 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.541 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.15 161.41 15.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.784 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -140.94 115.89 9.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.396 -179.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.52 HG21 ' CD1' ' A' ' 46' ' ' LEU . 7.1 pt -112.75 140.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.579 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -103.53 102.97 12.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.27 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 2.7 mtp -74.64 147.39 41.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.122 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.518 ' N ' ' CG2' ' A' ' 44' ' ' THR . 0.2 OUTLIER -64.2 -55.13 23.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.399 -178.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -108.03 169.81 8.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 111.451 -179.094 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' N ' ' OG1' ' A' ' 61' ' ' THR . 24.1 mt-10 -71.33 -47.75 54.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.64 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.463 ' O ' ' OG1' ' A' ' 67' ' ' THR . 5.7 mt-10 -49.33 -31.6 9.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.262 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 40' ' ' PHE . . . -70.62 -51.6 27.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.769 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HA ' ' SD ' ' A' ' 59' ' ' MET . . . -67.14 -66.1 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.315 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.46 ' ND2' ' OG ' ' A' ' 16' ' ' SER . 53.4 m-80 -37.92 -45.32 0.85 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.989 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.567 HG21 ' CD2' ' A' ' 40' ' ' PHE . 43.7 m -64.68 -53.44 47.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.141 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.584 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -35.36 -64.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.041 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.577 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 75.1 t -68.47 -46.69 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.286 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -46.47 -64.41 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.174 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -62.11 -38.1 87.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.562 ' CE1' ' HB3' ' A' ' 77' ' ' PRO . 18.1 m-85 -87.73 19.66 3.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 69' ' ' VAL . 20.3 m -83.78 -35.36 24.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.923 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 t -113.29 -40.51 3.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.49 HG11 ' N ' ' A' ' 76' ' ' THR . 68.9 t -75.53 138.63 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.49 ' N ' HG11 ' A' ' 75' ' ' VAL . 2.4 m -90.42 112.11 51.07 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.275 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.562 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 58.8 Cg_endo -98.05 109.62 0.08 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 123.24 2.627 . . . . 0.0 112.299 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.446 ' HB ' ' C ' ' A' ' 82' ' ' GLN . 0.7 OUTLIER -110.71 157.62 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 111.002 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.452 HD23 ' HG3' ' A' ' 32' ' ' GLU . 3.4 tm? -107.26 100.92 10.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.523 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.75 -58.72 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.997 0.427 . . . . 0.0 110.493 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.39 24.65 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.417 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.446 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -129.64 104.57 17.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.717 0.294 . . . . 0.0 110.584 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HA ' ' CB ' ' A' ' 78' ' ' VAL . 28.0 Cg_endo -63.45 117.79 4.73 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.563 2.175 . . . . 0.0 112.634 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.4 pt -131.63 111.28 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.628 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.466 ' OH ' ' OG1' ' A' ' 76' ' ' THR . 19.8 m-85 -77.9 165.68 23.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.442 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 87' ' ' GLN . 39.6 mm -119.54 142.56 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.827 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.517 ' N ' HG23 ' A' ' 86' ' ' ILE . 2.1 mm-40 -141.98 170.72 15.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.06 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.577 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 32.7 m-85 -91.15 168.48 11.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.498 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . 3.8 t -146.93 166.36 27.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.836 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.416 ' O ' ' CG ' ' A' ' 90' ' ' ASN . 25.2 t30 -178.12 49.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.84 -80.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.977 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -74.43 56.14 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.918 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -42.84 152.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.4 ' CD1' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -110.78 127.87 55.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.95 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -54.79 145.65 19.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.1 p -82.12 128.91 34.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -164.93 175.76 9.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -66.64 0.85 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.971 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.8 0.333 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.97 -97.08 2.34 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.396 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.406 HG21 ' OD1' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -115.08 132.39 23.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.894 0.378 . . . . 0.0 111.103 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 16' ' ' SER . 71.1 Cg_exo -50.55 129.62 27.21 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.729 2.286 . . . . 0.0 112.325 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 0.3 OUTLIER 175.14 119.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.407 ' HD3' ' HG2' ' A' ' 93' ' ' GLU . 1.1 ttt85 -138.87 -57.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.428 HG11 ' O ' ' A' ' 91' ' ' HIS . 7.3 p -88.63 104.94 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.093 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.505 ' CG2' ' HG2' ' A' ' 68' ' ' MET . 47.3 mm -84.04 117.94 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.552 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 3.2 t-160 -82.59 153.0 25.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.525 ' CD1' HG12 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -123.31 110.54 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.083 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.46 171.0 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER 44.22 40.19 3.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.892 0.377 . . . . 0.0 110.297 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.534 HD12 ' CD1' ' A' ' 84' ' ' ILE . 8.1 tp -123.73 117.39 27.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.34 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.465 ' O ' ' C ' ' A' ' 26' ' ' ILE . 39.2 Cg_endo -67.03 74.09 0.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.299 1.999 . . . . 0.0 111.209 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.58 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 29.1 mm -30.06 148.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.208 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER 100.81 10.59 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.657 -178.192 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.14 -151.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.877 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 32' ' ' GLU . 71.7 p -124.76 145.14 49.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.978 0.418 . . . . 0.0 111.613 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.473 ' O ' HG13 ' A' ' 34' ' ' ILE . 79.0 mt-10 -62.78 -63.73 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.57 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.69 -31.11 0.23 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.785 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.458 ' HB2' ' OG1' ' A' ' 29' ' ' THR . 7.3 mm-40 -79.45 -63.73 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 110.248 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.7 t -56.77 -63.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.408 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.524 HG23 ' CG2' ' A' ' 43' ' ' VAL . 1.6 mt -46.8 -47.62 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.964 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -42.7 -50.68 5.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.376 179.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.509 ' O ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 mp -57.47 -31.48 66.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.263 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -90.45 -16.42 55.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.333 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.534 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 19.8 mt -48.96 -56.42 15.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.66 0.267 . . . . 0.0 110.986 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 31.8 Cg_endo -63.88 -18.63 64.65 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.526 2.15 . . . . 0.0 112.11 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 37.0 m-85 -77.26 -14.67 59.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.718 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.94 -101.66 0.24 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.124 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -150.62 149.43 29.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.825 0.345 . . . . 0.0 111.09 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.524 ' CG2' HG23 ' A' ' 34' ' ' ILE . 55.0 t -100.08 115.85 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.343 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.505 ' CG2' ' N ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -96.56 2.11 52.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.522 -178.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.6 OUTLIER 170.83 142.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.937 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.486 ' CD1' HG23 ' A' ' 57' ' ' ILE . 39.7 tp -144.4 115.4 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.021 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.62 138.3 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.476 ' HB3' HG23 ' A' ' 26' ' ' ILE . 5.3 mmm -116.14 103.79 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -89.55 91.48 8.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.812 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.517 ' HE2' ' CB ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -45.63 -26.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.887 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . -77.79 118.93 5.12 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.458 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 6.6 mtmm 85.09 -10.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 0.0 111.013 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.49 ' HA ' ' CG1' ' A' ' 26' ' ' ILE . 0.6 OUTLIER 61.89 58.75 1.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.053 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.466 ' C ' ' CD1' ' A' ' 26' ' ' ILE . 3.4 mm-40 -137.72 133.15 33.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.734 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.546 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.16 161.75 14.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.655 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -143.76 115.86 8.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.528 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.486 HG23 ' CD1' ' A' ' 46' ' ' LEU . 5.9 pt -109.9 154.93 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.259 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.465 ' O ' HG23 ' A' ' 44' ' ' THR . 0.7 OUTLIER -116.33 111.18 19.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.807 0.337 . . . . 0.0 111.536 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.522 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 8.5 mmm -80.14 137.42 36.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.023 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.505 ' N ' ' CG2' ' A' ' 44' ' ' THR . 0.2 OUTLIER -65.49 -41.3 93.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.419 . . . . 0.0 110.633 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -119.23 176.61 5.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.095 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.52 ' N ' ' OG1' ' A' ' 61' ' ' THR . 1.6 mp0 -73.73 -50.38 21.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.838 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -46.02 -29.32 1.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.643 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 59' ' ' MET . . . -75.94 -51.08 13.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.016 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.504 ' CA ' HD11 ' A' ' 19' ' ' ILE . . . -64.09 -61.03 2.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.099 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.406 ' OD1' HG21 ' A' ' 14' ' ' VAL . 3.3 m-80 -44.78 -62.09 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.665 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.57 ' CG2' ' CD2' ' A' ' 40' ' ' PHE . 88.9 m -46.22 -51.83 13.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.98 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.578 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 7.1 tpt -34.63 -61.17 0.41 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.98 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.62 ' CG1' ' CE2' ' A' ' 88' ' ' PHE . 68.9 t -79.75 -54.59 10.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.246 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.405 ' O ' ' HB ' ' A' ' 73' ' ' THR . 20.5 m-20 -38.33 -64.18 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.305 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -60.97 -45.52 94.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.192 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 68' ' ' MET . 13.1 m-30 -73.42 -1.0 16.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.249 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 69' ' ' VAL . 46.8 m -59.16 -36.77 75.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 110.817 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.7 m -112.71 -44.08 3.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.6 t -80.92 126.69 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.571 ' OG1' ' CZ ' ' A' ' 85' ' ' TYR . 3.0 m -89.31 134.94 31.9 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.07 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.467 ' O ' HG12 ' A' ' 84' ' ' ILE . 46.5 Cg_endo -97.69 80.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.982 2.455 . . . . 0.0 112.292 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.509 HG21 ' N ' ' A' ' 79' ' ' LEU . 1.4 p -92.21 158.73 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.509 ' N ' HG21 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -148.6 132.09 16.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.229 -179.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.9 18.8 1.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.18 15.3 52.03 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.66 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.445 ' C ' HG23 ' A' ' 78' ' ' VAL . 74.0 mt-30 -113.68 96.78 41.95 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.054 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 14.9 Cg_exo -69.29 108.7 2.05 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.903 2.402 . . . . 0.0 112.608 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.534 ' CD1' HD12 ' A' ' 24' ' ' LEU . 3.7 pt -117.24 110.21 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.521 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.571 ' CZ ' ' OG1' ' A' ' 76' ' ' THR . 2.4 m-85 -86.02 152.3 23.02 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.879 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.525 HG12 ' CD1' ' A' ' 21' ' ' ILE . 3.8 mt -126.59 140.46 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.466 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -157.14 172.71 18.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 111.166 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.62 ' CE2' ' CG1' ' A' ' 69' ' ' VAL . 6.0 m-85 -76.0 128.8 35.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.02 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 20' ' ' HIS . 0.7 OUTLIER -152.14 179.64 8.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.75 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 55.91 -152.74 0.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.559 ' CE1' ' HG3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -92.17 -172.79 3.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.853 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -77.24 -19.91 55.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -133.72 146.65 50.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 26.2 tp -79.89 117.92 21.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HG3' ' CE1' ' A' ' 91' ' ' HIS . 2.6 mmtp -88.32 133.87 33.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.846 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.4 m -123.03 111.26 16.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.099 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 73.19 90.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.7 p -155.98 -41.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.83 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.856 0.36 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.502 ' C ' ' CG2' ' A' ' 14' ' ' VAL . . . 85.15 -95.16 1.95 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.489 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.502 ' CG2' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER 55.1 153.87 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.975 0.416 . . . . 0.0 111.188 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.573 ' HB3' ' CD1' ' A' ' 88' ' ' PHE . 33.5 Cg_exo -59.4 -67.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.776 2.317 . . . . 0.0 112.278 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 1.3 m 158.89 172.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.33 -24.98 22.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.7 t -87.9 111.66 22.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.122 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.432 HG23 ' CG ' ' A' ' 68' ' ' MET . 48.7 mm -97.08 105.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.22 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 87' ' ' GLN . 6.6 t-160 -79.02 119.74 22.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 85' ' ' TYR . 10.2 mt -96.72 124.53 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.292 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -107.69 171.2 7.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.605 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 49.01 39.36 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.167 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.529 ' CD1' HG21 ' A' ' 84' ' ' ILE . 9.5 tp -129.16 98.27 24.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.515 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 39.9 Cg_exo -56.14 77.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.518 2.146 . . . . 0.0 111.519 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.565 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 19.4 mm -31.54 125.45 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.065 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 2.1 t70 146.31 -15.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.144 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.52 ' CG1' ' HG ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -55.15 -154.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.4 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 p -124.41 146.93 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.985 0.421 . . . . 0.0 111.683 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.458 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 3.2 mp0 -66.67 -49.35 66.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.62 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -45.41 -36.0 5.6 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.981 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.52 ' HG2' ' CD1' ' A' ' 79' ' ' LEU . 2.8 tp10 -81.96 -61.05 2.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.791 0.329 . . . . 0.0 110.606 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.7 t -52.76 -59.88 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.553 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.465 HD13 HD22 ' A' ' 46' ' ' LEU . 33.7 mt -54.07 -40.79 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.544 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -50.92 -40.56 57.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.147 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.524 ' CD1' ' OH ' ' A' ' 72' ' ' TYR . 2.1 mm? -65.9 -28.34 68.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.068 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.577 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -81.22 -20.65 64.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.375 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.501 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -46.11 -56.42 10.69 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.702 0.287 . . . . 0.0 110.575 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 35.4 Cg_exo -59.56 -19.98 55.07 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.385 2.057 . . . . 0.0 111.061 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.577 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 6.2 m-30 -92.02 16.16 11.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.655 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.18 -111.14 3.02 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.034 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.463 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -150.79 154.59 37.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 0.0 111.209 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.0 t -101.82 116.92 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.509 ' CG2' ' CG ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -98.89 9.38 43.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.448 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' THR . 8.4 t-20 175.61 144.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.465 HD22 HD13 ' A' ' 34' ' ' ILE . 5.2 tp -151.91 126.69 9.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -141.01 107.56 5.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.463 ' HB3' HD13 ' A' ' 26' ' ' ILE . 2.7 mmm -86.29 118.87 26.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.79 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.459 ' O ' HG13 ' A' ' 26' ' ' ILE . 14.7 tp -102.02 100.36 10.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.084 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.462 ' CE ' ' HA ' ' A' ' 27' ' ' ASP . 1.4 mmtp -53.83 -19.05 3.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -37.68 -96.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.696 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -100.94 48.1 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.328 . . . . 0.0 110.981 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 25.6 m120 39.93 73.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 52' ' ' LYS . 5.0 mt-30 -151.05 133.24 15.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.64 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.53 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.6 165.33 11.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.744 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.542 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -143.87 115.9 8.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.308 -179.543 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 57' ' ' ILE . 15.0 pt -119.52 139.26 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.675 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.0 103.84 13.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.256 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.459 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -69.84 146.21 51.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.248 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.509 ' CG ' ' CG2' ' A' ' 44' ' ' THR . 0.2 OUTLIER -66.22 -47.0 75.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.329 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.95 168.94 9.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.426 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.425 ' HB3' HG13 ' A' ' 14' ' ' VAL . 5.6 mp0 -72.05 -47.21 53.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.682 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -50.53 -26.93 5.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.408 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 40' ' ' PHE . . . -74.39 -52.41 12.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.852 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.456 ' HA ' ' SD ' ' A' ' 59' ' ' MET . . . -53.89 -58.43 7.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.197 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 70' ' ' ASN . 1.7 m-20 -46.54 -64.71 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.568 HG21 ' CD1' ' A' ' 40' ' ' PHE . 19.9 m -40.83 -55.43 2.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.569 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -36.12 -63.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.037 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 65.2 t -83.37 -58.47 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.257 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 66' ' ' ASN . 21.1 t-20 -37.6 -36.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 67' ' ' THR . 2.1 t80 -78.19 -52.73 8.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.991 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.524 ' OH ' ' CD1' ' A' ' 36' ' ' LEU . 13.4 m-85 -65.89 -9.1 26.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.054 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 72' ' ' TYR . 28.6 m -38.1 -36.66 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.936 0.398 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 t -110.32 -56.62 2.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.739 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.43 120.91 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.581 HG21 ' CD1' ' A' ' 85' ' ' TYR . 1.5 m -94.3 141.47 23.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.263 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.523 ' CD ' HG22 ' A' ' 76' ' ' THR . 58.2 Cg_endo -98.43 137.6 0.36 Allowed 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.436 2.757 . . . . 0.0 112.311 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.521 ' CB ' ' HA ' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -122.91 179.94 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.948 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.52 ' CD1' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -140.92 118.73 11.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.85 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 47.33 24.28 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.536 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.51 15.38 23.11 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.412 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.441 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -120.3 97.9 48.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.521 ' HA ' ' CB ' ' A' ' 78' ' ' VAL . 39.6 Cg_exo -57.3 129.06 32.13 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.976 2.45 . . . . 0.0 112.802 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.529 HG21 ' CD1' ' A' ' 24' ' ' LEU . 5.3 pt -133.45 109.33 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.203 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.602 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -80.4 146.57 31.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.086 -178.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.523 ' CG2' ' HG3' ' A' ' 68' ' ' MET . 5.9 mt -126.4 108.75 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.412 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.527 ' HA ' ' CG1' ' A' ' 69' ' ' VAL . 30.0 mt-30 -140.39 166.09 25.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 111.366 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.573 ' CD1' ' HB3' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -74.03 120.38 19.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.656 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.465 ' OG ' ' ND1' ' A' ' 20' ' ' HIS . 0.6 OUTLIER -151.52 141.62 22.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.046 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 91' ' ' HIS . 1.5 m-20 69.39 -76.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.977 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 90' ' ' ASN . 6.7 m80 85.72 -13.57 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.799 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 93' ' ' GLU . 6.2 mttp -55.26 89.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -41.47 168.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.831 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.5 mt -67.64 100.23 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -138.94 162.04 35.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.959 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 73.2 p -91.9 102.23 14.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.093 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER 160.99 -61.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.26 80.17 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.937 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.967 179.933 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.838 0.351 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.78 -98.81 2.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.5 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.88 145.58 58.36 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 111.139 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.11 95.46 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.755 2.303 . . . . 0.0 112.223 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.577 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . 3.1 m -141.35 137.6 32.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.987 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.07 -49.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.85 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.463 ' HB ' ' OG ' ' A' ' 89' ' ' SER . 7.3 t -88.03 100.43 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.04 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.523 HG23 ' CD1' ' A' ' 21' ' ' ILE . 37.4 mm -81.21 105.7 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.239 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.692 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 10.2 t-160 -84.65 107.58 16.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.837 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.523 ' CD1' HG23 ' A' ' 19' ' ' ILE . 1.7 mm -82.86 119.35 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.187 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.97 173.42 6.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.685 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 3.1 tmtt? 43.22 41.99 3.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.536 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.454 HD11 HG23 ' A' ' 84' ' ' ILE . 6.3 tp -127.79 130.45 23.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.46 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 73.6 Cg_endo -76.49 74.75 4.62 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.592 2.194 . . . . 0.0 111.742 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.567 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 15.0 mm -32.83 110.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.143 0.497 . . . . 0.0 110.659 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.567 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 6.3 t70 146.69 -17.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.539 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.493 HG11 ' N ' ' A' ' 29' ' ' THR . 1.7 p -51.19 -168.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.373 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.493 ' N ' HG11 ' A' ' 28' ' ' VAL . 45.2 p -105.77 145.91 30.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.12 0.486 . . . . 0.0 111.808 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.9 mp0 -62.08 -46.12 90.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.672 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.64 -36.77 0.76 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.085 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.428 ' OE1' ' HB2' ' A' ' 79' ' ' LEU . 91.9 mt-10 -75.12 -51.18 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 110.454 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.3 t -64.07 -61.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.523 HG21 ' CG2' ' A' ' 43' ' ' VAL . 1.1 mt -50.82 -46.82 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.097 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 3.7 t -45.62 -45.12 13.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.583 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.462 ' HB3' ' OH ' ' A' ' 72' ' ' TYR . 68.6 mt -69.16 -21.27 64.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.539 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -87.1 -28.37 25.76 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.526 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.489 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -40.86 -53.14 6.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.698 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.489 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 19.6 Cg_exo -65.71 -34.33 41.27 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.718 2.279 . . . . 0.0 111.786 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.585 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 15.6 m-30 -65.83 -39.3 90.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.833 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.521 ' O ' ' CD ' ' A' ' 42' ' ' LYS . . . 165.68 -98.52 0.15 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.42 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -150.48 141.64 23.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.79 0.328 . . . . 0.0 110.94 179.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.523 ' CG2' HG21 ' A' ' 34' ' ' ILE . 55.5 t -88.68 86.49 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -80.62 7.44 10.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.322 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 170.75 137.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.027 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.518 HD21 ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -147.92 98.4 2.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 48' ' ' MET . 6.5 tt -97.88 149.16 22.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.816 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.47 ' HB3' HG22 ' A' ' 26' ' ' ILE . 8.2 mtt -125.21 110.65 14.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.148 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.48 ' O ' HG13 ' A' ' 26' ' ' ILE . 6.0 tp -88.42 96.4 10.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.751 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.531 ' CD ' HG23 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -74.73 0.56 14.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.255 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.63 -9.03 36.07 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.404 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -160.46 -64.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.778 0.323 . . . . 0.0 111.001 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER 155.08 43.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.551 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.497 ' HB3' ' NE2' ' A' ' 20' ' ' HIS . 63.8 mt-30 -130.44 133.09 46.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.11 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.543 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.81 163.06 13.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.715 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.692 ' CE2' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -148.0 115.78 6.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.134 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.524 ' CD1' ' SD ' ' A' ' 59' ' ' MET . 22.0 pt -112.18 137.18 45.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.78 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.73 102.67 14.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.731 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.526 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 17.7 mmm -67.02 124.02 21.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.645 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.555 ' N ' ' OG1' ' A' ' 44' ' ' THR . 2.8 m120 -35.69 -33.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.78 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -144.67 176.78 9.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.971 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.512 ' N ' ' OG1' ' A' ' 61' ' ' THR . 1.2 mp0 -72.88 -44.76 60.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.95 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -50.25 -24.55 2.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.947 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 59' ' ' MET . . . -83.47 -49.72 9.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.465 ' O ' HD12 ' A' ' 19' ' ' ILE . . . -65.41 -31.2 72.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.369 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -70.09 -54.49 12.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.494 HG21 ' CD1' ' A' ' 40' ' ' PHE . 24.1 m -56.62 -22.63 35.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.269 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.576 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -69.03 -65.01 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.066 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 21.6 t -67.97 -48.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.277 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -52.77 -40.47 63.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.037 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.428 ' CB ' ' O ' ' A' ' 67' ' ' THR . 3.5 t80 -67.81 -44.53 77.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.462 ' OH ' ' HB3' ' A' ' 36' ' ' LEU . 41.0 m-85 -85.84 12.48 9.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' A' ' 70' ' ' ASN . 54.1 m -66.26 -13.84 61.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.2 m -127.77 -39.8 1.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.832 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.76 138.74 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.529 HG22 ' CD ' ' A' ' 77' ' ' PRO . 1.3 m -103.33 142.56 24.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.01 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.529 ' CD ' HG22 ' A' ' 76' ' ' THR . 30.2 Cg_endo -95.24 145.08 1.4 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 123.103 2.535 . . . . 0.0 112.097 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.46 ' HB ' ' C ' ' A' ' 82' ' ' GLN . 0.7 OUTLIER -133.29 166.28 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 0.0 110.994 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.596 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -107.88 107.63 18.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.406 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER 28.92 34.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.327 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 115.93 36.24 1.16 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.559 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.541 ' CB ' ' HG ' ' A' ' 79' ' ' LEU . 2.5 tt0 -151.34 97.18 3.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.076 0.465 . . . . 0.0 110.613 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.4 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 38.7 Cg_exo -61.16 126.2 18.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.004 2.47 . . . . 0.0 112.959 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 84' ' ' ILE . 9.4 pt -137.73 107.7 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.273 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.452 ' O ' HG22 ' A' ' 21' ' ' ILE . 2.6 m-85 -68.85 146.88 52.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.99 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.529 ' CG2' ' HG2' ' A' ' 68' ' ' MET . 6.5 mt -126.31 103.75 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.203 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' HIS . 4.1 mt-30 -126.64 174.27 8.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.899 0.381 . . . . 0.0 111.142 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 16' ' ' SER . 71.4 m-85 -71.27 167.44 19.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.511 ' CA ' ' HB2' ' A' ' 20' ' ' HIS . 1.1 p -108.3 176.23 5.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.792 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.87 42.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.0 34.59 13.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -75.5 76.0 2.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -52.26 138.86 25.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.4 mt -48.2 114.47 0.95 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.49 154.73 23.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.84 123.55 25.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -67.23 138.68 57.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.3 -20.34 19.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.957 179.961 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.862 0.363 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.78 70.63 1.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.451 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.1 156.72 48.15 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.919 0.39 . . . . 0.0 111.141 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.43 87.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.713 2.275 . . . . 0.0 112.334 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.415 ' O ' ' OG ' ' A' ' 16' ' ' SER . 10.0 p -143.74 95.25 2.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 58' ' ' GLU . 3.5 mtm180 -137.22 -42.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 89' ' ' SER . 9.6 t -87.91 133.81 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.544 ' HB ' ' CG2' ' A' ' 57' ' ' ILE . 4.8 mm -115.61 102.42 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.395 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 87' ' ' GLN . 4.7 t-160 -79.08 113.98 17.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.598 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.523 ' CG1' ' HB3' ' A' ' 55' ' ' ALA . 4.1 mm -82.83 127.03 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.347 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -108.79 171.33 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.671 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HG2' ' CZ ' ' A' ' 85' ' ' TYR . 1.9 tptp 43.66 33.17 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.27 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 2.2 tp -115.46 110.66 44.74 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.103 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.516 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 43.8 Cg_endo -68.22 61.69 1.04 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.277 1.985 . . . . 0.0 110.991 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.622 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 37.5 mm -8.5 105.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.468 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.622 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 24.6 t70 129.18 24.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 O-C-N 124.408 1.067 . . . . 0.0 111.325 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.51 ' O ' ' CG2' ' A' ' 29' ' ' THR . 5.2 p -85.23 8.38 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.376 0.607 . . . . 0.0 111.031 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 28' ' ' VAL . 3.0 p 90.29 146.82 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.976 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' HD13 ' A' ' 34' ' ' ILE . 37.2 mp0 -74.92 -40.19 60.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.228 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -53.86 -25.9 31.65 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.96 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.549 ' CG ' ' CD1' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -80.39 -50.31 10.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 110.551 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.451 HG12 HD22 ' A' ' 46' ' ' LEU . 12.4 t -62.29 -51.26 74.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.748 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 30' ' ' GLU . 1.5 mp -64.32 -41.51 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.442 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.9 t -49.74 -33.3 15.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.181 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.449 ' O ' ' HD2' ' A' ' 39' ' ' PRO . 6.6 mt -75.43 -34.9 61.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.547 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -70.03 -26.09 74.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.457 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -37.87 -61.23 0.81 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.367 . . . . 0.0 110.723 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.2 Cg_endo -65.87 -22.51 56.16 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.57 2.18 . . . . 0.0 111.626 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 13.1 m-30 -80.77 0.45 34.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.976 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.8 -101.69 0.85 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.375 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.448 ' O ' ' HE3' ' A' ' 59' ' ' MET . 5.7 mtpm? -150.32 145.56 26.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 111.481 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.51 122.58 41.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.651 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.579 ' CG2' ' N ' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -99.15 -14.32 19.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.211 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.1 t-20 172.88 142.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.676 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' PHE . 5.3 tp -148.52 95.93 2.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.998 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.434 HD21 ' O ' ' A' ' 48' ' ' MET . 7.1 tt -95.33 127.48 41.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.434 ' O ' HD21 ' A' ' 47' ' ' LEU . 27.9 mtp -94.59 137.03 34.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.971 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.2 tp -124.06 101.82 7.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.784 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.529 ' CD ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -59.6 -13.86 11.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.21 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -35.15 -95.36 0.01 OUTLIER Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.619 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 63.8 mmtt -104.03 44.11 1.04 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.914 0.388 . . . . 0.0 110.774 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 4.9 m120 48.76 75.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.912 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.499 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 21.8 mt-30 -157.65 138.42 13.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.619 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.534 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -109.28 167.97 9.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -139.55 115.66 10.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.283 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.544 ' CG2' ' HB ' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -127.56 144.03 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.655 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.504 ' N ' HG12 ' A' ' 57' ' ' ILE . 15.5 mt-10 -121.53 133.14 55.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.895 0.379 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.519 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 27.9 mmm -92.09 151.28 20.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.589 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.579 ' N ' ' CG2' ' A' ' 44' ' ' THR . 0.4 OUTLIER -68.65 -26.73 65.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.952 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.8 t -131.17 138.22 49.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.091 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.39 -21.02 2.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.821 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -73.59 -36.59 65.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 40' ' ' PHE . . . -67.43 -49.87 61.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.489 ' N ' ' HG3' ' A' ' 59' ' ' MET . . . -55.78 -56.91 14.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -41.97 -68.48 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.986 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.558 HG22 ' CD1' ' A' ' 40' ' ' PHE . 19.4 m -40.93 -49.83 3.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.114 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.578 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -38.4 -64.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.977 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 54.1 t -77.09 -59.0 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -41.88 -27.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.056 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.423 ' CB ' ' O ' ' A' ' 67' ' ' THR . 10.7 t80 -85.46 -45.43 11.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.948 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.577 ' CE1' ' HG3' ' A' ' 77' ' ' PRO . 19.2 m-85 -82.9 9.12 10.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 m -70.13 -23.63 63.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.05 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.9 t -116.65 -34.2 4.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.788 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.7 p -113.8 126.82 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.989 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.496 HG21 ' CE1' ' A' ' 85' ' ' TYR . 2.0 m -97.6 131.26 27.37 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.151 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.577 ' HG3' ' CE1' ' A' ' 72' ' ' TYR . 72.5 Cg_endo -98.33 120.87 0.14 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 123.178 2.585 . . . . 0.0 112.411 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.51 HG23 ' N ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -95.07 -179.96 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.856 179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.549 ' CD1' ' CG ' ' A' ' 32' ' ' GLU . 2.4 mm? -139.96 115.53 10.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.951 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.07 21.41 1.02 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.728 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.42 15.72 16.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.465 ' O ' HG22 ' A' ' 84' ' ' ILE . 18.7 mm100 -122.83 97.98 43.33 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.027 0.441 . . . . 0.0 110.956 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.481 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 22.2 Cg_exo -64.91 105.9 0.71 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.974 2.449 . . . . 0.0 112.746 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.519 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 1.6 pt -119.9 112.39 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.641 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -76.71 156.03 32.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.94 -178.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.528 ' CG2' HG23 ' A' ' 19' ' ' ILE . 7.7 mt -126.15 104.27 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.327 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -113.84 175.3 5.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 111.346 -179.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.573 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 44.3 m-85 -73.1 -178.45 2.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.041 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.438 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 41.8 t -117.03 164.06 15.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.81 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -114.3 41.09 2.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.016 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -144.22 152.41 40.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -58.86 3.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -115.46 160.73 19.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.943 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.5 tp -62.77 132.32 51.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -55.96 111.34 0.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.843 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 p -111.78 137.68 49.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.105 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -94.29 -21.36 19.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.956 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.33 40.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.927 179.958 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 2.2 m . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.845 0.355 . . . . 2.83 110.898 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -108.15 -40.74 5.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 2.95 110.887 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.3 t -93.56 135.86 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 1.11 111.149 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.808 HG21 ' HG2' ' A' ' 68' ' ' MET . 36.5 mm -107.97 109.83 29.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.71 111.146 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.671 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 6.4 t-160 -83.08 109.14 16.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 1.52 110.865 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.49 HG23 HG13 ' A' ' 86' ' ' ILE . 4.3 mt -83.44 122.26 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.95 111.194 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -103.61 174.82 5.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 2.83 110.735 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 42.85 41.36 2.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 2.58 110.74 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.506 HD12 HG21 ' A' ' 84' ' ' ILE . 3.6 tp -128.19 127.02 23.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 1.2 110.705 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.518 ' O ' ' C ' ' A' ' 26' ' ' ILE . 72.0 Cg_endo -75.58 71.66 5.28 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.504 2.136 . . . . 1.05 112.036 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.838 HG21 ' N ' ' A' ' 50' ' ' LYS . 15.9 mm -27.22 110.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.1 0.476 . . . . 2.15 110.876 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 4.0 t70 146.07 -18.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.291 -0.868 . . . . 2.16 109.451 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 29' ' ' THR . 1.8 p -52.41 -167.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 115.628 -0.714 . . . . 1.61 109.842 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.685 ' H ' HG22 ' A' ' 28' ' ' VAL . 45.9 p -99.36 145.21 27.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.069 0.461 . . . . 0.57 111.773 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.6 mp0 -70.32 -46.77 63.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.761 -0.654 . . . . 2.01 110.504 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.04 -28.64 0.16 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.543 -0.837 . . . . 0.56 111.936 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.738 ' HB3' HD21 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -83.96 -57.26 3.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.319 . . . . 2.48 110.491 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.5 t -51.5 -49.96 31.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.953 0.406 . . . . 0.6 110.575 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.544 ' CG1' HG21 ' A' ' 43' ' ' VAL . 1.2 mp -69.97 -38.23 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.68 110.558 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -49.1 -38.76 25.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 1.31 110.373 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.964 HD22 ' OH ' ' A' ' 72' ' ' TYR . 12.1 mt -72.7 -38.55 67.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.946 -0.57 . . . . 1.49 110.358 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.604 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -71.54 -20.34 78.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 0.52 112.305 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -41.65 -60.52 1.86 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.852 0.358 . . . . 1.5 110.775 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 30.1 Cg_endo -63.29 -34.63 66.64 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.714 2.276 . . . . 0.54 111.939 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.661 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.8 m-30 -60.22 -32.62 71.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.974 -0.557 . . . . 1.33 110.678 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 157.85 -102.29 0.21 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.86 -0.686 . . . . 0.43 112.231 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.453 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 28.5 mttt -150.4 137.31 19.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.762 0.315 . . . . 2.37 111.023 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.544 HG21 ' CG1' ' A' ' 34' ' ' ILE . 45.5 t -87.83 121.72 38.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.6 110.468 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 1.056 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -96.27 -2.0 46.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 1.12 111.459 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 170.98 152.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 1.47 111.056 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.956 HD13 HG22 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -145.38 100.52 3.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 1.38 110.89 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 48' ' ' MET . 2.8 tt -108.33 113.74 27.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 1.42 110.918 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.603 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.8 mmm -90.79 94.91 9.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.84 110.865 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.571 ' C ' HG21 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -74.53 93.05 2.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 1.78 110.843 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.838 ' N ' HG21 ' A' ' 26' ' ' ILE . 3.4 mmtp -51.95 -18.74 1.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 1.64 111.09 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -33.71 -95.21 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.798 -0.715 . . . . 2.03 112.622 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 26.5 mttt -107.9 55.88 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 3.29 110.975 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 72.5 m-20 40.56 68.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 1.39 110.948 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.757 ' C ' HD11 ' A' ' 26' ' ' ILE . 10.7 mt-30 -146.99 129.35 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 1.69 110.747 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.708 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.7 160.21 16.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.37 110.891 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.671 ' CE2' ' CD2' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -142.77 115.86 8.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.307 -0.406 . . . . 1.4 111.187 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.956 HG22 HD13 ' A' ' 46' ' ' LEU . 6.1 pt -114.64 146.82 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.69 110.771 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.784 ' O ' HG23 ' A' ' 44' ' ' THR . 1.6 mt-10 -111.8 123.18 49.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.289 -0.414 . . . . 1.96 111.222 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.497 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -90.77 137.41 32.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 1.11 110.251 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 1.056 ' CG ' HG22 ' A' ' 44' ' ' THR . 2.3 m120 -68.4 -20.74 64.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.418 -0.356 . . . . 1.37 111.484 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.61 HG23 ' HB2' ' A' ' 64' ' ' ALA . 1.4 t -129.84 146.88 51.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 1.27 111.326 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.48 -46.09 89.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.088 -0.505 . . . . 1.95 110.779 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.64 -23.42 17.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 2.13 110.721 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.61 ' HB2' HG23 ' A' ' 61' ' ' THR . . . -78.21 -54.84 5.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.41 111.029 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -52.72 -52.61 55.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.34 111.138 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -54.18 -67.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 1.77 110.986 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.661 HG22 ' CD1' ' A' ' 40' ' ' PHE . 22.7 m -40.97 -38.25 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.48 111.277 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.808 ' HG2' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -52.12 -65.18 0.6 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.98 111.024 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 99.8 t -75.08 -49.85 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.51 111.128 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.453 ' O ' ' OG1' ' A' ' 73' ' ' THR . 13.0 t-20 -43.39 -60.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 1.59 110.997 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -55.97 -42.26 76.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.34 110.965 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.964 ' OH ' HD22 ' A' ' 36' ' ' LEU . 16.3 m-85 -74.5 0.2 15.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 1.21 111.073 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 32.0 m -50.11 -29.04 8.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.355 -0.384 . . . . 0.76 110.952 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.25 -57.19 1.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 1.34 110.779 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 40.8 t -80.28 124.69 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 1.34 110.979 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.517 HG23 ' HD2' ' A' ' 77' ' ' PRO . 1.2 m -102.41 144.22 28.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.86 111.241 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.966 ' HG2' HD12 ' A' ' 86' ' ' ILE . 22.6 Cg_endo -94.56 135.02 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.199 2.599 . . . . 0.8 111.961 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -114.6 177.73 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 1.36 111.222 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.738 HD21 ' HB3' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -131.99 112.56 12.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 2.49 110.927 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 46.58 23.37 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 4.66 110.725 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.09 9.17 20.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.875 -0.679 . . . . 0.95 112.649 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.471 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -117.0 97.64 51.02 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.97 0.414 . . . . 2.3 110.819 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.562 ' HA ' HG12 ' A' ' 78' ' ' VAL . 36.6 Cg_exo -57.64 117.12 3.77 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.852 2.368 . . . . 0.64 112.615 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.506 HG21 HD12 ' A' ' 24' ' ' LEU . 3.3 pt -118.64 107.73 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.43 110.67 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.433 ' CE1' HG21 ' A' ' 76' ' ' THR . 20.6 m-85 -65.42 148.4 51.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 1.78 111.648 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.966 HD12 ' HG2' ' A' ' 77' ' ' PRO . 4.2 mt -126.23 103.87 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.809 -0.632 . . . . 0.58 110.556 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' HIS . 11.8 mt-30 -112.67 170.79 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.395 . . . . 2.36 111.147 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 37.4 m-85 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 1.46 110.885 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.446 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 1.4 p . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.798 0.332 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -76.72 -20.03 57.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.943 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 t -90.11 107.51 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.122 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.498 ' HB ' HG12 ' A' ' 57' ' ' ILE . 24.9 mm -94.39 108.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.184 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.624 ' NE2' ' CE2' ' A' ' 56' ' ' PHE . 4.7 t-160 -79.32 109.62 13.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.744 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 85' ' ' TYR . 16.4 mt -83.99 131.1 34.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.363 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -109.29 168.27 9.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.635 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.5 OUTLIER 46.43 44.22 12.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.0 110.377 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.909 HD23 HG21 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -129.44 95.72 29.42 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.972 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.443 ' HA ' ' CG ' ' A' ' 53' ' ' ASN . 50.5 Cg_exo -53.32 78.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.699 2.266 . . . . 0.0 111.932 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.918 HG23 ' HB3' ' A' ' 48' ' ' MET . 29.6 mm -34.62 118.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.084 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.4 t0 149.76 -19.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.06 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 29' ' ' THR . 6.1 m -55.44 -155.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.783 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.538 ' N ' HG23 ' A' ' 28' ' ' VAL . 71.2 p -114.0 145.69 41.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.923 0.392 . . . . 0.0 111.64 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.848 ' O ' HD12 ' A' ' 34' ' ' ILE . 9.5 mp0 -63.47 -34.19 77.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.602 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.12 -38.18 65.94 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.182 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.944 ' OE1' HD12 ' A' ' 79' ' ' LEU . 3.6 mm-40 -68.59 -58.97 3.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.785 0.326 . . . . 0.0 110.608 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.0 t -53.28 -45.5 55.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.743 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 30' ' ' GLU . 1.4 mp -66.63 -39.58 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.395 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.36 -43.37 5.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.144 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 77' ' ' PRO . 8.5 mt -77.71 -25.35 49.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.291 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -81.43 -16.33 74.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.405 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.493 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -58.9 -54.73 53.51 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.738 0.304 . . . . 0.0 110.725 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 31.6 Cg_exo -58.19 -50.08 10.85 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.569 2.179 . . . . 0.0 111.828 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 27.2 m-85 -53.68 -32.61 52.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.783 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.71 -104.08 0.23 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.186 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -150.45 143.77 24.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 111.007 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.743 HG21 HG13 ' A' ' 34' ' ' ILE . 49.9 t -86.92 114.59 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.518 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.996 HG22 ' ND2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -89.26 -4.5 58.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.458 -179.287 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 176.4 151.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.812 HD23 ' HB3' ' A' ' 30' ' ' GLU . 3.9 tp -137.63 125.76 22.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.007 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 tp -134.09 123.74 24.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.918 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.5 mmm -109.66 121.82 46.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.529 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 12.8 mt -98.89 91.62 5.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.976 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.898 ' CE ' HG22 ' A' ' 26' ' ' ILE . 13.6 mmtp -41.22 -27.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.966 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -81.24 129.6 9.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.545 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 0.9 OUTLIER 67.28 16.37 10.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 110.997 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.443 ' CG ' ' HA ' ' A' ' 25' ' ' PRO . 78.1 m-20 36.35 78.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.808 ' C ' HD11 ' A' ' 26' ' ' ILE . 2.4 mt-30 -150.21 132.91 15.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.993 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.613 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.7 167.81 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.767 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.624 ' CE2' ' NE2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -148.09 115.99 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.305 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.775 HG22 HD13 ' A' ' 46' ' ' LEU . 6.5 pt -108.71 155.09 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.768 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.798 ' O ' HG23 ' A' ' 44' ' ' THR . 0.0 OUTLIER -119.51 119.28 33.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.775 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 38.7 mmm -89.98 141.47 28.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.632 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.996 ' ND2' HG22 ' A' ' 44' ' ' THR . 1.7 m120 -73.76 -27.03 60.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.909 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.5 t -123.92 137.94 54.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.234 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -51.27 -38.2 51.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.687 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -59.08 -27.88 65.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.689 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -75.81 -47.24 26.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 16' ' ' SER . . . -60.4 -57.09 14.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.993 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -51.82 -70.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.537 HG22 ' CE1' ' A' ' 40' ' ' PHE . 12.7 m -41.8 -27.48 0.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . 1.005 ' SD ' HG21 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -59.62 -65.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.568 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 72.0 t -74.92 -37.61 41.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.481 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 8.2 t30 -59.23 -63.66 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.994 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' A' ' 67' ' ' THR . 2.8 t80 -49.31 -45.72 45.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.11 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.583 ' CD2' ' HG3' ' A' ' 77' ' ' PRO . 22.4 m-30 -83.83 11.57 7.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.106 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.481 ' OG1' ' HA ' ' A' ' 70' ' ' ASN . 21.5 m -62.29 -30.24 70.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.2 t -113.66 -39.19 4.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.5 p -106.18 129.95 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.144 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.3 m -98.61 142.48 24.67 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.85 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.619 ' HG2' HD12 ' A' ' 86' ' ' ILE . 26.8 Cg_endo -95.01 137.67 0.84 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 123.028 2.485 . . . . 0.0 112.214 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.828 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -123.65 -179.87 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 111.21 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.944 HD12 ' OE1' ' A' ' 32' ' ' GLU . 1.9 mm? -137.97 107.43 6.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.963 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 56.88 16.67 2.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.935 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.46 8.63 14.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.655 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.471 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -116.01 97.67 49.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.008 0.432 . . . . 0.0 110.95 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.612 ' HB3' HG12 ' A' ' 78' ' ' VAL . 74.3 Cg_endo -75.84 135.93 18.16 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.894 2.396 . . . . 0.0 112.853 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.909 HG21 HD23 ' A' ' 24' ' ' LEU . 9.2 pt -136.97 110.11 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.497 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.65 ' O ' HG23 ' A' ' 21' ' ' ILE . 8.1 m-85 -60.47 143.55 53.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.587 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 1.005 HG21 ' SD ' ' A' ' 68' ' ' MET . 7.1 mt -125.85 104.07 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.528 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' HIS . 3.9 mt-30 -115.13 172.83 6.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.1 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.568 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 45.5 m-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.84 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.827 0.346 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -68.06 -7.27 27.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.033 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 t -87.99 122.49 39.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.031 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.583 HD11 ' CA ' ' A' ' 65' ' ' ALA . 3.9 mm -119.28 116.85 52.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.211 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.481 ' HB3' ' O ' ' A' ' 88' ' ' PHE . 16.9 t60 -88.28 153.59 21.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.721 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.697 HG23 ' O ' ' A' ' 85' ' ' TYR . 2.3 mp -133.37 110.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.478 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' LYS . 2.8 ttm180 -88.09 167.4 13.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.827 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 43.77 90.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.784 HD11 HG21 ' A' ' 28' ' ' VAL . 4.7 tp -167.66 115.42 0.65 Allowed Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.447 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 26' ' ' ILE . 37.4 Cg_exo -59.08 73.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.466 2.111 . . . . 0.0 111.062 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.56 ' CG1' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -30.01 153.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.989 -178.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER 87.46 9.43 0.16 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.983 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.784 HG21 HD11 ' A' ' 24' ' ' LEU . 1.4 t -57.86 -149.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.806 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 33' ' ' VAL . 17.9 p -124.52 149.81 46.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.16 0.505 . . . . 0.0 111.899 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 2.1 mt-10 -68.75 -47.11 67.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.789 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 35' ' ' SER . . . -51.34 -37.27 39.02 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.348 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.564 ' HG2' HD21 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -78.63 -64.93 1.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.753 0.311 . . . . 0.0 110.768 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 29' ' ' THR . 47.9 t -45.59 -52.72 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.971 HG12 HG21 ' A' ' 43' ' ' VAL . 1.5 mp -65.7 -40.17 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.315 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -39.17 -42.42 0.96 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.924 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.006 HD22 ' OH ' ' A' ' 72' ' ' TYR . 11.1 mt -73.21 -40.63 64.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.02 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -77.22 -3.97 82.9 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.399 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.536 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 9.3 mt -61.44 -58.3 19.53 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.182 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 19.7 Cg_endo -58.3 -32.02 95.07 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.511 2.141 . . . . 0.0 112.105 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.592 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 22.0 m-30 -58.04 -28.51 64.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.683 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.76 -98.03 0.17 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.18 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.415 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 19.3 mmtp -150.47 146.01 26.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 0.0 111.022 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.971 HG21 HG12 ' A' ' 34' ' ' ILE . 67.0 t -89.73 116.43 31.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.763 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 1.002 HG22 ' ND2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -92.82 -9.71 39.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.244 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.424 ' HB2' ' OE1' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -176.88 146.95 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.725 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.758 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.1 tm? -132.59 124.83 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.024 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.747 HD12 ' CD2' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -141.23 141.4 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.708 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.663 ' N ' HD13 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -129.3 103.08 6.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.784 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.783 HD23 ' CE1' ' A' ' 56' ' ' PHE . 3.4 mm? -70.18 107.82 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.832 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HA ' HG21 ' A' ' 26' ' ' ILE . 5.9 mttp -91.68 81.13 5.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.943 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.23 -56.43 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.284 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -123.17 18.29 9.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.919 0.39 . . . . 0.0 110.544 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.56 ' HA ' ' CG1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 68.81 86.47 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.953 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 53' ' ' ASN . 64.8 mt-30 -160.12 129.52 5.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 111.431 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . . . -113.75 163.27 15.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.241 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.783 ' CE1' HD23 ' A' ' 49' ' ' LEU . 5.8 m-85 -148.1 118.59 7.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.839 0.352 . . . . 0.0 111.599 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.755 HD12 ' SD ' ' A' ' 59' ' ' MET . 7.0 pt -118.53 140.85 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.527 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.775 ' O ' HG23 ' A' ' 44' ' ' THR . 61.6 mt-10 -103.34 123.65 47.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.292 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.871 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 23.4 mmm -98.81 134.49 41.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 1.002 ' ND2' HG22 ' A' ' 44' ' ' THR . 1.1 m120 -72.28 -20.56 61.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.27 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.9 t -134.67 129.14 34.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.909 0.385 . . . . 0.0 111.231 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -38.99 -49.55 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -46.06 -32.23 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.871 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -75.29 -48.88 21.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.583 ' CA ' HD11 ' A' ' 19' ' ' ILE . . . -66.58 -59.23 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -50.59 -65.82 0.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.075 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.7 m -40.7 -46.78 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.27 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.706 ' SD ' HD11 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -44.98 -65.11 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.275 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.645 HG13 ' HA ' ' A' ' 87' ' ' GLN . 24.7 t -71.89 -51.54 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.297 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -49.96 -26.51 4.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.186 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -85.53 -64.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.169 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 1.006 ' OH ' HD22 ' A' ' 36' ' ' LEU . 27.2 m-85 -56.46 -16.54 6.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.989 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 72' ' ' TYR . 69.7 m -35.54 -31.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.023 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 72' ' ' TYR . 7.7 t -112.4 -62.94 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 6.2 p -82.15 121.71 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.054 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.556 HG21 ' CE1' ' A' ' 85' ' ' TYR . 2.5 m -95.59 145.85 30.28 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.032 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.551 ' HD2' HG23 ' A' ' 76' ' ' THR . 37.1 Cg_endo -97.23 163.61 0.96 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.299 2.666 . . . . 0.0 112.032 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.531 ' HB ' ' N ' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -153.24 152.41 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.899 0.381 . . . . 0.0 111.105 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.564 HD21 ' HG2' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -98.78 100.83 12.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.406 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 28.6 mmt180 67.27 -59.51 0.39 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.469 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -159.44 22.92 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.404 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.454 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 26.1 mp0 -126.1 97.8 34.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.392 . . . . 0.0 110.936 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.531 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 19.9 Cg_exo -66.19 129.47 21.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 123.047 2.498 . . . . 0.0 112.714 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.747 HD12 HD13 ' A' ' 24' ' ' LEU . 6.1 pt -134.47 118.52 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.57 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.697 ' O ' HG23 ' A' ' 21' ' ' ILE . 4.6 m-85 -78.66 148.88 33.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.847 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.62 HG21 ' CG ' ' A' ' 68' ' ' MET . 4.0 mt -126.26 109.09 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.473 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.645 ' HA ' HG13 ' A' ' 69' ' ' VAL . 70.8 mm-40 -120.87 173.79 7.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.013 0.435 . . . . 0.0 111.149 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.627 ' CD1' HG21 ' A' ' 69' ' ' VAL . 30.1 m-85 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.886 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.5 p . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.53 -53.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.73 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.26 143.59 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.806 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.531 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 20.9 mm -118.41 103.07 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.376 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.549 ' NE2' ' CZ ' ' A' ' 56' ' ' PHE . 4.5 t-160 -79.03 144.95 34.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.338 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 85' ' ' TYR . 9.5 mt -133.05 138.68 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.918 0.39 . . . . 0.0 111.457 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.543 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 12.2 ptm180 -123.42 170.35 10.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.467 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 52.2 38.98 25.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.216 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.764 ' HA ' HG22 ' A' ' 84' ' ' ILE . 2.7 tp -125.22 119.85 25.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.466 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 26' ' ' ILE . 20.2 Cg_endo -60.49 80.15 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.274 1.982 . . . . 0.0 110.716 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.79 HG21 ' C ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -32.18 154.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.733 -178.641 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 28' ' ' VAL . 22.3 t0 79.23 2.37 2.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.171 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.667 HG22 ' H ' ' A' ' 29' ' ' THR . 2.0 p -54.81 -165.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.667 ' H ' HG22 ' A' ' 28' ' ' VAL . 55.1 p -104.26 144.72 31.23 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.904 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.782 ' HG3' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -62.06 -46.66 88.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.487 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.3 -29.45 0.12 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.64 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.827 ' CD ' HD23 ' A' ' 79' ' ' LEU . 2.7 tp10 -83.34 -60.96 1.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 0.0 110.259 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 t -55.45 -58.87 3.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.597 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.703 ' HA ' HG21 ' A' ' 43' ' ' VAL . 1.3 mt -53.24 -53.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.489 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.5 m -39.29 -50.2 1.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.571 ' O ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -61.09 -32.39 72.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.747 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.57 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -83.03 -25.77 47.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.608 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.466 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -39.21 -60.65 1.16 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.709 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 43.1 Cg_endo -67.8 -22.88 42.4 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.548 2.165 . . . . 0.0 111.651 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.636 ' CD1' HG22 ' A' ' 67' ' ' THR . 16.1 m-30 -76.34 -6.47 51.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.043 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.19 -103.23 0.44 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.334 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.4 138.23 19.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.154 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.703 HG21 ' HA ' ' A' ' 34' ' ' ILE . 43.2 t -92.53 89.96 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 110.328 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 1.122 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -74.82 1.9 11.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.867 -179.068 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.573 ' ND2' ' O ' ' A' ' 44' ' ' THR . 0.5 OUTLIER 170.69 158.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.939 0.4 . . . . 0.0 111.456 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.014 HD13 HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -152.58 102.25 2.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.582 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.628 ' N ' HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -95.6 104.5 16.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.523 ' CE ' HG12 ' A' ' 28' ' ' VAL . 46.9 mmm -78.19 107.95 11.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.553 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.956 HD13 ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -88.91 101.58 14.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.862 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.557 ' HD2' ' CG2' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -74.3 -168.39 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.072 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.42 -100.68 2.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.429 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -74.13 -69.87 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.736 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.523 ' HA ' ' CG1' ' A' ' 26' ' ' ILE . 3.9 m-20 159.97 77.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.627 ' HB2' HD12 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -159.33 161.83 35.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.863 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.536 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -151.38 163.98 37.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.705 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -143.0 115.77 8.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.871 0.367 . . . . 0.0 111.242 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.014 HG22 HD13 ' A' ' 46' ' ' LEU . 31.2 pt -105.17 133.01 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.552 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.66 102.64 14.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.84 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.46 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -64.46 157.21 27.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.489 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 1.122 ' ND2' HG23 ' A' ' 44' ' ' THR . 5.7 m120 -68.79 -39.42 80.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.647 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -133.18 169.81 16.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.168 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.429 ' N ' ' OG1' ' A' ' 61' ' ' THR . 2.4 mp0 -73.31 -36.2 66.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.773 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -60.91 -40.08 91.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.719 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 40' ' ' PHE . . . -64.45 -49.09 72.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.46 ' HA ' ' SD ' ' A' ' 59' ' ' MET . . . -50.44 -53.23 31.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.221 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -46.49 -63.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.114 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.636 HG22 ' CD1' ' A' ' 40' ' ' PHE . 24.8 m -40.91 -46.77 2.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.309 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.703 ' SD ' HD11 ' A' ' 57' ' ' ILE . 0.9 OUTLIER -46.64 -65.01 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 -179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.736 HG11 ' CD2' ' A' ' 88' ' ' PHE . 46.1 t -70.61 -54.2 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.451 ' O ' ' OG1' ' A' ' 73' ' ' THR . 5.7 t-20 -38.75 -64.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -59.18 -31.2 68.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.013 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.485 ' OH ' ' HG ' ' A' ' 36' ' ' LEU . 14.0 m-30 -89.22 20.11 3.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.048 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 32.5 m -78.57 -22.64 46.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.841 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.1 m -124.34 -41.08 2.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.683 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.8 t -89.96 130.12 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.544 HG23 ' HD2' ' A' ' 77' ' ' PRO . 2.8 m -91.82 146.14 32.41 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.025 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.736 ' CG ' HD12 ' A' ' 86' ' ' ILE . 26.8 Cg_endo -95.97 138.5 0.72 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 123.262 2.641 . . . . 0.0 112.165 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 83' ' ' PRO . 16.9 t -125.02 154.51 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.127 0.489 . . . . 0.0 111.402 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.025 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -114.18 99.89 7.96 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.188 178.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.476 ' HB2' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER 62.24 -62.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.029 0.443 . . . . 0.0 110.182 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -159.45 23.86 0.3 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.371 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.447 ' C ' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -128.79 97.77 26.32 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 110.693 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.528 ' N ' HG13 ' A' ' 78' ' ' VAL . 52.9 Cg_exo -55.3 106.01 0.17 Allowed 'Trans proline' 0 C--O 1.23 0.125 0 C-N-CA 122.833 2.355 . . . . 0.0 112.707 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.764 HG22 ' HA ' ' A' ' 24' ' ' LEU . 2.6 pt -107.28 107.71 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.465 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.59 ' O ' HG23 ' A' ' 21' ' ' ILE . 8.9 m-30 -65.12 142.18 58.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.63 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.736 HD12 ' CG ' ' A' ' 77' ' ' PRO . 13.5 mt -126.14 134.24 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.372 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -149.78 172.17 15.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 0.0 111.04 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.736 ' CD2' HG11 ' A' ' 69' ' ' VAL . 39.4 m-85 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.803 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 23.4 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.825 0.345 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -11.7 61.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -114.12 142.79 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 68' ' ' MET . 11.4 mm -127.04 143.18 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.918 ' C ' HD13 ' A' ' 21' ' ' ILE . 7.2 t-80 -110.86 156.28 21.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.672 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.975 HD12 HG12 ' A' ' 86' ' ' ILE . 2.5 mm -128.31 106.93 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.425 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -83.61 171.22 13.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.646 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER 39.32 31.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.947 0.403 . . . . 0.0 110.354 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.929 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -102.07 107.41 52.55 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.288 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.627 ' N ' HD22 ' A' ' 24' ' ' LEU . 53.2 Cg_exo -51.98 82.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.484 2.122 . . . . 0.0 111.534 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.529 HG21 ' N ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -34.24 155.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.022 -179.297 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 25.1 t0 80.88 -3.05 1.8 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.223 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.682 HG22 ' H ' ' A' ' 29' ' ' THR . 2.0 p -54.64 -166.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.682 ' H ' HG22 ' A' ' 28' ' ' VAL . 69.8 p -100.2 144.19 29.51 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.862 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.793 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -63.74 -40.63 97.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.312 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -58.39 -28.09 61.56 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.982 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.444 ' HG3' ' OG1' ' A' ' 29' ' ' THR . 30.5 mt-10 -70.71 -64.59 0.87 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.361 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.673 HG12 HG21 ' A' ' 57' ' ' ILE . 46.8 t -55.2 -43.07 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.555 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.793 HD12 ' O ' ' A' ' 30' ' ' GLU . 1.6 mp -70.1 -42.81 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.5 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 3.4 t -40.3 -42.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.027 0.441 . . . . 0.0 110.138 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.604 HD22 ' OH ' ' A' ' 72' ' ' TYR . 81.5 mt -73.03 -37.89 66.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.101 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.589 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -76.49 -11.69 84.95 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.332 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.765 ' CD2' HG22 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -55.93 -61.04 7.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.818 0.342 . . . . 0.0 110.794 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.6 Cg_endo -66.12 -21.14 56.16 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.649 2.233 . . . . 0.0 111.772 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.592 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 16.3 m-30 -70.04 -28.78 65.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.626 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.3 -99.14 0.18 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.13 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.4 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 14.3 mtpt -150.63 135.89 17.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.826 0.346 . . . . 0.0 111.079 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.759 HG21 ' CG1' ' A' ' 34' ' ' ILE . 42.4 t -86.6 118.13 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.27 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 1.062 HG22 ' ND2' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -88.78 -8.61 54.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.698 -179.039 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 44' ' ' THR . 1.3 t-20 170.85 165.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.885 0.374 . . . . 0.0 111.275 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.88 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -139.85 113.9 8.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.883 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.611 ' CD1' HD21 ' A' ' 49' ' ' LEU . 1.3 tm? -122.75 120.44 33.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.853 ' C ' HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -108.43 145.09 35.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.91 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.853 HD23 ' C ' ' A' ' 48' ' ' MET . 2.1 mt -117.09 102.69 9.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.795 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.529 ' N ' HG21 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -72.71 136.71 45.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.4 -80.0 0.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.693 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.49 8.16 14.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 111.079 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.482 ' O ' ' HG2' ' A' ' 54' ' ' GLN . 2.5 m-20 56.89 84.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.068 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.492 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 51.8 mt-30 -159.25 123.45 3.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.398 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 24' ' ' LEU . . . -109.7 170.12 8.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.527 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.538 ' CD1' ' C ' ' A' ' 55' ' ' ALA . 28.1 m-85 -148.23 143.22 26.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.01 0.433 . . . . 0.0 111.383 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.89 HD11 ' SD ' ' A' ' 68' ' ' MET . 1.0 OUTLIER -144.33 125.18 8.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.494 179.334 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.806 ' O ' HG23 ' A' ' 44' ' ' THR . 38.3 mt-10 -93.74 127.13 39.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.258 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.502 ' CE ' ' HB1' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -99.98 146.44 26.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.164 179.489 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 1.062 ' ND2' HG22 ' A' ' 44' ' ' THR . 0.2 OUTLIER -88.78 -9.22 52.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.716 0.293 . . . . 0.0 110.69 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.55 160.55 21.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.138 0.494 . . . . 0.0 111.785 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -80.84 -37.8 29.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.305 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 63' ' ' GLU . 1.1 tp10 -71.09 -23.02 62.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.061 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.502 ' HB1' ' CE ' ' A' ' 59' ' ' MET . . . -74.27 -43.29 57.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.692 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.803 ' HB1' ' O ' ' A' ' 16' ' ' SER . . . -65.46 -66.06 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.211 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -52.22 -63.2 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 71' ' ' TYR . 77.3 m -40.73 -47.72 2.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.371 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.89 ' SD ' HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -46.36 -65.26 0.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.068 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 68.0 t -68.51 -54.83 18.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.233 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 73' ' ' THR . 8.9 t-20 -46.52 -62.2 1.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.07 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.483 ' HB3' ' O ' ' A' ' 67' ' ' THR . 4.0 t80 -43.42 -48.81 7.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.153 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.604 ' OH ' HD22 ' A' ' 36' ' ' LEU . 39.6 m-85 -80.52 7.37 10.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.242 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.472 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 20.4 m -49.03 -32.39 9.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.96 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.3 m -115.36 -56.06 2.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -81.1 134.64 26.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.189 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.7 HG23 ' HD2' ' A' ' 77' ' ' PRO . 8.1 m -92.17 152.19 42.37 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.886 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.7 ' HD2' HG23 ' A' ' 76' ' ' THR . 9.6 Cg_endo -91.4 94.05 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.194 2.596 . . . . 0.0 112.315 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.878 ' C ' HD12 ' A' ' 79' ' ' LEU . 3.5 t -86.3 154.51 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.878 HD12 ' C ' ' A' ' 78' ' ' VAL . 9.5 mp -144.29 100.96 3.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 59.92 14.6 4.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.724 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 83' ' ' PRO . . . 115.33 -3.23 22.1 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -102.71 97.72 9.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.329 . . . . 0.0 110.77 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 89.5 Cg_endo -79.11 96.78 1.09 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.8 2.333 . . . . 0.0 112.511 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.52 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 2.0 pt -100.81 107.74 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.738 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 12.1 m-85 -66.29 148.84 51.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.546 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.975 HG12 HD12 ' A' ' 21' ' ' ILE . 4.6 mt -126.27 111.88 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.473 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.434 ' OE1' ' HB3' ' A' ' 85' ' ' TYR . 3.1 mp0 -128.25 173.11 10.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.909 0.385 . . . . 0.0 111.155 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 72.7 m-85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.819 0.342 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.11 -53.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.98 103.92 14.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.995 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.491 HD11 HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -87.25 134.03 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.544 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 9.3 t-160 -97.19 114.38 26.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 85' ' ' TYR . 11.2 mt -89.31 123.69 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -107.68 168.68 9.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 5.9 tmtt? 49.02 37.16 9.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.634 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.688 HD13 HD12 ' A' ' 84' ' ' ILE . 2.5 tp -120.83 126.95 26.47 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.003 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.483 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 58.1 Cg_endo -71.74 76.5 1.96 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.45 2.1 . . . . 0.0 111.449 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.954 HD11 ' C ' ' A' ' 54' ' ' GLN . 34.2 mm -34.42 155.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.837 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 24.7 t0 86.64 -4.97 0.72 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.776 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.74 HG13 ' N ' ' A' ' 29' ' ' THR . 1.8 p -59.95 -154.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.744 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.74 ' N ' HG13 ' A' ' 28' ' ' VAL . 43.8 p -105.99 144.79 32.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.184 0.516 . . . . 0.0 112.082 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.633 ' O ' HD12 ' A' ' 34' ' ' ILE . 11.2 mp0 -69.66 -35.25 74.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.517 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 35' ' ' SER . . . -53.58 -30.72 43.15 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.913 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.7 ' HG2' HD23 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -77.26 -57.88 3.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.447 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.5 t -53.1 -43.14 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.977 ' CG1' HG21 ' A' ' 43' ' ' VAL . 1.5 mp -72.45 -46.87 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.589 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -38.62 -34.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.355 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 77' ' ' PRO . 18.3 mt -82.38 -39.26 22.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.51 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -72.32 -17.51 77.61 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.38 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.582 ' CD2' HG22 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -46.81 -60.67 3.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.876 0.369 . . . . 0.0 110.806 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.6 Cg_endo -66.05 -30.78 47.18 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.716 2.277 . . . . 0.0 112.11 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.618 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.1 m-30 -63.73 -40.44 96.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.597 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 64' ' ' ALA . . . 168.57 -98.78 0.14 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.395 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.456 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -151.09 142.5 23.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.719 0.295 . . . . 0.0 110.923 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.977 HG21 ' CG1' ' A' ' 34' ' ' ILE . 42.8 t -88.76 82.54 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.213 0.53 . . . . 0.0 110.687 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.991 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -66.57 -7.3 19.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.42 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 176.68 145.74 0.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.914 0.388 . . . . 0.0 111.249 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.967 HD13 HG22 ' A' ' 57' ' ' ILE . 4.9 tp -136.4 103.07 5.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.53 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 47' ' ' LEU . 3.2 tm? -105.87 105.17 15.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.3 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.6 mmm -90.5 99.61 12.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.302 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.455 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -85.64 110.92 19.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.306 -179.513 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.554 ' CE ' HG22 ' A' ' 26' ' ' ILE . 10.1 mmtp -62.34 -172.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.349 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . 55.22 114.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.029 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER 88.87 -21.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.914 0.387 . . . . 0.0 110.669 -179.446 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.484 ' HA ' HG12 ' A' ' 26' ' ' ILE . 0.8 OUTLIER 68.11 63.73 0.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.494 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.954 ' C ' HD11 ' A' ' 26' ' ' ILE . 7.2 mm-40 -136.07 126.5 26.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.758 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.781 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.75 160.12 16.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -142.32 115.91 9.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.033 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.967 HG22 HD13 ' A' ' 46' ' ' LEU . 13.8 pt -113.42 140.91 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -96.22 102.73 14.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.632 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.812 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 7.1 mmm -66.34 116.07 6.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.0 110.779 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.991 ' ND2' HG23 ' A' ' 44' ' ' THR . 4.9 m120 -33.68 -49.72 0.32 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.328 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.76 -173.01 2.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.125 0.488 . . . . 0.0 112.079 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 64' ' ' ALA . 2.1 mt-10 -72.39 -57.45 4.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.177 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -38.92 -30.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.065 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.812 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -76.63 -56.29 4.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -54.34 -55.47 28.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.382 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -56.0 -70.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.618 HG22 ' CD1' ' A' ' 40' ' ' PHE . 21.1 m -42.47 -39.34 2.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.215 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.594 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -49.17 -62.84 1.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 72.2 t -80.79 -50.42 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.308 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -45.37 -39.03 6.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.195 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 67' ' ' THR . 4.3 t80 -78.01 -57.94 3.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.19 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.503 ' OH ' HD22 ' A' ' 36' ' ' LEU . 14.5 m-85 -62.14 -12.03 17.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.14 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.2 m -39.66 -29.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.011 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 72' ' ' TYR . 10.7 t -116.81 -45.9 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.795 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.39 131.83 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.556 ' OG1' ' CE2' ' A' ' 85' ' ' TYR . 1.3 m -97.62 142.41 24.52 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.979 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.52 ' CG ' HD12 ' A' ' 86' ' ' ILE . 19.1 Cg_endo -93.86 128.93 0.62 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.022 2.481 . . . . 0.0 112.076 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.699 HG13 ' C ' ' A' ' 82' ' ' GLN . 3.3 t -115.89 149.18 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.192 0.52 . . . . 0.0 111.427 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.036 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -114.09 107.98 16.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.371 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.683 ' N ' HD22 ' A' ' 79' ' ' LEU . 5.2 mtt180 62.93 -61.33 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 0.0 110.517 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -163.64 24.84 0.19 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.455 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.699 ' C ' HG13 ' A' ' 78' ' ' VAL . 1.2 tp60 -128.05 110.04 19.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.616 ' N ' HG13 ' A' ' 78' ' ' VAL . 37.8 Cg_endo -66.73 96.79 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.61 2.207 . . . . 0.0 112.385 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.688 HD12 HD13 ' A' ' 24' ' ' LEU . 3.3 pt -100.63 107.94 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.767 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CE2' ' OG1' ' A' ' 76' ' ' THR . 6.4 m-85 -75.28 153.64 37.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.525 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.568 HG21 ' CG ' ' A' ' 68' ' ' MET . 5.7 mt -126.01 112.12 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.561 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 20' ' ' HIS . 9.1 mt-30 -125.45 166.27 16.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 111.1 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.579 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 74.6 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.832 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 64.9 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.851 0.358 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -123.75 -47.99 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.91 97.92 7.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.982 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.851 HG21 ' SD ' ' A' ' 68' ' ' MET . 37.3 mm -82.41 110.52 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.292 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' GLN . 11.1 t-80 -80.59 156.51 26.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.047 HG21 HD12 ' A' ' 24' ' ' LEU . 1.4 mt -131.13 107.84 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.404 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' HG2' ' HB2' ' A' ' 85' ' ' TYR . 2.4 ptm180 -96.38 176.03 6.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.503 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 43.52 32.94 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.975 0.416 . . . . 0.0 110.252 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.047 HD12 HG21 ' A' ' 21' ' ' ILE . 1.4 tt -118.08 99.72 51.9 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.94 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.61 ' HD2' HG22 ' A' ' 84' ' ' ILE . 29.4 Cg_endo -63.25 67.15 0.16 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.178 1.919 . . . . 0.0 111.163 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.017 HD11 ' C ' ' A' ' 54' ' ' GLN . 47.7 mm -15.28 112.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 123.987 0.805 . . . . 0.0 112.085 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.6 t70 149.41 -10.71 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.51 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 29' ' ' THR . 6.0 m -60.96 -11.91 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.287 0.565 . . . . 0.0 111.809 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 28' ' ' VAL . 3.0 p 90.64 154.16 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.991 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . 4.7 mp0 -70.38 -41.39 73.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.512 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -42.35 -35.4 1.86 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.039 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.48 ' OE2' ' HB3' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -80.51 -45.28 17.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.865 0.364 . . . . 0.0 110.581 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 57' ' ' ILE . 16.6 t -59.32 -58.2 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.969 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.841 HG13 HG21 ' A' ' 43' ' ' VAL . 1.5 mp -64.8 -40.68 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.661 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -41.58 -43.5 2.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.988 0.423 . . . . 0.0 110.292 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.519 ' CG ' ' OH ' ' A' ' 72' ' ' TYR . 7.4 mp -72.21 -36.71 69.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.5 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -70.82 -21.31 78.03 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.43 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.457 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -44.87 -61.31 2.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.74 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 39.8 Cg_endo -67.05 -41.16 10.27 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.609 2.206 . . . . 0.0 111.648 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.62 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.1 m-30 -54.39 -28.43 43.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.687 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 42' ' ' LYS . . . 154.0 -106.92 0.31 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.191 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 59' ' ' MET . 17.3 mtpt -150.78 142.17 23.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.0 111.002 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.841 HG21 HG13 ' A' ' 34' ' ' ILE . 42.0 t -86.71 117.82 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.5 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 1.014 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -91.75 -6.01 52.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.437 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -172.46 155.32 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.877 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.028 ' CD2' HG22 ' A' ' 57' ' ' ILE . 2.7 tm? -151.14 113.81 4.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 47' ' ' LEU . 6.6 tt -136.5 116.81 13.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.2 mtp -95.44 139.64 31.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.469 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -125.48 91.42 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.945 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.555 ' HD2' ' CG2' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -45.02 -26.18 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.938 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.35 127.82 10.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.53 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.7 OUTLIER 66.89 8.3 5.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.79 0.329 . . . . 0.0 110.901 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.503 ' HA ' HG12 ' A' ' 26' ' ' ILE . 73.6 m-20 45.88 84.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 1.017 ' C ' HD11 ' A' ' 26' ' ' ILE . 67.5 mt-30 -159.2 135.71 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.595 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.808 ' HB3' HD12 ' A' ' 21' ' ' ILE . . . -109.29 166.6 10.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.794 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.537 ' CD1' ' C ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -139.72 117.45 11.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.478 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.028 HG22 ' CD2' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -127.37 152.07 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.618 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.47 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 35.7 mt-10 -120.05 142.06 49.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.41 . . . . 0.0 111.295 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.694 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -110.74 130.39 55.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.174 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 1.014 ' CG ' HG22 ' A' ' 44' ' ' THR . 2.9 m120 -68.56 -15.47 63.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.64 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 61' ' ' THR . 12.3 t -132.21 125.34 30.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 111.271 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -43.46 -41.94 4.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.692 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.416 ' O ' ' OG1' ' A' ' 67' ' ' THR . 8.3 tt0 -57.12 -20.82 27.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.815 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -84.47 -46.93 11.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.968 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.848 ' HB1' HD11 ' A' ' 19' ' ' ILE . . . -64.25 -49.44 71.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.042 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.77 -44.28 90.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.494 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.62 HG22 ' CD1' ' A' ' 40' ' ' PHE . 18.2 m -60.34 -32.74 71.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.851 ' SD ' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -58.36 -63.13 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.618 HG21 ' CE1' ' A' ' 88' ' ' PHE . 8.4 t -70.31 -51.06 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.07 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.459 ' O ' ' OG1' ' A' ' 73' ' ' THR . 6.8 t30 -44.06 -63.96 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.964 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 67' ' ' THR . 10.7 t80 -55.59 -35.69 66.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.574 ' CD2' ' O ' ' A' ' 68' ' ' MET . 17.8 m-85 -83.23 9.86 9.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 53.6 m -59.52 -28.37 67.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.13 -45.73 1.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.8 t -83.43 110.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.628 HG23 ' HD2' ' A' ' 77' ' ' PRO . 4.1 m -88.17 149.18 44.57 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.845 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.628 ' HD2' HG23 ' A' ' 76' ' ' THR . 18.3 Cg_endo -95.28 113.43 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.226 2.617 . . . . 0.0 112.3 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 79' ' ' LEU . 22.1 t -100.26 160.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.988 0.423 . . . . 0.0 111.167 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.948 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -156.27 133.91 10.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.713 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.547 ' HB3' HD22 ' A' ' 79' ' ' LEU . 2.0 ttt-85 37.24 30.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.94 0.4 . . . . 0.0 110.423 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 80.53 50.19 5.45 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.803 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.527 ' O ' HD12 ' A' ' 79' ' ' LEU . 1.7 mm-40 -155.2 97.68 2.41 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.05 96.56 0.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.585 2.19 . . . . 0.0 112.496 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.664 HD12 ' HG ' ' A' ' 24' ' ' LEU . 4.4 pt -95.15 111.14 25.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.67 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.509 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 4.6 m-30 -72.52 152.94 41.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.521 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 21' ' ' ILE . 6.5 mt -126.14 104.77 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.519 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -131.6 171.49 13.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 111.097 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 69' ' ' VAL . 1.4 m-85 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 6.5 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.767 0.318 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.89 -49.06 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.848 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.05 126.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.069 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.574 ' CG2' HG23 ' A' ' 86' ' ' ILE . 48.0 mm -101.88 112.82 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.234 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.479 ' HB3' ' O ' ' A' ' 88' ' ' PHE . 4.9 t-80 -87.49 112.89 22.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.524 HG23 HG13 ' A' ' 86' ' ' ILE . 4.8 mt -82.78 127.9 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.303 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HG2' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -114.03 151.83 31.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.66 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.486 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 64.4 34.86 10.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.553 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.64 HD13 HD12 ' A' ' 84' ' ' ILE . 4.8 tp -119.84 129.23 25.46 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.891 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.632 ' HD2' HD12 ' A' ' 24' ' ' LEU . 73.6 Cg_endo -76.63 69.64 6.67 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.484 2.123 . . . . 0.0 111.79 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.846 HD11 ' C ' ' A' ' 54' ' ' GLN . 6.1 mm -30.64 108.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.236 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 2.2 t70 148.69 -19.48 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.673 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.68 HG22 ' H ' ' A' ' 29' ' ' THR . 1.9 p -54.69 -162.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.857 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.68 ' H ' HG22 ' A' ' 28' ' ' VAL . 39.8 p -107.91 145.79 33.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.104 0.478 . . . . 0.0 111.885 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.545 ' HB3' HD23 ' A' ' 46' ' ' LEU . 7.8 mp0 -63.07 -46.7 86.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.635 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.85 -29.36 0.17 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.782 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.581 ' OE1' HD22 ' A' ' 79' ' ' LEU . 12.8 mm-40 -81.32 -55.03 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.254 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.1 t -61.26 -57.91 9.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.64 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.581 HG23 HG21 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -53.76 -50.26 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.066 179.631 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.8 m -42.12 -43.43 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.39 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.593 HD22 ' OH ' ' A' ' 72' ' ' TYR . 19.9 mt -63.99 -33.91 76.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.36 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -81.62 -23.12 58.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.521 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.525 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -40.49 -58.47 2.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.826 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.1 Cg_endo -66.18 -40.28 15.83 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.616 2.21 . . . . 0.0 111.947 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.628 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.5 m-30 -55.23 -30.45 60.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.575 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 156.9 -104.41 0.25 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.094 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.422 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -150.43 137.95 19.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 111.03 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 34' ' ' ILE . 51.4 t -86.99 121.47 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.403 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.961 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -96.76 -0.73 47.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.574 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 44' ' ' THR . 44.4 t30 178.06 149.44 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.982 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.86 HD13 HG22 ' A' ' 57' ' ' ILE . 1.5 tp -139.91 103.17 4.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.59 HD13 ' N ' ' A' ' 48' ' ' MET . 0.5 OUTLIER -115.5 113.85 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.935 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.629 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.4 mmm -99.65 99.58 10.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.604 ' C ' HG21 ' A' ' 26' ' ' ILE . 14.8 tp -82.04 97.41 8.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.81 ' CE ' HG22 ' A' ' 26' ' ' ILE . 3.4 mmtp -49.0 -21.5 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.303 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -79.34 126.07 7.29 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.698 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.507 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 1.8 mttt 71.36 7.19 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 111.314 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 53.4 m-20 49.98 62.09 2.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.035 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.846 ' C ' HD11 ' A' ' 26' ' ' ILE . 14.0 mm-40 -139.98 134.9 32.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.585 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.77 166.82 10.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.81 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -146.85 115.92 6.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.244 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.86 HG22 HD13 ' A' ' 46' ' ' LEU . 6.8 pt -118.03 143.04 29.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.698 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.755 ' O ' HG23 ' A' ' 44' ' ' THR . 0.5 OUTLIER -109.64 124.38 51.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.23 -179.651 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.523 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -91.66 138.68 31.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.351 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.961 ' CG ' HG22 ' A' ' 44' ' ' THR . 2.4 m120 -67.25 -27.05 66.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.326 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.443 HG23 ' HB2' ' A' ' 64' ' ' ALA . 3.6 t -123.85 140.26 53.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.921 0.391 . . . . 0.0 111.377 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -54.43 -42.11 70.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.773 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -56.65 -29.28 62.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.632 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -72.04 -52.35 17.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.874 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 68' ' ' MET . . . -51.88 -60.97 2.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.08 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -44.99 -68.49 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.628 HG22 ' CD1' ' A' ' 40' ' ' PHE . 86.3 m -40.91 -36.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.979 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.968 ' SD ' HG21 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -51.67 -65.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.833 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 78.9 t -79.7 -49.26 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.172 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -41.99 -57.16 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.027 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -61.25 -50.37 73.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.053 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.593 ' OH ' HD22 ' A' ' 36' ' ' LEU . 20.2 m-30 -73.76 -0.42 15.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.259 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 69' ' ' VAL . 95.0 m -51.82 -20.68 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.931 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 t -127.21 -51.87 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.83 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.4 p -89.73 123.41 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.03 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.4 m -99.02 142.2 24.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.986 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.478 ' O ' HG12 ' A' ' 84' ' ' ILE . 45.6 Cg_endo -96.94 109.63 0.1 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.271 2.647 . . . . 0.0 112.292 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.992 ' O ' HD23 ' A' ' 79' ' ' LEU . 1.4 m -100.86 -179.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.992 HD23 ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -154.95 122.97 5.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.684 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 2.8 ttp180 63.32 11.82 5.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.715 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.81 19.97 15.89 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.5 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.449 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 4.5 mm-40 -116.59 97.61 50.43 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.82 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.417 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 17.2 Cg_exo -67.24 115.41 3.65 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.969 2.446 . . . . 0.0 112.55 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.64 HD12 HD13 ' A' ' 24' ' ' LEU . 3.3 pt -122.01 107.82 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 21' ' ' ILE . 3.5 m-85 -76.03 150.75 37.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.661 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.968 HG21 ' SD ' ' A' ' 68' ' ' MET . 5.6 mt -126.11 109.67 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 20' ' ' HIS . 2.5 mt-30 -117.13 173.29 6.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.128 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.587 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 47.9 m-85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.95 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.565 ' OG ' ' CE1' ' A' ' 88' ' ' PHE . 42.2 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.401 ' HG2' ' OE2' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -166.44 -42.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.94 107.94 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.109 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.815 ' CG2' HG23 ' A' ' 86' ' ' ILE . 1.4 mp -93.58 113.38 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.587 ' CD2' ' HB3' ' A' ' 54' ' ' GLN . 4.5 t-80 -84.24 117.5 23.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.361 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.758 HG22 ' HB2' ' A' ' 24' ' ' LEU . 9.9 mt -87.76 98.32 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.501 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -77.57 177.29 8.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.452 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER 37.19 38.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 110.555 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.758 ' HB2' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -123.65 99.94 38.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.934 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.452 ' HA ' ' CG ' ' A' ' 53' ' ' ASN . 34.6 Cg_exo -57.33 74.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.569 2.179 . . . . 0.0 111.771 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.899 HG23 ' HB3' ' A' ' 48' ' ' MET . 16.2 mm -33.23 119.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.1 t0 150.95 -19.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.952 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 29' ' ' THR . 6.1 m -54.99 -153.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.797 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.552 ' N ' HG23 ' A' ' 28' ' ' VAL . 40.6 p -112.05 145.7 39.23 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.06 0.457 . . . . 0.0 111.815 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.823 ' CD ' HD12 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -65.28 -56.16 14.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.545 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.89 -33.15 0.4 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.999 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.596 ' HG2' HD21 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -68.63 -58.33 4.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.476 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.02 -48.52 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.622 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.873 ' CG1' HG21 ' A' ' 43' ' ' VAL . 1.6 mp -65.08 -38.2 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.513 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -47.51 -41.44 20.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.649 HD23 ' OH ' ' A' ' 72' ' ' TYR . 8.5 mp -71.5 -33.53 69.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.2 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.597 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -69.92 -25.25 75.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.346 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.516 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -41.76 -59.77 2.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 110.856 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 28.5 Cg_endo -62.87 -23.06 74.27 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.67 2.247 . . . . 0.0 111.883 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.597 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 13.7 m-30 -76.64 -38.69 54.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.507 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.13 -102.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.158 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -150.52 146.55 26.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.777 0.323 . . . . 0.0 110.987 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.873 HG21 ' CG1' ' A' ' 34' ' ' ILE . 55.8 t -86.86 112.55 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.525 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.966 HG22 ' ND2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -88.19 -13.64 40.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.202 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 170.93 119.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.051 HD23 HG22 ' A' ' 57' ' ' ILE . 1.2 tm? -123.83 117.41 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.999 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.646 ' N ' HD22 ' A' ' 46' ' ' LEU . 8.9 tt -117.84 128.55 54.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.848 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.899 ' HB3' HG23 ' A' ' 26' ' ' ILE . 9.1 mtp -106.16 139.05 41.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.708 ' C ' HG21 ' A' ' 26' ' ' ILE . 37.3 mt -120.22 103.85 9.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.642 ' N ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -55.51 -17.37 5.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . -84.08 116.52 4.27 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.439 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER 82.65 -8.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 111.059 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.452 ' CG ' ' HA ' ' A' ' 25' ' ' PRO . 85.1 m-20 61.29 77.53 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.968 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.587 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 48.8 mt-30 -155.06 130.8 9.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.665 ' CA ' HD11 ' A' ' 26' ' ' ILE . . . -109.72 162.54 14.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.779 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -144.9 116.11 7.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.367 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.051 HG22 HD23 ' A' ' 46' ' ' LEU . 8.0 pt -110.19 155.04 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.815 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.761 ' O ' HG23 ' A' ' 44' ' ' THR . 0.0 OUTLIER -122.04 119.11 30.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.785 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 32.7 mmm -90.77 142.54 27.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.698 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.966 ' ND2' HG22 ' A' ' 44' ' ' THR . 1.7 m120 -72.88 -23.87 60.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.912 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.5 t -130.35 137.39 49.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.229 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -48.29 -42.85 32.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.45 ' O ' ' CB ' ' A' ' 67' ' ' THR . 10.8 mp0 -53.03 -30.07 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.749 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.785 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -77.25 -47.28 20.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.988 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -65.75 -58.94 4.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.045 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -54.68 -59.5 4.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.813 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.45 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 18.6 m -40.93 -49.0 3.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.977 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.589 ' HA ' ' CZ ' ' A' ' 40' ' ' PHE . 2.1 ttm -46.18 -63.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.82 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.773 HG13 ' HG3' ' A' ' 87' ' ' GLN . 39.1 t -68.91 -15.97 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.136 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.453 ' O ' ' OG1' ' A' ' 73' ' ' THR . 1.2 t-20 -72.82 -64.12 1.03 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 5.0 t80 -60.86 -24.4 65.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.649 ' OH ' HD23 ' A' ' 36' ' ' LEU . 24.5 m-85 -93.07 19.99 7.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.059 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 91.6 m -72.03 -31.1 65.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -118.79 -50.55 2.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.789 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.8 t -82.48 119.92 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.982 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.5 m -87.59 141.93 32.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.921 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.75 ' HG2' HD12 ' A' ' 86' ' ' ILE . 35.5 Cg_endo -95.81 142.88 1.08 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.081 2.52 . . . . 0.0 112.255 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' A' ' 83' ' ' PRO . 2.0 m -129.21 -179.69 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.165 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.636 HD23 ' HG3' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -141.75 108.5 5.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.636 ' HG3' HD23 ' A' ' 79' ' ' LEU . 21.1 mtm-85 61.26 14.02 5.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.502 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.29 7.78 20.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.361 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.453 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 6.3 tp60 -113.54 103.75 55.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.974 0.416 . . . . 0.0 110.896 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.762 ' HA ' HG12 ' A' ' 78' ' ' VAL . 24.6 Cg_exo -63.01 121.02 8.74 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.943 2.429 . . . . 0.0 112.617 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.601 HG22 ' HA ' ' A' ' 24' ' ' LEU . 2.4 pt -122.34 107.56 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.513 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 20.4 m-85 -62.08 141.54 58.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.036 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.815 HG23 ' CG2' ' A' ' 19' ' ' ILE . 6.5 mt -126.55 107.92 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.466 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.773 ' HG3' HG13 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -152.88 169.55 22.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 111.192 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.577 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 1.1 m-85 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.568 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.885 0.374 . . . . 0.0 111.061 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.405 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -86.23 -24.64 25.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.887 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.477 ' O ' HD13 ' A' ' 19' ' ' ILE . 71.7 t -87.86 144.27 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.035 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.5 ' CG2' HG23 ' A' ' 86' ' ' ILE . 34.8 mm -122.4 107.89 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.213 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' GLN . 5.4 t-160 -78.82 121.9 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.806 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.788 HD12 HG12 ' A' ' 86' ' ' ILE . 4.3 mm -100.45 112.65 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.241 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 174.16 6.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.795 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER 45.06 44.01 7.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.675 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.777 ' HA ' HG22 ' A' ' 84' ' ' ILE . 3.2 tp -134.46 109.34 11.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 26' ' ' ILE . 33.0 Cg_endo -64.51 74.84 0.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.401 2.067 . . . . 0.0 111.729 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.801 HG23 ' HB3' ' A' ' 48' ' ' MET . 15.3 mm -31.83 117.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.052 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 3.6 t70 151.16 -19.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.162 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 29' ' ' THR . 5.7 m -54.86 -155.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.881 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.538 ' N ' HG23 ' A' ' 28' ' ' VAL . 81.2 p -112.38 145.03 40.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 111.674 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.48 ' HB3' HD11 ' A' ' 34' ' ' ILE . 32.6 mt-10 -65.36 -50.6 64.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.438 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.99 -28.33 0.23 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.036 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.867 ' OE1' HD23 ' A' ' 79' ' ' LEU . 37.5 mt-10 -78.46 -52.15 8.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.403 . . . . 0.0 110.494 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.54 -57.47 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.729 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.528 HD11 HD23 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -53.14 -40.74 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 8.0 t -54.94 -43.07 73.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.698 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.554 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 6.3 mp -74.87 -11.27 60.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.761 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.65 -22.13 8.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.769 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.437 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -50.73 -52.54 55.77 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.66 0.267 . . . . 0.0 110.985 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 39.7 Cg_exo -60.01 -24.2 75.7 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.484 2.123 . . . . 0.0 111.668 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.863 ' CD2' HG22 ' A' ' 67' ' ' THR . 79.0 m-85 -82.03 7.24 13.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.035 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.13 -108.67 1.0 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.292 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.541 ' HB3' ' ND2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -150.55 146.05 26.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.101 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.453 HG21 HG23 ' A' ' 34' ' ' ILE . 55.2 t -99.81 97.04 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.937 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -87.8 22.23 2.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.302 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.9 OUTLIER 171.67 147.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.069 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.698 HD12 ' C ' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -155.05 97.26 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.828 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.676 HD13 ' N ' ' A' ' 48' ' ' MET . 2.3 tm? -105.36 122.29 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.011 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.801 ' HB3' HG23 ' A' ' 26' ' ' ILE . 6.9 mtt -102.17 116.82 33.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.624 ' C ' HG21 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -88.88 101.06 13.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.605 ' CE ' HG22 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -82.03 48.13 1.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.98 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -129.57 -60.49 0.1 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.249 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -108.32 12.3 26.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 85.8 m-20 62.72 64.89 0.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.914 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.585 ' C ' HD11 ' A' ' 26' ' ' ILE . 78.3 mt-30 -148.0 134.17 19.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.843 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.67 ' CA ' HD11 ' A' ' 26' ' ' ILE . . . -109.66 157.68 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.735 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -140.95 115.85 9.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.239 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.499 HG22 HD13 ' A' ' 46' ' ' LEU . 22.5 pt -114.91 138.18 45.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.797 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -104.6 102.7 12.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.993 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.473 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -62.9 128.31 35.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.408 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.937 ' ND2' HG23 ' A' ' 44' ' ' THR . 0.3 OUTLIER -48.13 -39.81 21.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.31 -179.312 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.46 HG23 ' HB2' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -118.11 163.43 16.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.872 0.367 . . . . 0.0 111.238 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -71.68 -44.75 63.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.828 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -55.13 -30.51 59.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.423 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -69.15 -46.51 67.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.643 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.568 ' HB1' ' O ' ' A' ' 16' ' ' SER . . . -58.12 -60.0 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.255 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -42.01 -58.28 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.962 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.863 HG22 ' CD2' ' A' ' 40' ' ' PHE . 22.3 m -50.81 -51.84 46.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.326 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.593 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 6.3 tpt -36.3 -60.15 0.59 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.071 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.584 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 76.3 t -79.41 -26.43 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.424 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 1.5 t-20 -58.69 -64.12 1.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.079 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.62 -36.22 83.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.054 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.581 ' CE1' ' HG3' ' A' ' 77' ' ' PRO . 22.4 m-85 -87.93 20.06 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.983 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 87.7 m -68.7 -44.57 73.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.024 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.6 t -113.62 -39.82 3.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.769 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.54 108.91 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.474 ' OG1' ' CE2' ' A' ' 85' ' ' TYR . 2.2 m -93.81 122.3 62.53 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.065 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.581 ' HG3' ' CE1' ' A' ' 72' ' ' TYR . 74.2 Cg_endo -96.79 120.17 0.18 Allowed 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 123.064 2.509 . . . . 0.0 112.215 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 83' ' ' PRO . 1.4 m -89.34 -179.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.235 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.974 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -141.71 133.53 27.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.688 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.776 ' HB2' HD22 ' A' ' 79' ' ' LEU . 0.5 OUTLIER 36.25 30.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.443 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 85.57 51.98 3.5 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.871 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.552 ' HB3' ' CD1' ' A' ' 79' ' ' LEU . 1.5 tt0 -155.2 97.74 2.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.984 0.421 . . . . 0.0 110.799 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.75 ' HA ' HG12 ' A' ' 78' ' ' VAL . 52.1 Cg_exo -54.8 107.28 0.22 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.866 2.377 . . . . 0.0 112.658 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.777 HG22 ' HA ' ' A' ' 24' ' ' LEU . 7.1 pt -116.83 107.75 23.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.701 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CE2' ' OG1' ' A' ' 76' ' ' THR . 27.7 m-85 -71.28 149.08 46.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.317 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.788 HG12 HD12 ' A' ' 21' ' ' ILE . 4.5 mt -124.68 103.81 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.631 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 20' ' ' HIS . 2.8 mt-30 -125.16 172.05 9.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.883 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.584 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 59.9 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.51 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.856 0.36 . . . . 0.0 110.986 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.512 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 15.1 ptp180 -72.04 -16.98 62.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 87.5 t -87.92 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.669 HG21 ' HG2' ' A' ' 68' ' ' MET . 24.1 mm -127.07 109.24 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.642 ' CD2' ' CZ ' ' A' ' 56' ' ' PHE . 11.5 t-160 -78.93 110.55 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.795 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.503 HG23 HG13 ' A' ' 86' ' ' ILE . 25.7 mt -82.91 130.44 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.55 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 3.0 ptt180 -112.4 177.24 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 44.15 30.93 0.48 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.684 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.794 ' HA ' HG22 ' A' ' 84' ' ' ILE . 5.8 tp -117.59 112.85 38.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.457 ' O ' ' C ' ' A' ' 26' ' ' ILE . 21.9 Cg_exo -64.48 69.55 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.399 2.066 . . . . 0.0 111.391 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.796 HG21 ' C ' ' A' ' 49' ' ' LEU . 5.1 mm -33.97 111.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.371 0.605 . . . . 0.0 110.717 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 4.4 t70 150.7 -22.9 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.98 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.673 HG13 ' N ' ' A' ' 29' ' ' THR . 2.1 p -56.79 -157.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.608 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.673 ' N ' HG13 ' A' ' 28' ' ' VAL . 38.1 p -98.73 144.16 28.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.217 0.532 . . . . 0.0 112.035 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.65 -48.3 27.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.36 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.61 -31.4 0.4 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.706 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.659 ' HG2' HD13 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -79.22 -51.9 8.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 110.398 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' THR . 12.1 t -56.08 -51.09 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.775 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.823 HG23 HG21 ' A' ' 43' ' ' VAL . 1.5 mp -66.51 -50.4 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.506 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 14.9 t -44.76 -40.57 6.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.378 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 77' ' ' PRO . 13.4 mt -63.26 -42.0 99.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.43 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -82.09 -8.99 85.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.387 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.588 HD13 HG22 ' A' ' 34' ' ' ILE . 1.3 tp -55.06 -60.05 9.16 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 110.724 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 19.7 Cg_endo -60.46 -17.85 50.34 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.611 2.208 . . . . 0.0 111.833 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.591 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 28.0 m-85 -76.99 -5.65 49.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.886 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 42' ' ' LYS . . . 141.1 -103.21 0.33 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.134 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.436 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 1.5 mmtp -150.46 138.88 20.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 111.067 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.823 HG21 HG23 ' A' ' 34' ' ' ILE . 54.0 t -89.2 120.23 37.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 1.009 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -95.17 -11.98 27.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.157 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 8.7 t30 174.08 146.53 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.839 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.021 HD22 ' N ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -144.6 125.03 13.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.818 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.021 ' N ' HD22 ' A' ' 46' ' ' LEU . 7.2 tt -131.33 123.05 27.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.039 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.534 ' CA ' HD12 ' A' ' 26' ' ' ILE . 3.3 mmm -89.18 109.77 20.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.749 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.796 ' C ' HG21 ' A' ' 26' ' ' ILE . 13.6 tp -84.14 109.46 17.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.081 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.662 ' HD2' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -86.84 44.7 1.19 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.819 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -115.84 -42.47 0.72 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.554 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 28.12 2.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 110.963 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 75.7 m-20 57.93 49.18 12.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.535 ' HB3' ' NE2' ' A' ' 20' ' ' HIS . 47.8 mt-30 -134.4 140.08 46.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.363 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.559 ' CA ' HD11 ' A' ' 26' ' ' ILE . . . -109.9 172.55 6.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.65 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.642 ' CZ ' ' CD2' ' A' ' 20' ' ' HIS . 11.9 m-85 -148.01 115.71 6.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.355 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.517 HG22 HD23 ' A' ' 46' ' ' LEU . 6.6 pt -114.41 155.13 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.662 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.866 ' O ' HG23 ' A' ' 44' ' ' THR . 6.7 mm-40 -118.36 122.9 43.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.992 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.899 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 24.3 mmm -94.26 133.47 37.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.515 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 1.009 ' CG ' HG22 ' A' ' 44' ' ' THR . 1.8 m120 -71.77 -24.82 61.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 110.924 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 64' ' ' ALA . 9.0 t -125.0 129.0 49.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.17 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -44.68 -38.56 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -59.01 -26.45 64.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.899 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -76.38 -51.35 12.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.059 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 17' ' ' ARG . . . -57.05 -64.12 0.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.058 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -44.73 -60.06 2.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.756 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.8 m -48.06 -35.88 12.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.034 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.669 ' HG2' HG21 ' A' ' 19' ' ' ILE . 9.4 tpt -51.52 -62.26 1.73 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.959 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.642 HG21 ' N ' ' A' ' 88' ' ' PHE . 46.1 t -77.53 -15.91 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.366 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.464 ' O ' ' OG1' ' A' ' 73' ' ' THR . 11.5 t-20 -76.46 -64.19 1.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.131 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -56.66 -38.47 72.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.128 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.526 ' CE2' ' CZ ' ' A' ' 40' ' ' PHE . 24.7 m-85 -84.72 12.78 6.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.07 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 89.0 m -67.88 -34.73 77.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.22 -40.71 3.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.08 156.93 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.009 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.562 HG23 ' HD2' ' A' ' 77' ' ' PRO . 2.5 m -122.64 147.3 50.16 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.776 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.562 ' HD2' HG23 ' A' ' 76' ' ' THR . 28.9 Cg_endo -96.39 75.73 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.338 2.692 . . . . 0.0 112.386 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.603 ' O ' HD23 ' A' ' 79' ' ' LEU . 12.3 t -70.91 158.08 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.227 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.659 HD13 ' HG2' ' A' ' 32' ' ' GLU . 53.5 mt -137.63 113.44 9.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.108 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 51.64 20.23 1.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.474 ' O ' ' HD3' ' A' ' 83' ' ' PRO . . . 105.99 8.74 33.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.668 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.411 ' C ' HG13 ' A' ' 78' ' ' VAL . 5.5 tp-100 -109.27 97.5 26.44 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.829 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 81' ' ' GLY . 13.5 Cg_exo -69.93 126.75 13.55 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 123.045 2.496 . . . . 0.0 112.434 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.794 HG22 ' HA ' ' A' ' 24' ' ' LEU . 8.0 pt -135.35 107.45 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.55 ' HB2' ' CG ' ' A' ' 22' ' ' ARG . 3.3 m-85 -75.03 151.08 38.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.397 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.667 HG21 ' HG3' ' A' ' 68' ' ' MET . 4.4 mt -125.91 122.05 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.562 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -130.91 169.98 15.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.149 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.642 ' N ' HG21 ' A' ' 69' ' ' VAL . 58.8 m-85 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.021 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.6 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.742 0.306 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -170.54 -45.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.917 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.94 138.59 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.875 HG21 ' SD ' ' A' ' 68' ' ' MET . 47.2 mm -119.14 105.52 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 87' ' ' GLN . 5.0 t-160 -78.98 107.59 11.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.718 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.67 HG23 HD13 ' A' ' 86' ' ' ILE . 9.5 mt -85.22 118.52 32.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.402 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.51 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -100.73 170.08 8.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.483 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.08 32.4 2.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.981 0.42 . . . . 0.0 110.253 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.975 HD13 HD12 ' A' ' 84' ' ' ILE . 4.2 tp -116.99 123.34 30.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.172 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' ILE . 57.1 Cg_endo -71.05 75.6 1.74 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.426 2.084 . . . . 0.0 111.597 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.957 HD11 ' C ' ' A' ' 54' ' ' GLN . 17.9 mm -30.91 148.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.117 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 96.43 7.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.788 -178.394 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.571 HG21 HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -63.25 -151.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.027 179.341 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.637 ' O ' HG23 ' A' ' 33' ' ' VAL . 71.8 p -120.26 148.9 43.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.007 0.432 . . . . 0.0 111.749 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.544 ' CG ' HD23 ' A' ' 46' ' ' LEU . 5.6 mp0 -66.28 -66.0 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.756 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.05 -29.53 0.2 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.154 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -82.51 -61.21 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.713 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 29' ' ' THR . 56.9 t -55.21 -53.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.851 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.971 ' CD1' HD22 ' A' ' 46' ' ' LEU . 1.4 mp -62.66 -33.99 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.279 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.563 ' HA ' HD22 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -51.07 -36.23 39.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.054 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.538 HD23 ' OH ' ' A' ' 72' ' ' TYR . 2.0 mt -70.64 -46.9 62.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.21 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.83 -13.6 82.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.281 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.84 HD13 HG22 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -48.79 -60.28 4.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.78 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 20.2 Cg_endo -60.77 -34.95 91.01 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.636 2.224 . . . . 0.0 111.731 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 67' ' ' THR . 39.7 m-85 -63.25 -12.39 28.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.999 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.73 -106.86 0.36 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.122 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.472 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -150.61 150.22 30.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.909 0.385 . . . . 0.0 111.139 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 34' ' ' ILE . 55.0 t -102.58 121.19 53.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.307 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.778 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -102.64 8.24 39.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.513 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 171.95 153.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.971 HD22 ' CD1' ' A' ' 34' ' ' ILE . 17.1 tp -140.53 131.2 25.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.949 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 tp -136.18 137.28 40.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.597 ' HB3' HG23 ' A' ' 26' ' ' ILE . 4.9 mmm -125.09 94.77 4.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.776 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.492 ' C ' HG21 ' A' ' 26' ' ' ILE . 27.6 tp -76.43 92.9 3.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.703 ' N ' HG21 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -60.65 159.23 11.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.011 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.71 -73.49 0.24 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.482 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -83.07 -8.87 59.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.788 0.327 . . . . 0.0 111.018 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER 68.65 47.43 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.957 ' C ' HD11 ' A' ' 26' ' ' ILE . 69.9 mt-30 -129.54 126.96 39.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.728 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.754 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.15 161.41 15.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.784 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -140.94 115.89 9.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.396 -179.395 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.788 HG22 ' CD1' ' A' ' 46' ' ' LEU . 7.1 pt -112.75 140.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.579 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 44' ' ' THR . 6.9 tt0 -103.53 102.97 12.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.27 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.456 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 2.7 mtp -74.64 147.39 41.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.122 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.778 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.2 OUTLIER -64.2 -55.13 23.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.399 -178.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -108.03 169.81 8.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 111.451 -179.094 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' N ' ' OG1' ' A' ' 61' ' ' THR . 24.1 mt-10 -71.33 -47.75 54.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.64 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -49.33 -31.6 9.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.262 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 40' ' ' PHE . . . -70.62 -51.6 27.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.769 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.456 ' HA ' ' SD ' ' A' ' 59' ' ' MET . . . -67.14 -66.1 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.315 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 65' ' ' ALA . 18.1 m120 -37.92 -45.32 0.85 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.989 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.879 HG22 ' CE2' ' A' ' 40' ' ' PHE . 43.7 m -64.68 -53.44 47.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.141 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.875 ' SD ' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -35.36 -64.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.041 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.795 HG22 HG22 ' A' ' 86' ' ' ILE . 75.1 t -68.47 -46.69 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.286 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 40.5 m-20 -46.47 -64.41 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.174 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -62.11 -38.1 87.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 77' ' ' PRO . 18.1 m-85 -87.73 19.66 3.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 69' ' ' VAL . 20.3 m -83.78 -35.36 24.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.923 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 t -113.29 -40.51 3.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.9 t -75.53 138.63 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.494 ' HG1' ' HH ' ' A' ' 85' ' ' TYR . 2.4 m -90.42 112.11 51.07 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.275 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.587 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 58.8 Cg_endo -98.05 109.62 0.08 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 123.24 2.627 . . . . 0.0 112.299 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HB ' ' C ' ' A' ' 82' ' ' GLN . 0.7 OUTLIER -110.71 157.62 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 111.002 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.501 ' C ' HD13 ' A' ' 79' ' ' LEU . 3.4 tm? -107.26 100.92 10.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.523 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.404 ' HB2' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER 71.75 -58.72 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.997 0.427 . . . . 0.0 110.493 -179.615 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.39 24.65 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.417 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -129.64 104.57 17.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.717 0.294 . . . . 0.0 110.584 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 82' ' ' GLN . 28.0 Cg_endo -63.45 117.79 4.73 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.563 2.175 . . . . 0.0 112.634 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.975 HD12 HD13 ' A' ' 24' ' ' LEU . 3.4 pt -131.63 111.28 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.628 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.51 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 19.8 m-85 -77.9 165.68 23.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.442 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.795 HG22 HG22 ' A' ' 69' ' ' VAL . 39.6 mm -119.54 142.56 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.827 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' HIS . 2.1 mm-40 -141.98 170.72 15.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.06 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.586 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 32.7 m-85 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.815 0.34 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -138.87 -57.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 18' ' ' VAL . 7.3 p -88.63 104.94 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.093 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.905 HG21 ' HG2' ' A' ' 68' ' ' MET . 47.3 mm -84.04 117.94 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.552 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 3.2 t-160 -82.59 153.0 25.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.899 HG13 ' HB3' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -123.31 110.54 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.083 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.46 171.0 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER 44.22 40.19 3.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.892 0.377 . . . . 0.0 110.297 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.908 HD13 HD12 ' A' ' 84' ' ' ILE . 8.1 tp -123.73 117.39 27.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.34 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.473 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 39.2 Cg_endo -67.03 74.09 0.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.299 1.999 . . . . 0.0 111.209 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.952 HD11 ' C ' ' A' ' 54' ' ' GLN . 29.1 mm -30.06 148.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.208 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER 100.81 10.59 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.657 -178.192 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.699 HG21 HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -67.14 -151.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.877 179.208 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.536 ' H ' HG12 ' A' ' 28' ' ' VAL . 71.7 p -124.76 145.14 49.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.978 0.418 . . . . 0.0 111.613 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.517 ' HG2' HD23 ' A' ' 46' ' ' LEU . 79.0 mt-10 -62.78 -63.73 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.57 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.69 -31.11 0.23 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.785 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HB2' ' OG1' ' A' ' 29' ' ' THR . 7.3 mm-40 -79.45 -63.73 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 110.248 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.7 t -56.77 -63.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.408 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.97 HG23 HG21 ' A' ' 43' ' ' VAL . 1.6 mt -46.8 -47.62 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.964 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -42.7 -50.68 5.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.376 179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.509 ' O ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 mp -57.47 -31.48 66.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.263 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -90.45 -16.42 55.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.333 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.543 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 19.8 mt -48.96 -56.42 15.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.66 0.267 . . . . 0.0 110.986 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 31.8 Cg_endo -63.88 -18.63 64.65 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.526 2.15 . . . . 0.0 112.11 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.959 ' CE2' HG22 ' A' ' 67' ' ' THR . 37.0 m-85 -77.26 -14.67 59.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.718 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.94 -101.66 0.24 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.124 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -150.62 149.43 29.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.825 0.345 . . . . 0.0 111.09 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.97 HG21 HG23 ' A' ' 34' ' ' ILE . 55.0 t -100.08 115.85 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.343 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.798 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -96.56 2.11 52.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.522 -178.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.6 OUTLIER 170.83 142.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.937 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.023 HD13 HG22 ' A' ' 57' ' ' ILE . 39.7 tp -144.4 115.4 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.021 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.62 138.3 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.606 ' HB3' HG23 ' A' ' 26' ' ' ILE . 5.3 mmm -116.14 103.79 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.62 ' C ' HG21 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -89.55 91.48 8.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.812 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.803 ' N ' HG21 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -45.63 -26.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.887 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . -77.79 118.93 5.12 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.458 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 6.6 mtmm 85.09 -10.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 0.0 111.013 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.502 ' HA ' ' CG1' ' A' ' 26' ' ' ILE . 0.6 OUTLIER 61.89 58.75 1.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.053 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.952 ' C ' HD11 ' A' ' 26' ' ' ILE . 3.4 mm-40 -137.72 133.15 33.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.734 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.899 ' HB3' HG13 ' A' ' 21' ' ' ILE . . . -109.16 161.75 14.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.655 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -143.76 115.86 8.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.528 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.023 HG22 HD13 ' A' ' 46' ' ' LEU . 5.9 pt -109.9 154.93 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.259 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.699 ' O ' HG23 ' A' ' 44' ' ' THR . 0.7 OUTLIER -116.33 111.18 19.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.807 0.337 . . . . 0.0 111.536 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.787 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 8.5 mmm -80.14 137.42 36.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.023 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.798 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.2 OUTLIER -65.49 -41.3 93.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.419 . . . . 0.0 110.633 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -119.23 176.61 5.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.095 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.52 ' N ' ' OG1' ' A' ' 61' ' ' THR . 1.6 mp0 -73.73 -50.38 21.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.838 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -46.02 -29.32 1.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.643 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.787 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -75.94 -51.08 13.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.016 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.509 ' CA ' HD11 ' A' ' 19' ' ' ILE . . . -64.09 -61.03 2.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.099 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -44.78 -62.09 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.665 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.959 HG22 ' CE2' ' A' ' 40' ' ' PHE . 88.9 m -46.22 -51.83 13.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.98 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.905 ' HG2' HG21 ' A' ' 19' ' ' ILE . 7.1 tpt -34.63 -61.17 0.41 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.98 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.885 HG11 ' CE2' ' A' ' 88' ' ' PHE . 68.9 t -79.75 -54.59 10.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.246 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.407 ' O ' ' HB ' ' A' ' 73' ' ' THR . 20.5 m-20 -38.33 -64.18 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.305 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -60.97 -45.52 94.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.192 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 68' ' ' MET . 13.1 m-30 -73.42 -1.0 16.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.249 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 69' ' ' VAL . 46.8 m -59.16 -36.77 75.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 110.817 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.7 m -112.71 -44.08 3.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.6 t -80.92 126.69 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.567 ' OG1' ' CZ ' ' A' ' 85' ' ' TYR . 3.0 m -89.31 134.94 31.9 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.07 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.48 ' O ' HG12 ' A' ' 84' ' ' ILE . 46.5 Cg_endo -97.69 80.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.982 2.455 . . . . 0.0 112.292 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.982 ' C ' HD23 ' A' ' 79' ' ' LEU . 1.4 p -92.21 158.73 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.982 HD23 ' C ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -148.6 132.09 16.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.229 -179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.9 18.8 1.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.18 15.3 52.03 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.66 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.444 ' C ' HG23 ' A' ' 78' ' ' VAL . 74.0 mt-30 -113.68 96.78 41.95 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.054 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.29 108.7 2.05 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.903 2.402 . . . . 0.0 112.608 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.908 HD12 HD13 ' A' ' 24' ' ' LEU . 3.7 pt -117.24 110.21 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.521 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.567 ' CZ ' ' OG1' ' A' ' 76' ' ' THR . 2.4 m-85 -86.02 152.3 23.02 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.879 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.656 HG12 HD13 ' A' ' 21' ' ' ILE . 3.8 mt -126.59 140.46 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.466 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.482 ' HA ' HG22 ' A' ' 69' ' ' VAL . 2.0 pt20 -157.14 172.71 18.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 111.166 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.885 ' CE2' HG11 ' A' ' 69' ' ' VAL . 6.0 m-85 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.02 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 1.3 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.797 0.332 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.33 -24.98 22.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.7 t -87.9 111.66 22.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.122 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.523 ' CG2' HG23 ' A' ' 86' ' ' ILE . 48.7 mm -97.08 105.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.22 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 87' ' ' GLN . 6.6 t-160 -79.02 119.74 22.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.652 HG23 HG13 ' A' ' 86' ' ' ILE . 10.2 mt -96.72 124.53 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.292 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -107.69 171.2 7.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.605 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 49.01 39.36 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.167 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.688 HD12 HG21 ' A' ' 84' ' ' ILE . 9.5 tp -129.16 98.27 24.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 53' ' ' ASN . 39.9 Cg_exo -56.14 77.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.518 2.146 . . . . 0.0 111.519 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.724 HG22 ' HE3' ' A' ' 50' ' ' LYS . 19.4 mm -31.54 125.45 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.065 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 2.1 t70 146.31 -15.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.144 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.737 HG11 ' HG ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -55.15 -154.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.4 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.576 ' H ' HG12 ' A' ' 28' ' ' VAL . 30.4 p -124.41 146.93 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.985 0.421 . . . . 0.0 111.683 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.617 ' HB3' HD12 ' A' ' 34' ' ' ILE . 3.2 mp0 -66.67 -49.35 66.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.62 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -45.41 -36.0 5.6 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.981 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.792 ' HG2' HD21 ' A' ' 79' ' ' LEU . 2.8 tp10 -81.96 -61.05 2.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.791 0.329 . . . . 0.0 110.606 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 29' ' ' THR . 47.7 t -52.76 -59.88 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.553 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.617 HD12 ' HB3' ' A' ' 30' ' ' GLU . 33.7 mt -54.07 -40.79 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.544 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -50.92 -40.56 57.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.147 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.951 HD12 ' OH ' ' A' ' 72' ' ' TYR . 2.1 mm? -65.9 -28.34 68.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.068 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -81.22 -20.65 64.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.375 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.509 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -46.11 -56.42 10.69 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.702 0.287 . . . . 0.0 110.575 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.509 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 35.4 Cg_exo -59.56 -19.98 55.07 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.385 2.057 . . . . 0.0 111.061 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.597 ' CD1' HG22 ' A' ' 67' ' ' THR . 6.2 m-30 -92.02 16.16 11.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.655 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.18 -111.14 3.02 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.034 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.463 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -150.79 154.59 37.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 0.0 111.209 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.455 HG21 HG12 ' A' ' 34' ' ' ILE . 59.0 t -101.82 116.92 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.762 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -98.89 9.38 43.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.448 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 44' ' ' THR . 8.4 t-20 175.61 144.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.887 HD13 HG22 ' A' ' 57' ' ' ILE . 5.2 tp -151.91 126.69 9.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.694 ' N ' HD12 ' A' ' 46' ' ' LEU . 3.4 tm? -141.01 107.56 5.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.713 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.7 mmm -86.29 118.87 26.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.79 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.546 ' C ' HG21 ' A' ' 26' ' ' ILE . 14.7 tp -102.02 100.36 10.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.084 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.724 ' HE3' HG22 ' A' ' 26' ' ' ILE . 1.4 mmtp -53.83 -19.05 3.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -37.68 -96.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.696 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -100.94 48.1 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.328 . . . . 0.0 110.981 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.451 ' CG ' ' HA ' ' A' ' 25' ' ' PRO . 85.6 m-20 39.93 73.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.605 ' C ' HD11 ' A' ' 26' ' ' ILE . 5.0 mt-30 -151.05 133.24 15.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.64 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.554 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.6 165.33 11.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.744 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -143.87 115.9 8.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.308 -179.543 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.887 HG22 HD13 ' A' ' 46' ' ' LEU . 15.0 pt -119.52 139.26 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.675 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 44' ' ' THR . 0.4 OUTLIER -108.0 103.84 13.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.256 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 0.9 OUTLIER -69.84 146.21 51.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.248 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.762 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.2 OUTLIER -66.22 -47.0 75.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.329 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.95 168.94 9.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.426 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -72.05 -47.21 53.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.682 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -50.53 -26.93 5.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.408 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 40' ' ' PHE . . . -74.39 -52.41 12.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.852 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -53.89 -58.43 7.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.197 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 70' ' ' ASN . 1.7 m-20 -46.54 -64.71 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.597 HG22 ' CD1' ' A' ' 40' ' ' PHE . 19.9 m -40.83 -55.43 2.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.784 ' SD ' HG21 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -36.12 -63.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.037 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.639 HG22 HG22 ' A' ' 86' ' ' ILE . 65.2 t -83.37 -58.47 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.257 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 66' ' ' ASN . 21.1 t-20 -37.6 -36.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.486 ' HB3' ' O ' ' A' ' 67' ' ' THR . 2.1 t80 -78.19 -52.73 8.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.991 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.951 ' OH ' HD12 ' A' ' 36' ' ' LEU . 13.4 m-85 -65.89 -9.1 26.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.054 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 72' ' ' TYR . 28.6 m -38.1 -36.66 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.936 0.398 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 t -110.32 -56.62 2.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.739 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.43 120.91 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.5 m -94.3 141.47 23.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.263 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 76' ' ' THR . 58.2 Cg_endo -98.43 137.6 0.36 Allowed 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.436 2.757 . . . . 0.0 112.311 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -122.91 179.94 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.948 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.792 HD21 ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -140.92 118.73 11.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.85 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 47.33 24.28 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.536 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.51 15.38 23.11 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.412 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.456 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -120.3 97.9 48.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.599 ' HA ' HG12 ' A' ' 78' ' ' VAL . 39.6 Cg_exo -57.3 129.06 32.13 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.976 2.45 . . . . 0.0 112.802 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.688 HG21 HD12 ' A' ' 24' ' ' LEU . 5.3 pt -133.45 109.33 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.203 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -80.4 146.57 31.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.086 -178.654 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.784 HG21 ' SD ' ' A' ' 68' ' ' MET . 5.9 mt -126.4 108.75 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.412 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.534 ' HA ' ' CG1' ' A' ' 69' ' ' VAL . 30.0 mt-30 -140.39 166.09 25.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 111.366 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.656 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.582 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . 3.1 m . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.847 0.356 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.07 -49.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.85 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 t -88.03 100.43 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.04 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.82 HD11 ' HB1' ' A' ' 65' ' ' ALA . 37.4 mm -81.21 105.7 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.239 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.692 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 10.2 t-160 -84.65 107.58 16.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.837 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.549 HG23 HG13 ' A' ' 86' ' ' ILE . 1.7 mm -82.86 119.35 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.187 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.97 173.42 6.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.685 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 3.1 tmtt? 43.22 41.99 3.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.536 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.814 HD12 ' HD2' ' A' ' 25' ' ' PRO . 6.3 tp -127.79 130.45 23.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.814 ' HD2' HD12 ' A' ' 24' ' ' LEU . 73.6 Cg_endo -76.49 74.75 4.62 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.592 2.194 . . . . 0.0 111.742 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.89 HD11 ' C ' ' A' ' 54' ' ' GLN . 15.0 mm -32.83 110.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.143 0.497 . . . . 0.0 110.659 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.567 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 6.3 t70 146.69 -17.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.539 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.69 HG22 ' H ' ' A' ' 29' ' ' THR . 1.7 p -51.19 -168.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.373 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.69 ' H ' HG22 ' A' ' 28' ' ' VAL . 45.2 p -105.77 145.91 30.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.12 0.486 . . . . 0.0 111.808 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.9 mp0 -62.08 -46.12 90.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.672 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.64 -36.77 0.76 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.085 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.442 ' OE1' ' HB2' ' A' ' 79' ' ' LEU . 91.9 mt-10 -75.12 -51.18 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 110.454 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.3 t -64.07 -61.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.02 HG23 HG21 ' A' ' 43' ' ' VAL . 1.1 mt -50.82 -46.82 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.097 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 3.7 t -45.62 -45.12 13.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.583 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.511 HD22 ' OH ' ' A' ' 72' ' ' TYR . 68.6 mt -69.16 -21.27 64.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.539 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -87.1 -28.37 25.76 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.526 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.493 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -40.86 -53.14 6.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.698 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 19.6 Cg_exo -65.71 -34.33 41.27 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.718 2.279 . . . . 0.0 111.786 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.596 ' CD1' HG22 ' A' ' 67' ' ' THR . 15.6 m-30 -65.83 -39.3 90.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.833 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.521 ' O ' ' CD ' ' A' ' 42' ' ' LYS . . . 165.68 -98.52 0.15 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.42 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -150.48 141.64 23.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.79 0.328 . . . . 0.0 110.94 179.868 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.02 HG21 HG23 ' A' ' 34' ' ' ILE . 55.5 t -88.68 86.49 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.908 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -80.62 7.44 10.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.322 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 170.75 137.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.027 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.976 HD23 HG22 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -147.92 98.4 2.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.545 ' N ' HD22 ' A' ' 46' ' ' LEU . 6.5 tt -97.88 149.16 22.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.816 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.812 ' HB3' HG23 ' A' ' 26' ' ' ILE . 8.2 mtt -125.21 110.65 14.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.148 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.645 ' C ' HG21 ' A' ' 26' ' ' ILE . 6.0 tp -88.42 96.4 10.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.751 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.714 ' CD ' HG22 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -74.73 0.56 14.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.255 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.63 -9.03 36.07 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.404 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -160.46 -64.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.778 0.323 . . . . 0.0 111.001 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.594 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 2.7 m-20 155.08 43.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.551 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.89 ' C ' HD11 ' A' ' 26' ' ' ILE . 12.2 mt-30 -130.44 133.09 46.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.11 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.766 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.81 163.06 13.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.715 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.692 ' CE2' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -148.0 115.78 6.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.134 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.976 HG22 HD23 ' A' ' 46' ' ' LEU . 22.0 pt -112.18 137.18 45.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.78 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.73 102.67 14.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.731 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.855 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 17.7 mmm -67.02 124.02 21.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.645 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.908 ' ND2' HG23 ' A' ' 44' ' ' THR . 2.8 m120 -35.69 -33.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.78 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -144.67 176.78 9.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.971 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.512 ' N ' ' OG1' ' A' ' 61' ' ' THR . 1.2 mp0 -72.88 -44.76 60.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.95 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -50.25 -24.55 2.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.947 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.855 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -83.47 -49.72 9.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.82 ' HB1' HD11 ' A' ' 19' ' ' ILE . . . -65.41 -31.2 72.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.369 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -70.09 -54.49 12.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.596 HG22 ' CD1' ' A' ' 40' ' ' PHE . 24.1 m -56.62 -22.63 35.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.269 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.585 ' SD ' HD11 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -69.03 -65.01 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.066 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 21.6 t -67.97 -48.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.277 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -52.77 -40.47 63.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.037 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.428 ' CB ' ' O ' ' A' ' 67' ' ' THR . 3.5 t80 -67.81 -44.53 77.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.511 ' OH ' HD22 ' A' ' 36' ' ' LEU . 41.0 m-85 -85.84 12.48 9.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 70' ' ' ASN . 54.1 m -66.26 -13.84 61.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.2 m -127.77 -39.8 1.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.832 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.76 138.74 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.484 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.3 m -103.33 142.56 24.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.01 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.761 ' HG2' HD12 ' A' ' 86' ' ' ILE . 30.2 Cg_endo -95.24 145.08 1.4 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 123.103 2.535 . . . . 0.0 112.097 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' HB ' ' C ' ' A' ' 82' ' ' GLN . 0.7 OUTLIER -133.29 166.28 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 0.0 110.994 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.793 HD12 ' C ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -107.88 107.63 18.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.406 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER 28.92 34.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.327 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 115.93 36.24 1.16 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.559 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.548 ' CB ' ' HG ' ' A' ' 79' ' ' LEU . 2.5 tt0 -151.34 97.18 3.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.076 0.465 . . . . 0.0 110.613 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.406 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 38.7 Cg_exo -61.16 126.2 18.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.004 2.47 . . . . 0.0 112.959 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.487 ' O ' HG13 ' A' ' 84' ' ' ILE . 9.4 pt -137.73 107.7 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.273 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -68.85 146.88 52.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.99 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.761 HD12 ' HG2' ' A' ' 77' ' ' PRO . 6.5 mt -126.31 103.75 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.203 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' HIS . 4.1 mt-30 -126.64 174.27 8.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.899 0.381 . . . . 0.0 111.142 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.582 ' CE1' ' HB3' ' A' ' 16' ' ' SER . 71.4 m-85 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.89 0.376 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 58' ' ' GLU . 3.5 mtm180 -137.22 -42.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 t -87.91 133.81 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.582 HG21 ' HG2' ' A' ' 68' ' ' MET . 4.8 mm -115.61 102.42 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.395 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.518 ' CD2' ' HB3' ' A' ' 54' ' ' GLN . 4.7 t-160 -79.08 113.98 17.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.598 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.911 HD12 HG12 ' A' ' 86' ' ' ILE . 4.1 mm -82.83 127.03 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.347 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -108.79 171.33 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.671 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HG2' ' CZ ' ' A' ' 85' ' ' TYR . 1.9 tptp 43.66 33.17 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.27 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.772 HD13 HD12 ' A' ' 84' ' ' ILE . 2.2 tp -115.46 110.66 44.74 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.103 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.51 ' O ' ' C ' ' A' ' 26' ' ' ILE . 43.8 Cg_endo -68.22 61.69 1.04 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.277 1.985 . . . . 0.0 110.991 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.913 HD11 ' C ' ' A' ' 54' ' ' GLN . 37.5 mm -8.5 105.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.468 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.622 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 24.6 t70 129.18 24.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 O-C-N 124.408 1.067 . . . . 0.0 111.325 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.731 ' C ' HG23 ' A' ' 29' ' ' THR . 5.2 p -85.23 8.38 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.376 0.607 . . . . 0.0 111.031 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.731 HG23 ' C ' ' A' ' 28' ' ' VAL . 3.0 p 90.29 146.82 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.976 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -74.92 -40.19 60.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.228 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -53.86 -25.9 31.65 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.96 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.807 ' HG3' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -80.39 -50.31 10.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 110.551 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.402 ' HB ' ' CD2' ' A' ' 46' ' ' LEU . 12.4 t -62.29 -51.26 74.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.748 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.32 -41.51 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.442 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.9 t -49.74 -33.3 15.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.181 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.849 HD13 ' CZ ' ' A' ' 72' ' ' TYR . 6.6 mt -75.43 -34.9 61.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -70.03 -26.09 74.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.464 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -37.87 -61.23 0.81 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.367 . . . . 0.0 110.723 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.2 Cg_endo -65.87 -22.51 56.16 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.57 2.18 . . . . 0.0 111.626 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.59 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 13.1 m-30 -80.77 0.45 34.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.976 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.8 -101.69 0.85 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.375 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -150.32 145.56 26.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 111.481 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.679 HG22 HD11 ' A' ' 57' ' ' ILE . 54.7 t -89.51 122.58 41.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.651 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 1.081 HG22 ' ND2' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -99.15 -14.32 19.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.211 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.1 t-20 172.88 142.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.676 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' PHE . 5.3 tp -148.52 95.93 2.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.998 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 47' ' ' LEU . 7.1 tt -95.33 127.48 41.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.66 ' HB3' HG23 ' A' ' 26' ' ' ILE . 27.9 mtp -94.59 137.03 34.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.971 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.471 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.2 tp -124.06 101.82 7.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.784 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.675 ' HE3' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -59.6 -13.86 11.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.21 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -35.15 -95.36 0.01 OUTLIER Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.619 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 63.8 mmtt -104.03 44.11 1.04 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.914 0.388 . . . . 0.0 110.774 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.513 ' HA ' HG12 ' A' ' 26' ' ' ILE . 37.7 m-20 48.76 75.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.912 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.913 ' C ' HD11 ' A' ' 26' ' ' ILE . 32.4 mt-30 -157.65 138.42 13.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.619 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.691 ' HB3' ' CG1' ' A' ' 21' ' ' ILE . . . -109.28 167.97 9.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -139.55 115.66 10.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.283 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.679 HD11 HG22 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -127.56 144.03 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.655 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.523 ' N ' HG12 ' A' ' 57' ' ' ILE . 15.5 mt-10 -121.53 133.14 55.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.895 0.379 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.869 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 27.9 mmm -92.09 151.28 20.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.589 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 1.081 ' ND2' HG22 ' A' ' 44' ' ' THR . 0.6 OUTLIER -68.65 -26.73 65.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.952 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.619 HG23 ' H ' ' A' ' 64' ' ' ALA . 4.8 t -131.17 138.22 49.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.091 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.39 -21.02 2.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.821 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -73.59 -36.59 65.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.869 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -67.43 -49.87 61.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' A' ' 19' ' ' ILE . . . -55.78 -56.91 14.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -41.97 -68.48 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.986 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.566 HG22 ' CD1' ' A' ' 40' ' ' PHE . 19.4 m -40.93 -49.83 3.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.114 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.59 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -38.4 -64.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.977 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 54.1 t -77.09 -59.0 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -41.88 -27.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.056 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.423 ' CB ' ' O ' ' A' ' 67' ' ' THR . 10.7 t80 -85.46 -45.43 11.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.948 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.849 ' CZ ' HD13 ' A' ' 36' ' ' LEU . 19.2 m-85 -82.9 9.12 10.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 m -70.13 -23.63 63.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.05 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.9 t -116.65 -34.2 4.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.788 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.7 p -113.8 126.82 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.989 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.523 HG21 ' CE1' ' A' ' 85' ' ' TYR . 2.0 m -97.6 131.26 27.37 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.151 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.575 ' HG3' ' CE1' ' A' ' 72' ' ' TYR . 72.5 Cg_endo -98.33 120.87 0.14 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 123.178 2.585 . . . . 0.0 112.411 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.677 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -95.07 -179.96 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.856 179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.807 HD12 ' HG3' ' A' ' 32' ' ' GLU . 2.4 mm? -139.96 115.53 10.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.951 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.07 21.41 1.02 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.728 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.42 15.72 16.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.524 ' O ' HG23 ' A' ' 84' ' ' ILE . 18.7 mm100 -122.83 97.98 43.33 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.027 0.441 . . . . 0.0 110.956 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 22.2 Cg_exo -64.91 105.9 0.71 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.974 2.449 . . . . 0.0 112.746 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.772 HD12 HD13 ' A' ' 24' ' ' LEU . 1.6 pt -119.9 112.39 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.641 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -76.71 156.03 32.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.94 -178.524 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.911 HG12 HD12 ' A' ' 21' ' ' ILE . 7.7 mt -126.15 104.27 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.327 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -113.84 175.3 5.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 111.346 -179.664 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.583 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 44.3 m-85 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.041 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.5 p . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.765 0.317 . . . . 6.45 111.194 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -37.64 151.82 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 3.85 112.434 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.1 OUTLIER -122.08 121.23 28.02 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.357 . . . . 3.33 111.062 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.04 86.12 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.739 2.292 . . . . 3.43 112.265 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 14' ' ' VAL . 2.2 m -138.63 101.47 4.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 2.83 110.898 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -108.15 -40.74 5.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 2.95 110.887 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' A' ' 89' ' ' SER . 77.3 t -93.56 135.86 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 1.11 111.149 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.808 HG21 ' HG2' ' A' ' 68' ' ' MET . 36.5 mm -107.97 109.83 29.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.71 111.146 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.671 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 6.4 t-160 -83.08 109.14 16.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 1.52 110.865 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.49 HG23 HG13 ' A' ' 86' ' ' ILE . 4.3 mt -83.44 122.26 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.95 111.194 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -103.61 174.82 5.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 2.83 110.735 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 42.85 41.36 2.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 2.58 110.74 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.506 HD12 HG21 ' A' ' 84' ' ' ILE . 3.6 tp -128.19 127.02 23.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 1.2 110.705 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.518 ' O ' ' C ' ' A' ' 26' ' ' ILE . 72.0 Cg_endo -75.58 71.66 5.28 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.504 2.136 . . . . 1.05 112.036 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.838 HG21 ' N ' ' A' ' 50' ' ' LYS . 15.9 mm -27.22 110.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.1 0.476 . . . . 2.15 110.876 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 4.0 t70 146.07 -18.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.291 -0.868 . . . . 2.16 109.451 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 29' ' ' THR . 1.8 p -52.41 -167.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 115.628 -0.714 . . . . 1.61 109.842 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.685 ' H ' HG22 ' A' ' 28' ' ' VAL . 45.9 p -99.36 145.21 27.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.069 0.461 . . . . 0.57 111.773 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.6 mp0 -70.32 -46.77 63.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.761 -0.654 . . . . 2.01 110.504 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.04 -28.64 0.16 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.543 -0.837 . . . . 0.56 111.936 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.738 ' HB3' HD21 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -83.96 -57.26 3.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.319 . . . . 2.48 110.491 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.5 t -51.5 -49.96 31.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.953 0.406 . . . . 0.6 110.575 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.544 ' CG1' HG21 ' A' ' 43' ' ' VAL . 1.2 mp -69.97 -38.23 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.68 110.558 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -49.1 -38.76 25.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 1.31 110.373 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.964 HD22 ' OH ' ' A' ' 72' ' ' TYR . 12.1 mt -72.7 -38.55 67.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.946 -0.57 . . . . 1.49 110.358 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.604 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -71.54 -20.34 78.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 0.52 112.305 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -41.65 -60.52 1.86 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.852 0.358 . . . . 1.5 110.775 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 30.1 Cg_endo -63.29 -34.63 66.64 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.714 2.276 . . . . 0.54 111.939 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.661 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.8 m-30 -60.22 -32.62 71.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.974 -0.557 . . . . 1.33 110.678 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 157.85 -102.29 0.21 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.86 -0.686 . . . . 0.43 112.231 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.453 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 28.5 mttt -150.4 137.31 19.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.762 0.315 . . . . 2.37 111.023 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.544 HG21 ' CG1' ' A' ' 34' ' ' ILE . 45.5 t -87.83 121.72 38.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.6 110.468 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 1.056 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -96.27 -2.0 46.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 1.12 111.459 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 170.98 152.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 1.47 111.056 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.956 HD13 HG22 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -145.38 100.52 3.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 1.38 110.89 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 48' ' ' MET . 2.8 tt -108.33 113.74 27.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 1.42 110.918 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.603 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.8 mmm -90.79 94.91 9.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.84 110.865 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.571 ' C ' HG21 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -74.53 93.05 2.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 1.78 110.843 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.838 ' N ' HG21 ' A' ' 26' ' ' ILE . 3.4 mmtp -51.95 -18.74 1.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 1.64 111.09 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -33.71 -95.21 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.798 -0.715 . . . . 2.03 112.622 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 26.5 mttt -107.9 55.88 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 3.29 110.975 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 72.5 m-20 40.56 68.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 1.39 110.948 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.757 ' C ' HD11 ' A' ' 26' ' ' ILE . 10.7 mt-30 -146.99 129.35 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 1.69 110.747 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.708 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.7 160.21 16.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.37 110.891 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.671 ' CE2' ' CD2' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -142.77 115.86 8.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.307 -0.406 . . . . 1.4 111.187 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.956 HG22 HD13 ' A' ' 46' ' ' LEU . 6.1 pt -114.64 146.82 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.69 110.771 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.784 ' O ' HG23 ' A' ' 44' ' ' THR . 1.6 mt-10 -111.8 123.18 49.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.289 -0.414 . . . . 1.96 111.222 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.497 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -90.77 137.41 32.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 1.11 110.251 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 1.056 ' CG ' HG22 ' A' ' 44' ' ' THR . 2.3 m120 -68.4 -20.74 64.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.418 -0.356 . . . . 1.37 111.484 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.61 HG23 ' HB2' ' A' ' 64' ' ' ALA . 1.4 t -129.84 146.88 51.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 1.27 111.326 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.48 -46.09 89.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.088 -0.505 . . . . 1.95 110.779 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.64 -23.42 17.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 2.13 110.721 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.61 ' HB2' HG23 ' A' ' 61' ' ' THR . . . -78.21 -54.84 5.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.41 111.029 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -52.72 -52.61 55.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.34 111.138 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -54.18 -67.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 1.77 110.986 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.661 HG22 ' CD1' ' A' ' 40' ' ' PHE . 22.7 m -40.97 -38.25 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.48 111.277 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.808 ' HG2' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -52.12 -65.18 0.6 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.98 111.024 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 99.8 t -75.08 -49.85 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.51 111.128 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.453 ' O ' ' OG1' ' A' ' 73' ' ' THR . 13.0 t-20 -43.39 -60.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 1.59 110.997 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -55.97 -42.26 76.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.34 110.965 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.964 ' OH ' HD22 ' A' ' 36' ' ' LEU . 16.3 m-85 -74.5 0.2 15.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 1.21 111.073 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 32.0 m -50.11 -29.04 8.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.355 -0.384 . . . . 0.76 110.952 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.25 -57.19 1.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 1.34 110.779 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 40.8 t -80.28 124.69 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 1.34 110.979 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.517 HG23 ' HD2' ' A' ' 77' ' ' PRO . 1.2 m -102.41 144.22 28.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.86 111.241 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.966 ' HG2' HD12 ' A' ' 86' ' ' ILE . 22.6 Cg_endo -94.56 135.02 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.199 2.599 . . . . 0.8 111.961 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -114.6 177.73 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 1.36 111.222 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.738 HD21 ' HB3' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -131.99 112.56 12.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 2.49 110.927 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 46.58 23.37 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 4.66 110.725 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.09 9.17 20.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.875 -0.679 . . . . 0.95 112.649 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.471 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -117.0 97.64 51.02 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.97 0.414 . . . . 2.3 110.819 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.562 ' HA ' HG12 ' A' ' 78' ' ' VAL . 36.6 Cg_exo -57.64 117.12 3.77 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.852 2.368 . . . . 0.64 112.615 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.506 HG21 HD12 ' A' ' 24' ' ' LEU . 3.3 pt -118.64 107.73 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.43 110.67 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.433 ' CE1' HG21 ' A' ' 76' ' ' THR . 20.6 m-85 -65.42 148.4 51.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 1.78 111.648 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.966 HD12 ' HG2' ' A' ' 77' ' ' PRO . 4.2 mt -126.23 103.87 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.809 -0.632 . . . . 0.58 110.556 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' HIS . 11.8 mt-30 -112.67 170.79 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.395 . . . . 2.36 111.147 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 37.4 m-85 -71.21 -175.89 1.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 1.46 110.885 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.526 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 28.9 t -96.1 174.05 7.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 2.39 110.887 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -126.92 27.33 6.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 3.81 110.89 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -158.46 159.38 35.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 5.38 110.904 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.54 -88.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 7.12 110.901 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -135.11 164.67 27.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 3.41 110.913 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.6 tp -74.63 123.31 24.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 2.36 110.907 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -88.62 131.38 35.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 6.5 110.845 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 98' ' ' SER . 0.1 OUTLIER -84.65 97.02 9.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 5.82 111.133 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.4 t0 40.77 -91.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 8.3 110.949 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 96' ' ' THR . 3.1 p -157.83 37.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 9.58 110.845 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.214 -0.898 . . . . 10.49 110.919 -179.999 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.816 0.341 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.03 -81.17 1.58 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.482 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.86 130.24 17.58 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.371 . . . . 0.0 111.138 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.58 ' HG3' ' CZ ' ' A' ' 88' ' ' PHE . 35.2 Cg_endo -65.79 -86.03 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.725 2.283 . . . . 0.0 112.308 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.446 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 1.4 p -178.6 162.19 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.856 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -76.72 -20.03 57.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.943 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 89' ' ' SER . 4.0 t -90.11 107.51 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.122 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.498 ' HB ' HG12 ' A' ' 57' ' ' ILE . 24.9 mm -94.39 108.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.184 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.624 ' NE2' ' CE2' ' A' ' 56' ' ' PHE . 4.7 t-160 -79.32 109.62 13.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.744 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 85' ' ' TYR . 16.4 mt -83.99 131.1 34.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.363 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -109.29 168.27 9.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.635 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.5 OUTLIER 46.43 44.22 12.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.0 110.377 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.909 HD23 HG21 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -129.44 95.72 29.42 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.972 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.443 ' HA ' ' CG ' ' A' ' 53' ' ' ASN . 50.5 Cg_exo -53.32 78.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.699 2.266 . . . . 0.0 111.932 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.918 HG23 ' HB3' ' A' ' 48' ' ' MET . 29.6 mm -34.62 118.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.084 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.4 t0 149.76 -19.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.06 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 29' ' ' THR . 6.1 m -55.44 -155.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.783 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.538 ' N ' HG23 ' A' ' 28' ' ' VAL . 71.2 p -114.0 145.69 41.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.923 0.392 . . . . 0.0 111.64 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.848 ' O ' HD12 ' A' ' 34' ' ' ILE . 9.5 mp0 -63.47 -34.19 77.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.602 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.12 -38.18 65.94 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.182 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.944 ' OE1' HD12 ' A' ' 79' ' ' LEU . 3.6 mm-40 -68.59 -58.97 3.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.785 0.326 . . . . 0.0 110.608 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.0 t -53.28 -45.5 55.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.743 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 30' ' ' GLU . 1.4 mp -66.63 -39.58 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.395 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.36 -43.37 5.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.144 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 77' ' ' PRO . 8.5 mt -77.71 -25.35 49.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.291 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -81.43 -16.33 74.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.405 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.493 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -58.9 -54.73 53.51 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.738 0.304 . . . . 0.0 110.725 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 31.6 Cg_exo -58.19 -50.08 10.85 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.569 2.179 . . . . 0.0 111.828 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 27.2 m-85 -53.68 -32.61 52.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.783 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.71 -104.08 0.23 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.186 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -150.45 143.77 24.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 111.007 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.743 HG21 HG13 ' A' ' 34' ' ' ILE . 49.9 t -86.92 114.59 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.518 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.996 HG22 ' ND2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -89.26 -4.5 58.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.458 -179.287 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 176.4 151.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.812 HD23 ' HB3' ' A' ' 30' ' ' GLU . 3.9 tp -137.63 125.76 22.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.007 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.516 HD22 HD21 ' A' ' 94' ' ' LEU . 7.0 tp -134.09 123.74 24.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.918 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.5 mmm -109.66 121.82 46.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.529 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 12.8 mt -98.89 91.62 5.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.976 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.898 ' CE ' HG22 ' A' ' 26' ' ' ILE . 13.6 mmtp -41.22 -27.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.966 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -81.24 129.6 9.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.545 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 0.9 OUTLIER 67.28 16.37 10.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 110.997 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.443 ' CG ' ' HA ' ' A' ' 25' ' ' PRO . 78.1 m-20 36.35 78.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.808 ' C ' HD11 ' A' ' 26' ' ' ILE . 2.4 mt-30 -150.21 132.91 15.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.993 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.613 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.7 167.81 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.767 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.624 ' CE2' ' NE2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -148.09 115.99 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.305 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.775 HG22 HD13 ' A' ' 46' ' ' LEU . 6.5 pt -108.71 155.09 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.768 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.798 ' O ' HG23 ' A' ' 44' ' ' THR . 0.0 OUTLIER -119.51 119.28 33.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.775 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 38.7 mmm -89.98 141.47 28.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.632 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.996 ' ND2' HG22 ' A' ' 44' ' ' THR . 1.7 m120 -73.76 -27.03 60.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.909 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.5 t -123.92 137.94 54.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.234 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -51.27 -38.2 51.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.687 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -59.08 -27.88 65.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.689 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -75.81 -47.24 26.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 16' ' ' SER . . . -60.4 -57.09 14.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.993 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.537 ' ND2' ' HD2' ' A' ' 15' ' ' PRO . 1.6 m-20 -51.82 -70.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.537 HG22 ' CE1' ' A' ' 40' ' ' PHE . 12.7 m -41.8 -27.48 0.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . 1.005 ' SD ' HG21 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -59.62 -65.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.568 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 72.0 t -74.92 -37.61 41.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.481 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 8.2 t30 -59.23 -63.66 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.994 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' A' ' 67' ' ' THR . 2.8 t80 -49.31 -45.72 45.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.11 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.583 ' CD2' ' HG3' ' A' ' 77' ' ' PRO . 22.4 m-30 -83.83 11.57 7.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.106 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.481 ' OG1' ' HA ' ' A' ' 70' ' ' ASN . 21.5 m -62.29 -30.24 70.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.2 t -113.66 -39.19 4.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.5 p -106.18 129.95 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.144 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.3 m -98.61 142.48 24.67 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.85 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.619 ' HG2' HD12 ' A' ' 86' ' ' ILE . 26.8 Cg_endo -95.01 137.67 0.84 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 123.028 2.485 . . . . 0.0 112.214 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.828 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -123.65 -179.87 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 111.21 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.944 HD12 ' OE1' ' A' ' 32' ' ' GLU . 1.9 mm? -137.97 107.43 6.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.963 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 56.88 16.67 2.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.935 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.46 8.63 14.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.655 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.471 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -116.01 97.67 49.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.008 0.432 . . . . 0.0 110.95 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.612 ' HB3' HG12 ' A' ' 78' ' ' VAL . 74.3 Cg_endo -75.84 135.93 18.16 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.894 2.396 . . . . 0.0 112.853 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.909 HG21 HD23 ' A' ' 24' ' ' LEU . 9.2 pt -136.97 110.11 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.497 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.65 ' O ' HG23 ' A' ' 21' ' ' ILE . 8.1 m-85 -60.47 143.55 53.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.587 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 1.005 HG21 ' SD ' ' A' ' 68' ' ' MET . 7.1 mt -125.85 104.07 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.528 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' HIS . 3.9 mt-30 -115.13 172.83 6.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.1 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CZ ' ' HG3' ' A' ' 15' ' ' PRO . 45.5 m-85 -71.73 179.97 2.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.84 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 20' ' ' HIS . 70.4 m -114.33 144.95 42.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -94.47 31.32 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.988 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -127.61 176.27 7.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.73 -36.77 6.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.68 164.56 29.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.938 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.516 HD21 HD22 ' A' ' 47' ' ' LEU . 0.4 OUTLIER -85.34 110.0 18.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.892 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -105.03 136.21 44.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.8 p -81.34 129.56 34.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.104 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -114.88 -39.52 3.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.0 t -178.87 169.87 1.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.97 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.1 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.847 -179.954 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.777 0.323 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.627 ' O ' HG23 ' A' ' 14' ' ' VAL . . . 40.85 77.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.456 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER 51.57 112.07 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.847 0.356 . . . . 0.0 111.207 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 35.0 Cg_endo -65.35 -86.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.609 2.206 . . . . 0.0 112.349 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 1.4 m 167.08 172.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.982 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -68.06 -7.27 27.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.033 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 t -87.99 122.49 39.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.031 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.583 HD11 ' CA ' ' A' ' 65' ' ' ALA . 3.9 mm -119.28 116.85 52.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.211 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.481 ' HB3' ' O ' ' A' ' 88' ' ' PHE . 16.9 t60 -88.28 153.59 21.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.721 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.697 HG23 ' O ' ' A' ' 85' ' ' TYR . 2.3 mp -133.37 110.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.478 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' LYS . 2.8 ttm180 -88.09 167.4 13.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.827 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 43.77 90.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.784 HD11 HG21 ' A' ' 28' ' ' VAL . 4.7 tp -167.66 115.42 0.65 Allowed Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.447 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 26' ' ' ILE . 37.4 Cg_exo -59.08 73.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.466 2.111 . . . . 0.0 111.062 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.56 ' CG1' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -30.01 153.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.989 -178.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER 87.46 9.43 0.16 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.983 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.784 HG21 HD11 ' A' ' 24' ' ' LEU . 1.4 t -57.86 -149.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.806 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 33' ' ' VAL . 17.9 p -124.52 149.81 46.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.16 0.505 . . . . 0.0 111.899 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 2.1 mt-10 -68.75 -47.11 67.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.789 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 35' ' ' SER . . . -51.34 -37.27 39.02 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.348 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.564 ' HG2' HD21 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -78.63 -64.93 1.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.753 0.311 . . . . 0.0 110.768 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 29' ' ' THR . 47.9 t -45.59 -52.72 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.971 HG12 HG21 ' A' ' 43' ' ' VAL . 1.5 mp -65.7 -40.17 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.315 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -39.17 -42.42 0.96 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.924 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.006 HD22 ' OH ' ' A' ' 72' ' ' TYR . 11.1 mt -73.21 -40.63 64.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.02 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -77.22 -3.97 82.9 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.399 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.536 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 9.3 mt -61.44 -58.3 19.53 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.182 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 19.7 Cg_endo -58.3 -32.02 95.07 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.511 2.141 . . . . 0.0 112.105 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.592 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 22.0 m-30 -58.04 -28.51 64.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.683 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.76 -98.03 0.17 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.18 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.415 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 19.3 mmtp -150.47 146.01 26.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 0.0 111.022 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.971 HG21 HG12 ' A' ' 34' ' ' ILE . 67.0 t -89.73 116.43 31.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.763 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 1.002 HG22 ' ND2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -92.82 -9.71 39.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.244 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.424 ' HB2' ' OE1' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -176.88 146.95 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.725 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.758 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.1 tm? -132.59 124.83 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.024 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.747 HD12 ' CD2' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -141.23 141.4 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.708 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.663 ' N ' HD13 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -129.3 103.08 6.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.784 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.783 HD23 ' CE1' ' A' ' 56' ' ' PHE . 3.4 mm? -70.18 107.82 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.832 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HA ' HG21 ' A' ' 26' ' ' ILE . 5.9 mttp -91.68 81.13 5.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.943 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.23 -56.43 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.284 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -123.17 18.29 9.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.919 0.39 . . . . 0.0 110.544 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.56 ' HA ' ' CG1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 68.81 86.47 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.953 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 53' ' ' ASN . 64.8 mt-30 -160.12 129.52 5.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 111.431 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . . . -113.75 163.27 15.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.241 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.783 ' CE1' HD23 ' A' ' 49' ' ' LEU . 5.8 m-85 -148.1 118.59 7.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.839 0.352 . . . . 0.0 111.599 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.755 HD12 ' SD ' ' A' ' 59' ' ' MET . 7.0 pt -118.53 140.85 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.527 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.775 ' O ' HG23 ' A' ' 44' ' ' THR . 61.6 mt-10 -103.34 123.65 47.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.292 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.871 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 23.4 mmm -98.81 134.49 41.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 1.002 ' ND2' HG22 ' A' ' 44' ' ' THR . 1.1 m120 -72.28 -20.56 61.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.27 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.9 t -134.67 129.14 34.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.909 0.385 . . . . 0.0 111.231 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -38.99 -49.55 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -46.06 -32.23 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.871 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -75.29 -48.88 21.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.583 ' CA ' HD11 ' A' ' 19' ' ' ILE . . . -66.58 -59.23 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -50.59 -65.82 0.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.075 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.7 m -40.7 -46.78 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.27 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.706 ' SD ' HD11 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -44.98 -65.11 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.275 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.645 HG13 ' HA ' ' A' ' 87' ' ' GLN . 24.7 t -71.89 -51.54 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.297 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -49.96 -26.51 4.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.186 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -85.53 -64.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.169 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 1.006 ' OH ' HD22 ' A' ' 36' ' ' LEU . 27.2 m-85 -56.46 -16.54 6.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.989 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 72' ' ' TYR . 69.7 m -35.54 -31.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.023 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 72' ' ' TYR . 7.7 t -112.4 -62.94 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 6.2 p -82.15 121.71 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.054 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.556 HG21 ' CE1' ' A' ' 85' ' ' TYR . 2.5 m -95.59 145.85 30.28 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.032 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.551 ' HD2' HG23 ' A' ' 76' ' ' THR . 37.1 Cg_endo -97.23 163.61 0.96 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.299 2.666 . . . . 0.0 112.032 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.531 ' HB ' ' N ' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -153.24 152.41 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.899 0.381 . . . . 0.0 111.105 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.564 HD21 ' HG2' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -98.78 100.83 12.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.406 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 28.6 mmt180 67.27 -59.51 0.39 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.469 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -159.44 22.92 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.404 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.454 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 26.1 mp0 -126.1 97.8 34.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.392 . . . . 0.0 110.936 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.531 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 19.9 Cg_exo -66.19 129.47 21.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 123.047 2.498 . . . . 0.0 112.714 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.747 HD12 HD13 ' A' ' 24' ' ' LEU . 6.1 pt -134.47 118.52 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.57 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.697 ' O ' HG23 ' A' ' 21' ' ' ILE . 4.6 m-85 -78.66 148.88 33.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.847 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.62 HG21 ' CG ' ' A' ' 68' ' ' MET . 4.0 mt -126.26 109.09 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.473 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.645 ' HA ' HG13 ' A' ' 69' ' ' VAL . 70.8 mm-40 -120.87 173.79 7.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.013 0.435 . . . . 0.0 111.149 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.627 ' CD1' HG21 ' A' ' 69' ' ' VAL . 30.1 m-85 -68.36 167.77 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.886 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.61 153.28 21.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.908 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -96.38 34.35 1.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.486 ' CB ' ' HD2' ' A' ' 95' ' ' LYS . 1.3 t60 -148.13 148.82 31.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -66.54 -72.34 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.992 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -102.85 168.58 9.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.4 ' HB2' ' OE2' ' A' ' 58' ' ' GLU . 8.5 tp -52.34 142.66 16.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.486 ' HD2' ' CB ' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -106.99 132.78 52.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.68 100.42 8.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.122 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -49.27 -32.61 11.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 99' ' ' SER . 19.6 m -120.01 125.89 49.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 98' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.978 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.52 164.02 52.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.498 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.09 142.65 38.97 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 111.151 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -51.66 130.19 32.76 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.704 2.269 . . . . 0.0 112.31 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.5 p -150.8 151.48 32.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.53 -53.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.73 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 89' ' ' SER . 21.8 t -90.26 143.59 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.806 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.531 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 20.9 mm -118.41 103.07 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.376 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.549 ' NE2' ' CZ ' ' A' ' 56' ' ' PHE . 4.5 t-160 -79.03 144.95 34.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.338 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 85' ' ' TYR . 9.5 mt -133.05 138.68 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.918 0.39 . . . . 0.0 111.457 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.543 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 12.2 ptm180 -123.42 170.35 10.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.467 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 52.2 38.98 25.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.216 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.764 ' HA ' HG22 ' A' ' 84' ' ' ILE . 2.7 tp -125.22 119.85 25.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.466 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 26' ' ' ILE . 20.2 Cg_endo -60.49 80.15 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.274 1.982 . . . . 0.0 110.716 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.79 HG21 ' C ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -32.18 154.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.733 -178.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 28' ' ' VAL . 22.3 t0 79.23 2.37 2.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.171 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.667 HG22 ' H ' ' A' ' 29' ' ' THR . 2.0 p -54.81 -165.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.667 ' H ' HG22 ' A' ' 28' ' ' VAL . 55.1 p -104.26 144.72 31.23 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.904 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.782 ' HG3' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -62.06 -46.66 88.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.487 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.3 -29.45 0.12 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.64 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.827 ' CD ' HD23 ' A' ' 79' ' ' LEU . 2.7 tp10 -83.34 -60.96 1.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 0.0 110.259 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 t -55.45 -58.87 3.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.597 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.703 ' HA ' HG21 ' A' ' 43' ' ' VAL . 1.3 mt -53.24 -53.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.489 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.5 m -39.29 -50.2 1.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.571 ' O ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -61.09 -32.39 72.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.747 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.57 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -83.03 -25.77 47.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.608 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.466 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -39.21 -60.65 1.16 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.709 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 43.1 Cg_endo -67.8 -22.88 42.4 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.548 2.165 . . . . 0.0 111.651 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.636 ' CD1' HG22 ' A' ' 67' ' ' THR . 16.1 m-30 -76.34 -6.47 51.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.043 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.19 -103.23 0.44 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.334 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.4 138.23 19.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.154 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.703 HG21 ' HA ' ' A' ' 34' ' ' ILE . 43.2 t -92.53 89.96 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 110.328 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 1.122 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -74.82 1.9 11.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.867 -179.068 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.573 ' ND2' ' O ' ' A' ' 44' ' ' THR . 0.5 OUTLIER 170.69 158.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.939 0.4 . . . . 0.0 111.456 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.014 HD13 HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -152.58 102.25 2.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.582 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.628 ' N ' HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -95.6 104.5 16.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.523 ' CE ' HG12 ' A' ' 28' ' ' VAL . 46.9 mmm -78.19 107.95 11.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.553 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.956 HD13 ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -88.91 101.58 14.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.862 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.557 ' HD2' ' CG2' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -74.3 -168.39 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.072 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.42 -100.68 2.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.429 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -74.13 -69.87 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.736 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.523 ' HA ' ' CG1' ' A' ' 26' ' ' ILE . 3.9 m-20 159.97 77.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.627 ' HB2' HD12 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -159.33 161.83 35.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.863 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.536 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -151.38 163.98 37.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.705 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -143.0 115.77 8.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.871 0.367 . . . . 0.0 111.242 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.014 HG22 HD13 ' A' ' 46' ' ' LEU . 31.2 pt -105.17 133.01 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.552 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.66 102.64 14.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.84 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.46 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -64.46 157.21 27.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.489 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 1.122 ' ND2' HG23 ' A' ' 44' ' ' THR . 5.7 m120 -68.79 -39.42 80.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.647 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -133.18 169.81 16.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.168 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.429 ' N ' ' OG1' ' A' ' 61' ' ' THR . 2.4 mp0 -73.31 -36.2 66.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.773 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -60.91 -40.08 91.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.719 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 40' ' ' PHE . . . -64.45 -49.09 72.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.46 ' HA ' ' SD ' ' A' ' 59' ' ' MET . . . -50.44 -53.23 31.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.221 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -46.49 -63.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.114 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.636 HG22 ' CD1' ' A' ' 40' ' ' PHE . 24.8 m -40.91 -46.77 2.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.309 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.703 ' SD ' HD11 ' A' ' 57' ' ' ILE . 0.9 OUTLIER -46.64 -65.01 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 -179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.736 HG11 ' CD2' ' A' ' 88' ' ' PHE . 46.1 t -70.61 -54.2 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.451 ' O ' ' OG1' ' A' ' 73' ' ' THR . 5.7 t-20 -38.75 -64.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -59.18 -31.2 68.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.013 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.485 ' OH ' ' HG ' ' A' ' 36' ' ' LEU . 14.0 m-30 -89.22 20.11 3.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.048 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 32.5 m -78.57 -22.64 46.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.841 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.1 m -124.34 -41.08 2.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.683 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.8 t -89.96 130.12 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.544 HG23 ' HD2' ' A' ' 77' ' ' PRO . 2.8 m -91.82 146.14 32.41 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.025 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.736 ' CG ' HD12 ' A' ' 86' ' ' ILE . 26.8 Cg_endo -95.97 138.5 0.72 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 123.262 2.641 . . . . 0.0 112.165 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 83' ' ' PRO . 16.9 t -125.02 154.51 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.127 0.489 . . . . 0.0 111.402 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.025 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -114.18 99.89 7.96 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.188 178.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.476 ' HB2' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER 62.24 -62.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.029 0.443 . . . . 0.0 110.182 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -159.45 23.86 0.3 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.371 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.447 ' C ' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -128.79 97.77 26.32 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 110.693 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.528 ' N ' HG13 ' A' ' 78' ' ' VAL . 52.9 Cg_exo -55.3 106.01 0.17 Allowed 'Trans proline' 0 C--O 1.23 0.125 0 C-N-CA 122.833 2.355 . . . . 0.0 112.707 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.764 HG22 ' HA ' ' A' ' 24' ' ' LEU . 2.6 pt -107.28 107.71 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.465 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.59 ' O ' HG23 ' A' ' 21' ' ' ILE . 8.9 m-30 -65.12 142.18 58.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.63 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.736 HD12 ' CG ' ' A' ' 77' ' ' PRO . 13.5 mt -126.14 134.24 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.372 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -149.78 172.17 15.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 0.0 111.04 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.736 ' CD2' HG11 ' A' ' 69' ' ' VAL . 39.4 m-85 -65.48 -173.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.893 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.455 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 1.7 t -142.37 139.9 31.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.503 ' O ' ' CB ' ' A' ' 91' ' ' HIS . 1.3 t-20 -36.34 -60.93 0.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.503 ' CB ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER 159.37 45.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.957 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 15.0 mmmt -88.09 73.43 9.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.929 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.435 ' C ' HD12 ' A' ' 94' ' ' LEU . 7.4 tt0 -65.47 138.63 58.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 94' ' ' LEU . 2.3 mp -98.12 147.64 24.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 145.0 25.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.915 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.34 123.59 28.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.078 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.5 t0 57.15 111.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -101.6 111.21 23.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.899 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.806 0.336 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.447 ' C ' ' HD2' ' A' ' 15' ' ' PRO . . . 82.36 102.03 0.44 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.565 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.763 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 29.3 m -124.32 24.63 0.11 Allowed Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.763 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 90.3 Cg_exo -35.43 -63.11 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.261 2.641 . . . . 0.0 112.45 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.803 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 23.4 m 36.17 63.64 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -11.7 61.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.043 HG11 ' HB3' ' A' ' 90' ' ' ASN . 12.6 p -114.12 142.79 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 68' ' ' MET . 11.4 mm -127.04 143.18 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.918 ' C ' HD13 ' A' ' 21' ' ' ILE . 7.2 t-80 -110.86 156.28 21.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.672 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.975 HD12 HG12 ' A' ' 86' ' ' ILE . 2.5 mm -128.31 106.93 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.425 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -83.61 171.22 13.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.646 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER 39.32 31.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.947 0.403 . . . . 0.0 110.354 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.929 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -102.07 107.41 52.55 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.288 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.627 ' N ' HD22 ' A' ' 24' ' ' LEU . 53.2 Cg_exo -51.98 82.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.484 2.122 . . . . 0.0 111.534 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.529 HG21 ' N ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -34.24 155.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.022 -179.297 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 25.1 t0 80.88 -3.05 1.8 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.223 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.682 HG22 ' H ' ' A' ' 29' ' ' THR . 2.0 p -54.64 -166.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.682 ' H ' HG22 ' A' ' 28' ' ' VAL . 69.8 p -100.2 144.19 29.51 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.862 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.793 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -63.74 -40.63 97.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.312 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -58.39 -28.09 61.56 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.982 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.444 ' HG3' ' OG1' ' A' ' 29' ' ' THR . 30.5 mt-10 -70.71 -64.59 0.87 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.361 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.673 HG12 HG21 ' A' ' 57' ' ' ILE . 46.8 t -55.2 -43.07 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.555 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.793 HD12 ' O ' ' A' ' 30' ' ' GLU . 1.6 mp -70.1 -42.81 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.5 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 3.4 t -40.3 -42.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.027 0.441 . . . . 0.0 110.138 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.604 HD22 ' OH ' ' A' ' 72' ' ' TYR . 81.5 mt -73.03 -37.89 66.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.101 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.589 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -76.49 -11.69 84.95 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.332 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.765 ' CD2' HG22 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -55.93 -61.04 7.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.818 0.342 . . . . 0.0 110.794 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.6 Cg_endo -66.12 -21.14 56.16 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.649 2.233 . . . . 0.0 111.772 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.592 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 16.3 m-30 -70.04 -28.78 65.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.626 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.3 -99.14 0.18 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.13 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.4 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 14.3 mtpt -150.63 135.89 17.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.826 0.346 . . . . 0.0 111.079 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.759 HG21 ' CG1' ' A' ' 34' ' ' ILE . 42.4 t -86.6 118.13 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.27 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 1.062 HG22 ' ND2' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -88.78 -8.61 54.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.698 -179.039 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 44' ' ' THR . 1.3 t-20 170.85 165.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.885 0.374 . . . . 0.0 111.275 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.88 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -139.85 113.9 8.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.883 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.611 ' CD1' HD21 ' A' ' 49' ' ' LEU . 1.3 tm? -122.75 120.44 33.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.853 ' C ' HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -108.43 145.09 35.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.91 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.853 HD23 ' C ' ' A' ' 48' ' ' MET . 2.1 mt -117.09 102.69 9.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.795 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.529 ' N ' HG21 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -72.71 136.71 45.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.4 -80.0 0.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.693 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.49 8.16 14.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 111.079 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.482 ' O ' ' HG2' ' A' ' 54' ' ' GLN . 2.5 m-20 56.89 84.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.068 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.492 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 51.8 mt-30 -159.25 123.45 3.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.398 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 24' ' ' LEU . . . -109.7 170.12 8.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.527 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.538 ' CD1' ' C ' ' A' ' 55' ' ' ALA . 28.1 m-85 -148.23 143.22 26.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.01 0.433 . . . . 0.0 111.383 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.89 HD11 ' SD ' ' A' ' 68' ' ' MET . 1.0 OUTLIER -144.33 125.18 8.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.494 179.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.806 ' O ' HG23 ' A' ' 44' ' ' THR . 38.3 mt-10 -93.74 127.13 39.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.258 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.502 ' CE ' ' HB1' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -99.98 146.44 26.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.164 179.489 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 1.062 ' ND2' HG22 ' A' ' 44' ' ' THR . 0.2 OUTLIER -88.78 -9.22 52.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.716 0.293 . . . . 0.0 110.69 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.55 160.55 21.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.138 0.494 . . . . 0.0 111.785 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -80.84 -37.8 29.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.305 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 63' ' ' GLU . 1.1 tp10 -71.09 -23.02 62.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.061 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.502 ' HB1' ' CE ' ' A' ' 59' ' ' MET . . . -74.27 -43.29 57.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.692 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.803 ' HB1' ' O ' ' A' ' 16' ' ' SER . . . -65.46 -66.06 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.211 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -52.22 -63.2 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 71' ' ' TYR . 77.3 m -40.73 -47.72 2.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.371 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.89 ' SD ' HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -46.36 -65.26 0.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.068 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 68.0 t -68.51 -54.83 18.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.233 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 73' ' ' THR . 8.9 t-20 -46.52 -62.2 1.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.07 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.483 ' HB3' ' O ' ' A' ' 67' ' ' THR . 4.0 t80 -43.42 -48.81 7.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.153 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.604 ' OH ' HD22 ' A' ' 36' ' ' LEU . 39.6 m-85 -80.52 7.37 10.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.242 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.472 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 20.4 m -49.03 -32.39 9.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.96 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.3 m -115.36 -56.06 2.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -81.1 134.64 26.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.189 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.7 HG23 ' HD2' ' A' ' 77' ' ' PRO . 8.1 m -92.17 152.19 42.37 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.886 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.7 ' HD2' HG23 ' A' ' 76' ' ' THR . 9.6 Cg_endo -91.4 94.05 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.194 2.596 . . . . 0.0 112.315 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.878 ' C ' HD12 ' A' ' 79' ' ' LEU . 3.5 t -86.3 154.51 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.878 HD12 ' C ' ' A' ' 78' ' ' VAL . 9.5 mp -144.29 100.96 3.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 59.92 14.6 4.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.724 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 83' ' ' PRO . . . 115.33 -3.23 22.1 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -102.71 97.72 9.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.329 . . . . 0.0 110.77 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 89.5 Cg_endo -79.11 96.78 1.09 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.8 2.333 . . . . 0.0 112.511 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.52 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 2.0 pt -100.81 107.74 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.738 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 12.1 m-85 -66.29 148.84 51.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.546 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.975 HG12 HD12 ' A' ' 21' ' ' ILE . 4.6 mt -126.27 111.88 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.473 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.434 ' OE1' ' HB3' ' A' ' 85' ' ' TYR . 3.1 mp0 -128.25 173.11 10.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.909 0.385 . . . . 0.0 111.155 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 72.7 m-85 -72.84 152.26 41.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.548 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -152.13 -174.97 5.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 1.043 ' HB3' HG11 ' A' ' 18' ' ' VAL . 0.9 OUTLIER 38.4 -162.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.955 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 92' ' ' LYS . 1.3 t-80 -105.03 -153.04 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 91' ' ' HIS . 6.1 mmtt -35.69 -64.07 0.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.406 ' OE2' ' HB2' ' A' ' 92' ' ' LYS . 0.7 OUTLIER -136.58 154.71 50.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.452 ' O ' ' OE2' ' A' ' 58' ' ' GLU . 9.3 tp -93.85 99.88 12.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.902 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.99 142.38 38.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.982 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.45 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -126.97 97.24 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 96' ' ' THR . 3.7 p30 164.57 178.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 99' ' ' SER . 12.5 m -153.31 34.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 98' ' ' SER . 2.0 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.866 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.781 0.324 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.703 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -115.29 -70.57 0.48 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.464 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -167.02 156.24 9.58 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.369 . . . . 0.0 111.153 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.7 105.45 1.11 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.77 2.313 . . . . 0.0 112.288 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.8 m -147.21 102.38 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.11 -53.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' A' ' 89' ' ' SER . 98.2 t -87.98 103.92 14.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.995 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.491 HD11 HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -87.25 134.03 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.544 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 9.3 t-160 -97.19 114.38 26.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 85' ' ' TYR . 11.2 mt -89.31 123.69 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -107.68 168.68 9.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 5.9 tmtt? 49.02 37.16 9.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.634 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.688 HD13 HD12 ' A' ' 84' ' ' ILE . 2.5 tp -120.83 126.95 26.47 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.003 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.483 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 58.1 Cg_endo -71.74 76.5 1.96 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.45 2.1 . . . . 0.0 111.449 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.954 HD11 ' C ' ' A' ' 54' ' ' GLN . 34.2 mm -34.42 155.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.837 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 24.7 t0 86.64 -4.97 0.72 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.776 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.74 HG13 ' N ' ' A' ' 29' ' ' THR . 1.8 p -59.95 -154.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.744 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.74 ' N ' HG13 ' A' ' 28' ' ' VAL . 43.8 p -105.99 144.79 32.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.184 0.516 . . . . 0.0 112.082 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.633 ' O ' HD12 ' A' ' 34' ' ' ILE . 11.2 mp0 -69.66 -35.25 74.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.517 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 35' ' ' SER . . . -53.58 -30.72 43.15 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.913 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.7 ' HG2' HD23 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -77.26 -57.88 3.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.447 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.5 t -53.1 -43.14 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.977 ' CG1' HG21 ' A' ' 43' ' ' VAL . 1.5 mp -72.45 -46.87 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.589 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -38.62 -34.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.355 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 77' ' ' PRO . 18.3 mt -82.38 -39.26 22.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.51 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -72.32 -17.51 77.61 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.38 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.582 ' CD2' HG22 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -46.81 -60.67 3.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.876 0.369 . . . . 0.0 110.806 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.6 Cg_endo -66.05 -30.78 47.18 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.716 2.277 . . . . 0.0 112.11 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.618 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.1 m-30 -63.73 -40.44 96.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.597 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 64' ' ' ALA . . . 168.57 -98.78 0.14 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.395 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.456 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -151.09 142.5 23.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.719 0.295 . . . . 0.0 110.923 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.977 HG21 ' CG1' ' A' ' 34' ' ' ILE . 42.8 t -88.76 82.54 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.213 0.53 . . . . 0.0 110.687 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.991 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -66.57 -7.3 19.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.42 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 176.68 145.74 0.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.914 0.388 . . . . 0.0 111.249 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.967 HD13 HG22 ' A' ' 57' ' ' ILE . 4.9 tp -136.4 103.07 5.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.53 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 47' ' ' LEU . 3.2 tm? -105.87 105.17 15.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.3 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.6 mmm -90.5 99.61 12.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.302 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.455 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -85.64 110.92 19.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.306 -179.513 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.554 ' CE ' HG22 ' A' ' 26' ' ' ILE . 10.1 mmtp -62.34 -172.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.349 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . 55.22 114.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.029 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER 88.87 -21.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.914 0.387 . . . . 0.0 110.669 -179.446 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.484 ' HA ' HG12 ' A' ' 26' ' ' ILE . 0.8 OUTLIER 68.11 63.73 0.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.494 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.954 ' C ' HD11 ' A' ' 26' ' ' ILE . 7.2 mm-40 -136.07 126.5 26.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.758 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.781 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.75 160.12 16.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -142.32 115.91 9.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.033 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.967 HG22 HD13 ' A' ' 46' ' ' LEU . 13.8 pt -113.42 140.91 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -96.22 102.73 14.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.632 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.812 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 7.1 mmm -66.34 116.07 6.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.0 110.779 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.991 ' ND2' HG23 ' A' ' 44' ' ' THR . 4.9 m120 -33.68 -49.72 0.32 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.328 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.76 -173.01 2.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.125 0.488 . . . . 0.0 112.079 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 64' ' ' ALA . 2.1 mt-10 -72.39 -57.45 4.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.177 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -38.92 -30.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.065 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.812 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -76.63 -56.29 4.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -54.34 -55.47 28.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.382 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -56.0 -70.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.618 HG22 ' CD1' ' A' ' 40' ' ' PHE . 21.1 m -42.47 -39.34 2.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.215 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.594 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -49.17 -62.84 1.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 72.2 t -80.79 -50.42 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.308 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -45.37 -39.03 6.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.195 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 67' ' ' THR . 4.3 t80 -78.01 -57.94 3.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.19 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.503 ' OH ' HD22 ' A' ' 36' ' ' LEU . 14.5 m-85 -62.14 -12.03 17.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.14 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.2 m -39.66 -29.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.011 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 72' ' ' TYR . 10.7 t -116.81 -45.9 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.795 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.39 131.83 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.556 ' OG1' ' CE2' ' A' ' 85' ' ' TYR . 1.3 m -97.62 142.41 24.52 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.979 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.52 ' CG ' HD12 ' A' ' 86' ' ' ILE . 19.1 Cg_endo -93.86 128.93 0.62 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.022 2.481 . . . . 0.0 112.076 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.699 HG13 ' C ' ' A' ' 82' ' ' GLN . 3.3 t -115.89 149.18 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.192 0.52 . . . . 0.0 111.427 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.036 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -114.09 107.98 16.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.371 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.683 ' N ' HD22 ' A' ' 79' ' ' LEU . 5.2 mtt180 62.93 -61.33 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 0.0 110.517 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -163.64 24.84 0.19 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.455 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.699 ' C ' HG13 ' A' ' 78' ' ' VAL . 1.2 tp60 -128.05 110.04 19.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.616 ' N ' HG13 ' A' ' 78' ' ' VAL . 37.8 Cg_endo -66.73 96.79 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.61 2.207 . . . . 0.0 112.385 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.688 HD12 HD13 ' A' ' 24' ' ' LEU . 3.3 pt -100.63 107.94 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.767 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CE2' ' OG1' ' A' ' 76' ' ' THR . 6.4 m-85 -75.28 153.64 37.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.525 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.568 HG21 ' CG ' ' A' ' 68' ' ' MET . 5.7 mt -126.01 112.12 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.561 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 20' ' ' HIS . 9.1 mt-30 -125.45 166.27 16.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 111.1 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.579 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 74.6 m-85 -61.72 177.53 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.832 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -133.84 148.09 51.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.99 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.19 17.65 2.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.71 -153.74 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -73.49 76.23 1.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.872 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 92' ' ' LYS . 77.1 mt-10 -38.99 160.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -85.43 137.85 32.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -109.35 128.87 55.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.405 ' O ' ' CG ' ' A' ' 97' ' ' ASP . 0.9 OUTLIER -110.42 109.55 19.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.097 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 96' ' ' THR . 3.4 p30 47.16 -165.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.29 112.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.25 -147.94 5.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.459 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -128.52 114.53 19.54 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 0.0 111.064 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.64 120.73 7.32 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.675 2.25 . . . . 0.0 112.317 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 64.9 m -151.12 158.62 44.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.942 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -123.75 -47.99 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.504 HG21 ' H ' ' A' ' 92' ' ' LYS . 3.4 t -87.91 97.92 7.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.982 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.851 HG21 ' SD ' ' A' ' 68' ' ' MET . 37.3 mm -82.41 110.52 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.292 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' GLN . 11.1 t-80 -80.59 156.51 26.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.047 HG21 HD12 ' A' ' 24' ' ' LEU . 1.4 mt -131.13 107.84 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.404 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' HG2' ' HB2' ' A' ' 85' ' ' TYR . 2.4 ptm180 -96.38 176.03 6.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.503 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 43.52 32.94 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.975 0.416 . . . . 0.0 110.252 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.047 HD12 HG21 ' A' ' 21' ' ' ILE . 1.4 tt -118.08 99.72 51.9 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.94 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.61 ' HD2' HG22 ' A' ' 84' ' ' ILE . 29.4 Cg_endo -63.25 67.15 0.16 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.178 1.919 . . . . 0.0 111.163 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.017 HD11 ' C ' ' A' ' 54' ' ' GLN . 47.7 mm -15.28 112.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 123.987 0.805 . . . . 0.0 112.085 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.6 t70 149.41 -10.71 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.51 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 29' ' ' THR . 6.0 m -60.96 -11.91 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.287 0.565 . . . . 0.0 111.809 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 28' ' ' VAL . 3.0 p 90.64 154.16 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.991 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . 4.7 mp0 -70.38 -41.39 73.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.512 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -42.35 -35.4 1.86 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.039 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.48 ' OE2' ' HB3' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -80.51 -45.28 17.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.865 0.364 . . . . 0.0 110.581 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 57' ' ' ILE . 16.6 t -59.32 -58.2 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.969 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.841 HG13 HG21 ' A' ' 43' ' ' VAL . 1.5 mp -64.8 -40.68 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.661 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -41.58 -43.5 2.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.988 0.423 . . . . 0.0 110.292 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.519 ' CG ' ' OH ' ' A' ' 72' ' ' TYR . 7.4 mp -72.21 -36.71 69.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.5 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -70.82 -21.31 78.03 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.43 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.457 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -44.87 -61.31 2.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.74 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 39.8 Cg_endo -67.05 -41.16 10.27 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.609 2.206 . . . . 0.0 111.648 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.62 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.1 m-30 -54.39 -28.43 43.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.687 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 42' ' ' LYS . . . 154.0 -106.92 0.31 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.191 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 59' ' ' MET . 17.3 mtpt -150.78 142.17 23.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.0 111.002 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.841 HG21 HG13 ' A' ' 34' ' ' ILE . 42.0 t -86.71 117.82 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.5 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 1.014 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -91.75 -6.01 52.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.437 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -172.46 155.32 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.877 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.028 ' CD2' HG22 ' A' ' 57' ' ' ILE . 2.7 tm? -151.14 113.81 4.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 47' ' ' LEU . 6.6 tt -136.5 116.81 13.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.2 mtp -95.44 139.64 31.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.469 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -125.48 91.42 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.945 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.555 ' HD2' ' CG2' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -45.02 -26.18 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.938 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.35 127.82 10.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.53 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.7 OUTLIER 66.89 8.3 5.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.79 0.329 . . . . 0.0 110.901 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.503 ' HA ' HG12 ' A' ' 26' ' ' ILE . 73.6 m-20 45.88 84.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 1.017 ' C ' HD11 ' A' ' 26' ' ' ILE . 67.5 mt-30 -159.2 135.71 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.595 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.808 ' HB3' HD12 ' A' ' 21' ' ' ILE . . . -109.29 166.6 10.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.794 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.537 ' CD1' ' C ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -139.72 117.45 11.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.478 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.028 HG22 ' CD2' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -127.37 152.07 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.618 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.47 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 35.7 mt-10 -120.05 142.06 49.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.41 . . . . 0.0 111.295 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.694 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -110.74 130.39 55.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.174 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 1.014 ' CG ' HG22 ' A' ' 44' ' ' THR . 2.9 m120 -68.56 -15.47 63.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.64 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 61' ' ' THR . 12.3 t -132.21 125.34 30.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 111.271 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -43.46 -41.94 4.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.692 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.416 ' O ' ' OG1' ' A' ' 67' ' ' THR . 8.3 tt0 -57.12 -20.82 27.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.815 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -84.47 -46.93 11.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.968 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.848 ' HB1' HD11 ' A' ' 19' ' ' ILE . . . -64.25 -49.44 71.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.042 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -64.77 -44.28 90.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.494 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.62 HG22 ' CD1' ' A' ' 40' ' ' PHE . 18.2 m -60.34 -32.74 71.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.851 ' SD ' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -58.36 -63.13 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.618 HG21 ' CE1' ' A' ' 88' ' ' PHE . 8.4 t -70.31 -51.06 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.07 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' O ' ' OG1' ' A' ' 73' ' ' THR . 6.8 t30 -44.06 -63.96 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.964 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 67' ' ' THR . 10.7 t80 -55.59 -35.69 66.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.574 ' CD2' ' O ' ' A' ' 68' ' ' MET . 17.8 m-85 -83.23 9.86 9.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 53.6 m -59.52 -28.37 67.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.13 -45.73 1.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.8 t -83.43 110.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.628 HG23 ' HD2' ' A' ' 77' ' ' PRO . 4.1 m -88.17 149.18 44.57 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.845 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.628 ' HD2' HG23 ' A' ' 76' ' ' THR . 18.3 Cg_endo -95.28 113.43 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.226 2.617 . . . . 0.0 112.3 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 79' ' ' LEU . 22.1 t -100.26 160.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.988 0.423 . . . . 0.0 111.167 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.948 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -156.27 133.91 10.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.713 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.547 ' HB3' HD22 ' A' ' 79' ' ' LEU . 2.0 ttt-85 37.24 30.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.94 0.4 . . . . 0.0 110.423 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 80.53 50.19 5.45 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.803 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.527 ' O ' HD12 ' A' ' 79' ' ' LEU . 1.7 mm-40 -155.2 97.68 2.41 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.05 96.56 0.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.585 2.19 . . . . 0.0 112.496 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.664 HD12 ' HG ' ' A' ' 24' ' ' LEU . 4.4 pt -95.15 111.14 25.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.67 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.509 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 4.6 m-30 -72.52 152.94 41.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.521 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 21' ' ' ILE . 6.5 mt -126.14 104.77 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.519 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -131.6 171.49 13.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 111.097 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 69' ' ' VAL . 1.4 m-85 -84.41 155.56 22.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.42 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 8.1 t -152.03 81.01 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.939 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 54.66 70.8 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.975 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.447 ' HA ' ' HB ' ' A' ' 18' ' ' VAL . 2.6 p-80 -44.77 96.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.504 ' H ' HG21 ' A' ' 18' ' ' VAL . 1.1 mtmm -128.79 90.31 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HA ' ' OE2' ' A' ' 58' ' ' GLU . 2.8 mt-10 -39.42 137.34 0.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -78.34 111.55 14.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.38 154.09 19.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 3.8 p -81.51 106.28 13.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.148 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 96' ' ' THR . 15.7 m-20 66.07 175.0 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -54.54 9.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.838 0.351 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' C ' ' HD2' ' A' ' 15' ' ' PRO . . . 74.57 93.54 0.14 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.501 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 14' ' ' VAL . 7.1 p -126.73 22.66 0.1 Allowed Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.766 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 35.0 Cg_endo -65.83 157.15 60.5 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.964 2.443 . . . . 0.0 112.264 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 6.5 t -175.4 146.8 0.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.89 -49.06 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.848 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.05 126.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.069 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.574 ' CG2' HG23 ' A' ' 86' ' ' ILE . 48.0 mm -101.88 112.82 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.234 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.551 ' HB2' ' CB ' ' A' ' 89' ' ' SER . 4.9 t-80 -87.49 112.89 22.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.524 HG23 HG13 ' A' ' 86' ' ' ILE . 4.8 mt -82.78 127.9 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.303 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HG2' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -114.03 151.83 31.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.66 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 64.4 34.86 10.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.553 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.64 HD13 HD12 ' A' ' 84' ' ' ILE . 4.8 tp -119.84 129.23 25.46 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.891 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.632 ' HD2' HD12 ' A' ' 24' ' ' LEU . 73.6 Cg_endo -76.63 69.64 6.67 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.484 2.123 . . . . 0.0 111.79 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.846 HD11 ' C ' ' A' ' 54' ' ' GLN . 6.1 mm -30.64 108.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.236 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 2.2 t70 148.69 -19.48 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.673 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.68 HG22 ' H ' ' A' ' 29' ' ' THR . 1.9 p -54.69 -162.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.857 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.68 ' H ' HG22 ' A' ' 28' ' ' VAL . 39.8 p -107.91 145.79 33.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.104 0.478 . . . . 0.0 111.885 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.545 ' HB3' HD23 ' A' ' 46' ' ' LEU . 7.8 mp0 -63.07 -46.7 86.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.635 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.85 -29.36 0.17 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.782 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.581 ' OE1' HD22 ' A' ' 79' ' ' LEU . 12.8 mm-40 -81.32 -55.03 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.254 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.1 t -61.26 -57.91 9.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.64 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.581 HG23 HG21 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -53.76 -50.26 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.066 179.631 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.8 m -42.12 -43.43 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.39 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.593 HD22 ' OH ' ' A' ' 72' ' ' TYR . 19.9 mt -63.99 -33.91 76.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.36 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -81.62 -23.12 58.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.521 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.525 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -40.49 -58.47 2.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.826 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.1 Cg_endo -66.18 -40.28 15.83 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.616 2.21 . . . . 0.0 111.947 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.628 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.5 m-30 -55.23 -30.45 60.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.575 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 156.9 -104.41 0.25 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.094 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.422 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -150.43 137.95 19.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 111.03 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 34' ' ' ILE . 51.4 t -86.99 121.47 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.403 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.961 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -96.76 -0.73 47.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.574 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 44' ' ' THR . 44.4 t30 178.06 149.44 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.982 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.86 HD13 HG22 ' A' ' 57' ' ' ILE . 1.5 tp -139.91 103.17 4.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.59 HD13 ' N ' ' A' ' 48' ' ' MET . 0.5 OUTLIER -115.5 113.85 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.935 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.629 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.4 mmm -99.65 99.58 10.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.604 ' C ' HG21 ' A' ' 26' ' ' ILE . 14.8 tp -82.04 97.41 8.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.81 ' CE ' HG22 ' A' ' 26' ' ' ILE . 3.4 mmtp -49.0 -21.5 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.303 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -79.34 126.07 7.29 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.698 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.507 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 1.8 mttt 71.36 7.19 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 111.314 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 53.4 m-20 49.98 62.09 2.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.035 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.846 ' C ' HD11 ' A' ' 26' ' ' ILE . 14.0 mm-40 -139.98 134.9 32.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.585 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.77 166.82 10.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.81 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -146.85 115.92 6.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.244 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.86 HG22 HD13 ' A' ' 46' ' ' LEU . 6.8 pt -118.03 143.04 29.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.698 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.755 ' O ' HG23 ' A' ' 44' ' ' THR . 0.5 OUTLIER -109.64 124.38 51.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.23 -179.651 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.523 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -91.66 138.68 31.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.351 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.961 ' CG ' HG22 ' A' ' 44' ' ' THR . 2.4 m120 -67.25 -27.05 66.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.326 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.443 HG23 ' HB2' ' A' ' 64' ' ' ALA . 3.6 t -123.85 140.26 53.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.921 0.391 . . . . 0.0 111.377 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -54.43 -42.11 70.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.773 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -56.65 -29.28 62.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.632 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -72.04 -52.35 17.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.874 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 68' ' ' MET . . . -51.88 -60.97 2.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.08 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -44.99 -68.49 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.628 HG22 ' CD1' ' A' ' 40' ' ' PHE . 86.3 m -40.91 -36.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.979 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.968 ' SD ' HG21 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -51.67 -65.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.833 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 78.9 t -79.7 -49.26 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.172 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -41.99 -57.16 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.027 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -61.25 -50.37 73.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.053 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.593 ' OH ' HD22 ' A' ' 36' ' ' LEU . 20.2 m-30 -73.76 -0.42 15.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.259 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 69' ' ' VAL . 95.0 m -51.82 -20.68 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.931 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 t -127.21 -51.87 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.83 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.4 p -89.73 123.41 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.03 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.4 m -99.02 142.2 24.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.986 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.478 ' O ' HG12 ' A' ' 84' ' ' ILE . 45.6 Cg_endo -96.94 109.63 0.1 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.271 2.647 . . . . 0.0 112.292 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.992 ' O ' HD23 ' A' ' 79' ' ' LEU . 1.4 m -100.86 -179.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.992 HD23 ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -154.95 122.97 5.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.684 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 2.8 ttp180 63.32 11.82 5.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.715 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.81 19.97 15.89 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.5 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.449 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 4.5 mm-40 -116.59 97.61 50.43 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.82 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.417 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 17.2 Cg_exo -67.24 115.41 3.65 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.969 2.446 . . . . 0.0 112.55 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.64 HD12 HD13 ' A' ' 24' ' ' LEU . 3.3 pt -122.01 107.82 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 21' ' ' ILE . 3.5 m-85 -76.03 150.75 37.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.661 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.968 HG21 ' SD ' ' A' ' 68' ' ' MET . 5.6 mt -126.11 109.67 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 20' ' ' HIS . 2.5 mt-30 -117.13 173.29 6.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.128 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.587 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 47.9 m-85 -71.73 156.12 39.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.95 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 20' ' ' HIS . 4.0 t -120.08 145.76 46.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 92' ' ' LYS . 1.9 m-20 -64.48 64.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.767 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.519 ' NE2' ' HG2' ' A' ' 93' ' ' GLU . 81.8 t60 38.04 -92.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.996 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.545 ' CG ' ' O ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER 51.83 80.47 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.08 0.467 . . . . 0.0 110.137 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.519 ' HG2' ' NE2' ' A' ' 91' ' ' HIS . 0.9 OUTLIER -48.4 118.43 2.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.911 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.9 mt -72.67 149.33 43.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.02 137.08 39.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.038 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 85.6 m -127.19 133.32 50.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.101 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -57.57 175.3 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 47.59 81.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.898 0.38 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.64 171.05 33.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.495 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.69 161.8 28.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 111.141 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.475 ' O ' ' HB3' ' A' ' 16' ' ' SER . 51.4 Cg_exo -52.71 -62.58 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.738 2.292 . . . . 0.0 112.316 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.565 ' OG ' ' CE1' ' A' ' 88' ' ' PHE . 42.2 t 68.53 159.01 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.943 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.401 ' HG2' ' OE2' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -166.44 -42.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 91' ' ' HIS . 21.6 t -101.94 107.94 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.109 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.815 ' CG2' HG23 ' A' ' 86' ' ' ILE . 1.4 mp -93.58 113.38 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.587 ' CD2' ' HB3' ' A' ' 54' ' ' GLN . 4.5 t-80 -84.24 117.5 23.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.361 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.758 HG22 ' HB2' ' A' ' 24' ' ' LEU . 9.9 mt -87.76 98.32 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.501 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -77.57 177.29 8.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.452 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER 37.19 38.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 110.555 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.758 ' HB2' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -123.65 99.94 38.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.934 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.452 ' HA ' ' CG ' ' A' ' 53' ' ' ASN . 34.6 Cg_exo -57.33 74.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.569 2.179 . . . . 0.0 111.771 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.899 HG23 ' HB3' ' A' ' 48' ' ' MET . 16.2 mm -33.23 119.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.1 t0 150.95 -19.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.952 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 29' ' ' THR . 6.1 m -54.99 -153.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.797 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.552 ' N ' HG23 ' A' ' 28' ' ' VAL . 40.6 p -112.05 145.7 39.23 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.06 0.457 . . . . 0.0 111.815 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.823 ' CD ' HD12 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -65.28 -56.16 14.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.545 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.89 -33.15 0.4 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.999 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.596 ' HG2' HD21 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -68.63 -58.33 4.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.476 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.02 -48.52 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.622 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.873 ' CG1' HG21 ' A' ' 43' ' ' VAL . 1.6 mp -65.08 -38.2 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.513 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -47.51 -41.44 20.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.649 HD23 ' OH ' ' A' ' 72' ' ' TYR . 8.5 mp -71.5 -33.53 69.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.2 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.597 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -69.92 -25.25 75.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.346 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.516 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -41.76 -59.77 2.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 110.856 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 28.5 Cg_endo -62.87 -23.06 74.27 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.67 2.247 . . . . 0.0 111.883 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.597 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 13.7 m-30 -76.64 -38.69 54.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.507 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.13 -102.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.158 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -150.52 146.55 26.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.777 0.323 . . . . 0.0 110.987 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.873 HG21 ' CG1' ' A' ' 34' ' ' ILE . 55.8 t -86.86 112.55 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.525 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.966 HG22 ' ND2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -88.19 -13.64 40.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.202 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 170.93 119.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.051 HD23 HG22 ' A' ' 57' ' ' ILE . 1.2 tm? -123.83 117.41 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.999 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.646 ' N ' HD22 ' A' ' 46' ' ' LEU . 8.9 tt -117.84 128.55 54.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.848 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.899 ' HB3' HG23 ' A' ' 26' ' ' ILE . 9.1 mtp -106.16 139.05 41.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.708 ' C ' HG21 ' A' ' 26' ' ' ILE . 37.3 mt -120.22 103.85 9.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.642 ' N ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -55.51 -17.37 5.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . -84.08 116.52 4.27 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.439 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER 82.65 -8.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 111.059 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.452 ' CG ' ' HA ' ' A' ' 25' ' ' PRO . 85.1 m-20 61.29 77.53 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.968 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.587 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 48.8 mt-30 -155.06 130.8 9.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.665 ' CA ' HD11 ' A' ' 26' ' ' ILE . . . -109.72 162.54 14.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.779 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -144.9 116.11 7.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.367 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.051 HG22 HD23 ' A' ' 46' ' ' LEU . 8.0 pt -110.19 155.04 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.815 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.761 ' O ' HG23 ' A' ' 44' ' ' THR . 0.0 OUTLIER -122.04 119.11 30.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.785 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 32.7 mmm -90.77 142.54 27.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.698 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.966 ' ND2' HG22 ' A' ' 44' ' ' THR . 1.7 m120 -72.88 -23.87 60.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.912 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.5 t -130.35 137.39 49.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.229 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -48.29 -42.85 32.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.45 ' O ' ' CB ' ' A' ' 67' ' ' THR . 10.8 mp0 -53.03 -30.07 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.749 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.785 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -77.25 -47.28 20.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.988 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -65.75 -58.94 4.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.045 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 6.4 m-20 -54.68 -59.5 4.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.813 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.45 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 18.6 m -40.93 -49.0 3.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.977 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.589 ' HA ' ' CZ ' ' A' ' 40' ' ' PHE . 2.1 ttm -46.18 -63.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.82 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.773 HG13 ' HG3' ' A' ' 87' ' ' GLN . 39.1 t -68.91 -15.97 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.136 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.453 ' O ' ' OG1' ' A' ' 73' ' ' THR . 1.2 t-20 -72.82 -64.12 1.03 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 5.0 t80 -60.86 -24.4 65.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.649 ' OH ' HD23 ' A' ' 36' ' ' LEU . 24.5 m-85 -93.07 19.99 7.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.059 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 91.6 m -72.03 -31.1 65.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -118.79 -50.55 2.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.789 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.8 t -82.48 119.92 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.982 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.5 m -87.59 141.93 32.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.921 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.75 ' HG2' HD12 ' A' ' 86' ' ' ILE . 35.5 Cg_endo -95.81 142.88 1.08 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.081 2.52 . . . . 0.0 112.255 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' A' ' 83' ' ' PRO . 2.0 m -129.21 -179.69 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.165 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.636 HD23 ' HG3' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -141.75 108.5 5.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.636 ' HG3' HD23 ' A' ' 79' ' ' LEU . 21.1 mtm-85 61.26 14.02 5.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.502 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.29 7.78 20.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.361 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.453 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 6.3 tp60 -113.54 103.75 55.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.974 0.416 . . . . 0.0 110.896 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.762 ' HA ' HG12 ' A' ' 78' ' ' VAL . 24.6 Cg_exo -63.01 121.02 8.74 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.943 2.429 . . . . 0.0 112.617 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.601 HG22 ' HA ' ' A' ' 24' ' ' LEU . 2.4 pt -122.34 107.56 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.513 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 20.4 m-85 -62.08 141.54 58.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.036 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.815 HG23 ' CG2' ' A' ' 19' ' ' ILE . 6.5 mt -126.55 107.92 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.466 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.773 ' HG3' HG13 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -152.88 169.55 22.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 111.192 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.577 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 1.1 m-85 -74.8 137.74 42.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.554 ' HB3' ' CB ' ' A' ' 20' ' ' HIS . 3.9 t -152.39 82.56 1.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.882 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 89' ' ' SER . 11.5 m-80 82.51 -152.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.481 ' O ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -139.54 -58.98 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.931 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt 38.88 64.6 0.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -39.06 139.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -88.0 110.27 20.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.84 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -105.53 109.47 21.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.818 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.5 p -115.13 131.25 56.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.147 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 98' ' ' SER . 0.2 OUTLIER -72.69 90.32 1.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 59.1 p 173.74 53.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.88 0.371 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 53.04 -98.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.464 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.728 HG21 ' CB ' ' A' ' 62' ' ' GLU . 7.6 p -37.11 111.98 0.55 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.18 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.608 ' HG3' ' CZ ' ' A' ' 88' ' ' PHE . 55.5 Cg_endo -70.24 -47.99 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.714 2.276 . . . . 0.0 112.395 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.568 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -157.96 159.45 36.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.061 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.405 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -86.23 -24.64 25.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.887 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.477 ' O ' HD13 ' A' ' 19' ' ' ILE . 71.7 t -87.86 144.27 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.035 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.5 ' CG2' HG23 ' A' ' 86' ' ' ILE . 34.8 mm -122.4 107.89 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.213 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' GLN . 5.4 t-160 -78.82 121.9 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.806 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.788 HD12 HG12 ' A' ' 86' ' ' ILE . 4.3 mm -100.45 112.65 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.241 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 174.16 6.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.795 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER 45.06 44.01 7.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.675 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.777 ' HA ' HG22 ' A' ' 84' ' ' ILE . 3.2 tp -134.46 109.34 11.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 26' ' ' ILE . 33.0 Cg_endo -64.51 74.84 0.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.401 2.067 . . . . 0.0 111.729 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.801 HG23 ' HB3' ' A' ' 48' ' ' MET . 15.3 mm -31.83 117.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.052 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 3.6 t70 151.16 -19.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.162 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 29' ' ' THR . 5.7 m -54.86 -155.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.881 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.538 ' N ' HG23 ' A' ' 28' ' ' VAL . 81.2 p -112.38 145.03 40.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 111.674 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.48 ' HB3' HD11 ' A' ' 34' ' ' ILE . 32.6 mt-10 -65.36 -50.6 64.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.438 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.99 -28.33 0.23 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.036 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.867 ' OE1' HD23 ' A' ' 79' ' ' LEU . 37.5 mt-10 -78.46 -52.15 8.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.403 . . . . 0.0 110.494 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.54 -57.47 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.729 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.528 HD11 HD23 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -53.14 -40.74 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 8.0 t -54.94 -43.07 73.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.698 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.554 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 6.3 mp -74.87 -11.27 60.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.761 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.65 -22.13 8.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.769 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.437 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -50.73 -52.54 55.77 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.66 0.267 . . . . 0.0 110.985 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 39.7 Cg_exo -60.01 -24.2 75.7 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.484 2.123 . . . . 0.0 111.668 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.863 ' CD2' HG22 ' A' ' 67' ' ' THR . 79.0 m-85 -82.03 7.24 13.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.035 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.13 -108.67 1.0 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.292 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.541 ' HB3' ' ND2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -150.55 146.05 26.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.101 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.453 HG21 HG23 ' A' ' 34' ' ' ILE . 55.2 t -99.81 97.04 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.937 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -87.8 22.23 2.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.302 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.9 OUTLIER 171.67 147.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.069 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.698 HD12 ' C ' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -155.05 97.26 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.828 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.676 HD13 ' N ' ' A' ' 48' ' ' MET . 2.3 tm? -105.36 122.29 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.011 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.801 ' HB3' HG23 ' A' ' 26' ' ' ILE . 6.9 mtt -102.17 116.82 33.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.624 ' C ' HG21 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -88.88 101.06 13.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.605 ' CE ' HG22 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -82.03 48.13 1.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.98 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -129.57 -60.49 0.1 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.249 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -108.32 12.3 26.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 85.8 m-20 62.72 64.89 0.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.914 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.585 ' C ' HD11 ' A' ' 26' ' ' ILE . 78.3 mt-30 -148.0 134.17 19.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.843 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.67 ' CA ' HD11 ' A' ' 26' ' ' ILE . . . -109.66 157.68 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.735 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -140.95 115.85 9.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.239 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.499 HG22 HD13 ' A' ' 46' ' ' LEU . 22.5 pt -114.91 138.18 45.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.797 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -104.6 102.7 12.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.993 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.473 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -62.9 128.31 35.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.408 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.937 ' ND2' HG23 ' A' ' 44' ' ' THR . 0.3 OUTLIER -48.13 -39.81 21.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.31 -179.312 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.46 HG23 ' HB2' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -118.11 163.43 16.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.872 0.367 . . . . 0.0 111.238 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.728 ' CB ' HG21 ' A' ' 14' ' ' VAL . 5.6 mp0 -71.68 -44.75 63.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.828 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -55.13 -30.51 59.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.423 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -69.15 -46.51 67.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.643 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.568 ' HB1' ' O ' ' A' ' 16' ' ' SER . . . -58.12 -60.0 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.255 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -42.01 -58.28 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.962 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.863 HG22 ' CD2' ' A' ' 40' ' ' PHE . 22.3 m -50.81 -51.84 46.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.326 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.593 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 6.3 tpt -36.3 -60.15 0.59 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.071 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.584 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 76.3 t -79.41 -26.43 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.424 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 1.5 t-20 -58.69 -64.12 1.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.079 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.62 -36.22 83.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.054 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.581 ' CE1' ' HG3' ' A' ' 77' ' ' PRO . 22.4 m-85 -87.93 20.06 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.983 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 87.7 m -68.7 -44.57 73.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.024 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.6 t -113.62 -39.82 3.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.769 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.54 108.91 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.474 ' OG1' ' CE2' ' A' ' 85' ' ' TYR . 2.2 m -93.81 122.3 62.53 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.065 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.581 ' HG3' ' CE1' ' A' ' 72' ' ' TYR . 74.2 Cg_endo -96.79 120.17 0.18 Allowed 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 123.064 2.509 . . . . 0.0 112.215 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 83' ' ' PRO . 1.4 m -89.34 -179.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.235 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.974 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -141.71 133.53 27.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.688 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.776 ' HB2' HD22 ' A' ' 79' ' ' LEU . 0.5 OUTLIER 36.25 30.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.443 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 85.57 51.98 3.5 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.871 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.552 ' HB3' ' CD1' ' A' ' 79' ' ' LEU . 1.5 tt0 -155.2 97.74 2.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.984 0.421 . . . . 0.0 110.799 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.75 ' HA ' HG12 ' A' ' 78' ' ' VAL . 52.1 Cg_exo -54.8 107.28 0.22 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.866 2.377 . . . . 0.0 112.658 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.777 HG22 ' HA ' ' A' ' 24' ' ' LEU . 7.1 pt -116.83 107.75 23.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.701 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CE2' ' OG1' ' A' ' 76' ' ' THR . 27.7 m-85 -71.28 149.08 46.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.317 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.788 HG12 HD12 ' A' ' 21' ' ' ILE . 4.5 mt -124.68 103.81 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.631 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 20' ' ' HIS . 2.8 mt-30 -125.16 172.05 9.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.883 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.608 ' CZ ' ' HG3' ' A' ' 15' ' ' PRO . 59.9 m-85 -68.88 -174.88 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.5 170.4 15.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.33 43.63 1.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -118.36 -177.83 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.57 -82.25 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.31 136.86 28.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.973 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mp -75.25 135.48 40.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.97 125.15 51.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 97' ' ' ASP . 0.9 OUTLIER -124.48 120.05 30.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.123 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER 42.99 -170.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.927 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 p -139.82 111.46 7.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.865 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.802 0.334 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 47.08 91.05 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.457 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 62' ' ' GLU . 1.9 t -63.86 130.19 94.3 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.888 0.375 . . . . 0.0 111.194 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 88' ' ' PHE . 75.1 Cg_exo -49.45 -64.68 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.731 2.287 . . . . 0.0 112.328 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.51 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 0.3 OUTLIER 165.36 156.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.986 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.512 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 15.1 ptp180 -72.04 -16.98 62.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.569 HG12 ' HB3' ' A' ' 89' ' ' SER . 87.5 t -87.92 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.669 HG21 ' HG2' ' A' ' 68' ' ' MET . 24.1 mm -127.07 109.24 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.642 ' CD2' ' CZ ' ' A' ' 56' ' ' PHE . 11.5 t-160 -78.93 110.55 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.795 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.503 HG23 HG13 ' A' ' 86' ' ' ILE . 25.7 mt -82.91 130.44 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.55 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 3.0 ptt180 -112.4 177.24 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 44.15 30.93 0.48 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.684 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.794 ' HA ' HG22 ' A' ' 84' ' ' ILE . 5.8 tp -117.59 112.85 38.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.457 ' O ' ' C ' ' A' ' 26' ' ' ILE . 21.9 Cg_exo -64.48 69.55 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.399 2.066 . . . . 0.0 111.391 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.796 HG21 ' C ' ' A' ' 49' ' ' LEU . 5.1 mm -33.97 111.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.371 0.605 . . . . 0.0 110.717 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 4.4 t70 150.7 -22.9 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.98 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.673 HG13 ' N ' ' A' ' 29' ' ' THR . 2.1 p -56.79 -157.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.608 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.673 ' N ' HG13 ' A' ' 28' ' ' VAL . 38.1 p -98.73 144.16 28.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.217 0.532 . . . . 0.0 112.035 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.65 -48.3 27.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.36 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.61 -31.4 0.4 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.706 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.659 ' HG2' HD13 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -79.22 -51.9 8.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 110.398 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' THR . 12.1 t -56.08 -51.09 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.775 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.823 HG23 HG21 ' A' ' 43' ' ' VAL . 1.5 mp -66.51 -50.4 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.506 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 14.9 t -44.76 -40.57 6.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.378 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 77' ' ' PRO . 13.4 mt -63.26 -42.0 99.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.43 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -82.09 -8.99 85.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.387 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.588 HD13 HG22 ' A' ' 34' ' ' ILE . 1.3 tp -55.06 -60.05 9.16 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 110.724 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 19.7 Cg_endo -60.46 -17.85 50.34 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.611 2.208 . . . . 0.0 111.833 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.591 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 28.0 m-85 -76.99 -5.65 49.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.886 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 42' ' ' LYS . . . 141.1 -103.21 0.33 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.134 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.436 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 1.5 mmtp -150.46 138.88 20.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 111.067 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.823 HG21 HG23 ' A' ' 34' ' ' ILE . 54.0 t -89.2 120.23 37.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 1.009 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -95.17 -11.98 27.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.157 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 8.7 t30 174.08 146.53 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.839 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.021 HD22 ' N ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -144.6 125.03 13.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.818 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.021 ' N ' HD22 ' A' ' 46' ' ' LEU . 7.2 tt -131.33 123.05 27.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.039 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.534 ' CA ' HD12 ' A' ' 26' ' ' ILE . 3.3 mmm -89.18 109.77 20.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.749 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.796 ' C ' HG21 ' A' ' 26' ' ' ILE . 13.6 tp -84.14 109.46 17.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.081 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.662 ' HD2' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -86.84 44.7 1.19 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.819 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -115.84 -42.47 0.72 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.554 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 28.12 2.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 110.963 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 75.7 m-20 57.93 49.18 12.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.535 ' HB3' ' NE2' ' A' ' 20' ' ' HIS . 47.8 mt-30 -134.4 140.08 46.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.363 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.559 ' CA ' HD11 ' A' ' 26' ' ' ILE . . . -109.9 172.55 6.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.65 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.642 ' CZ ' ' CD2' ' A' ' 20' ' ' HIS . 11.9 m-85 -148.01 115.71 6.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.355 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.517 HG22 HD23 ' A' ' 46' ' ' LEU . 6.6 pt -114.41 155.13 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.662 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.866 ' O ' HG23 ' A' ' 44' ' ' THR . 6.7 mm-40 -118.36 122.9 43.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.992 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.899 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 24.3 mmm -94.26 133.47 37.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.515 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 1.009 ' CG ' HG22 ' A' ' 44' ' ' THR . 1.8 m120 -71.77 -24.82 61.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 110.924 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 64' ' ' ALA . 9.0 t -125.0 129.0 49.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.17 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.619 ' HB3' HG11 ' A' ' 14' ' ' VAL . 2.0 mp0 -44.68 -38.56 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.846 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -59.01 -26.45 64.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.899 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -76.38 -51.35 12.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.059 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 17' ' ' ARG . . . -57.05 -64.12 0.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.058 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.454 ' OD1' ' HG2' ' A' ' 15' ' ' PRO . 2.3 m-20 -44.73 -60.06 2.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.756 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.8 m -48.06 -35.88 12.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.034 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.669 ' HG2' HG21 ' A' ' 19' ' ' ILE . 9.4 tpt -51.52 -62.26 1.73 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.959 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.642 HG21 ' N ' ' A' ' 88' ' ' PHE . 46.1 t -77.53 -15.91 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.366 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.464 ' O ' ' OG1' ' A' ' 73' ' ' THR . 11.5 t-20 -76.46 -64.19 1.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.131 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -56.66 -38.47 72.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.128 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.526 ' CE2' ' CZ ' ' A' ' 40' ' ' PHE . 24.7 m-85 -84.72 12.78 6.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.07 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 89.0 m -67.88 -34.73 77.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.22 -40.71 3.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.08 156.93 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.009 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.562 HG23 ' HD2' ' A' ' 77' ' ' PRO . 2.5 m -122.64 147.3 50.16 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.776 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.562 ' HD2' HG23 ' A' ' 76' ' ' THR . 28.9 Cg_endo -96.39 75.73 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.338 2.692 . . . . 0.0 112.386 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.603 ' O ' HD23 ' A' ' 79' ' ' LEU . 12.3 t -70.91 158.08 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.227 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.659 HD13 ' HG2' ' A' ' 32' ' ' GLU . 53.5 mt -137.63 113.44 9.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.108 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 51.64 20.23 1.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.474 ' O ' ' HD3' ' A' ' 83' ' ' PRO . . . 105.99 8.74 33.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.668 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.411 ' C ' HG13 ' A' ' 78' ' ' VAL . 5.5 tp-100 -109.27 97.5 26.44 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.829 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 81' ' ' GLY . 13.5 Cg_exo -69.93 126.75 13.55 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 123.045 2.496 . . . . 0.0 112.434 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.794 HG22 ' HA ' ' A' ' 24' ' ' LEU . 8.0 pt -135.35 107.45 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.55 ' HB2' ' CG ' ' A' ' 22' ' ' ARG . 3.3 m-85 -75.03 151.08 38.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.397 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.667 HG21 ' HG3' ' A' ' 68' ' ' MET . 4.4 mt -125.91 122.05 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.562 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -130.91 169.98 15.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.149 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.642 ' N ' HG21 ' A' ' 69' ' ' VAL . 58.8 m-85 -64.09 -179.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.021 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.569 ' HB3' HG12 ' A' ' 18' ' ' VAL . 87.9 p -113.76 -171.38 1.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -125.74 -39.6 2.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -68.13 -172.81 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 -43.69 3.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.5 163.28 27.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.443 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -78.98 118.41 20.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -63.44 120.58 11.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.28 135.39 54.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.112 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -101.09 51.64 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -133.23 95.74 3.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.849 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 98' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.942 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.796 0.331 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.08 63.48 0.61 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 14' ' ' VAL . 8.4 p -51.61 118.84 12.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.796 0.331 . . . . 0.0 111.123 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.48 115.89 2.5 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.704 2.269 . . . . 0.0 112.352 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.6 p -140.17 159.86 41.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.922 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -170.54 -45.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.917 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.609 HG13 ' HB3' ' A' ' 89' ' ' SER . 7.5 p -87.94 138.59 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.875 HG21 ' SD ' ' A' ' 68' ' ' MET . 47.2 mm -119.14 105.52 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 87' ' ' GLN . 5.0 t-160 -78.98 107.59 11.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.718 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.67 HG23 HD13 ' A' ' 86' ' ' ILE . 9.5 mt -85.22 118.52 32.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.402 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -100.73 170.08 8.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.483 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.08 32.4 2.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.981 0.42 . . . . 0.0 110.253 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.975 HD13 HD12 ' A' ' 84' ' ' ILE . 4.2 tp -116.99 123.34 30.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.172 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' ILE . 57.1 Cg_endo -71.05 75.6 1.74 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.426 2.084 . . . . 0.0 111.597 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.957 HD11 ' C ' ' A' ' 54' ' ' GLN . 17.9 mm -30.91 148.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.117 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 96.43 7.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.788 -178.394 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.571 HG21 HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -63.25 -151.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.027 179.341 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.637 ' O ' HG23 ' A' ' 33' ' ' VAL . 71.8 p -120.26 148.9 43.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.007 0.432 . . . . 0.0 111.749 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.544 ' CG ' HD23 ' A' ' 46' ' ' LEU . 5.6 mp0 -66.28 -66.0 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.756 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.05 -29.53 0.2 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.154 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -82.51 -61.21 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.713 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 29' ' ' THR . 56.9 t -55.21 -53.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.851 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.971 ' CD1' HD22 ' A' ' 46' ' ' LEU . 1.4 mp -62.66 -33.99 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.279 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.563 ' HA ' HD22 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -51.07 -36.23 39.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.054 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.538 HD23 ' OH ' ' A' ' 72' ' ' TYR . 2.0 mt -70.64 -46.9 62.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.21 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.83 -13.6 82.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.281 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.84 HD13 HG22 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -48.79 -60.28 4.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.78 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 20.2 Cg_endo -60.77 -34.95 91.01 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.636 2.224 . . . . 0.0 111.731 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 67' ' ' THR . 39.7 m-85 -63.25 -12.39 28.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.999 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.73 -106.86 0.36 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.122 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.472 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -150.61 150.22 30.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.909 0.385 . . . . 0.0 111.139 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 34' ' ' ILE . 55.0 t -102.58 121.19 53.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.307 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.778 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -102.64 8.24 39.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.513 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 171.95 153.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.971 HD22 ' CD1' ' A' ' 34' ' ' ILE . 17.1 tp -140.53 131.2 25.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.949 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 tp -136.18 137.28 40.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.597 ' HB3' HG23 ' A' ' 26' ' ' ILE . 4.9 mmm -125.09 94.77 4.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.776 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.492 ' C ' HG21 ' A' ' 26' ' ' ILE . 27.6 tp -76.43 92.9 3.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.703 ' N ' HG21 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -60.65 159.23 11.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.011 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.71 -73.49 0.24 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.482 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -83.07 -8.87 59.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.788 0.327 . . . . 0.0 111.018 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER 68.65 47.43 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.957 ' C ' HD11 ' A' ' 26' ' ' ILE . 69.9 mt-30 -129.54 126.96 39.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.728 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.754 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.15 161.41 15.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.784 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -140.94 115.89 9.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.396 -179.395 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.788 HG22 ' CD1' ' A' ' 46' ' ' LEU . 7.1 pt -112.75 140.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.579 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 44' ' ' THR . 6.9 tt0 -103.53 102.97 12.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.27 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.456 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 2.7 mtp -74.64 147.39 41.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.122 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.778 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.2 OUTLIER -64.2 -55.13 23.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.399 -178.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -108.03 169.81 8.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 111.451 -179.094 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' N ' ' OG1' ' A' ' 61' ' ' THR . 24.1 mt-10 -71.33 -47.75 54.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.64 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -49.33 -31.6 9.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.262 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 40' ' ' PHE . . . -70.62 -51.6 27.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.769 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.456 ' HA ' ' SD ' ' A' ' 59' ' ' MET . . . -67.14 -66.1 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.315 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.521 HD22 ' CG1' ' A' ' 14' ' ' VAL . 18.1 m120 -37.92 -45.32 0.85 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.989 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.879 HG22 ' CE2' ' A' ' 40' ' ' PHE . 43.7 m -64.68 -53.44 47.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.141 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.875 ' SD ' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -35.36 -64.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.041 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.795 HG22 HG22 ' A' ' 86' ' ' ILE . 75.1 t -68.47 -46.69 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.286 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 40.5 m-20 -46.47 -64.41 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.174 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -62.11 -38.1 87.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 77' ' ' PRO . 18.1 m-85 -87.73 19.66 3.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 69' ' ' VAL . 20.3 m -83.78 -35.36 24.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.923 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 t -113.29 -40.51 3.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.9 t -75.53 138.63 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.494 ' HG1' ' HH ' ' A' ' 85' ' ' TYR . 2.4 m -90.42 112.11 51.07 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.275 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.587 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 58.8 Cg_endo -98.05 109.62 0.08 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 123.24 2.627 . . . . 0.0 112.299 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HB ' ' C ' ' A' ' 82' ' ' GLN . 0.7 OUTLIER -110.71 157.62 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 111.002 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.501 ' C ' HD13 ' A' ' 79' ' ' LEU . 3.4 tm? -107.26 100.92 10.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.523 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.404 ' HB2' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER 71.75 -58.72 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.997 0.427 . . . . 0.0 110.493 -179.615 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.39 24.65 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.417 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -129.64 104.57 17.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.717 0.294 . . . . 0.0 110.584 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 82' ' ' GLN . 28.0 Cg_endo -63.45 117.79 4.73 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.563 2.175 . . . . 0.0 112.634 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.975 HD12 HD13 ' A' ' 24' ' ' LEU . 3.4 pt -131.63 111.28 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.628 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.51 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 19.8 m-85 -77.9 165.68 23.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.442 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.795 HG22 HG22 ' A' ' 69' ' ' VAL . 39.6 mm -119.54 142.56 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.827 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' HIS . 2.1 mm-40 -141.98 170.72 15.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.06 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.586 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 32.7 m-85 -91.15 168.48 11.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.609 ' HB3' HG13 ' A' ' 18' ' ' VAL . 3.8 t -146.93 166.36 27.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.836 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.416 ' O ' ' CG ' ' A' ' 90' ' ' ASN . 25.2 t30 -178.12 49.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.84 -80.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.977 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -74.43 56.14 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.918 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -42.84 152.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.4 ' CD1' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -110.78 127.87 55.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.95 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -54.79 145.65 19.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.1 p -82.12 128.91 34.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -164.93 175.76 9.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -66.64 0.85 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.971 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.8 0.333 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.97 -97.08 2.34 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.396 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.08 132.39 23.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.894 0.378 . . . . 0.0 111.103 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 16' ' ' SER . 71.1 Cg_exo -50.55 129.62 27.21 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.729 2.286 . . . . 0.0 112.325 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 0.3 OUTLIER 175.14 119.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.424 ' HD3' ' HG2' ' A' ' 93' ' ' GLU . 1.1 ttt85 -138.87 -57.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 18' ' ' VAL . 7.3 p -88.63 104.94 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.093 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.905 HG21 ' HG2' ' A' ' 68' ' ' MET . 47.3 mm -84.04 117.94 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.552 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 3.2 t-160 -82.59 153.0 25.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.899 HG13 ' HB3' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -123.31 110.54 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.083 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.46 171.0 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER 44.22 40.19 3.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.892 0.377 . . . . 0.0 110.297 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.908 HD13 HD12 ' A' ' 84' ' ' ILE . 8.1 tp -123.73 117.39 27.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.34 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.473 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 39.2 Cg_endo -67.03 74.09 0.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.299 1.999 . . . . 0.0 111.209 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.952 HD11 ' C ' ' A' ' 54' ' ' GLN . 29.1 mm -30.06 148.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.208 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER 100.81 10.59 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.657 -178.192 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.699 HG21 HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -67.14 -151.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.877 179.208 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.536 ' H ' HG12 ' A' ' 28' ' ' VAL . 71.7 p -124.76 145.14 49.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.978 0.418 . . . . 0.0 111.613 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.517 ' HG2' HD23 ' A' ' 46' ' ' LEU . 79.0 mt-10 -62.78 -63.73 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.57 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.69 -31.11 0.23 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.785 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HB2' ' OG1' ' A' ' 29' ' ' THR . 7.3 mm-40 -79.45 -63.73 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 110.248 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.7 t -56.77 -63.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.408 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.97 HG23 HG21 ' A' ' 43' ' ' VAL . 1.6 mt -46.8 -47.62 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.964 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -42.7 -50.68 5.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.376 179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.509 ' O ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 mp -57.47 -31.48 66.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.263 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -90.45 -16.42 55.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.333 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.543 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 19.8 mt -48.96 -56.42 15.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.66 0.267 . . . . 0.0 110.986 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 31.8 Cg_endo -63.88 -18.63 64.65 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.526 2.15 . . . . 0.0 112.11 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.959 ' CE2' HG22 ' A' ' 67' ' ' THR . 37.0 m-85 -77.26 -14.67 59.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.718 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.94 -101.66 0.24 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.124 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -150.62 149.43 29.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.825 0.345 . . . . 0.0 111.09 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.97 HG21 HG23 ' A' ' 34' ' ' ILE . 55.0 t -100.08 115.85 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.343 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.798 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -96.56 2.11 52.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.522 -178.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.6 OUTLIER 170.83 142.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.937 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.023 HD13 HG22 ' A' ' 57' ' ' ILE . 39.7 tp -144.4 115.4 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.021 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.62 138.3 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.606 ' HB3' HG23 ' A' ' 26' ' ' ILE . 5.3 mmm -116.14 103.79 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.62 ' C ' HG21 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -89.55 91.48 8.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.812 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.803 ' N ' HG21 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -45.63 -26.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.887 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . -77.79 118.93 5.12 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.458 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 6.6 mtmm 85.09 -10.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 0.0 111.013 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.502 ' HA ' ' CG1' ' A' ' 26' ' ' ILE . 0.6 OUTLIER 61.89 58.75 1.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.053 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.952 ' C ' HD11 ' A' ' 26' ' ' ILE . 3.4 mm-40 -137.72 133.15 33.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.734 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.899 ' HB3' HG13 ' A' ' 21' ' ' ILE . . . -109.16 161.75 14.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.655 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -143.76 115.86 8.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.528 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.023 HG22 HD13 ' A' ' 46' ' ' LEU . 5.9 pt -109.9 154.93 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.259 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.699 ' O ' HG23 ' A' ' 44' ' ' THR . 0.7 OUTLIER -116.33 111.18 19.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.807 0.337 . . . . 0.0 111.536 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.787 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 8.5 mmm -80.14 137.42 36.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.023 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.798 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.2 OUTLIER -65.49 -41.3 93.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.419 . . . . 0.0 110.633 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -119.23 176.61 5.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.095 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.52 ' N ' ' OG1' ' A' ' 61' ' ' THR . 1.6 mp0 -73.73 -50.38 21.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.838 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -46.02 -29.32 1.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.643 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.787 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -75.94 -51.08 13.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.016 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.509 ' CA ' HD11 ' A' ' 19' ' ' ILE . . . -64.09 -61.03 2.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.099 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -44.78 -62.09 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.665 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.959 HG22 ' CE2' ' A' ' 40' ' ' PHE . 88.9 m -46.22 -51.83 13.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.98 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.905 ' HG2' HG21 ' A' ' 19' ' ' ILE . 7.1 tpt -34.63 -61.17 0.41 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.98 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.885 HG11 ' CE2' ' A' ' 88' ' ' PHE . 68.9 t -79.75 -54.59 10.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.246 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.407 ' O ' ' HB ' ' A' ' 73' ' ' THR . 20.5 m-20 -38.33 -64.18 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.305 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -60.97 -45.52 94.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.192 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 68' ' ' MET . 13.1 m-30 -73.42 -1.0 16.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.249 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 69' ' ' VAL . 46.8 m -59.16 -36.77 75.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 110.817 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.7 m -112.71 -44.08 3.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.6 t -80.92 126.69 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.567 ' OG1' ' CZ ' ' A' ' 85' ' ' TYR . 3.0 m -89.31 134.94 31.9 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.07 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.48 ' O ' HG12 ' A' ' 84' ' ' ILE . 46.5 Cg_endo -97.69 80.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.982 2.455 . . . . 0.0 112.292 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.982 ' C ' HD23 ' A' ' 79' ' ' LEU . 1.4 p -92.21 158.73 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.982 HD23 ' C ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -148.6 132.09 16.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.229 -179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.9 18.8 1.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.18 15.3 52.03 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.66 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.444 ' C ' HG23 ' A' ' 78' ' ' VAL . 74.0 mt-30 -113.68 96.78 41.95 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.054 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.29 108.7 2.05 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.903 2.402 . . . . 0.0 112.608 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.908 HD12 HD13 ' A' ' 24' ' ' LEU . 3.7 pt -117.24 110.21 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.521 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.567 ' CZ ' ' OG1' ' A' ' 76' ' ' THR . 2.4 m-85 -86.02 152.3 23.02 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.879 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.656 HG12 HD13 ' A' ' 21' ' ' ILE . 3.8 mt -126.59 140.46 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.466 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.482 ' HA ' HG22 ' A' ' 69' ' ' VAL . 2.0 pt20 -157.14 172.71 18.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 111.166 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.885 ' CE2' HG11 ' A' ' 69' ' ' VAL . 6.0 m-85 -76.0 128.8 35.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.02 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 20' ' ' HIS . 0.7 OUTLIER -152.14 179.64 8.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.75 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 55.91 -152.74 0.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.578 ' CE1' ' HG3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -92.17 -172.79 3.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.853 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -77.24 -19.91 55.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.424 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -133.72 146.65 50.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 26.2 tp -79.89 117.92 21.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.578 ' HG3' ' CE1' ' A' ' 91' ' ' HIS . 2.6 mmtp -88.32 133.87 33.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.846 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.4 m -123.03 111.26 16.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.099 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 73.19 90.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.7 p -155.98 -41.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.83 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.856 0.36 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.624 ' O ' HG23 ' A' ' 14' ' ' VAL . . . 85.15 -95.16 1.95 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.489 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.643 HG12 ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER 55.1 153.87 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.975 0.416 . . . . 0.0 111.188 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.643 ' HD2' HG12 ' A' ' 14' ' ' VAL . 33.5 Cg_exo -59.4 -67.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.776 2.317 . . . . 0.0 112.278 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 1.3 m 158.89 172.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.33 -24.98 22.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 93' ' ' GLU . 94.7 t -87.9 111.66 22.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.122 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.523 ' CG2' HG23 ' A' ' 86' ' ' ILE . 48.7 mm -97.08 105.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.22 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 87' ' ' GLN . 6.6 t-160 -79.02 119.74 22.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.652 HG23 HG13 ' A' ' 86' ' ' ILE . 10.2 mt -96.72 124.53 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.292 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -107.69 171.2 7.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.605 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 49.01 39.36 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.167 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.688 HD12 HG21 ' A' ' 84' ' ' ILE . 9.5 tp -129.16 98.27 24.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 53' ' ' ASN . 39.9 Cg_exo -56.14 77.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.518 2.146 . . . . 0.0 111.519 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.724 HG22 ' HE3' ' A' ' 50' ' ' LYS . 19.4 mm -31.54 125.45 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.065 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 2.1 t70 146.31 -15.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.144 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.737 HG11 ' HG ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -55.15 -154.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.4 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.576 ' H ' HG12 ' A' ' 28' ' ' VAL . 30.4 p -124.41 146.93 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.985 0.421 . . . . 0.0 111.683 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.617 ' HB3' HD12 ' A' ' 34' ' ' ILE . 3.2 mp0 -66.67 -49.35 66.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.62 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -45.41 -36.0 5.6 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.981 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.792 ' HG2' HD21 ' A' ' 79' ' ' LEU . 2.8 tp10 -81.96 -61.05 2.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.791 0.329 . . . . 0.0 110.606 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 29' ' ' THR . 47.7 t -52.76 -59.88 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.553 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.617 HD12 ' HB3' ' A' ' 30' ' ' GLU . 33.7 mt -54.07 -40.79 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.544 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -50.92 -40.56 57.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.147 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.951 HD12 ' OH ' ' A' ' 72' ' ' TYR . 2.1 mm? -65.9 -28.34 68.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.068 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -81.22 -20.65 64.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.375 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.509 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -46.11 -56.42 10.69 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.702 0.287 . . . . 0.0 110.575 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.509 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 35.4 Cg_exo -59.56 -19.98 55.07 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.385 2.057 . . . . 0.0 111.061 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.597 ' CD1' HG22 ' A' ' 67' ' ' THR . 6.2 m-30 -92.02 16.16 11.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.655 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.18 -111.14 3.02 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.034 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.463 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -150.79 154.59 37.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 0.0 111.209 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.455 HG21 HG12 ' A' ' 34' ' ' ILE . 59.0 t -101.82 116.92 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.762 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -98.89 9.38 43.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.448 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 44' ' ' THR . 8.4 t-20 175.61 144.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.887 HD13 HG22 ' A' ' 57' ' ' ILE . 5.2 tp -151.91 126.69 9.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.694 ' N ' HD12 ' A' ' 46' ' ' LEU . 3.4 tm? -141.01 107.56 5.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.713 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.7 mmm -86.29 118.87 26.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.79 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.546 ' C ' HG21 ' A' ' 26' ' ' ILE . 14.7 tp -102.02 100.36 10.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.084 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.724 ' HE3' HG22 ' A' ' 26' ' ' ILE . 1.4 mmtp -53.83 -19.05 3.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -37.68 -96.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.696 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -100.94 48.1 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.328 . . . . 0.0 110.981 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.451 ' CG ' ' HA ' ' A' ' 25' ' ' PRO . 85.6 m-20 39.93 73.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.605 ' C ' HD11 ' A' ' 26' ' ' ILE . 5.0 mt-30 -151.05 133.24 15.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.64 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.554 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.6 165.33 11.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.744 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -143.87 115.9 8.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.308 -179.543 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.887 HG22 HD13 ' A' ' 46' ' ' LEU . 15.0 pt -119.52 139.26 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.675 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 44' ' ' THR . 0.4 OUTLIER -108.0 103.84 13.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.256 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 0.9 OUTLIER -69.84 146.21 51.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.248 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.762 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.2 OUTLIER -66.22 -47.0 75.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.329 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.95 168.94 9.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.426 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.5 ' HB3' HG11 ' A' ' 14' ' ' VAL . 5.6 mp0 -72.05 -47.21 53.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.682 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -50.53 -26.93 5.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.408 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 40' ' ' PHE . . . -74.39 -52.41 12.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.852 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -53.89 -58.43 7.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.197 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 70' ' ' ASN . 1.7 m-20 -46.54 -64.71 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.597 HG22 ' CD1' ' A' ' 40' ' ' PHE . 19.9 m -40.83 -55.43 2.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.784 ' SD ' HG21 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -36.12 -63.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.037 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.639 HG22 HG22 ' A' ' 86' ' ' ILE . 65.2 t -83.37 -58.47 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.257 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 66' ' ' ASN . 21.1 t-20 -37.6 -36.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.486 ' HB3' ' O ' ' A' ' 67' ' ' THR . 2.1 t80 -78.19 -52.73 8.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.991 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.951 ' OH ' HD12 ' A' ' 36' ' ' LEU . 13.4 m-85 -65.89 -9.1 26.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.054 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 72' ' ' TYR . 28.6 m -38.1 -36.66 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.936 0.398 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 t -110.32 -56.62 2.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.739 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.43 120.91 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.5 m -94.3 141.47 23.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.263 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 76' ' ' THR . 58.2 Cg_endo -98.43 137.6 0.36 Allowed 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.436 2.757 . . . . 0.0 112.311 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -122.91 179.94 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.948 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.792 HD21 ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -140.92 118.73 11.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.85 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 47.33 24.28 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.536 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.51 15.38 23.11 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.412 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.456 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -120.3 97.9 48.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.599 ' HA ' HG12 ' A' ' 78' ' ' VAL . 39.6 Cg_exo -57.3 129.06 32.13 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.976 2.45 . . . . 0.0 112.802 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.688 HG21 HD12 ' A' ' 24' ' ' LEU . 5.3 pt -133.45 109.33 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.203 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -80.4 146.57 31.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.086 -178.654 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.784 HG21 ' SD ' ' A' ' 68' ' ' MET . 5.9 mt -126.4 108.75 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.412 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.534 ' HA ' ' CG1' ' A' ' 69' ' ' VAL . 30.0 mt-30 -140.39 166.09 25.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 111.366 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -74.03 120.38 19.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.656 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 20' ' ' HIS . 0.6 OUTLIER -151.52 141.62 22.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.046 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 91' ' ' HIS . 1.5 m-20 69.39 -76.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.977 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 90' ' ' ASN . 6.7 m80 85.72 -13.57 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.799 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 93' ' ' GLU . 6.2 mttp -55.26 89.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -41.47 168.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.831 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.5 mt -67.64 100.23 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -138.94 162.04 35.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.959 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 73.2 p -91.9 102.23 14.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.093 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER 160.99 -61.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.26 80.17 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.937 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.967 179.933 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.838 0.351 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.78 -98.81 2.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.5 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.88 145.58 58.36 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 111.139 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.11 95.46 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.755 2.303 . . . . 0.0 112.223 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.582 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . 3.1 m -141.35 137.6 32.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.987 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.07 -49.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.85 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.471 ' HB ' ' OG ' ' A' ' 89' ' ' SER . 7.3 t -88.03 100.43 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.04 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.82 HD11 ' HB1' ' A' ' 65' ' ' ALA . 37.4 mm -81.21 105.7 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.239 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.692 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 10.2 t-160 -84.65 107.58 16.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.837 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.549 HG23 HG13 ' A' ' 86' ' ' ILE . 1.7 mm -82.86 119.35 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.187 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.97 173.42 6.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.685 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 3.1 tmtt? 43.22 41.99 3.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.536 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.814 HD12 ' HD2' ' A' ' 25' ' ' PRO . 6.3 tp -127.79 130.45 23.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.814 ' HD2' HD12 ' A' ' 24' ' ' LEU . 73.6 Cg_endo -76.49 74.75 4.62 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.592 2.194 . . . . 0.0 111.742 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.89 HD11 ' C ' ' A' ' 54' ' ' GLN . 15.0 mm -32.83 110.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.143 0.497 . . . . 0.0 110.659 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.567 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 6.3 t70 146.69 -17.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.539 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.69 HG22 ' H ' ' A' ' 29' ' ' THR . 1.7 p -51.19 -168.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.373 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.69 ' H ' HG22 ' A' ' 28' ' ' VAL . 45.2 p -105.77 145.91 30.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.12 0.486 . . . . 0.0 111.808 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.9 mp0 -62.08 -46.12 90.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.672 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.64 -36.77 0.76 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.085 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.442 ' OE1' ' HB2' ' A' ' 79' ' ' LEU . 91.9 mt-10 -75.12 -51.18 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 110.454 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.3 t -64.07 -61.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.02 HG23 HG21 ' A' ' 43' ' ' VAL . 1.1 mt -50.82 -46.82 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.097 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 3.7 t -45.62 -45.12 13.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.583 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.511 HD22 ' OH ' ' A' ' 72' ' ' TYR . 68.6 mt -69.16 -21.27 64.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.539 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -87.1 -28.37 25.76 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.526 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.493 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -40.86 -53.14 6.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.698 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 19.6 Cg_exo -65.71 -34.33 41.27 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.718 2.279 . . . . 0.0 111.786 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.596 ' CD1' HG22 ' A' ' 67' ' ' THR . 15.6 m-30 -65.83 -39.3 90.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.833 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.521 ' O ' ' CD ' ' A' ' 42' ' ' LYS . . . 165.68 -98.52 0.15 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.42 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -150.48 141.64 23.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.79 0.328 . . . . 0.0 110.94 179.868 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.02 HG21 HG23 ' A' ' 34' ' ' ILE . 55.5 t -88.68 86.49 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.908 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -80.62 7.44 10.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.322 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 170.75 137.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.027 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.976 HD23 HG22 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -147.92 98.4 2.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.545 ' N ' HD22 ' A' ' 46' ' ' LEU . 6.5 tt -97.88 149.16 22.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.816 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.812 ' HB3' HG23 ' A' ' 26' ' ' ILE . 8.2 mtt -125.21 110.65 14.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.148 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.645 ' C ' HG21 ' A' ' 26' ' ' ILE . 6.0 tp -88.42 96.4 10.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.751 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.714 ' CD ' HG22 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -74.73 0.56 14.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.255 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.63 -9.03 36.07 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.404 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -160.46 -64.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.778 0.323 . . . . 0.0 111.001 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.594 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 2.7 m-20 155.08 43.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.551 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.89 ' C ' HD11 ' A' ' 26' ' ' ILE . 12.2 mt-30 -130.44 133.09 46.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.11 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.766 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.81 163.06 13.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.715 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.692 ' CE2' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -148.0 115.78 6.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.134 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.976 HG22 HD23 ' A' ' 46' ' ' LEU . 22.0 pt -112.18 137.18 45.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.78 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.73 102.67 14.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.731 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.855 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 17.7 mmm -67.02 124.02 21.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.645 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.908 ' ND2' HG23 ' A' ' 44' ' ' THR . 2.8 m120 -35.69 -33.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.78 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -144.67 176.78 9.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.971 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.512 ' N ' ' OG1' ' A' ' 61' ' ' THR . 1.2 mp0 -72.88 -44.76 60.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.95 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -50.25 -24.55 2.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.947 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.855 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -83.47 -49.72 9.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.82 ' HB1' HD11 ' A' ' 19' ' ' ILE . . . -65.41 -31.2 72.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.369 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -70.09 -54.49 12.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.596 HG22 ' CD1' ' A' ' 40' ' ' PHE . 24.1 m -56.62 -22.63 35.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.269 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.585 ' SD ' HD11 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -69.03 -65.01 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.066 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 21.6 t -67.97 -48.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.277 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -52.77 -40.47 63.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.037 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.428 ' CB ' ' O ' ' A' ' 67' ' ' THR . 3.5 t80 -67.81 -44.53 77.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.511 ' OH ' HD22 ' A' ' 36' ' ' LEU . 41.0 m-85 -85.84 12.48 9.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 70' ' ' ASN . 54.1 m -66.26 -13.84 61.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.2 m -127.77 -39.8 1.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.832 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.76 138.74 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.484 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.3 m -103.33 142.56 24.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.01 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.761 ' HG2' HD12 ' A' ' 86' ' ' ILE . 30.2 Cg_endo -95.24 145.08 1.4 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 123.103 2.535 . . . . 0.0 112.097 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' HB ' ' C ' ' A' ' 82' ' ' GLN . 0.7 OUTLIER -133.29 166.28 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 0.0 110.994 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.793 HD12 ' C ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -107.88 107.63 18.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.406 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER 28.92 34.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.327 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 115.93 36.24 1.16 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.559 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.548 ' CB ' ' HG ' ' A' ' 79' ' ' LEU . 2.5 tt0 -151.34 97.18 3.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.076 0.465 . . . . 0.0 110.613 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.406 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 38.7 Cg_exo -61.16 126.2 18.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.004 2.47 . . . . 0.0 112.959 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.487 ' O ' HG13 ' A' ' 84' ' ' ILE . 9.4 pt -137.73 107.7 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.273 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -68.85 146.88 52.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.99 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.761 HD12 ' HG2' ' A' ' 77' ' ' PRO . 6.5 mt -126.31 103.75 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.203 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' HIS . 4.1 mt-30 -126.64 174.27 8.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.899 0.381 . . . . 0.0 111.142 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.582 ' CE1' ' HB3' ' A' ' 16' ' ' SER . 71.4 m-85 -71.27 167.44 19.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.528 ' CA ' ' HB2' ' A' ' 20' ' ' HIS . 1.1 p -108.3 176.23 5.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.792 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.87 42.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.0 34.59 13.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -75.5 76.0 2.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -52.26 138.86 25.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.4 mt -48.2 114.47 0.95 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.49 154.73 23.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.84 123.55 25.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -67.23 138.68 57.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.3 -20.34 19.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.957 179.961 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.862 0.363 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.78 70.63 1.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.451 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.1 156.72 48.15 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.919 0.39 . . . . 0.0 111.141 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.43 87.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.713 2.275 . . . . 0.0 112.334 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.0 p -143.74 95.25 2.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 58' ' ' GLU . 3.5 mtm180 -137.22 -42.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 89' ' ' SER . 9.6 t -87.91 133.81 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.582 HG21 ' HG2' ' A' ' 68' ' ' MET . 4.8 mm -115.61 102.42 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.395 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.518 ' CD2' ' HB3' ' A' ' 54' ' ' GLN . 4.7 t-160 -79.08 113.98 17.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.598 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.911 HD12 HG12 ' A' ' 86' ' ' ILE . 4.1 mm -82.83 127.03 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.347 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -108.79 171.33 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.671 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HG2' ' CZ ' ' A' ' 85' ' ' TYR . 1.9 tptp 43.66 33.17 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.27 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.772 HD13 HD12 ' A' ' 84' ' ' ILE . 2.2 tp -115.46 110.66 44.74 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.103 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.51 ' O ' ' C ' ' A' ' 26' ' ' ILE . 43.8 Cg_endo -68.22 61.69 1.04 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.277 1.985 . . . . 0.0 110.991 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.913 HD11 ' C ' ' A' ' 54' ' ' GLN . 37.5 mm -8.5 105.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.468 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.622 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 24.6 t70 129.18 24.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 O-C-N 124.408 1.067 . . . . 0.0 111.325 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.731 ' C ' HG23 ' A' ' 29' ' ' THR . 5.2 p -85.23 8.38 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.376 0.607 . . . . 0.0 111.031 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.731 HG23 ' C ' ' A' ' 28' ' ' VAL . 3.0 p 90.29 146.82 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.976 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -74.92 -40.19 60.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.228 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -53.86 -25.9 31.65 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.96 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.807 ' HG3' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -80.39 -50.31 10.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 110.551 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.402 ' HB ' ' CD2' ' A' ' 46' ' ' LEU . 12.4 t -62.29 -51.26 74.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.748 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.32 -41.51 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.442 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.9 t -49.74 -33.3 15.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.181 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.849 HD13 ' CZ ' ' A' ' 72' ' ' TYR . 6.6 mt -75.43 -34.9 61.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -70.03 -26.09 74.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.464 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -37.87 -61.23 0.81 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.367 . . . . 0.0 110.723 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.2 Cg_endo -65.87 -22.51 56.16 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.57 2.18 . . . . 0.0 111.626 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.59 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 13.1 m-30 -80.77 0.45 34.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.976 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.8 -101.69 0.85 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.375 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -150.32 145.56 26.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 111.481 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.679 HG22 HD11 ' A' ' 57' ' ' ILE . 54.7 t -89.51 122.58 41.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.651 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 1.081 HG22 ' ND2' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -99.15 -14.32 19.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.211 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.1 t-20 172.88 142.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.676 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' PHE . 5.3 tp -148.52 95.93 2.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.998 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 47' ' ' LEU . 7.1 tt -95.33 127.48 41.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.66 ' HB3' HG23 ' A' ' 26' ' ' ILE . 27.9 mtp -94.59 137.03 34.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.971 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.471 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.2 tp -124.06 101.82 7.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.784 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.675 ' HE3' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -59.6 -13.86 11.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.21 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -35.15 -95.36 0.01 OUTLIER Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.619 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 63.8 mmtt -104.03 44.11 1.04 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.914 0.388 . . . . 0.0 110.774 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.513 ' HA ' HG12 ' A' ' 26' ' ' ILE . 37.7 m-20 48.76 75.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.912 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.913 ' C ' HD11 ' A' ' 26' ' ' ILE . 32.4 mt-30 -157.65 138.42 13.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.619 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.691 ' HB3' ' CG1' ' A' ' 21' ' ' ILE . . . -109.28 167.97 9.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -139.55 115.66 10.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.283 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.679 HD11 HG22 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -127.56 144.03 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.655 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.523 ' N ' HG12 ' A' ' 57' ' ' ILE . 15.5 mt-10 -121.53 133.14 55.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.895 0.379 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.869 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 27.9 mmm -92.09 151.28 20.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.589 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 1.081 ' ND2' HG22 ' A' ' 44' ' ' THR . 0.6 OUTLIER -68.65 -26.73 65.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.952 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.619 HG23 ' H ' ' A' ' 64' ' ' ALA . 4.8 t -131.17 138.22 49.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.091 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.39 -21.02 2.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.821 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -73.59 -36.59 65.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.869 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -67.43 -49.87 61.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' A' ' 19' ' ' ILE . . . -55.78 -56.91 14.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -41.97 -68.48 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.986 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.566 HG22 ' CD1' ' A' ' 40' ' ' PHE . 19.4 m -40.93 -49.83 3.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.114 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.59 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -38.4 -64.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.977 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 54.1 t -77.09 -59.0 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -41.88 -27.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.056 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.423 ' CB ' ' O ' ' A' ' 67' ' ' THR . 10.7 t80 -85.46 -45.43 11.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.948 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.849 ' CZ ' HD13 ' A' ' 36' ' ' LEU . 19.2 m-85 -82.9 9.12 10.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 m -70.13 -23.63 63.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.05 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.9 t -116.65 -34.2 4.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.788 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.7 p -113.8 126.82 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.989 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.523 HG21 ' CE1' ' A' ' 85' ' ' TYR . 2.0 m -97.6 131.26 27.37 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.151 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.575 ' HG3' ' CE1' ' A' ' 72' ' ' TYR . 72.5 Cg_endo -98.33 120.87 0.14 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 123.178 2.585 . . . . 0.0 112.411 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.677 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -95.07 -179.96 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.856 179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.807 HD12 ' HG3' ' A' ' 32' ' ' GLU . 2.4 mm? -139.96 115.53 10.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.951 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.07 21.41 1.02 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.728 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.42 15.72 16.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.524 ' O ' HG23 ' A' ' 84' ' ' ILE . 18.7 mm100 -122.83 97.98 43.33 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.027 0.441 . . . . 0.0 110.956 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 22.2 Cg_exo -64.91 105.9 0.71 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.974 2.449 . . . . 0.0 112.746 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.772 HD12 HD13 ' A' ' 24' ' ' LEU . 1.6 pt -119.9 112.39 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.641 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -76.71 156.03 32.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.94 -178.524 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.911 HG12 HD12 ' A' ' 21' ' ' ILE . 7.7 mt -126.15 104.27 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.327 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -113.84 175.3 5.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 111.346 -179.664 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.583 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 44.3 m-85 -73.1 -178.45 2.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.041 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.468 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 41.8 t -117.03 164.06 15.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.81 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -114.3 41.09 2.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.016 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -144.22 152.41 40.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -58.86 3.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -115.46 160.73 19.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.943 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 94' ' ' LEU . 11.5 tp -62.77 132.32 51.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -55.96 111.34 0.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.843 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 p -111.78 137.68 49.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.105 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -94.29 -21.36 19.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.956 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.33 40.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.927 179.958 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 2.2 m . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.845 0.355 . . . . 2.8300000000000001 110.898 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -108.15 -40.74 5.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 2.9500000000000002 110.887 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.3 t -93.56 135.86 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 1.1100000000000001 111.149 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.808 HG21 ' HG2' ' A' ' 68' ' ' MET . 36.5 mm -107.97 109.83 29.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.70999999999999996 111.146 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.671 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 6.4 t-160 -83.08 109.14 16.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 1.52 110.865 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.49 HG23 HG13 ' A' ' 86' ' ' ILE . 4.3 mt -83.44 122.26 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.94999999999999996 111.194 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -103.61 174.82 5.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 2.8300000000000001 110.735 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 42.85 41.36 2.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 2.5800000000000001 110.74 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.506 HD12 HG21 ' A' ' 84' ' ' ILE . 3.6 tp -128.19 127.02 23.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 1.2 110.705 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.572 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 72.0 Cg_endo -75.58 71.66 5.28 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.504 2.136 . . . . 1.05 112.036 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.838 HG21 ' N ' ' A' ' 50' ' ' LYS . 15.9 mm -27.22 110.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.1 0.476 . . . . 2.1499999999999999 110.876 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 4.0 t70 146.07 -18.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.291 -0.868 . . . . 2.1600000000000001 109.451 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 29' ' ' THR . 1.8 p -52.41 -167.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 115.628 -0.714 . . . . 1.6100000000000001 109.842 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.685 ' H ' HG22 ' A' ' 28' ' ' VAL . 45.9 p -99.36 145.21 27.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.069 0.461 . . . . 0.56999999999999995 111.773 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.6 mp0 -70.32 -46.77 63.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.761 -0.654 . . . . 2.0099999999999998 110.504 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.04 -28.64 0.16 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.543 -0.837 . . . . 0.56000000000000005 111.936 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.738 ' HB3' HD21 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -83.96 -57.26 3.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.319 . . . . 2.48 110.491 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.5 t -51.5 -49.96 31.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.953 0.406 . . . . 0.59999999999999998 110.575 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.544 ' CG1' HG21 ' A' ' 43' ' ' VAL . 1.2 mp -69.97 -38.23 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.68000000000000005 110.558 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -49.1 -38.76 25.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 1.3100000000000001 110.373 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.964 HD22 ' OH ' ' A' ' 72' ' ' TYR . 12.1 mt -72.7 -38.55 67.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.946 -0.57 . . . . 1.49 110.358 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.604 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -71.54 -20.34 78.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 0.52000000000000002 112.305 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -41.65 -60.52 1.86 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.852 0.358 . . . . 1.5 110.775 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 30.1 Cg_endo -63.29 -34.63 66.64 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.714 2.276 . . . . 0.54000000000000004 111.939 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.661 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.8 m-30 -60.22 -32.62 71.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.974 -0.557 . . . . 1.3300000000000001 110.678 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 157.85 -102.29 0.21 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.86 -0.686 . . . . 0.42999999999999999 112.231 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.59 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 28.5 mttt -150.4 137.31 19.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.762 0.315 . . . . 2.3700000000000001 111.023 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.544 HG21 ' CG1' ' A' ' 34' ' ' ILE . 45.5 t -87.83 121.72 38.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.59999999999999998 110.468 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 1.056 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -96.27 -2.0 46.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 1.1200000000000001 111.459 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 170.98 152.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 1.47 111.056 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.956 HD13 HG22 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -145.38 100.52 3.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 1.3799999999999999 110.89 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 48' ' ' MET . 2.8 tt -108.33 113.74 27.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 1.4199999999999999 110.918 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.603 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.8 mmm -90.79 94.91 9.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.83999999999999997 110.865 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.571 ' C ' HG21 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -74.53 93.05 2.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 1.78 110.843 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.838 ' N ' HG21 ' A' ' 26' ' ' ILE . 3.4 mmtp -51.95 -18.74 1.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 1.6399999999999999 111.09 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -33.71 -95.21 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.798 -0.715 . . . . 2.0299999999999998 112.622 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 26.5 mttt -107.9 55.88 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 3.29 110.975 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 14.8 m120 40.56 68.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 1.3899999999999999 110.948 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.757 ' C ' HD11 ' A' ' 26' ' ' ILE . 10.7 mt-30 -146.99 129.35 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 1.6899999999999999 110.747 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.708 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.7 160.21 16.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.37 110.891 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.671 ' CE2' ' CD2' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -142.77 115.86 8.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.307 -0.406 . . . . 1.3999999999999999 111.187 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.956 HG22 HD13 ' A' ' 46' ' ' LEU . 6.1 pt -114.64 146.82 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.68999999999999995 110.771 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.784 ' O ' HG23 ' A' ' 44' ' ' THR . 1.6 mt-10 -111.8 123.18 49.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.289 -0.414 . . . . 1.96 111.222 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.497 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -90.77 137.41 32.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 1.1100000000000001 110.251 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 1.056 ' CG ' HG22 ' A' ' 44' ' ' THR . 1.2 m-80 -68.4 -20.74 64.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.418 -0.356 . . . . 1.3700000000000001 111.484 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.61 HG23 ' HB2' ' A' ' 64' ' ' ALA . 1.4 t -129.84 146.88 51.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 1.27 111.326 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.48 -46.09 89.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.088 -0.505 . . . . 1.95 110.779 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.64 -23.42 17.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 2.1299999999999999 110.721 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.61 ' HB2' HG23 ' A' ' 61' ' ' THR . . . -78.21 -54.84 5.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.40999999999999998 111.029 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -52.72 -52.61 55.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.34000000000000002 111.138 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -54.18 -67.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 1.77 110.986 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.661 HG22 ' CD1' ' A' ' 40' ' ' PHE . 22.7 m -40.97 -38.25 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.47999999999999998 111.277 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.808 ' HG2' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -52.12 -65.18 0.6 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.97999999999999998 111.024 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 99.8 t -75.08 -49.85 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.51000000000000001 111.128 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.453 ' O ' ' OG1' ' A' ' 73' ' ' THR . 13.0 t-20 -43.39 -60.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 1.5900000000000001 110.997 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -55.97 -42.26 76.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.3400000000000001 110.965 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.964 ' OH ' HD22 ' A' ' 36' ' ' LEU . 16.3 m-85 -74.5 0.2 15.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 1.21 111.073 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 32.0 m -50.11 -29.04 8.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.355 -0.384 . . . . 0.76000000000000001 110.952 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.25 -57.19 1.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 1.3400000000000001 110.779 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 40.8 t -80.28 124.69 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 1.3400000000000001 110.979 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.517 HG23 ' HD2' ' A' ' 77' ' ' PRO . 1.2 m -102.41 144.22 28.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.85999999999999999 111.241 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.966 ' HG2' HD12 ' A' ' 86' ' ' ILE . 22.6 Cg_endo -94.56 135.02 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.199 2.599 . . . . 0.80000000000000004 111.961 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -114.6 177.73 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 1.3600000000000001 111.222 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.738 HD21 ' HB3' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -131.99 112.56 12.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 2.4900000000000002 110.927 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 46.58 23.37 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 4.6600000000000001 110.725 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.09 9.17 20.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.875 -0.679 . . . . 0.94999999999999996 112.649 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.471 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -117.0 97.64 51.02 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.97 0.414 . . . . 2.2999999999999998 110.819 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.562 ' HA ' HG12 ' A' ' 78' ' ' VAL . 36.6 Cg_exo -57.64 117.12 3.77 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.852 2.368 . . . . 0.64000000000000001 112.615 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.506 HG21 HD12 ' A' ' 24' ' ' LEU . 3.3 pt -118.64 107.73 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.42999999999999999 110.67 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.433 ' CE1' HG21 ' A' ' 76' ' ' THR . 20.6 m-85 -65.42 148.4 51.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 1.78 111.648 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.966 HD12 ' HG2' ' A' ' 77' ' ' PRO . 4.2 mt -126.23 103.87 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.809 -0.632 . . . . 0.57999999999999996 110.556 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' HIS . 11.8 mt-30 -112.67 170.79 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.395 . . . . 2.3599999999999999 111.147 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 37.4 m-85 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 1.46 110.885 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.446 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 1.4 p . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.798 0.332 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -76.72 -20.03 57.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.943 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 t -90.11 107.51 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.122 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.498 ' HB ' HG12 ' A' ' 57' ' ' ILE . 24.9 mm -94.39 108.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.184 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.624 ' NE2' ' CE2' ' A' ' 56' ' ' PHE . 4.7 t-160 -79.32 109.62 13.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.744 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 85' ' ' TYR . 16.4 mt -83.99 131.1 34.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.363 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -109.29 168.27 9.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.635 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.5 OUTLIER 46.43 44.22 12.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.0 110.377 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.909 HD23 HG21 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -129.44 95.72 29.42 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.972 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.559 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 50.5 Cg_exo -53.32 78.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.699 2.266 . . . . 0.0 111.932 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.918 HG23 ' HB3' ' A' ' 48' ' ' MET . 29.6 mm -34.62 118.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.084 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.4 t0 149.76 -19.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.06 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 29' ' ' THR . 6.1 m -55.44 -155.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.783 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.538 ' N ' HG23 ' A' ' 28' ' ' VAL . 71.2 p -114.0 145.69 41.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.923 0.392 . . . . 0.0 111.64 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.848 ' O ' HD12 ' A' ' 34' ' ' ILE . 9.5 mp0 -63.47 -34.19 77.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.602 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.12 -38.18 65.94 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.182 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.944 ' OE1' HD12 ' A' ' 79' ' ' LEU . 3.6 mm-40 -68.59 -58.97 3.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.785 0.326 . . . . 0.0 110.608 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.0 t -53.28 -45.5 55.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.743 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 30' ' ' GLU . 1.4 mp -66.63 -39.58 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.395 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.36 -43.37 5.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.144 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 77' ' ' PRO . 8.5 mt -77.71 -25.35 49.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.291 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -81.43 -16.33 74.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.405 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.493 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -58.9 -54.73 53.51 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.738 0.304 . . . . 0.0 110.725 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 31.6 Cg_exo -58.19 -50.08 10.85 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.569 2.179 . . . . 0.0 111.828 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 27.2 m-85 -53.68 -32.61 52.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.783 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.71 -104.08 0.23 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.186 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 8.8 mttm -150.45 143.77 24.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 111.007 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.743 HG21 HG13 ' A' ' 34' ' ' ILE . 49.9 t -86.92 114.59 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.518 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.953 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -89.26 -4.5 58.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.458 -179.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 176.4 151.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.812 HD23 ' HB3' ' A' ' 30' ' ' GLU . 3.9 tp -137.63 125.76 22.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.007 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.0 tp -134.09 123.74 24.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.918 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.5 mmm -109.66 121.82 46.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.529 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 12.8 mt -98.89 91.62 5.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.976 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.898 ' CE ' HG22 ' A' ' 26' ' ' ILE . 13.6 mmtp -41.22 -27.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.966 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -81.24 129.6 9.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.545 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 0.9 OUTLIER 67.28 16.37 10.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 110.997 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.559 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 21.8 m120 36.35 78.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.808 ' C ' HD11 ' A' ' 26' ' ' ILE . 2.4 mt-30 -150.21 132.91 15.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.993 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.613 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.7 167.81 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.767 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.624 ' CE2' ' NE2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -148.09 115.99 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.305 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.775 HG22 HD13 ' A' ' 46' ' ' LEU . 6.5 pt -108.71 155.09 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.768 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.798 ' O ' HG23 ' A' ' 44' ' ' THR . 0.0 OUTLIER -119.51 119.28 33.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.775 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 38.7 mmm -89.98 141.47 28.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.632 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.953 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.8 OUTLIER -73.76 -27.03 60.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.909 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.5 t -123.92 137.94 54.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.234 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -51.27 -38.2 51.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.687 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -59.08 -27.88 65.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.689 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -75.81 -47.24 26.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 16' ' ' SER . . . -60.4 -57.09 14.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.993 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -51.82 -70.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.537 HG22 ' CE1' ' A' ' 40' ' ' PHE . 12.7 m -41.8 -27.48 0.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 1.005 ' SD ' HG21 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -59.62 -65.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.568 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 72.0 t -74.92 -37.61 41.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.481 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 8.2 t30 -59.23 -63.66 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.994 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' A' ' 67' ' ' THR . 2.8 t80 -49.31 -45.72 45.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.11 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.583 ' CE2' ' HG3' ' A' ' 77' ' ' PRO . 22.4 m-30 -83.83 11.57 7.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.106 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.481 ' OG1' ' HA ' ' A' ' 70' ' ' ASN . 21.5 m -62.29 -30.24 70.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.2 t -113.66 -39.19 4.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.5 p -106.18 129.95 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.144 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.3 m -98.61 142.48 24.67 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.85 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.619 ' HG2' HD12 ' A' ' 86' ' ' ILE . 26.8 Cg_endo -95.01 137.67 0.84 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 123.028 2.485 . . . . 0.0 112.214 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.828 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -123.65 -179.87 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 111.21 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.944 HD12 ' OE1' ' A' ' 32' ' ' GLU . 1.9 mm? -137.97 107.43 6.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.963 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 56.88 16.67 2.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.935 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.46 8.63 14.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.655 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.471 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -116.01 97.67 49.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.008 0.432 . . . . 0.0 110.95 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.612 ' HB3' HG12 ' A' ' 78' ' ' VAL . 74.3 Cg_endo -75.84 135.93 18.16 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.894 2.396 . . . . 0.0 112.853 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.909 HG21 HD23 ' A' ' 24' ' ' LEU . 9.2 pt -136.97 110.11 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.497 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.65 ' O ' HG23 ' A' ' 21' ' ' ILE . 8.1 m-85 -60.47 143.55 53.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.587 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 1.005 HG21 ' SD ' ' A' ' 68' ' ' MET . 7.1 mt -125.85 104.07 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.528 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' HIS . 3.9 mt-30 -115.13 172.83 6.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.1 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.568 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 45.5 m-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.84 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.827 0.346 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -68.06 -7.27 27.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.033 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 t -87.99 122.49 39.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.031 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.583 HD11 ' CA ' ' A' ' 65' ' ' ALA . 3.9 mm -119.28 116.85 52.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.211 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.481 ' HB3' ' O ' ' A' ' 88' ' ' PHE . 6.9 t-80 -88.28 153.59 21.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.721 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.697 HG23 ' O ' ' A' ' 85' ' ' TYR . 2.3 mp -133.37 110.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.478 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' LYS . 2.8 ttm180 -88.09 167.4 13.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.827 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 43.77 90.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.784 HD11 HG21 ' A' ' 28' ' ' VAL . 4.7 tp -167.66 115.42 0.65 Allowed Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.447 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 26' ' ' ILE . 37.4 Cg_exo -59.08 73.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.466 2.111 . . . . 0.0 111.062 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.56 ' CG1' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -30.01 153.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.989 -178.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER 87.46 9.43 0.16 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.983 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.784 HG21 HD11 ' A' ' 24' ' ' LEU . 1.4 t -57.86 -149.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.806 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 33' ' ' VAL . 17.9 p -124.52 149.81 46.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.16 0.505 . . . . 0.0 111.899 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 2.1 mt-10 -68.75 -47.11 67.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.789 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 35' ' ' SER . . . -51.34 -37.27 39.02 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.348 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.564 ' HG2' HD21 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -78.63 -64.93 1.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.753 0.311 . . . . 0.0 110.768 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 29' ' ' THR . 47.9 t -45.59 -52.72 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.971 HG12 HG21 ' A' ' 43' ' ' VAL . 1.5 mp -65.7 -40.17 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.315 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -39.17 -42.42 0.96 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.924 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.006 HD22 ' OH ' ' A' ' 72' ' ' TYR . 11.1 mt -73.21 -40.63 64.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.02 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -77.22 -3.97 82.9 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.399 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.536 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 9.3 mt -61.44 -58.3 19.53 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.182 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 19.7 Cg_endo -58.3 -32.02 95.07 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.511 2.141 . . . . 0.0 112.105 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.592 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 22.0 m-30 -58.04 -28.51 64.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.683 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.76 -98.03 0.17 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.18 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.569 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 19.3 mmtp -150.47 146.01 26.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 0.0 111.022 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.971 HG21 HG12 ' A' ' 34' ' ' ILE . 67.0 t -89.73 116.43 31.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.763 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.955 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -92.82 -9.71 39.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.244 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.424 ' HB2' ' OE1' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -176.88 146.95 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.725 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.758 ' C ' HD13 ' A' ' 46' ' ' LEU . 2.1 tm? -132.59 124.83 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.024 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.747 HD12 ' CD2' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -141.23 141.4 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.708 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.663 ' N ' HD13 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -129.3 103.08 6.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.784 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.783 HD23 ' CE1' ' A' ' 56' ' ' PHE . 3.4 mm? -70.18 107.82 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.832 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HA ' HG21 ' A' ' 26' ' ' ILE . 5.9 mttp -91.68 81.13 5.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.943 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.23 -56.43 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.284 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -123.17 18.29 9.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.919 0.39 . . . . 0.0 110.544 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.56 ' HA ' ' CG1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 68.81 86.47 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.953 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 53' ' ' ASN . 26.6 mt-30 -160.12 129.52 5.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 111.431 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . . . -113.75 163.27 15.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.241 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.783 ' CE1' HD23 ' A' ' 49' ' ' LEU . 5.8 m-85 -148.1 118.59 7.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.839 0.352 . . . . 0.0 111.599 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.755 HD12 ' SD ' ' A' ' 59' ' ' MET . 7.0 pt -118.53 140.85 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.527 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.775 ' O ' HG23 ' A' ' 44' ' ' THR . 61.6 mt-10 -103.34 123.65 47.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.292 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.871 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 23.4 mmm -98.81 134.49 41.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.955 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.5 OUTLIER -72.28 -20.56 61.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.27 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.9 t -134.67 129.14 34.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.909 0.385 . . . . 0.0 111.231 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -38.99 -49.55 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -46.06 -32.23 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.871 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -75.29 -48.88 21.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.583 ' CA ' HD11 ' A' ' 19' ' ' ILE . . . -66.58 -59.23 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -50.59 -65.82 0.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.075 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.7 m -40.7 -46.78 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.27 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.706 ' SD ' HD11 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -44.98 -65.11 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.275 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.645 HG13 ' HA ' ' A' ' 87' ' ' GLN . 24.7 t -71.89 -51.54 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.297 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -49.96 -26.51 4.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.186 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -85.53 -64.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.169 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 1.006 ' OH ' HD22 ' A' ' 36' ' ' LEU . 27.2 m-85 -56.46 -16.54 6.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.989 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 72' ' ' TYR . 69.7 m -35.54 -31.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.023 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 72' ' ' TYR . 7.7 t -112.4 -62.94 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 6.2 p -82.15 121.71 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.054 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.556 HG21 ' CE1' ' A' ' 85' ' ' TYR . 2.5 m -95.59 145.85 30.28 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.032 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.551 ' HD2' HG23 ' A' ' 76' ' ' THR . 37.1 Cg_endo -97.23 163.61 0.96 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.299 2.666 . . . . 0.0 112.032 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.531 ' HB ' ' N ' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -153.24 152.41 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.899 0.381 . . . . 0.0 111.105 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.564 HD21 ' HG2' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -98.78 100.83 12.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.406 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 28.6 mmt180 67.27 -59.51 0.39 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.469 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -159.44 22.92 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.404 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.454 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 26.1 mp0 -126.1 97.8 34.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.392 . . . . 0.0 110.936 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.531 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 19.9 Cg_exo -66.19 129.47 21.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 123.047 2.498 . . . . 0.0 112.714 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.747 HD12 HD13 ' A' ' 24' ' ' LEU . 6.1 pt -134.47 118.52 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.57 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.697 ' O ' HG23 ' A' ' 21' ' ' ILE . 4.6 m-85 -78.66 148.88 33.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.847 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.62 HG21 ' CG ' ' A' ' 68' ' ' MET . 4.0 mt -126.26 109.09 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.473 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.645 ' HA ' HG13 ' A' ' 69' ' ' VAL . 70.8 mm-40 -120.87 173.79 7.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.013 0.435 . . . . 0.0 111.149 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.627 ' CD1' HG21 ' A' ' 69' ' ' VAL . 30.1 m-85 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.886 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.5 p . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.53 -53.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.73 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.26 143.59 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.806 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.531 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 20.9 mm -118.41 103.07 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.376 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.549 ' NE2' ' CZ ' ' A' ' 56' ' ' PHE . 4.5 t-160 -79.03 144.95 34.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.338 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 85' ' ' TYR . 9.5 mt -133.05 138.68 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.918 0.39 . . . . 0.0 111.457 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.543 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 12.2 ptm180 -123.42 170.35 10.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.467 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 52.2 38.98 25.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.216 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.764 ' HA ' HG22 ' A' ' 84' ' ' ILE . 2.7 tp -125.22 119.85 25.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.466 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 26' ' ' ILE . 20.2 Cg_endo -60.49 80.15 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.274 1.982 . . . . 0.0 110.716 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.79 HG21 ' C ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -32.18 154.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.733 -178.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 28' ' ' VAL . 22.3 t0 79.23 2.37 2.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.171 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.667 HG22 ' H ' ' A' ' 29' ' ' THR . 2.0 p -54.81 -165.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.667 ' H ' HG22 ' A' ' 28' ' ' VAL . 55.1 p -104.26 144.72 31.23 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.904 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.782 ' HG3' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -62.06 -46.66 88.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.487 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.3 -29.45 0.12 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.64 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.827 ' CD ' HD23 ' A' ' 79' ' ' LEU . 2.7 tp10 -83.34 -60.96 1.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 0.0 110.259 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 t -55.45 -58.87 3.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.597 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.703 ' HA ' HG21 ' A' ' 43' ' ' VAL . 1.3 mt -53.24 -53.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.489 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.5 m -39.29 -50.2 1.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.571 ' O ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -61.09 -32.39 72.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.747 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.57 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -83.03 -25.77 47.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.608 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.466 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -39.21 -60.65 1.16 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.709 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 43.1 Cg_endo -67.8 -22.88 42.4 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.548 2.165 . . . . 0.0 111.651 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.636 ' CD1' HG22 ' A' ' 67' ' ' THR . 16.1 m-30 -76.34 -6.47 51.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.043 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.19 -103.23 0.44 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.334 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.512 ' HB3' ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -150.4 138.23 19.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.154 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.703 HG21 ' HA ' ' A' ' 34' ' ' ILE . 43.2 t -92.53 89.96 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 110.328 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.972 HG23 ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -74.82 1.9 11.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.867 -179.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 44' ' ' THR . 0.7 OUTLIER 170.69 158.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.939 0.4 . . . . 0.0 111.456 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.014 HD13 HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -152.58 102.25 2.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.582 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.628 ' N ' HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -95.6 104.5 16.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.523 ' CE ' HG12 ' A' ' 28' ' ' VAL . 46.9 mmm -78.19 107.95 11.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.553 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.956 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -88.91 101.58 14.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.862 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.557 ' HD2' ' CG2' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -74.3 -168.39 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.072 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.42 -100.68 2.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.429 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -74.13 -69.87 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.736 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.577 ' ND2' ' CD1' ' A' ' 26' ' ' ILE . 0.6 OUTLIER 159.97 77.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.627 ' HB2' HD12 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -159.33 161.83 35.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.863 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.536 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -151.38 163.98 37.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.705 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -143.0 115.77 8.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.871 0.367 . . . . 0.0 111.242 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.014 HG22 HD13 ' A' ' 46' ' ' LEU . 31.2 pt -105.17 133.01 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.552 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.66 102.64 14.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.84 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.46 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -64.46 157.21 27.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.489 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.972 ' OD1' HG23 ' A' ' 44' ' ' THR . 2.6 m-80 -68.79 -39.42 80.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.647 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -133.18 169.81 16.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.168 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.429 ' N ' ' OG1' ' A' ' 61' ' ' THR . 2.4 mp0 -73.31 -36.2 66.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.773 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -60.91 -40.08 91.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.719 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 40' ' ' PHE . . . -64.45 -49.09 72.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.46 ' HA ' ' SD ' ' A' ' 59' ' ' MET . . . -50.44 -53.23 31.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.221 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -46.49 -63.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.114 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.636 HG22 ' CD1' ' A' ' 40' ' ' PHE . 24.8 m -40.91 -46.77 2.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.309 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.703 ' SD ' HD11 ' A' ' 57' ' ' ILE . 0.9 OUTLIER -46.64 -65.01 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 -179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.736 HG11 ' CD2' ' A' ' 88' ' ' PHE . 46.1 t -70.61 -54.2 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.451 ' O ' ' OG1' ' A' ' 73' ' ' THR . 5.7 t-20 -38.75 -64.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -59.18 -31.2 68.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.013 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.485 ' OH ' ' HG ' ' A' ' 36' ' ' LEU . 14.0 m-30 -89.22 20.11 3.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.048 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 32.5 m -78.57 -22.64 46.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.841 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.1 m -124.34 -41.08 2.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.683 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.8 t -89.96 130.12 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.544 HG23 ' HD2' ' A' ' 77' ' ' PRO . 2.8 m -91.82 146.14 32.41 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.025 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.736 ' CG ' HD12 ' A' ' 86' ' ' ILE . 26.8 Cg_endo -95.97 138.5 0.72 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 123.262 2.641 . . . . 0.0 112.165 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 83' ' ' PRO . 16.9 t -125.02 154.51 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.127 0.489 . . . . 0.0 111.402 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.025 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -114.18 99.89 7.96 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.188 178.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.476 ' HB2' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER 62.24 -62.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.029 0.443 . . . . 0.0 110.182 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -159.45 23.86 0.3 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.371 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.447 ' C ' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -128.79 97.77 26.32 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 110.693 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.528 ' N ' HG13 ' A' ' 78' ' ' VAL . 52.9 Cg_exo -55.3 106.01 0.17 Allowed 'Trans proline' 0 C--O 1.23 0.125 0 C-N-CA 122.833 2.355 . . . . 0.0 112.707 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.764 HG22 ' HA ' ' A' ' 24' ' ' LEU . 2.6 pt -107.28 107.71 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.465 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.59 ' O ' HG23 ' A' ' 21' ' ' ILE . 8.9 m-30 -65.12 142.18 58.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.63 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.736 HD12 ' CG ' ' A' ' 77' ' ' PRO . 13.5 mt -126.14 134.24 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.372 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -149.78 172.17 15.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 0.0 111.04 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.736 ' CD2' HG11 ' A' ' 69' ' ' VAL . 39.4 m-85 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.803 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 23.4 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.825 0.345 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -11.7 61.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -114.12 142.79 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 68' ' ' MET . 11.4 mm -127.04 143.18 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.918 ' C ' HD13 ' A' ' 21' ' ' ILE . 7.2 t-80 -110.86 156.28 21.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.672 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.975 HD12 HG12 ' A' ' 86' ' ' ILE . 2.5 mm -128.31 106.93 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.425 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -83.61 171.22 13.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.646 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER 39.32 31.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.947 0.403 . . . . 0.0 110.354 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.929 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -102.07 107.41 52.55 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.288 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.627 ' N ' HD22 ' A' ' 24' ' ' LEU . 53.2 Cg_exo -51.98 82.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.484 2.122 . . . . 0.0 111.534 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.578 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -34.24 155.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.022 -179.297 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 25.1 t0 80.88 -3.05 1.8 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.223 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.682 HG22 ' H ' ' A' ' 29' ' ' THR . 2.0 p -54.64 -166.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.682 ' H ' HG22 ' A' ' 28' ' ' VAL . 69.8 p -100.2 144.19 29.51 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.862 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.793 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -63.74 -40.63 97.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.312 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -58.39 -28.09 61.56 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.982 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.444 ' HG3' ' OG1' ' A' ' 29' ' ' THR . 30.5 mt-10 -70.71 -64.59 0.87 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.361 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.673 HG12 HG21 ' A' ' 57' ' ' ILE . 46.8 t -55.2 -43.07 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.555 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.793 HD12 ' O ' ' A' ' 30' ' ' GLU . 1.6 mp -70.1 -42.81 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.5 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 3.4 t -40.3 -42.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.027 0.441 . . . . 0.0 110.138 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.604 HD22 ' OH ' ' A' ' 72' ' ' TYR . 81.5 mt -73.03 -37.89 66.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.101 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.589 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -76.49 -11.69 84.95 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.332 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.765 ' CD2' HG22 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -55.93 -61.04 7.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.818 0.342 . . . . 0.0 110.794 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.6 Cg_endo -66.12 -21.14 56.16 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.649 2.233 . . . . 0.0 111.772 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.592 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 16.3 m-30 -70.04 -28.78 65.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.626 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.3 -99.14 0.18 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.13 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.555 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 14.3 mtpt -150.63 135.89 17.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.826 0.346 . . . . 0.0 111.079 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.759 HG21 ' CG1' ' A' ' 34' ' ' ILE . 42.4 t -86.6 118.13 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.27 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 1.014 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -88.78 -8.61 54.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.698 -179.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 44' ' ' THR . 1.3 t-20 170.85 165.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.885 0.374 . . . . 0.0 111.275 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.88 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -139.85 113.9 8.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.883 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.611 ' CD1' HD21 ' A' ' 49' ' ' LEU . 1.3 tm? -122.75 120.44 33.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.853 ' C ' HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -108.43 145.09 35.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.91 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.853 HD23 ' C ' ' A' ' 48' ' ' MET . 2.1 mt -117.09 102.69 9.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.795 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.529 ' N ' HG21 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -72.71 136.71 45.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.4 -80.0 0.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.693 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.49 8.16 14.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 111.079 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.578 ' ND2' ' CD1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 56.89 84.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.068 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.492 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 51.8 mt-30 -159.25 123.45 3.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.398 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 24' ' ' LEU . . . -109.7 170.12 8.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.527 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.538 ' CD1' ' C ' ' A' ' 55' ' ' ALA . 28.1 m-85 -148.23 143.22 26.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.01 0.433 . . . . 0.0 111.383 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.89 HD11 ' SD ' ' A' ' 68' ' ' MET . 1.0 OUTLIER -144.33 125.18 8.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.494 179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.806 ' O ' HG23 ' A' ' 44' ' ' THR . 38.3 mt-10 -93.74 127.13 39.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.258 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.502 ' CE ' ' HB1' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -99.98 146.44 26.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.164 179.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 1.014 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.1 OUTLIER -88.78 -9.22 52.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.716 0.293 . . . . 0.0 110.69 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.55 160.55 21.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.138 0.494 . . . . 0.0 111.785 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -80.84 -37.8 29.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.305 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 63' ' ' GLU . 1.1 tp10 -71.09 -23.02 62.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.061 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.502 ' HB1' ' CE ' ' A' ' 59' ' ' MET . . . -74.27 -43.29 57.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.692 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.803 ' HB1' ' O ' ' A' ' 16' ' ' SER . . . -65.46 -66.06 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.211 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -52.22 -63.2 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 71' ' ' TYR . 77.3 m -40.73 -47.72 2.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.371 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.89 ' SD ' HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -46.36 -65.26 0.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.068 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 68.0 t -68.51 -54.83 18.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.233 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 73' ' ' THR . 8.9 t-20 -46.52 -62.2 1.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.07 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.483 ' HB3' ' O ' ' A' ' 67' ' ' THR . 4.0 t80 -43.42 -48.81 7.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.153 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.604 ' OH ' HD22 ' A' ' 36' ' ' LEU . 39.6 m-85 -80.52 7.37 10.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.242 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.472 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 20.4 m -49.03 -32.39 9.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.96 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.3 m -115.36 -56.06 2.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -81.1 134.64 26.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.189 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.7 HG23 ' HD2' ' A' ' 77' ' ' PRO . 8.1 m -92.17 152.19 42.37 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.886 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.7 ' HD2' HG23 ' A' ' 76' ' ' THR . 9.6 Cg_endo -91.4 94.05 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.194 2.596 . . . . 0.0 112.315 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.878 ' C ' HD12 ' A' ' 79' ' ' LEU . 3.5 t -86.3 154.51 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.878 HD12 ' C ' ' A' ' 78' ' ' VAL . 9.5 mp -144.29 100.96 3.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 59.92 14.6 4.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.724 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 83' ' ' PRO . . . 115.33 -3.23 22.1 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -102.71 97.72 9.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.329 . . . . 0.0 110.77 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 89.5 Cg_endo -79.11 96.78 1.09 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.8 2.333 . . . . 0.0 112.511 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.52 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 2.0 pt -100.81 107.74 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.738 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 12.1 m-85 -66.29 148.84 51.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.546 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.975 HG12 HD12 ' A' ' 21' ' ' ILE . 4.6 mt -126.27 111.88 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.473 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.434 ' OE1' ' HB3' ' A' ' 85' ' ' TYR . 3.1 mp0 -128.25 173.11 10.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.909 0.385 . . . . 0.0 111.155 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 72.7 m-85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.819 0.342 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.11 -53.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.98 103.92 14.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.995 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.491 HD11 HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -87.25 134.03 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.544 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 9.3 t-160 -97.19 114.38 26.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 85' ' ' TYR . 11.2 mt -89.31 123.69 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -107.68 168.68 9.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 5.9 tmtt? 49.02 37.16 9.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.634 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.688 HD13 HD12 ' A' ' 84' ' ' ILE . 2.5 tp -120.83 126.95 26.47 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.003 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.483 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 58.1 Cg_endo -71.74 76.5 1.96 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.45 2.1 . . . . 0.0 111.449 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.954 HD11 ' C ' ' A' ' 54' ' ' GLN . 34.2 mm -34.42 155.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.837 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 24.7 t0 86.64 -4.97 0.72 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.776 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.74 HG13 ' N ' ' A' ' 29' ' ' THR . 1.8 p -59.95 -154.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.744 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.74 ' N ' HG13 ' A' ' 28' ' ' VAL . 43.8 p -105.99 144.79 32.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.184 0.516 . . . . 0.0 112.082 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.633 ' O ' HD12 ' A' ' 34' ' ' ILE . 11.2 mp0 -69.66 -35.25 74.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.517 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 35' ' ' SER . . . -53.58 -30.72 43.15 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.913 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.7 ' HG2' HD23 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -77.26 -57.88 3.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.447 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.5 t -53.1 -43.14 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.977 ' CG1' HG21 ' A' ' 43' ' ' VAL . 1.5 mp -72.45 -46.87 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.589 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -38.62 -34.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.355 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 77' ' ' PRO . 18.3 mt -82.38 -39.26 22.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.51 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -72.32 -17.51 77.61 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.38 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.582 ' CD2' HG22 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -46.81 -60.67 3.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.876 0.369 . . . . 0.0 110.806 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.6 Cg_endo -66.05 -30.78 47.18 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.716 2.277 . . . . 0.0 112.11 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.618 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.1 m-30 -63.73 -40.44 96.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.597 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 64' ' ' ALA . . . 168.57 -98.78 0.14 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.395 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.456 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -151.09 142.5 23.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.719 0.295 . . . . 0.0 110.923 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.977 HG21 ' CG1' ' A' ' 34' ' ' ILE . 42.8 t -88.76 82.54 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.213 0.53 . . . . 0.0 110.687 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.991 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -66.57 -7.3 19.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.42 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 176.68 145.74 0.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.914 0.388 . . . . 0.0 111.249 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.967 HD13 HG22 ' A' ' 57' ' ' ILE . 4.9 tp -136.4 103.07 5.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.53 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 47' ' ' LEU . 3.2 tm? -105.87 105.17 15.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.3 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.6 mmm -90.5 99.61 12.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.302 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.455 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -85.64 110.92 19.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.306 -179.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.554 ' CE ' HG22 ' A' ' 26' ' ' ILE . 10.1 mmtp -62.34 -172.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.349 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . 55.22 114.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.029 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER 88.87 -21.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.914 0.387 . . . . 0.0 110.669 -179.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.484 ' HA ' HG12 ' A' ' 26' ' ' ILE . 0.8 OUTLIER 68.11 63.73 0.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.494 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.954 ' C ' HD11 ' A' ' 26' ' ' ILE . 7.2 mm-40 -136.07 126.5 26.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.758 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.781 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.75 160.12 16.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -142.32 115.91 9.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.033 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.967 HG22 HD13 ' A' ' 46' ' ' LEU . 13.8 pt -113.42 140.91 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -96.22 102.73 14.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.632 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.812 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 7.1 mmm -66.34 116.07 6.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.0 110.779 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.991 ' ND2' HG23 ' A' ' 44' ' ' THR . 4.9 m120 -33.68 -49.72 0.32 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.328 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.76 -173.01 2.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.125 0.488 . . . . 0.0 112.079 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 64' ' ' ALA . 2.1 mt-10 -72.39 -57.45 4.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.177 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -38.92 -30.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.065 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.812 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -76.63 -56.29 4.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -54.34 -55.47 28.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.382 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -56.0 -70.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.618 HG22 ' CD1' ' A' ' 40' ' ' PHE . 21.1 m -42.47 -39.34 2.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.215 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.594 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -49.17 -62.84 1.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 72.2 t -80.79 -50.42 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.308 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -45.37 -39.03 6.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.195 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 67' ' ' THR . 4.3 t80 -78.01 -57.94 3.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.19 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.503 ' OH ' HD22 ' A' ' 36' ' ' LEU . 14.5 m-85 -62.14 -12.03 17.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.14 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.2 m -39.66 -29.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.011 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 72' ' ' TYR . 10.7 t -116.81 -45.9 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.795 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.39 131.83 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.556 ' OG1' ' CE2' ' A' ' 85' ' ' TYR . 1.3 m -97.62 142.41 24.52 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.979 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.52 ' CG ' HD12 ' A' ' 86' ' ' ILE . 19.1 Cg_endo -93.86 128.93 0.62 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.022 2.481 . . . . 0.0 112.076 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.699 HG13 ' C ' ' A' ' 82' ' ' GLN . 3.3 t -115.89 149.18 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.192 0.52 . . . . 0.0 111.427 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.036 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -114.09 107.98 16.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.371 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.683 ' N ' HD22 ' A' ' 79' ' ' LEU . 5.2 mtt180 62.93 -61.33 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 0.0 110.517 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -163.64 24.84 0.19 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.455 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.699 ' C ' HG13 ' A' ' 78' ' ' VAL . 1.2 tp60 -128.05 110.04 19.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.616 ' N ' HG13 ' A' ' 78' ' ' VAL . 37.8 Cg_endo -66.73 96.79 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.61 2.207 . . . . 0.0 112.385 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.688 HD12 HD13 ' A' ' 24' ' ' LEU . 3.3 pt -100.63 107.94 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.767 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CE2' ' OG1' ' A' ' 76' ' ' THR . 6.4 m-85 -75.28 153.64 37.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.525 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.568 HG21 ' CG ' ' A' ' 68' ' ' MET . 5.7 mt -126.01 112.12 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.561 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 20' ' ' HIS . 9.1 mt-30 -125.45 166.27 16.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 111.1 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.579 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 74.6 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.832 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 64.9 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.851 0.358 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -123.75 -47.99 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.91 97.92 7.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.982 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.851 HG21 ' SD ' ' A' ' 68' ' ' MET . 37.3 mm -82.41 110.52 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.292 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' GLN . 11.1 t-80 -80.59 156.51 26.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.047 HG21 HD12 ' A' ' 24' ' ' LEU . 1.4 mt -131.13 107.84 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.404 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' HG2' ' HB2' ' A' ' 85' ' ' TYR . 2.4 ptm180 -96.38 176.03 6.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.503 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 43.52 32.94 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.975 0.416 . . . . 0.0 110.252 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.047 HD12 HG21 ' A' ' 21' ' ' ILE . 1.4 tt -118.08 99.72 51.9 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.94 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.61 ' HD2' HG22 ' A' ' 84' ' ' ILE . 29.4 Cg_endo -63.25 67.15 0.16 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.178 1.919 . . . . 0.0 111.163 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.017 HD11 ' C ' ' A' ' 54' ' ' GLN . 47.7 mm -15.28 112.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 123.987 0.805 . . . . 0.0 112.085 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.6 t70 149.41 -10.71 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.51 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 29' ' ' THR . 6.0 m -60.96 -11.91 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.287 0.565 . . . . 0.0 111.809 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 28' ' ' VAL . 3.0 p 90.64 154.16 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.991 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . 4.7 mp0 -70.38 -41.39 73.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.512 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -42.35 -35.4 1.86 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.039 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.48 ' OE2' ' HB3' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -80.51 -45.28 17.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.865 0.364 . . . . 0.0 110.581 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 57' ' ' ILE . 16.6 t -59.32 -58.2 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.969 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.841 HG13 HG21 ' A' ' 43' ' ' VAL . 1.5 mp -64.8 -40.68 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.661 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -41.58 -43.5 2.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.988 0.423 . . . . 0.0 110.292 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.519 ' CG ' ' OH ' ' A' ' 72' ' ' TYR . 7.4 mp -72.21 -36.71 69.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.5 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -70.82 -21.31 78.03 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.43 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.457 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -44.87 -61.31 2.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.74 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 39.8 Cg_endo -67.05 -41.16 10.27 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.609 2.206 . . . . 0.0 111.648 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.62 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.1 m-30 -54.39 -28.43 43.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.687 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 42' ' ' LYS . . . 154.0 -106.92 0.31 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.191 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.572 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 17.3 mtpt -150.78 142.17 23.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.0 111.002 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.841 HG21 HG13 ' A' ' 34' ' ' ILE . 42.0 t -86.71 117.82 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.5 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 1.014 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -91.75 -6.01 52.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.437 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -172.46 155.32 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.877 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.028 ' CD2' HG22 ' A' ' 57' ' ' ILE . 2.7 tm? -151.14 113.81 4.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 47' ' ' LEU . 6.6 tt -136.5 116.81 13.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.2 mtp -95.44 139.64 31.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.469 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -125.48 91.42 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.945 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.555 ' HD2' ' CG2' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -45.02 -26.18 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.938 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.35 127.82 10.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.53 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.7 OUTLIER 66.89 8.3 5.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.79 0.329 . . . . 0.0 110.901 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.566 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 16.7 m120 45.88 84.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 1.017 ' C ' HD11 ' A' ' 26' ' ' ILE . 67.5 mt-30 -159.2 135.71 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.595 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.808 ' HB3' HD12 ' A' ' 21' ' ' ILE . . . -109.29 166.6 10.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.794 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.537 ' CD1' ' C ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -139.72 117.45 11.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.478 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.028 HG22 ' CD2' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -127.37 152.07 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.618 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.47 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 35.7 mt-10 -120.05 142.06 49.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.41 . . . . 0.0 111.295 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.694 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -110.74 130.39 55.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.174 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 1.014 ' CG ' HG22 ' A' ' 44' ' ' THR . 1.5 m-80 -68.56 -15.47 63.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.64 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 61' ' ' THR . 12.3 t -132.21 125.34 30.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 111.271 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -43.46 -41.94 4.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.692 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.416 ' O ' ' OG1' ' A' ' 67' ' ' THR . 8.3 tt0 -57.12 -20.82 27.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.815 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -84.47 -46.93 11.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.968 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.848 ' HB1' HD11 ' A' ' 19' ' ' ILE . . . -64.25 -49.44 71.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.042 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -44.28 90.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.494 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.62 HG22 ' CD1' ' A' ' 40' ' ' PHE . 18.2 m -60.34 -32.74 71.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.851 ' SD ' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -58.36 -63.13 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.618 HG21 ' CE1' ' A' ' 88' ' ' PHE . 8.4 t -70.31 -51.06 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.07 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.459 ' O ' ' OG1' ' A' ' 73' ' ' THR . 6.8 t30 -44.06 -63.96 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.964 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 67' ' ' THR . 10.7 t80 -55.59 -35.69 66.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.574 ' CD2' ' O ' ' A' ' 68' ' ' MET . 17.8 m-85 -83.23 9.86 9.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 53.6 m -59.52 -28.37 67.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.13 -45.73 1.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.8 t -83.43 110.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.628 HG23 ' HD2' ' A' ' 77' ' ' PRO . 4.1 m -88.17 149.18 44.57 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.845 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.628 ' HD2' HG23 ' A' ' 76' ' ' THR . 18.3 Cg_endo -95.28 113.43 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.226 2.617 . . . . 0.0 112.3 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 79' ' ' LEU . 22.1 t -100.26 160.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.988 0.423 . . . . 0.0 111.167 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.948 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -156.27 133.91 10.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.713 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.547 ' HB3' HD22 ' A' ' 79' ' ' LEU . 2.0 ttt-85 37.24 30.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.94 0.4 . . . . 0.0 110.423 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 80.53 50.19 5.45 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.803 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.527 ' O ' HD12 ' A' ' 79' ' ' LEU . 1.7 mm-40 -155.2 97.68 2.41 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.05 96.56 0.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.585 2.19 . . . . 0.0 112.496 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.664 HD12 ' HG ' ' A' ' 24' ' ' LEU . 4.4 pt -95.15 111.14 25.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.67 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.509 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 4.6 m-30 -72.52 152.94 41.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.521 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 21' ' ' ILE . 6.5 mt -126.14 104.77 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.519 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -131.6 171.49 13.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 111.097 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 69' ' ' VAL . 1.4 m-85 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 6.5 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.767 0.318 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.89 -49.06 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.848 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.05 126.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.069 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.574 ' CG2' HG23 ' A' ' 86' ' ' ILE . 48.0 mm -101.88 112.82 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.234 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.479 ' HB3' ' O ' ' A' ' 88' ' ' PHE . 4.9 t-80 -87.49 112.89 22.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.524 HG23 HG13 ' A' ' 86' ' ' ILE . 4.8 mt -82.78 127.9 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.303 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HG2' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -114.03 151.83 31.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.66 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.486 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 64.4 34.86 10.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.553 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.64 HD13 HD12 ' A' ' 84' ' ' ILE . 4.8 tp -119.84 129.23 25.46 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.891 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.632 ' HD2' HD12 ' A' ' 24' ' ' LEU . 73.6 Cg_endo -76.63 69.64 6.67 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.484 2.123 . . . . 0.0 111.79 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.846 HD11 ' C ' ' A' ' 54' ' ' GLN . 6.1 mm -30.64 108.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.236 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 2.2 t70 148.69 -19.48 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.673 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.68 HG22 ' H ' ' A' ' 29' ' ' THR . 1.9 p -54.69 -162.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.857 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.68 ' H ' HG22 ' A' ' 28' ' ' VAL . 39.8 p -107.91 145.79 33.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.104 0.478 . . . . 0.0 111.885 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.545 ' HB3' HD23 ' A' ' 46' ' ' LEU . 7.8 mp0 -63.07 -46.7 86.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.635 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.85 -29.36 0.17 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.782 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.581 ' OE1' HD22 ' A' ' 79' ' ' LEU . 12.8 mm-40 -81.32 -55.03 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.254 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.1 t -61.26 -57.91 9.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.64 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.581 HG23 HG21 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -53.76 -50.26 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.066 179.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.8 m -42.12 -43.43 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.39 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.593 HD22 ' OH ' ' A' ' 72' ' ' TYR . 19.9 mt -63.99 -33.91 76.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.36 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -81.62 -23.12 58.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.521 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.525 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -40.49 -58.47 2.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.826 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.1 Cg_endo -66.18 -40.28 15.83 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.616 2.21 . . . . 0.0 111.947 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.628 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.5 m-30 -55.23 -30.45 60.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.575 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 156.9 -104.41 0.25 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.094 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.577 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -150.43 137.95 19.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 111.03 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 34' ' ' ILE . 51.4 t -86.99 121.47 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.403 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.961 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -96.76 -0.73 47.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.574 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 44' ' ' THR . 44.4 t30 178.06 149.44 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.982 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.86 HD13 HG22 ' A' ' 57' ' ' ILE . 1.5 tp -139.91 103.17 4.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.59 HD13 ' N ' ' A' ' 48' ' ' MET . 0.5 OUTLIER -115.5 113.85 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.935 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.629 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.4 mmm -99.65 99.58 10.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.604 ' C ' HG21 ' A' ' 26' ' ' ILE . 14.8 tp -82.04 97.41 8.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.81 ' CE ' HG22 ' A' ' 26' ' ' ILE . 3.4 mmtp -49.0 -21.5 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.303 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -79.34 126.07 7.29 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.698 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.507 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 1.8 mttt 71.36 7.19 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 111.314 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 8.2 m120 49.98 62.09 2.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.035 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.846 ' C ' HD11 ' A' ' 26' ' ' ILE . 14.0 mm-40 -139.98 134.9 32.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.585 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.77 166.82 10.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.81 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -146.85 115.92 6.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.244 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.86 HG22 HD13 ' A' ' 46' ' ' LEU . 6.8 pt -118.03 143.04 29.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.698 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.755 ' O ' HG23 ' A' ' 44' ' ' THR . 0.5 OUTLIER -109.64 124.38 51.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.23 -179.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.523 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -91.66 138.68 31.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.351 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.961 ' CG ' HG22 ' A' ' 44' ' ' THR . 1.2 m-80 -67.25 -27.05 66.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.326 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.443 HG23 ' HB2' ' A' ' 64' ' ' ALA . 3.6 t -123.85 140.26 53.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.921 0.391 . . . . 0.0 111.377 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -54.43 -42.11 70.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.773 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -56.65 -29.28 62.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.632 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -72.04 -52.35 17.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.874 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 68' ' ' MET . . . -51.88 -60.97 2.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.08 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -44.99 -68.49 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.628 HG22 ' CD1' ' A' ' 40' ' ' PHE . 86.3 m -40.91 -36.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.979 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.968 ' SD ' HG21 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -51.67 -65.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.833 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 78.9 t -79.7 -49.26 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.172 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -41.99 -57.16 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.027 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -61.25 -50.37 73.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.053 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.593 ' OH ' HD22 ' A' ' 36' ' ' LEU . 20.2 m-30 -73.76 -0.42 15.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.259 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 69' ' ' VAL . 95.0 m -51.82 -20.68 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.931 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 t -127.21 -51.87 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.83 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.4 p -89.73 123.41 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.03 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.4 m -99.02 142.2 24.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.986 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.478 ' O ' HG12 ' A' ' 84' ' ' ILE . 45.6 Cg_endo -96.94 109.63 0.1 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.271 2.647 . . . . 0.0 112.292 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.992 ' O ' HD23 ' A' ' 79' ' ' LEU . 1.4 m -100.86 -179.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.992 HD23 ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -154.95 122.97 5.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.684 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 80' ' ' ARG . 2.8 ttp180 63.32 11.82 5.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.715 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.81 19.97 15.89 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.5 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.449 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 4.5 mm-40 -116.59 97.61 50.43 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.82 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.417 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 17.2 Cg_exo -67.24 115.41 3.65 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.969 2.446 . . . . 0.0 112.55 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.64 HD12 HD13 ' A' ' 24' ' ' LEU . 3.3 pt -122.01 107.82 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 21' ' ' ILE . 3.5 m-85 -76.03 150.75 37.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.661 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.968 HG21 ' SD ' ' A' ' 68' ' ' MET . 5.6 mt -126.11 109.67 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 20' ' ' HIS . 2.5 mt-30 -117.13 173.29 6.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.128 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.587 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 47.9 m-85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.95 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.565 ' OG ' ' CE1' ' A' ' 88' ' ' PHE . 42.2 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.77 0.319 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.401 ' HG2' ' OE2' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -166.44 -42.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.94 107.94 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.109 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.815 ' CG2' HG23 ' A' ' 86' ' ' ILE . 1.4 mp -93.58 113.38 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.587 ' CD2' ' HB3' ' A' ' 54' ' ' GLN . 4.5 t-80 -84.24 117.5 23.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.361 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.758 HG22 ' HB2' ' A' ' 24' ' ' LEU . 9.9 mt -87.76 98.32 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.501 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -77.57 177.29 8.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.452 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER 37.19 38.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 110.555 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.758 ' HB2' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -123.65 99.94 38.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.934 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.56 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 34.6 Cg_exo -57.33 74.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.569 2.179 . . . . 0.0 111.771 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.899 HG23 ' HB3' ' A' ' 48' ' ' MET . 16.2 mm -33.23 119.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.1 t0 150.95 -19.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.952 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 29' ' ' THR . 6.1 m -54.99 -153.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.797 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.552 ' N ' HG23 ' A' ' 28' ' ' VAL . 40.6 p -112.05 145.7 39.23 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.06 0.457 . . . . 0.0 111.815 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.823 ' CD ' HD12 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -65.28 -56.16 14.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.545 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.89 -33.15 0.4 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.999 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.596 ' HG2' HD21 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -68.63 -58.33 4.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.476 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.02 -48.52 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.622 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.873 ' CG1' HG21 ' A' ' 43' ' ' VAL . 1.6 mp -65.08 -38.2 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.513 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -47.51 -41.44 20.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.649 HD23 ' OH ' ' A' ' 72' ' ' TYR . 8.5 mp -71.5 -33.53 69.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.2 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.597 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -69.92 -25.25 75.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.346 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.516 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -41.76 -59.77 2.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 110.856 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 28.5 Cg_endo -62.87 -23.06 74.27 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.67 2.247 . . . . 0.0 111.883 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.597 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 13.7 m-30 -76.64 -38.69 54.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.507 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.13 -102.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.158 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.534 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 3.4 mtmm -150.52 146.55 26.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.777 0.323 . . . . 0.0 110.987 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.873 HG21 ' CG1' ' A' ' 34' ' ' ILE . 55.8 t -86.86 112.55 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.525 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.946 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -88.19 -13.64 40.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.202 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 170.93 119.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.051 HD23 HG22 ' A' ' 57' ' ' ILE . 1.2 tm? -123.83 117.41 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.999 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.646 ' N ' HD22 ' A' ' 46' ' ' LEU . 8.9 tt -117.84 128.55 54.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.848 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.899 ' HB3' HG23 ' A' ' 26' ' ' ILE . 9.1 mtp -106.16 139.05 41.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.708 ' C ' HG21 ' A' ' 26' ' ' ILE . 37.3 mt -120.22 103.85 9.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.642 ' N ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -55.51 -17.37 5.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . -84.08 116.52 4.27 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.439 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER 82.65 -8.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 111.059 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.56 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 25.6 m120 61.29 77.53 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.968 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.587 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 48.8 mt-30 -155.06 130.8 9.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.665 ' CA ' HD11 ' A' ' 26' ' ' ILE . . . -109.72 162.54 14.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.779 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.604 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -144.9 116.11 7.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.367 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.051 HG22 HD23 ' A' ' 46' ' ' LEU . 8.0 pt -110.19 155.04 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.815 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.761 ' O ' HG23 ' A' ' 44' ' ' THR . 0.0 OUTLIER -122.04 119.11 30.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.785 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 32.7 mmm -90.77 142.54 27.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.698 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.946 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -72.88 -23.87 60.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.912 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.5 t -130.35 137.39 49.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.229 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -48.29 -42.85 32.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.45 ' O ' ' CB ' ' A' ' 67' ' ' THR . 10.8 mp0 -53.03 -30.07 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.749 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.785 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -77.25 -47.28 20.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.988 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -65.75 -58.94 4.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.045 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -54.68 -59.5 4.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.813 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.45 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 18.6 m -40.93 -49.0 3.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.977 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.589 ' HA ' ' CZ ' ' A' ' 40' ' ' PHE . 2.1 ttm -46.18 -63.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.82 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.773 HG13 ' HG3' ' A' ' 87' ' ' GLN . 39.1 t -68.91 -15.97 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.136 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.453 ' O ' ' OG1' ' A' ' 73' ' ' THR . 1.2 t-20 -72.82 -64.12 1.03 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 5.0 t80 -60.86 -24.4 65.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.649 ' OH ' HD23 ' A' ' 36' ' ' LEU . 24.5 m-85 -93.07 19.99 7.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.059 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 91.6 m -72.03 -31.1 65.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -118.79 -50.55 2.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.789 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.8 t -82.48 119.92 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.982 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.5 m -87.59 141.93 32.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.921 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.75 ' HG2' HD12 ' A' ' 86' ' ' ILE . 35.5 Cg_endo -95.81 142.88 1.08 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.081 2.52 . . . . 0.0 112.255 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' A' ' 83' ' ' PRO . 2.0 m -129.21 -179.69 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.165 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.636 HD23 ' HG3' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -141.75 108.5 5.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.636 ' HG3' HD23 ' A' ' 79' ' ' LEU . 21.1 mtm-85 61.26 14.02 5.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.502 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.29 7.78 20.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.361 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.453 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 6.3 tp60 -113.54 103.75 55.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.974 0.416 . . . . 0.0 110.896 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.762 ' HA ' HG12 ' A' ' 78' ' ' VAL . 24.6 Cg_exo -63.01 121.02 8.74 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.943 2.429 . . . . 0.0 112.617 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.601 HG22 ' HA ' ' A' ' 24' ' ' LEU . 2.4 pt -122.34 107.56 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.513 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 20.4 m-85 -62.08 141.54 58.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.036 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.815 HG23 ' CG2' ' A' ' 19' ' ' ILE . 6.5 mt -126.55 107.92 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.466 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.773 ' HG3' HG13 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -152.88 169.55 22.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 111.192 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.577 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 1.1 m-85 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.568 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.885 0.374 . . . . 0.0 111.061 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.405 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -86.23 -24.64 25.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.887 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.477 ' O ' HD13 ' A' ' 19' ' ' ILE . 71.7 t -87.86 144.27 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.035 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.5 ' CG2' HG23 ' A' ' 86' ' ' ILE . 34.8 mm -122.4 107.89 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.213 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' GLN . 5.4 t-160 -78.82 121.9 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.806 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.788 HD12 HG12 ' A' ' 86' ' ' ILE . 4.3 mm -100.45 112.65 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.241 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 174.16 6.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.795 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER 45.06 44.01 7.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.675 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.777 ' HA ' HG22 ' A' ' 84' ' ' ILE . 3.2 tp -134.46 109.34 11.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.557 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 33.0 Cg_endo -64.51 74.84 0.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.401 2.067 . . . . 0.0 111.729 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.801 HG23 ' HB3' ' A' ' 48' ' ' MET . 15.3 mm -31.83 117.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.052 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 3.6 t70 151.16 -19.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.162 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 29' ' ' THR . 5.7 m -54.86 -155.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.881 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.538 ' N ' HG23 ' A' ' 28' ' ' VAL . 81.2 p -112.38 145.03 40.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 111.674 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.48 ' HB3' HD11 ' A' ' 34' ' ' ILE . 32.6 mt-10 -65.36 -50.6 64.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.438 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.99 -28.33 0.23 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.036 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.867 ' OE1' HD23 ' A' ' 79' ' ' LEU . 37.5 mt-10 -78.46 -52.15 8.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.403 . . . . 0.0 110.494 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.54 -57.47 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.729 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.528 HD11 HD23 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -53.14 -40.74 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 8.0 t -54.94 -43.07 73.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.698 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.554 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 6.3 mp -74.87 -11.27 60.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.761 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.65 -22.13 8.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.769 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.437 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -50.73 -52.54 55.77 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.66 0.267 . . . . 0.0 110.985 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 39.7 Cg_exo -60.01 -24.2 75.7 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.484 2.123 . . . . 0.0 111.668 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.863 ' CD2' HG22 ' A' ' 67' ' ' THR . 79.0 m-85 -82.03 7.24 13.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.035 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.13 -108.67 1.0 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.292 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.541 ' HB3' ' ND2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -150.55 146.05 26.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.101 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.453 HG21 HG23 ' A' ' 34' ' ' ILE . 55.2 t -99.81 97.04 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.937 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -87.8 22.23 2.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.302 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.9 OUTLIER 171.67 147.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.069 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.698 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -155.05 97.26 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.828 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.676 HD13 ' N ' ' A' ' 48' ' ' MET . 2.3 tm? -105.36 122.29 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.011 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.801 ' HB3' HG23 ' A' ' 26' ' ' ILE . 6.9 mtt -102.17 116.82 33.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.624 ' C ' HG21 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -88.88 101.06 13.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.605 ' CE ' HG22 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -82.03 48.13 1.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.98 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -129.57 -60.49 0.1 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.249 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -108.32 12.3 26.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.557 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 24.8 m120 62.72 64.89 0.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.914 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.585 ' C ' HD11 ' A' ' 26' ' ' ILE . 78.3 mt-30 -148.0 134.17 19.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.843 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.67 ' CA ' HD11 ' A' ' 26' ' ' ILE . . . -109.66 157.68 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.735 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -140.95 115.85 9.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.239 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.499 HG22 HD13 ' A' ' 46' ' ' LEU . 22.5 pt -114.91 138.18 45.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.797 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -104.6 102.7 12.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.993 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.473 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -62.9 128.31 35.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.408 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.937 ' ND2' HG23 ' A' ' 44' ' ' THR . 0.3 OUTLIER -48.13 -39.81 21.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.31 -179.312 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.46 HG23 ' HB2' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -118.11 163.43 16.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.872 0.367 . . . . 0.0 111.238 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -71.68 -44.75 63.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.828 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -55.13 -30.51 59.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.423 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -69.15 -46.51 67.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.643 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.568 ' HB1' ' O ' ' A' ' 16' ' ' SER . . . -58.12 -60.0 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.255 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -42.01 -58.28 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.962 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.863 HG22 ' CD2' ' A' ' 40' ' ' PHE . 22.3 m -50.81 -51.84 46.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.326 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.593 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 6.3 tpt -36.3 -60.15 0.59 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.071 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.584 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 76.3 t -79.41 -26.43 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.424 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 1.5 t-20 -58.69 -64.12 1.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.079 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.62 -36.22 83.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.054 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.581 ' CE1' ' HG3' ' A' ' 77' ' ' PRO . 22.4 m-85 -87.93 20.06 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.983 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 87.7 m -68.7 -44.57 73.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.024 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.6 t -113.62 -39.82 3.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.769 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.54 108.91 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.474 ' OG1' ' CE2' ' A' ' 85' ' ' TYR . 2.2 m -93.81 122.3 62.53 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.065 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.581 ' HG3' ' CE1' ' A' ' 72' ' ' TYR . 74.2 Cg_endo -96.79 120.17 0.18 Allowed 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 123.064 2.509 . . . . 0.0 112.215 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 83' ' ' PRO . 1.4 m -89.34 -179.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.235 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.974 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -141.71 133.53 27.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.688 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.776 ' HB2' HD22 ' A' ' 79' ' ' LEU . 0.5 OUTLIER 36.25 30.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.443 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 85.57 51.98 3.5 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.871 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.552 ' HB3' ' CD1' ' A' ' 79' ' ' LEU . 1.5 tt0 -155.2 97.74 2.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.984 0.421 . . . . 0.0 110.799 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.75 ' HA ' HG12 ' A' ' 78' ' ' VAL . 52.1 Cg_exo -54.8 107.28 0.22 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.866 2.377 . . . . 0.0 112.658 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.777 HG22 ' HA ' ' A' ' 24' ' ' LEU . 7.1 pt -116.83 107.75 23.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.701 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CE2' ' OG1' ' A' ' 76' ' ' THR . 27.7 m-85 -71.28 149.08 46.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.317 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.788 HG12 HD12 ' A' ' 21' ' ' ILE . 4.5 mt -124.68 103.81 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.631 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 20' ' ' HIS . 2.8 mt-30 -125.16 172.05 9.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.883 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.584 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 59.9 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.51 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.856 0.36 . . . . 0.0 110.986 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.512 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 15.1 ptp180 -72.04 -16.98 62.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 87.5 t -87.92 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.669 HG21 ' HG2' ' A' ' 68' ' ' MET . 24.1 mm -127.07 109.24 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.642 ' CD2' ' CZ ' ' A' ' 56' ' ' PHE . 11.5 t-160 -78.93 110.55 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.795 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.503 HG23 HG13 ' A' ' 86' ' ' ILE . 25.7 mt -82.91 130.44 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.55 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 3.0 ptt180 -112.4 177.24 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 44.15 30.93 0.48 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.684 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.794 ' HA ' HG22 ' A' ' 84' ' ' ILE . 5.8 tp -117.59 112.85 38.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.564 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 21.9 Cg_exo -64.48 69.55 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.399 2.066 . . . . 0.0 111.391 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.796 HG21 ' C ' ' A' ' 49' ' ' LEU . 5.1 mm -33.97 111.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.371 0.605 . . . . 0.0 110.717 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 4.4 t70 150.7 -22.9 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.98 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.673 HG13 ' N ' ' A' ' 29' ' ' THR . 2.1 p -56.79 -157.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.608 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.673 ' N ' HG13 ' A' ' 28' ' ' VAL . 38.1 p -98.73 144.16 28.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.217 0.532 . . . . 0.0 112.035 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.65 -48.3 27.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.36 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.61 -31.4 0.4 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.706 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.659 ' HG2' HD13 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -79.22 -51.9 8.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 110.398 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' THR . 12.1 t -56.08 -51.09 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.775 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.823 HG23 HG21 ' A' ' 43' ' ' VAL . 1.5 mp -66.51 -50.4 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.506 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 14.9 t -44.76 -40.57 6.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.378 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 77' ' ' PRO . 13.4 mt -63.26 -42.0 99.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.43 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -82.09 -8.99 85.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.387 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.588 HD13 HG22 ' A' ' 34' ' ' ILE . 1.3 tp -55.06 -60.05 9.16 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 110.724 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 19.7 Cg_endo -60.46 -17.85 50.34 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.611 2.208 . . . . 0.0 111.833 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.591 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 28.0 m-85 -76.99 -5.65 49.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.886 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 42' ' ' LYS . . . 141.1 -103.21 0.33 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.134 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.581 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 1.5 mmtp -150.46 138.88 20.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 111.067 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.823 HG21 HG23 ' A' ' 34' ' ' ILE . 54.0 t -89.2 120.23 37.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 1.009 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -95.17 -11.98 27.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.157 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 8.7 t30 174.08 146.53 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.839 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.021 HD22 ' N ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -144.6 125.03 13.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.818 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.021 ' N ' HD22 ' A' ' 46' ' ' LEU . 7.2 tt -131.33 123.05 27.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.039 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.534 ' CA ' HD12 ' A' ' 26' ' ' ILE . 3.3 mmm -89.18 109.77 20.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.749 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.796 ' C ' HG21 ' A' ' 26' ' ' ILE . 13.6 tp -84.14 109.46 17.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.081 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.662 ' HD2' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -86.84 44.7 1.19 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.819 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -115.84 -42.47 0.72 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.554 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 28.12 2.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 110.963 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 18.9 m120 57.93 49.18 12.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.535 ' HB3' ' NE2' ' A' ' 20' ' ' HIS . 47.8 mt-30 -134.4 140.08 46.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.363 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.559 ' CA ' HD11 ' A' ' 26' ' ' ILE . . . -109.9 172.55 6.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.65 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.642 ' CZ ' ' CD2' ' A' ' 20' ' ' HIS . 11.9 m-85 -148.01 115.71 6.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.355 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.517 HG22 HD23 ' A' ' 46' ' ' LEU . 6.6 pt -114.41 155.13 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.662 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.866 ' O ' HG23 ' A' ' 44' ' ' THR . 6.7 mm-40 -118.36 122.9 43.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.992 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.899 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 24.3 mmm -94.26 133.47 37.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.515 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 1.009 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -71.77 -24.82 61.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 110.924 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 64' ' ' ALA . 9.0 t -125.0 129.0 49.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.17 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -44.68 -38.56 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -59.01 -26.45 64.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.899 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -76.38 -51.35 12.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.059 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 17' ' ' ARG . . . -57.05 -64.12 0.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.058 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -44.73 -60.06 2.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.756 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.8 m -48.06 -35.88 12.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.034 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.669 ' HG2' HG21 ' A' ' 19' ' ' ILE . 9.4 tpt -51.52 -62.26 1.73 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.959 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.642 HG21 ' N ' ' A' ' 88' ' ' PHE . 46.1 t -77.53 -15.91 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.366 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.464 ' O ' ' OG1' ' A' ' 73' ' ' THR . 11.5 t-20 -76.46 -64.19 1.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.131 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -56.66 -38.47 72.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.128 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.526 ' CE2' ' CZ ' ' A' ' 40' ' ' PHE . 24.7 m-85 -84.72 12.78 6.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.07 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 89.0 m -67.88 -34.73 77.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.22 -40.71 3.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.08 156.93 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.009 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.562 HG23 ' HD2' ' A' ' 77' ' ' PRO . 2.5 m -122.64 147.3 50.16 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.776 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.562 ' HD2' HG23 ' A' ' 76' ' ' THR . 28.9 Cg_endo -96.39 75.73 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.338 2.692 . . . . 0.0 112.386 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.603 ' O ' HD23 ' A' ' 79' ' ' LEU . 12.3 t -70.91 158.08 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.227 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.659 HD13 ' HG2' ' A' ' 32' ' ' GLU . 53.5 mt -137.63 113.44 9.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.108 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 51.64 20.23 1.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.474 ' O ' ' HD3' ' A' ' 83' ' ' PRO . . . 105.99 8.74 33.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.668 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.411 ' C ' HG13 ' A' ' 78' ' ' VAL . 5.5 tp-100 -109.27 97.5 26.44 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.829 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 81' ' ' GLY . 13.5 Cg_exo -69.93 126.75 13.55 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 123.045 2.496 . . . . 0.0 112.434 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.794 HG22 ' HA ' ' A' ' 24' ' ' LEU . 8.0 pt -135.35 107.45 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.55 ' HB2' ' CG ' ' A' ' 22' ' ' ARG . 3.3 m-85 -75.03 151.08 38.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.397 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.667 HG21 ' HG3' ' A' ' 68' ' ' MET . 4.4 mt -125.91 122.05 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.562 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.49 ' NE2' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -130.91 169.98 15.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.149 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.642 ' N ' HG21 ' A' ' 69' ' ' VAL . 58.8 m-85 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.021 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.46 ' OG ' ' ND2' ' A' ' 66' ' ' ASN . 87.6 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.742 0.306 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -170.54 -45.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.917 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.94 138.59 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.875 HG21 ' SD ' ' A' ' 68' ' ' MET . 47.2 mm -119.14 105.52 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 87' ' ' GLN . 5.0 t-160 -78.98 107.59 11.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.718 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.67 HG23 HD13 ' A' ' 86' ' ' ILE . 9.5 mt -85.22 118.52 32.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.402 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.51 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -100.73 170.08 8.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.483 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.08 32.4 2.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.981 0.42 . . . . 0.0 110.253 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.975 HD13 HD12 ' A' ' 84' ' ' ILE . 4.2 tp -116.99 123.34 30.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.172 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' ILE . 57.1 Cg_endo -71.05 75.6 1.74 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.426 2.084 . . . . 0.0 111.597 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.957 HD11 ' C ' ' A' ' 54' ' ' GLN . 17.9 mm -30.91 148.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.117 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 96.43 7.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.788 -178.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.571 HG21 HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -63.25 -151.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.027 179.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.637 ' O ' HG23 ' A' ' 33' ' ' VAL . 71.8 p -120.26 148.9 43.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.007 0.432 . . . . 0.0 111.749 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.544 ' CG ' HD23 ' A' ' 46' ' ' LEU . 5.6 mp0 -66.28 -66.0 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.756 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.05 -29.53 0.2 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.154 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.51 ' N ' ' OE1' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -82.51 -61.21 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.713 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 29' ' ' THR . 56.9 t -55.21 -53.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.851 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.971 ' CD1' HD22 ' A' ' 46' ' ' LEU . 1.4 mp -62.66 -33.99 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.279 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.563 ' HA ' HD22 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -51.07 -36.23 39.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.054 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.538 HD23 ' OH ' ' A' ' 72' ' ' TYR . 2.0 mt -70.64 -46.9 62.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.21 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.83 -13.6 82.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.281 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.84 HD13 HG22 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -48.79 -60.28 4.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.78 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 20.2 Cg_endo -60.77 -34.95 91.01 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.636 2.224 . . . . 0.0 111.731 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 67' ' ' THR . 39.7 m-85 -63.25 -12.39 28.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.999 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.73 -106.86 0.36 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.122 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.472 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -150.61 150.22 30.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.909 0.385 . . . . 0.0 111.139 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 34' ' ' ILE . 55.0 t -102.58 121.19 53.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.307 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.778 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -102.64 8.24 39.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.513 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.95 153.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.971 HD22 ' CD1' ' A' ' 34' ' ' ILE . 17.1 tp -140.53 131.2 25.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.949 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 tp -136.18 137.28 40.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.597 ' HB3' HG23 ' A' ' 26' ' ' ILE . 4.9 mmm -125.09 94.77 4.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.776 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.492 ' C ' HG21 ' A' ' 26' ' ' ILE . 27.6 tp -76.43 92.9 3.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.703 ' N ' HG21 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -60.65 159.23 11.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.011 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.71 -73.49 0.24 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.482 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -83.07 -8.87 59.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.788 0.327 . . . . 0.0 111.018 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER 68.65 47.43 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.957 ' C ' HD11 ' A' ' 26' ' ' ILE . 17.2 mt-30 -129.54 126.96 39.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.728 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.754 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.15 161.41 15.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.784 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -140.94 115.89 9.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.396 -179.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.788 HG22 ' CD1' ' A' ' 46' ' ' LEU . 7.1 pt -112.75 140.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.579 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 44' ' ' THR . 6.9 tt0 -103.53 102.97 12.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.27 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.456 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 2.7 mtp -74.64 147.39 41.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.122 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.778 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.2 OUTLIER -64.2 -55.13 23.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.399 -178.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -108.03 169.81 8.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 111.451 -179.094 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' N ' ' OG1' ' A' ' 61' ' ' THR . 24.1 mt-10 -71.33 -47.75 54.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.64 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -49.33 -31.6 9.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.262 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 40' ' ' PHE . . . -70.62 -51.6 27.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.769 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.456 ' HA ' ' SD ' ' A' ' 59' ' ' MET . . . -67.14 -66.1 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.315 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.46 ' ND2' ' OG ' ' A' ' 16' ' ' SER . 53.4 m-80 -37.92 -45.32 0.85 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.989 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.879 HG22 ' CE2' ' A' ' 40' ' ' PHE . 43.7 m -64.68 -53.44 47.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.141 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.875 ' SD ' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -35.36 -64.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.041 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.795 HG22 HG22 ' A' ' 86' ' ' ILE . 75.1 t -68.47 -46.69 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.286 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 40.5 m-20 -46.47 -64.41 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.174 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -62.11 -38.1 87.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 77' ' ' PRO . 18.1 m-85 -87.73 19.66 3.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 69' ' ' VAL . 20.3 m -83.78 -35.36 24.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.923 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 t -113.29 -40.51 3.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.9 t -75.53 138.63 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.494 ' HG1' ' HH ' ' A' ' 85' ' ' TYR . 2.4 m -90.42 112.11 51.07 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.275 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.587 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 58.8 Cg_endo -98.05 109.62 0.08 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 123.24 2.627 . . . . 0.0 112.299 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HB ' ' C ' ' A' ' 82' ' ' GLN . 0.7 OUTLIER -110.71 157.62 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 111.002 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.501 ' C ' HD13 ' A' ' 79' ' ' LEU . 3.4 tm? -107.26 100.92 10.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.523 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.404 ' HB2' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER 71.75 -58.72 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.997 0.427 . . . . 0.0 110.493 -179.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.39 24.65 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.417 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -129.64 104.57 17.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.717 0.294 . . . . 0.0 110.584 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 82' ' ' GLN . 28.0 Cg_endo -63.45 117.79 4.73 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.563 2.175 . . . . 0.0 112.634 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.975 HD12 HD13 ' A' ' 24' ' ' LEU . 3.4 pt -131.63 111.28 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.628 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.51 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 19.8 m-85 -77.9 165.68 23.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.442 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.795 HG22 HG22 ' A' ' 69' ' ' VAL . 39.6 mm -119.54 142.56 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.827 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' HIS . 2.1 mm-40 -141.98 170.72 15.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.06 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.586 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 32.7 m-85 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.815 0.34 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -138.87 -57.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 18' ' ' VAL . 7.3 p -88.63 104.94 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.093 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.905 HG21 ' HG2' ' A' ' 68' ' ' MET . 47.3 mm -84.04 117.94 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.552 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 3.2 t-160 -82.59 153.0 25.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.899 HG13 ' HB3' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -123.31 110.54 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.083 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.46 171.0 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER 44.22 40.19 3.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.892 0.377 . . . . 0.0 110.297 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.908 HD13 HD12 ' A' ' 84' ' ' ILE . 8.1 tp -123.73 117.39 27.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.34 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.473 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 39.2 Cg_endo -67.03 74.09 0.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.299 1.999 . . . . 0.0 111.209 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.952 HD11 ' C ' ' A' ' 54' ' ' GLN . 29.1 mm -30.06 148.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.208 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER 100.81 10.59 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.657 -178.192 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.699 HG21 HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -67.14 -151.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.877 179.208 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.536 ' H ' HG12 ' A' ' 28' ' ' VAL . 71.7 p -124.76 145.14 49.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.978 0.418 . . . . 0.0 111.613 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.517 ' HG2' HD23 ' A' ' 46' ' ' LEU . 79.0 mt-10 -62.78 -63.73 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.57 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.69 -31.11 0.23 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.785 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HB2' ' OG1' ' A' ' 29' ' ' THR . 7.3 mm-40 -79.45 -63.73 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 110.248 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.7 t -56.77 -63.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.408 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.97 HG23 HG21 ' A' ' 43' ' ' VAL . 1.6 mt -46.8 -47.62 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.964 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -42.7 -50.68 5.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.376 179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.509 ' O ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 mp -57.47 -31.48 66.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.263 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -90.45 -16.42 55.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.333 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.543 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 19.8 mt -48.96 -56.42 15.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.66 0.267 . . . . 0.0 110.986 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 31.8 Cg_endo -63.88 -18.63 64.65 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.526 2.15 . . . . 0.0 112.11 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.959 ' CE2' HG22 ' A' ' 67' ' ' THR . 37.0 m-85 -77.26 -14.67 59.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.718 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.94 -101.66 0.24 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.124 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -150.62 149.43 29.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.825 0.345 . . . . 0.0 111.09 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.97 HG21 HG23 ' A' ' 34' ' ' ILE . 55.0 t -100.08 115.85 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.343 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.798 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -96.56 2.11 52.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.522 -178.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.6 OUTLIER 170.83 142.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.937 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.023 HD13 HG22 ' A' ' 57' ' ' ILE . 39.7 tp -144.4 115.4 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.021 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.62 138.3 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.606 ' HB3' HG23 ' A' ' 26' ' ' ILE . 5.3 mmm -116.14 103.79 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.62 ' C ' HG21 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -89.55 91.48 8.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.812 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.803 ' N ' HG21 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -45.63 -26.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.887 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . -77.79 118.93 5.12 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.458 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 6.6 mtmm 85.09 -10.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 0.0 111.013 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.502 ' HA ' ' CG1' ' A' ' 26' ' ' ILE . 0.6 OUTLIER 61.89 58.75 1.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.053 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.952 ' C ' HD11 ' A' ' 26' ' ' ILE . 3.4 mm-40 -137.72 133.15 33.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.734 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.899 ' HB3' HG13 ' A' ' 21' ' ' ILE . . . -109.16 161.75 14.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.655 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -143.76 115.86 8.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.528 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.023 HG22 HD13 ' A' ' 46' ' ' LEU . 5.9 pt -109.9 154.93 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.259 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.699 ' O ' HG23 ' A' ' 44' ' ' THR . 0.7 OUTLIER -116.33 111.18 19.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.807 0.337 . . . . 0.0 111.536 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.787 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 8.5 mmm -80.14 137.42 36.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.023 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.798 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.2 OUTLIER -65.49 -41.3 93.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.419 . . . . 0.0 110.633 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -119.23 176.61 5.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.095 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.52 ' N ' ' OG1' ' A' ' 61' ' ' THR . 1.6 mp0 -73.73 -50.38 21.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.838 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -46.02 -29.32 1.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.643 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.787 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -75.94 -51.08 13.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.016 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.509 ' CA ' HD11 ' A' ' 19' ' ' ILE . . . -64.09 -61.03 2.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.099 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -44.78 -62.09 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.665 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.959 HG22 ' CE2' ' A' ' 40' ' ' PHE . 88.9 m -46.22 -51.83 13.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.98 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.905 ' HG2' HG21 ' A' ' 19' ' ' ILE . 7.1 tpt -34.63 -61.17 0.41 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.98 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.885 HG11 ' CE2' ' A' ' 88' ' ' PHE . 68.9 t -79.75 -54.59 10.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.246 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.407 ' O ' ' HB ' ' A' ' 73' ' ' THR . 20.5 m-20 -38.33 -64.18 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.305 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -60.97 -45.52 94.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.192 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 68' ' ' MET . 13.1 m-30 -73.42 -1.0 16.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.249 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 69' ' ' VAL . 46.8 m -59.16 -36.77 75.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 110.817 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.7 m -112.71 -44.08 3.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.6 t -80.92 126.69 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.567 ' OG1' ' CZ ' ' A' ' 85' ' ' TYR . 3.0 m -89.31 134.94 31.9 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.07 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.48 ' O ' HG12 ' A' ' 84' ' ' ILE . 46.5 Cg_endo -97.69 80.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.982 2.455 . . . . 0.0 112.292 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.982 ' C ' HD23 ' A' ' 79' ' ' LEU . 1.4 p -92.21 158.73 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.982 HD23 ' C ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -148.6 132.09 16.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.229 -179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.9 18.8 1.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.18 15.3 52.03 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.66 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.444 ' C ' HG23 ' A' ' 78' ' ' VAL . 74.0 mt-30 -113.68 96.78 41.95 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.054 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.29 108.7 2.05 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.903 2.402 . . . . 0.0 112.608 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.908 HD12 HD13 ' A' ' 24' ' ' LEU . 3.7 pt -117.24 110.21 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.521 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.567 ' CZ ' ' OG1' ' A' ' 76' ' ' THR . 2.4 m-85 -86.02 152.3 23.02 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.879 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.656 HG12 HD13 ' A' ' 21' ' ' ILE . 3.8 mt -126.59 140.46 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.466 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.482 ' HA ' HG22 ' A' ' 69' ' ' VAL . 2.0 pt20 -157.14 172.71 18.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 111.166 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.885 ' CE2' HG11 ' A' ' 69' ' ' VAL . 6.0 m-85 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.02 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 1.3 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.797 0.332 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.33 -24.98 22.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.7 t -87.9 111.66 22.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.122 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.523 ' CG2' HG23 ' A' ' 86' ' ' ILE . 48.7 mm -97.08 105.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.22 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 87' ' ' GLN . 6.6 t-160 -79.02 119.74 22.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.652 HG23 HG13 ' A' ' 86' ' ' ILE . 10.2 mt -96.72 124.53 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.292 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -107.69 171.2 7.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.605 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 49.01 39.36 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.167 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.688 HD12 HG21 ' A' ' 84' ' ' ILE . 9.5 tp -129.16 98.27 24.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.555 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 39.9 Cg_exo -56.14 77.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.518 2.146 . . . . 0.0 111.519 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.724 HG22 ' HE3' ' A' ' 50' ' ' LYS . 19.4 mm -31.54 125.45 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.065 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 2.1 t70 146.31 -15.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.144 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.737 HG11 ' HG ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -55.15 -154.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.4 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.576 ' H ' HG12 ' A' ' 28' ' ' VAL . 30.4 p -124.41 146.93 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.985 0.421 . . . . 0.0 111.683 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.617 ' HB3' HD12 ' A' ' 34' ' ' ILE . 3.2 mp0 -66.67 -49.35 66.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.62 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -45.41 -36.0 5.6 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.981 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.792 ' HG2' HD21 ' A' ' 79' ' ' LEU . 2.8 tp10 -81.96 -61.05 2.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.791 0.329 . . . . 0.0 110.606 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 29' ' ' THR . 47.7 t -52.76 -59.88 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.553 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.617 HD12 ' HB3' ' A' ' 30' ' ' GLU . 33.7 mt -54.07 -40.79 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.544 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -50.92 -40.56 57.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.147 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.951 HD12 ' OH ' ' A' ' 72' ' ' TYR . 2.1 mm? -65.9 -28.34 68.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.068 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -81.22 -20.65 64.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.375 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.509 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -46.11 -56.42 10.69 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.702 0.287 . . . . 0.0 110.575 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.509 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 35.4 Cg_exo -59.56 -19.98 55.07 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.385 2.057 . . . . 0.0 111.061 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.597 ' CD1' HG22 ' A' ' 67' ' ' THR . 6.2 m-30 -92.02 16.16 11.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.655 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.18 -111.14 3.02 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.034 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.463 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -150.79 154.59 37.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 0.0 111.209 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.455 HG21 HG12 ' A' ' 34' ' ' ILE . 59.0 t -101.82 116.92 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.762 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -98.89 9.38 43.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.448 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 44' ' ' THR . 8.4 t-20 175.61 144.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.887 HD13 HG22 ' A' ' 57' ' ' ILE . 5.2 tp -151.91 126.69 9.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.694 ' N ' HD12 ' A' ' 46' ' ' LEU . 3.4 tm? -141.01 107.56 5.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.713 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.7 mmm -86.29 118.87 26.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.79 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.546 ' C ' HG21 ' A' ' 26' ' ' ILE . 14.7 tp -102.02 100.36 10.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.084 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.724 ' HE3' HG22 ' A' ' 26' ' ' ILE . 1.4 mmtp -53.83 -19.05 3.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -37.68 -96.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.696 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -100.94 48.1 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.328 . . . . 0.0 110.981 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.555 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 25.6 m120 39.93 73.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.605 ' C ' HD11 ' A' ' 26' ' ' ILE . 5.0 mt-30 -151.05 133.24 15.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.64 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.554 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.6 165.33 11.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.744 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.542 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -143.87 115.9 8.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.308 -179.543 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.887 HG22 HD13 ' A' ' 46' ' ' LEU . 15.0 pt -119.52 139.26 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.675 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 44' ' ' THR . 0.4 OUTLIER -108.0 103.84 13.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.256 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 0.9 OUTLIER -69.84 146.21 51.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.248 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.762 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.2 OUTLIER -66.22 -47.0 75.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.329 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.95 168.94 9.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.426 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -72.05 -47.21 53.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.682 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -50.53 -26.93 5.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.408 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 40' ' ' PHE . . . -74.39 -52.41 12.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.852 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -53.89 -58.43 7.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.197 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 70' ' ' ASN . 1.7 m-20 -46.54 -64.71 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.597 HG22 ' CD1' ' A' ' 40' ' ' PHE . 19.9 m -40.83 -55.43 2.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.784 ' SD ' HG21 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -36.12 -63.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.037 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.639 HG22 HG22 ' A' ' 86' ' ' ILE . 65.2 t -83.37 -58.47 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.257 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 66' ' ' ASN . 21.1 t-20 -37.6 -36.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.486 ' HB3' ' O ' ' A' ' 67' ' ' THR . 2.1 t80 -78.19 -52.73 8.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.991 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.951 ' OH ' HD12 ' A' ' 36' ' ' LEU . 13.4 m-85 -65.89 -9.1 26.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.054 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 72' ' ' TYR . 28.6 m -38.1 -36.66 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.936 0.398 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 t -110.32 -56.62 2.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.739 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.43 120.91 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.5 m -94.3 141.47 23.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.263 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 76' ' ' THR . 58.2 Cg_endo -98.43 137.6 0.36 Allowed 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.436 2.757 . . . . 0.0 112.311 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -122.91 179.94 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.948 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.792 HD21 ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -140.92 118.73 11.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.85 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 47.33 24.28 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.536 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.51 15.38 23.11 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.412 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.456 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -120.3 97.9 48.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.599 ' HA ' HG12 ' A' ' 78' ' ' VAL . 39.6 Cg_exo -57.3 129.06 32.13 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.976 2.45 . . . . 0.0 112.802 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.688 HG21 HD12 ' A' ' 24' ' ' LEU . 5.3 pt -133.45 109.33 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.203 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.602 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -80.4 146.57 31.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.086 -178.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.784 HG21 ' SD ' ' A' ' 68' ' ' MET . 5.9 mt -126.4 108.75 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.412 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.534 ' HA ' ' CG1' ' A' ' 69' ' ' VAL . 30.0 mt-30 -140.39 166.09 25.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 111.366 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.656 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.582 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . 3.1 m . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.847 0.356 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.07 -49.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.85 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 t -88.03 100.43 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.04 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.82 HD11 ' HB1' ' A' ' 65' ' ' ALA . 37.4 mm -81.21 105.7 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.239 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.692 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 10.2 t-160 -84.65 107.58 16.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.837 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.549 HG23 HG13 ' A' ' 86' ' ' ILE . 1.7 mm -82.86 119.35 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.187 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.97 173.42 6.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.685 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 3.1 tmtt? 43.22 41.99 3.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.536 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.814 HD12 ' HD2' ' A' ' 25' ' ' PRO . 6.3 tp -127.79 130.45 23.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.814 ' HD2' HD12 ' A' ' 24' ' ' LEU . 73.6 Cg_endo -76.49 74.75 4.62 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.592 2.194 . . . . 0.0 111.742 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.89 HD11 ' C ' ' A' ' 54' ' ' GLN . 15.0 mm -32.83 110.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.143 0.497 . . . . 0.0 110.659 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.567 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 6.3 t70 146.69 -17.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.539 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.69 HG22 ' H ' ' A' ' 29' ' ' THR . 1.7 p -51.19 -168.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.373 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.69 ' H ' HG22 ' A' ' 28' ' ' VAL . 45.2 p -105.77 145.91 30.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.12 0.486 . . . . 0.0 111.808 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.9 mp0 -62.08 -46.12 90.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.672 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.64 -36.77 0.76 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.085 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.442 ' OE1' ' HB2' ' A' ' 79' ' ' LEU . 91.9 mt-10 -75.12 -51.18 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 110.454 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.3 t -64.07 -61.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.02 HG23 HG21 ' A' ' 43' ' ' VAL . 1.1 mt -50.82 -46.82 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.097 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 3.7 t -45.62 -45.12 13.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.583 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.511 HD22 ' OH ' ' A' ' 72' ' ' TYR . 68.6 mt -69.16 -21.27 64.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.539 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -87.1 -28.37 25.76 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.526 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.493 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -40.86 -53.14 6.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.698 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 19.6 Cg_exo -65.71 -34.33 41.27 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.718 2.279 . . . . 0.0 111.786 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.596 ' CD1' HG22 ' A' ' 67' ' ' THR . 15.6 m-30 -65.83 -39.3 90.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.833 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.521 ' O ' ' CD ' ' A' ' 42' ' ' LYS . . . 165.68 -98.52 0.15 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.42 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -150.48 141.64 23.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.79 0.328 . . . . 0.0 110.94 179.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.02 HG21 HG23 ' A' ' 34' ' ' ILE . 55.5 t -88.68 86.49 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.908 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -80.62 7.44 10.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.322 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 170.75 137.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.027 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.976 HD23 HG22 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -147.92 98.4 2.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.545 ' N ' HD22 ' A' ' 46' ' ' LEU . 6.5 tt -97.88 149.16 22.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.816 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.812 ' HB3' HG23 ' A' ' 26' ' ' ILE . 8.2 mtt -125.21 110.65 14.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.148 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.645 ' C ' HG21 ' A' ' 26' ' ' ILE . 6.0 tp -88.42 96.4 10.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.751 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.714 ' CD ' HG22 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -74.73 0.56 14.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.255 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.63 -9.03 36.07 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.404 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -160.46 -64.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.778 0.323 . . . . 0.0 111.001 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER 155.08 43.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.551 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.89 ' C ' HD11 ' A' ' 26' ' ' ILE . 63.8 mt-30 -130.44 133.09 46.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.11 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.766 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.81 163.06 13.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.715 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.692 ' CE2' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -148.0 115.78 6.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.134 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.976 HG22 HD23 ' A' ' 46' ' ' LEU . 22.0 pt -112.18 137.18 45.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.78 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.73 102.67 14.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.731 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.855 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 17.7 mmm -67.02 124.02 21.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.645 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.908 ' ND2' HG23 ' A' ' 44' ' ' THR . 2.8 m120 -35.69 -33.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.78 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -144.67 176.78 9.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.971 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.512 ' N ' ' OG1' ' A' ' 61' ' ' THR . 1.2 mp0 -72.88 -44.76 60.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.95 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -50.25 -24.55 2.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.947 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.855 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -83.47 -49.72 9.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.82 ' HB1' HD11 ' A' ' 19' ' ' ILE . . . -65.41 -31.2 72.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.369 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -70.09 -54.49 12.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.596 HG22 ' CD1' ' A' ' 40' ' ' PHE . 24.1 m -56.62 -22.63 35.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.269 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.585 ' SD ' HD11 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -69.03 -65.01 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.066 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 21.6 t -67.97 -48.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.277 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -52.77 -40.47 63.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.037 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.428 ' CB ' ' O ' ' A' ' 67' ' ' THR . 3.5 t80 -67.81 -44.53 77.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.511 ' OH ' HD22 ' A' ' 36' ' ' LEU . 41.0 m-85 -85.84 12.48 9.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 70' ' ' ASN . 54.1 m -66.26 -13.84 61.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.2 m -127.77 -39.8 1.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.832 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.76 138.74 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.484 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.3 m -103.33 142.56 24.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.01 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.761 ' HG2' HD12 ' A' ' 86' ' ' ILE . 30.2 Cg_endo -95.24 145.08 1.4 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 123.103 2.535 . . . . 0.0 112.097 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' HB ' ' C ' ' A' ' 82' ' ' GLN . 0.7 OUTLIER -133.29 166.28 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 0.0 110.994 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.793 ' C ' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -107.88 107.63 18.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.406 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER 28.92 34.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.327 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 115.93 36.24 1.16 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.559 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.548 ' CB ' ' HG ' ' A' ' 79' ' ' LEU . 2.5 tt0 -151.34 97.18 3.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.076 0.465 . . . . 0.0 110.613 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.406 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 38.7 Cg_exo -61.16 126.2 18.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.004 2.47 . . . . 0.0 112.959 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.487 ' O ' HG13 ' A' ' 84' ' ' ILE . 9.4 pt -137.73 107.7 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.273 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -68.85 146.88 52.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.99 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.761 HD12 ' HG2' ' A' ' 77' ' ' PRO . 6.5 mt -126.31 103.75 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.203 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' HIS . 4.1 mt-30 -126.64 174.27 8.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.899 0.381 . . . . 0.0 111.142 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.582 ' CE1' ' HB3' ' A' ' 16' ' ' SER . 71.4 m-85 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.89 0.376 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 58' ' ' GLU . 3.5 mtm180 -137.22 -42.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 t -87.91 133.81 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.582 HG21 ' HG2' ' A' ' 68' ' ' MET . 4.8 mm -115.61 102.42 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.395 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.518 ' CD2' ' HB3' ' A' ' 54' ' ' GLN . 4.7 t-160 -79.08 113.98 17.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.598 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.911 HD12 HG12 ' A' ' 86' ' ' ILE . 4.1 mm -82.83 127.03 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.347 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -108.79 171.33 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.671 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HG2' ' CZ ' ' A' ' 85' ' ' TYR . 1.9 tptp 43.66 33.17 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.27 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.772 HD13 HD12 ' A' ' 84' ' ' ILE . 2.2 tp -115.46 110.66 44.74 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.103 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.568 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 43.8 Cg_endo -68.22 61.69 1.04 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.277 1.985 . . . . 0.0 110.991 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.913 HD11 ' C ' ' A' ' 54' ' ' GLN . 37.5 mm -8.5 105.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.468 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.622 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 24.6 t70 129.18 24.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 O-C-N 124.408 1.067 . . . . 0.0 111.325 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.731 ' C ' HG23 ' A' ' 29' ' ' THR . 5.2 p -85.23 8.38 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.376 0.607 . . . . 0.0 111.031 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.731 HG23 ' C ' ' A' ' 28' ' ' VAL . 3.0 p 90.29 146.82 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.976 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -74.92 -40.19 60.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.228 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -53.86 -25.9 31.65 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.96 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.807 ' HG3' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -80.39 -50.31 10.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 110.551 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.402 ' HB ' ' CD2' ' A' ' 46' ' ' LEU . 12.4 t -62.29 -51.26 74.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.748 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.32 -41.51 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.442 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.9 t -49.74 -33.3 15.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.181 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.849 HD13 ' CZ ' ' A' ' 72' ' ' TYR . 6.6 mt -75.43 -34.9 61.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -70.03 -26.09 74.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.464 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -37.87 -61.23 0.81 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.367 . . . . 0.0 110.723 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.2 Cg_endo -65.87 -22.51 56.16 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.57 2.18 . . . . 0.0 111.626 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.59 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 13.1 m-30 -80.77 0.45 34.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.976 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.8 -101.69 0.85 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.375 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' CB ' HD21 ' A' ' 60' ' ' ASN . 5.7 mtpm? -150.32 145.56 26.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 111.481 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.679 HG22 HD11 ' A' ' 57' ' ' ILE . 54.7 t -89.51 122.58 41.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.651 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.931 HG22 ' OD1' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -99.15 -14.32 19.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.211 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.1 t-20 172.88 142.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.676 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' PHE . 5.3 tp -148.52 95.93 2.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.998 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 47' ' ' LEU . 7.1 tt -95.33 127.48 41.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.66 ' HB3' HG23 ' A' ' 26' ' ' ILE . 27.9 mtp -94.59 137.03 34.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.971 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.471 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.2 tp -124.06 101.82 7.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.784 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.675 ' HE3' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -59.6 -13.86 11.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.21 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -35.15 -95.36 0.01 OUTLIER Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.619 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 63.8 mmtt -104.03 44.11 1.04 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.914 0.388 . . . . 0.0 110.774 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.568 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 4.9 m120 48.76 75.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.912 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.913 ' C ' HD11 ' A' ' 26' ' ' ILE . 21.8 mt-30 -157.65 138.42 13.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.619 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.691 ' HB3' ' CG1' ' A' ' 21' ' ' ILE . . . -109.28 167.97 9.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -139.55 115.66 10.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.283 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.679 HD11 HG22 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -127.56 144.03 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.655 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.523 ' N ' HG12 ' A' ' 57' ' ' ILE . 15.5 mt-10 -121.53 133.14 55.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.895 0.379 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.869 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 27.9 mmm -92.09 151.28 20.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.589 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.931 ' OD1' HG22 ' A' ' 44' ' ' THR . 0.4 OUTLIER -68.65 -26.73 65.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.952 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.619 HG23 ' H ' ' A' ' 64' ' ' ALA . 4.8 t -131.17 138.22 49.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.091 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.39 -21.02 2.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.821 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -73.59 -36.59 65.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.869 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -67.43 -49.87 61.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' A' ' 19' ' ' ILE . . . -55.78 -56.91 14.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -41.97 -68.48 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.986 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.566 HG22 ' CD1' ' A' ' 40' ' ' PHE . 19.4 m -40.93 -49.83 3.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.114 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.59 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -38.4 -64.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.977 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 54.1 t -77.09 -59.0 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -41.88 -27.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.056 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.423 ' CB ' ' O ' ' A' ' 67' ' ' THR . 10.7 t80 -85.46 -45.43 11.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.948 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.849 ' CZ ' HD13 ' A' ' 36' ' ' LEU . 19.2 m-85 -82.9 9.12 10.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 m -70.13 -23.63 63.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.05 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.9 t -116.65 -34.2 4.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.788 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.7 p -113.8 126.82 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.989 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.523 HG21 ' CE1' ' A' ' 85' ' ' TYR . 2.0 m -97.6 131.26 27.37 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.151 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.575 ' HG3' ' CE1' ' A' ' 72' ' ' TYR . 72.5 Cg_endo -98.33 120.87 0.14 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 123.178 2.585 . . . . 0.0 112.411 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.677 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -95.07 -179.96 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.856 179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.807 HD12 ' HG3' ' A' ' 32' ' ' GLU . 2.4 mm? -139.96 115.53 10.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.951 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.07 21.41 1.02 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.728 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.42 15.72 16.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.524 ' O ' HG23 ' A' ' 84' ' ' ILE . 18.7 mm100 -122.83 97.98 43.33 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.027 0.441 . . . . 0.0 110.956 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 22.2 Cg_exo -64.91 105.9 0.71 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.974 2.449 . . . . 0.0 112.746 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.772 HD12 HD13 ' A' ' 24' ' ' LEU . 1.6 pt -119.9 112.39 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.641 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -76.71 156.03 32.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.94 -178.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.911 HG12 HD12 ' A' ' 21' ' ' ILE . 7.7 mt -126.15 104.27 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.327 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -113.84 175.3 5.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 111.346 -179.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.583 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 44.3 m-85 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.041 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.5 p . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.765 0.317 . . . . 6.4500000000000002 111.194 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -37.64 151.82 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 3.8500000000000001 112.434 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.1 OUTLIER -122.08 121.23 28.02 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.357 . . . . 3.3300000000000001 111.062 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.04 86.12 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.739 2.292 . . . . 3.4300000000000002 112.265 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 14' ' ' VAL . 2.2 m -138.63 101.47 4.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 2.8300000000000001 110.898 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -108.15 -40.74 5.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 2.9500000000000002 110.887 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' A' ' 89' ' ' SER . 77.3 t -93.56 135.86 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 1.1100000000000001 111.149 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.808 HG21 ' HG2' ' A' ' 68' ' ' MET . 36.5 mm -107.97 109.83 29.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.70999999999999996 111.146 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.671 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 6.4 t-160 -83.08 109.14 16.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 1.52 110.865 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.49 HG23 HG13 ' A' ' 86' ' ' ILE . 4.3 mt -83.44 122.26 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.94999999999999996 111.194 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -103.61 174.82 5.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 2.8300000000000001 110.735 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 42.85 41.36 2.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 2.5800000000000001 110.74 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.506 HD12 HG21 ' A' ' 84' ' ' ILE . 3.6 tp -128.19 127.02 23.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 1.2 110.705 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.572 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 72.0 Cg_endo -75.58 71.66 5.28 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.504 2.136 . . . . 1.05 112.036 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.838 HG21 ' N ' ' A' ' 50' ' ' LYS . 15.9 mm -27.22 110.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.1 0.476 . . . . 2.1499999999999999 110.876 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 4.0 t70 146.07 -18.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.291 -0.868 . . . . 2.1600000000000001 109.451 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 29' ' ' THR . 1.8 p -52.41 -167.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 115.628 -0.714 . . . . 1.6100000000000001 109.842 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.685 ' H ' HG22 ' A' ' 28' ' ' VAL . 45.9 p -99.36 145.21 27.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.069 0.461 . . . . 0.56999999999999995 111.773 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 32' ' ' GLU . 2.6 mp0 -70.32 -46.77 63.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.761 -0.654 . . . . 2.0099999999999998 110.504 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.04 -28.64 0.16 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.543 -0.837 . . . . 0.56000000000000005 111.936 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.738 ' HB3' HD21 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -83.96 -57.26 3.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.319 . . . . 2.48 110.491 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.5 t -51.5 -49.96 31.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.953 0.406 . . . . 0.59999999999999998 110.575 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.544 ' CG1' HG21 ' A' ' 43' ' ' VAL . 1.2 mp -69.97 -38.23 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.68000000000000005 110.558 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -49.1 -38.76 25.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 1.3100000000000001 110.373 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.964 HD22 ' OH ' ' A' ' 72' ' ' TYR . 12.1 mt -72.7 -38.55 67.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.946 -0.57 . . . . 1.49 110.358 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.604 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -71.54 -20.34 78.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 0.52000000000000002 112.305 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -41.65 -60.52 1.86 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.852 0.358 . . . . 1.5 110.775 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 30.1 Cg_endo -63.29 -34.63 66.64 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.714 2.276 . . . . 0.54000000000000004 111.939 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.661 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.8 m-30 -60.22 -32.62 71.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.974 -0.557 . . . . 1.3300000000000001 110.678 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 157.85 -102.29 0.21 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.86 -0.686 . . . . 0.42999999999999999 112.231 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.59 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 28.5 mttt -150.4 137.31 19.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.762 0.315 . . . . 2.3700000000000001 111.023 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.544 HG21 ' CG1' ' A' ' 34' ' ' ILE . 45.5 t -87.83 121.72 38.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.59999999999999998 110.468 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 1.056 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -96.27 -2.0 46.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 1.1200000000000001 111.459 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 170.98 152.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.326 -0.397 . . . . 1.47 111.056 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.956 HD13 HG22 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -145.38 100.52 3.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 1.3799999999999999 110.89 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 48' ' ' MET . 2.8 tt -108.33 113.74 27.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 1.4199999999999999 110.918 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.603 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.8 mmm -90.79 94.91 9.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.83999999999999997 110.865 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.571 ' C ' HG21 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -74.53 93.05 2.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 1.78 110.843 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.838 ' N ' HG21 ' A' ' 26' ' ' ILE . 3.4 mmtp -51.95 -18.74 1.47 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 1.6399999999999999 111.09 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -33.71 -95.21 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.798 -0.715 . . . . 2.0299999999999998 112.622 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 26.5 mttt -107.9 55.88 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 3.29 110.975 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 14.8 m120 40.56 68.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 1.3899999999999999 110.948 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.757 ' C ' HD11 ' A' ' 26' ' ' ILE . 10.7 mt-30 -146.99 129.35 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 1.6899999999999999 110.747 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.708 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.7 160.21 16.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.37 110.891 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.671 ' CE2' ' CD2' ' A' ' 20' ' ' HIS . 0.1 OUTLIER -142.77 115.86 8.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.307 -0.406 . . . . 1.3999999999999999 111.187 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.956 HG22 HD13 ' A' ' 46' ' ' LEU . 6.1 pt -114.64 146.82 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.68999999999999995 110.771 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.784 ' O ' HG23 ' A' ' 44' ' ' THR . 1.6 mt-10 -111.8 123.18 49.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.289 -0.414 . . . . 1.96 111.222 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.497 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -90.77 137.41 32.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 1.1100000000000001 110.251 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 1.056 ' CG ' HG22 ' A' ' 44' ' ' THR . 1.2 m-80 -68.4 -20.74 64.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.418 -0.356 . . . . 1.3700000000000001 111.484 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.61 HG23 ' HB2' ' A' ' 64' ' ' ALA . 1.4 t -129.84 146.88 51.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 1.27 111.326 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.48 -46.09 89.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.088 -0.505 . . . . 1.95 110.779 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.64 -23.42 17.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 2.1299999999999999 110.721 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.61 ' HB2' HG23 ' A' ' 61' ' ' THR . . . -78.21 -54.84 5.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.40999999999999998 111.029 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -52.72 -52.61 55.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.34000000000000002 111.138 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -54.18 -67.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 1.77 110.986 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.661 HG22 ' CD1' ' A' ' 40' ' ' PHE . 22.7 m -40.97 -38.25 0.94 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.47999999999999998 111.277 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.808 ' HG2' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -52.12 -65.18 0.6 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.97999999999999998 111.024 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 99.8 t -75.08 -49.85 26.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.51000000000000001 111.128 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.453 ' O ' ' OG1' ' A' ' 73' ' ' THR . 13.0 t-20 -43.39 -60.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 1.5900000000000001 110.997 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -55.97 -42.26 76.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.3400000000000001 110.965 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.964 ' OH ' HD22 ' A' ' 36' ' ' LEU . 16.3 m-85 -74.5 0.2 15.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 1.21 111.073 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 32.0 m -50.11 -29.04 8.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.355 -0.384 . . . . 0.76000000000000001 110.952 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.25 -57.19 1.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 1.3400000000000001 110.779 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 40.8 t -80.28 124.69 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 1.3400000000000001 110.979 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.517 HG23 ' HD2' ' A' ' 77' ' ' PRO . 1.2 m -102.41 144.22 28.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.85999999999999999 111.241 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.966 ' HG2' HD12 ' A' ' 86' ' ' ILE . 22.6 Cg_endo -94.56 135.02 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.199 2.599 . . . . 0.80000000000000004 111.961 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -114.6 177.73 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 1.3600000000000001 111.222 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.738 HD21 ' HB3' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -131.99 112.56 12.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 2.4900000000000002 110.927 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 46.58 23.37 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 4.6600000000000001 110.725 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.09 9.17 20.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.875 -0.679 . . . . 0.94999999999999996 112.649 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.471 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -117.0 97.64 51.02 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.97 0.414 . . . . 2.2999999999999998 110.819 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.562 ' HA ' HG12 ' A' ' 78' ' ' VAL . 36.6 Cg_exo -57.64 117.12 3.77 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.852 2.368 . . . . 0.64000000000000001 112.615 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.506 HG21 HD12 ' A' ' 24' ' ' LEU . 3.3 pt -118.64 107.73 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.42999999999999999 110.67 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.433 ' CE1' HG21 ' A' ' 76' ' ' THR . 20.6 m-85 -65.42 148.4 51.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 1.78 111.648 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.966 HD12 ' HG2' ' A' ' 77' ' ' PRO . 4.2 mt -126.23 103.87 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.809 -0.632 . . . . 0.57999999999999996 110.556 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' HIS . 11.8 mt-30 -112.67 170.79 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.395 . . . . 2.3599999999999999 111.147 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 37.4 m-85 -71.21 -175.89 1.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 1.46 110.885 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.526 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 28.9 t -96.1 174.05 7.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 2.3900000000000001 110.887 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -126.92 27.33 6.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 3.8100000000000001 110.89 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -158.46 159.38 35.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 5.3799999999999999 110.904 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.54 -88.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 7.1200000000000001 110.901 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -135.11 164.67 27.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 3.4100000000000001 110.913 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.6 tp -74.63 123.31 24.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 2.3599999999999999 110.907 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -88.62 131.38 35.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 6.5 110.845 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 98' ' ' SER . 0.1 OUTLIER -84.65 97.02 9.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 5.8200000000000003 111.133 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.4 t0 40.77 -91.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 8.3000000000000007 110.949 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 96' ' ' THR . 3.1 p -157.83 37.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 9.5800000000000001 110.845 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.214 -0.898 . . . . 10.49 110.919 -179.999 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.816 0.341 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.03 -81.17 1.58 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.482 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.86 130.24 17.58 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.371 . . . . 0.0 111.138 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.58 ' HG3' ' CZ ' ' A' ' 88' ' ' PHE . 35.2 Cg_endo -65.79 -86.03 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.725 2.283 . . . . 0.0 112.308 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.446 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 1.4 p -178.6 162.19 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.856 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -76.72 -20.03 57.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.943 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 89' ' ' SER . 4.0 t -90.11 107.51 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.122 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.498 ' HB ' HG12 ' A' ' 57' ' ' ILE . 24.9 mm -94.39 108.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.184 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.624 ' NE2' ' CE2' ' A' ' 56' ' ' PHE . 4.7 t-160 -79.32 109.62 13.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.744 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 85' ' ' TYR . 16.4 mt -83.99 131.1 34.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.363 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -109.29 168.27 9.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.635 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.5 OUTLIER 46.43 44.22 12.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.0 110.377 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.909 HD23 HG21 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -129.44 95.72 29.42 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.972 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.559 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 50.5 Cg_exo -53.32 78.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.699 2.266 . . . . 0.0 111.932 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.918 HG23 ' HB3' ' A' ' 48' ' ' MET . 29.6 mm -34.62 118.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.084 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.4 t0 149.76 -19.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.06 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 29' ' ' THR . 6.1 m -55.44 -155.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.783 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.538 ' N ' HG23 ' A' ' 28' ' ' VAL . 71.2 p -114.0 145.69 41.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.923 0.392 . . . . 0.0 111.64 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.848 ' O ' HD12 ' A' ' 34' ' ' ILE . 9.5 mp0 -63.47 -34.19 77.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.602 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.12 -38.18 65.94 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.182 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.944 ' OE1' HD12 ' A' ' 79' ' ' LEU . 3.6 mm-40 -68.59 -58.97 3.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.785 0.326 . . . . 0.0 110.608 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.0 t -53.28 -45.5 55.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.743 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 30' ' ' GLU . 1.4 mp -66.63 -39.58 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.395 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -43.36 -43.37 5.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.144 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 77' ' ' PRO . 8.5 mt -77.71 -25.35 49.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.291 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -81.43 -16.33 74.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.405 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.493 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -58.9 -54.73 53.51 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.738 0.304 . . . . 0.0 110.725 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 31.6 Cg_exo -58.19 -50.08 10.85 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.569 2.179 . . . . 0.0 111.828 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 27.2 m-85 -53.68 -32.61 52.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.783 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.71 -104.08 0.23 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.186 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 8.8 mttm -150.45 143.77 24.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.886 0.374 . . . . 0.0 111.007 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.743 HG21 HG13 ' A' ' 34' ' ' ILE . 49.9 t -86.92 114.59 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.518 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.953 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -89.26 -4.5 58.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.458 -179.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 176.4 151.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.812 HD23 ' HB3' ' A' ' 30' ' ' GLU . 3.9 tp -137.63 125.76 22.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.007 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.516 HD22 HD21 ' A' ' 94' ' ' LEU . 7.0 tp -134.09 123.74 24.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.725 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.918 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.5 mmm -109.66 121.82 46.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.529 HD12 ' CZ ' ' A' ' 56' ' ' PHE . 12.8 mt -98.89 91.62 5.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.976 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.898 ' CE ' HG22 ' A' ' 26' ' ' ILE . 13.6 mmtp -41.22 -27.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.966 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -81.24 129.6 9.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.545 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 0.9 OUTLIER 67.28 16.37 10.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 0.0 110.997 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.559 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 21.8 m120 36.35 78.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.808 ' C ' HD11 ' A' ' 26' ' ' ILE . 2.4 mt-30 -150.21 132.91 15.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.993 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.613 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.7 167.81 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.767 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.624 ' CE2' ' NE2' ' A' ' 20' ' ' HIS . 0.2 OUTLIER -148.09 115.99 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.305 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.775 HG22 HD13 ' A' ' 46' ' ' LEU . 6.5 pt -108.71 155.09 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.768 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.798 ' O ' HG23 ' A' ' 44' ' ' THR . 0.0 OUTLIER -119.51 119.28 33.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.775 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 38.7 mmm -89.98 141.47 28.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.632 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.953 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.8 OUTLIER -73.76 -27.03 60.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.909 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.5 t -123.92 137.94 54.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.234 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -51.27 -38.2 51.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.687 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -59.08 -27.88 65.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.689 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -75.81 -47.24 26.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 16' ' ' SER . . . -60.4 -57.09 14.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.993 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.537 ' ND2' ' HD2' ' A' ' 15' ' ' PRO . 1.6 m-20 -51.82 -70.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.537 HG22 ' CE1' ' A' ' 40' ' ' PHE . 12.7 m -41.8 -27.48 0.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 1.005 ' SD ' HG21 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -59.62 -65.21 0.71 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.865 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.568 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 72.0 t -74.92 -37.61 41.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.481 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 8.2 t30 -59.23 -63.66 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.994 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' A' ' 67' ' ' THR . 2.8 t80 -49.31 -45.72 45.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.11 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.583 ' CE2' ' HG3' ' A' ' 77' ' ' PRO . 22.4 m-30 -83.83 11.57 7.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.106 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.481 ' OG1' ' HA ' ' A' ' 70' ' ' ASN . 21.5 m -62.29 -30.24 70.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.2 t -113.66 -39.19 4.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.5 p -106.18 129.95 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.144 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.3 m -98.61 142.48 24.67 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.85 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.619 ' HG2' HD12 ' A' ' 86' ' ' ILE . 26.8 Cg_endo -95.01 137.67 0.84 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 123.028 2.485 . . . . 0.0 112.214 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.828 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -123.65 -179.87 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 111.21 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.944 HD12 ' OE1' ' A' ' 32' ' ' GLU . 1.9 mm? -137.97 107.43 6.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.963 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 56.88 16.67 2.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.935 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.46 8.63 14.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.655 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.471 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -116.01 97.67 49.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.008 0.432 . . . . 0.0 110.95 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.612 ' HB3' HG12 ' A' ' 78' ' ' VAL . 74.3 Cg_endo -75.84 135.93 18.16 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.894 2.396 . . . . 0.0 112.853 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.909 HG21 HD23 ' A' ' 24' ' ' LEU . 9.2 pt -136.97 110.11 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.497 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.65 ' O ' HG23 ' A' ' 21' ' ' ILE . 8.1 m-85 -60.47 143.55 53.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.587 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 1.005 HG21 ' SD ' ' A' ' 68' ' ' MET . 7.1 mt -125.85 104.07 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.528 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' HIS . 3.9 mt-30 -115.13 172.83 6.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 0.0 111.1 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CZ ' ' HG3' ' A' ' 15' ' ' PRO . 45.5 m-85 -71.73 179.97 2.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.84 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.456 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 70.4 m -114.33 144.95 42.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -94.47 31.32 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.988 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -127.61 176.27 7.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.73 -36.77 6.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.68 164.56 29.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.938 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.516 HD21 HD22 ' A' ' 47' ' ' LEU . 0.4 OUTLIER -85.34 110.0 18.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.892 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -105.03 136.21 44.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.8 p -81.34 129.56 34.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.104 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -114.88 -39.52 3.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.0 t -178.87 169.87 1.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.97 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.1 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.847 -179.954 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.777 0.323 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.627 ' O ' HG23 ' A' ' 14' ' ' VAL . . . 40.85 77.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.456 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER 51.57 112.07 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.847 0.356 . . . . 0.0 111.207 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 35.0 Cg_endo -65.35 -86.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.609 2.206 . . . . 0.0 112.349 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 1.4 m 167.08 172.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.982 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -68.06 -7.27 27.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.033 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 t -87.99 122.49 39.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.031 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.583 HD11 ' CA ' ' A' ' 65' ' ' ALA . 3.9 mm -119.28 116.85 52.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.211 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.481 ' HB3' ' O ' ' A' ' 88' ' ' PHE . 6.9 t-80 -88.28 153.59 21.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.721 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.697 HG23 ' O ' ' A' ' 85' ' ' TYR . 2.3 mp -133.37 110.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.478 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 23' ' ' LYS . 2.8 ttm180 -88.09 167.4 13.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.827 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 43.77 90.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.784 HD11 HG21 ' A' ' 28' ' ' VAL . 4.7 tp -167.66 115.42 0.65 Allowed Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.447 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 26' ' ' ILE . 37.4 Cg_exo -59.08 73.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.466 2.111 . . . . 0.0 111.062 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.56 ' CG1' ' HA ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -30.01 153.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.989 -178.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER 87.46 9.43 0.16 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.983 -179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.784 HG21 HD11 ' A' ' 24' ' ' LEU . 1.4 t -57.86 -149.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.806 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 33' ' ' VAL . 17.9 p -124.52 149.81 46.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.16 0.505 . . . . 0.0 111.899 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 2.1 mt-10 -68.75 -47.11 67.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.789 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 35' ' ' SER . . . -51.34 -37.27 39.02 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.348 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.564 ' HG2' HD21 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -78.63 -64.93 1.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.753 0.311 . . . . 0.0 110.768 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 29' ' ' THR . 47.9 t -45.59 -52.72 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.971 HG12 HG21 ' A' ' 43' ' ' VAL . 1.5 mp -65.7 -40.17 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.315 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -39.17 -42.42 0.96 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.924 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.006 HD22 ' OH ' ' A' ' 72' ' ' TYR . 11.1 mt -73.21 -40.63 64.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.02 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -77.22 -3.97 82.9 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.399 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.536 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 9.3 mt -61.44 -58.3 19.53 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.182 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 19.7 Cg_endo -58.3 -32.02 95.07 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.511 2.141 . . . . 0.0 112.105 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.592 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 22.0 m-30 -58.04 -28.51 64.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.683 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.76 -98.03 0.17 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.18 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.569 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 19.3 mmtp -150.47 146.01 26.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 0.0 111.022 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.971 HG21 HG12 ' A' ' 34' ' ' ILE . 67.0 t -89.73 116.43 31.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.763 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.955 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -92.82 -9.71 39.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.244 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.424 ' HB2' ' OE1' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -176.88 146.95 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.725 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.758 ' C ' HD13 ' A' ' 46' ' ' LEU . 2.1 tm? -132.59 124.83 29.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.024 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.747 HD12 ' CD2' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -141.23 141.4 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.708 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.663 ' N ' HD13 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -129.3 103.08 6.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.784 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.783 HD23 ' CE1' ' A' ' 56' ' ' PHE . 3.4 mm? -70.18 107.82 3.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.832 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HA ' HG21 ' A' ' 26' ' ' ILE . 5.9 mttp -91.68 81.13 5.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.943 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.23 -56.43 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.284 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -123.17 18.29 9.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.919 0.39 . . . . 0.0 110.544 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.56 ' HA ' ' CG1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 68.81 86.47 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.953 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 53' ' ' ASN . 26.6 mt-30 -160.12 129.52 5.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.421 . . . . 0.0 111.431 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . . . -113.75 163.27 15.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.241 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.783 ' CE1' HD23 ' A' ' 49' ' ' LEU . 5.8 m-85 -148.1 118.59 7.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.839 0.352 . . . . 0.0 111.599 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.755 HD12 ' SD ' ' A' ' 59' ' ' MET . 7.0 pt -118.53 140.85 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.527 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.775 ' O ' HG23 ' A' ' 44' ' ' THR . 61.6 mt-10 -103.34 123.65 47.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.292 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.871 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 23.4 mmm -98.81 134.49 41.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.955 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.5 OUTLIER -72.28 -20.56 61.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.27 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.9 t -134.67 129.14 34.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.909 0.385 . . . . 0.0 111.231 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -38.99 -49.55 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -46.06 -32.23 2.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.86 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.871 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -75.29 -48.88 21.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.583 ' CA ' HD11 ' A' ' 19' ' ' ILE . . . -66.58 -59.23 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -50.59 -65.82 0.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.075 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.7 m -40.7 -46.78 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.27 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.706 ' SD ' HD11 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -44.98 -65.11 0.57 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.275 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.645 HG13 ' HA ' ' A' ' 87' ' ' GLN . 24.7 t -71.89 -51.54 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.297 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -49.96 -26.51 4.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.186 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -85.53 -64.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.169 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 1.006 ' OH ' HD22 ' A' ' 36' ' ' LEU . 27.2 m-85 -56.46 -16.54 6.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.989 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 72' ' ' TYR . 69.7 m -35.54 -31.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.023 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 72' ' ' TYR . 7.7 t -112.4 -62.94 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 6.2 p -82.15 121.71 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.054 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.556 HG21 ' CE1' ' A' ' 85' ' ' TYR . 2.5 m -95.59 145.85 30.28 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.032 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.551 ' HD2' HG23 ' A' ' 76' ' ' THR . 37.1 Cg_endo -97.23 163.61 0.96 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.299 2.666 . . . . 0.0 112.032 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.531 ' HB ' ' N ' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -153.24 152.41 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.899 0.381 . . . . 0.0 111.105 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.564 HD21 ' HG2' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -98.78 100.83 12.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.406 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 28.6 mmt180 67.27 -59.51 0.39 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.469 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -159.44 22.92 0.29 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.404 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.454 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 26.1 mp0 -126.1 97.8 34.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.392 . . . . 0.0 110.936 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.531 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 19.9 Cg_exo -66.19 129.47 21.75 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 123.047 2.498 . . . . 0.0 112.714 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.747 HD12 HD13 ' A' ' 24' ' ' LEU . 6.1 pt -134.47 118.52 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.57 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.697 ' O ' HG23 ' A' ' 21' ' ' ILE . 4.6 m-85 -78.66 148.88 33.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.847 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.62 HG21 ' CG ' ' A' ' 68' ' ' MET . 4.0 mt -126.26 109.09 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.473 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.645 ' HA ' HG13 ' A' ' 69' ' ' VAL . 70.8 mm-40 -120.87 173.79 7.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.013 0.435 . . . . 0.0 111.149 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.627 ' CD1' HG21 ' A' ' 69' ' ' VAL . 30.1 m-85 -68.36 167.77 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.886 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.61 153.28 21.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.908 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -96.38 34.35 1.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.486 ' CB ' ' HD2' ' A' ' 95' ' ' LYS . 1.3 t60 -148.13 148.82 31.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -66.54 -72.34 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.992 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -102.85 168.58 9.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.4 ' HB2' ' OE2' ' A' ' 58' ' ' GLU . 8.5 tp -52.34 142.66 16.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.486 ' HD2' ' CB ' ' A' ' 91' ' ' HIS . 0.0 OUTLIER -106.99 132.78 52.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.68 100.42 8.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.122 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -49.27 -32.61 11.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 99' ' ' SER . 19.6 m -120.01 125.89 49.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 98' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.978 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.9 p . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.52 164.02 52.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.498 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.09 142.65 38.97 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 111.151 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -51.66 130.19 32.76 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.704 2.269 . . . . 0.0 112.31 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.5 p -150.8 151.48 32.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.53 -53.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.73 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 89' ' ' SER . 21.8 t -90.26 143.59 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.806 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.531 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 20.9 mm -118.41 103.07 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.376 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.549 ' NE2' ' CZ ' ' A' ' 56' ' ' PHE . 4.5 t-160 -79.03 144.95 34.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.338 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 85' ' ' TYR . 9.5 mt -133.05 138.68 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.918 0.39 . . . . 0.0 111.457 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.543 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 12.2 ptm180 -123.42 170.35 10.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.467 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 52.2 38.98 25.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.216 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.764 ' HA ' HG22 ' A' ' 84' ' ' ILE . 2.7 tp -125.22 119.85 25.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.466 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 26' ' ' ILE . 20.2 Cg_endo -60.49 80.15 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.274 1.982 . . . . 0.0 110.716 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.79 HG21 ' C ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -32.18 154.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.733 -178.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 28' ' ' VAL . 22.3 t0 79.23 2.37 2.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.171 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.667 HG22 ' H ' ' A' ' 29' ' ' THR . 2.0 p -54.81 -165.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.667 ' H ' HG22 ' A' ' 28' ' ' VAL . 55.1 p -104.26 144.72 31.23 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.904 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.782 ' HG3' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -62.06 -46.66 88.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.487 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.3 -29.45 0.12 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.64 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.827 ' CD ' HD23 ' A' ' 79' ' ' LEU . 2.7 tp10 -83.34 -60.96 1.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 0.0 110.259 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 t -55.45 -58.87 3.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.597 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.703 ' HA ' HG21 ' A' ' 43' ' ' VAL . 1.3 mt -53.24 -53.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.489 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.5 m -39.29 -50.2 1.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.571 ' O ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -61.09 -32.39 72.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.747 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.57 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -83.03 -25.77 47.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.608 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.466 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -39.21 -60.65 1.16 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 110.709 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 43.1 Cg_endo -67.8 -22.88 42.4 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.548 2.165 . . . . 0.0 111.651 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.636 ' CD1' HG22 ' A' ' 67' ' ' THR . 16.1 m-30 -76.34 -6.47 51.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.043 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.19 -103.23 0.44 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.334 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.512 ' HB3' ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -150.4 138.23 19.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.154 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.703 HG21 ' HA ' ' A' ' 34' ' ' ILE . 43.2 t -92.53 89.96 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.132 0.492 . . . . 0.0 110.328 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.972 HG23 ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -74.82 1.9 11.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.867 -179.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 44' ' ' THR . 0.7 OUTLIER 170.69 158.47 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.939 0.4 . . . . 0.0 111.456 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.014 HD13 HG22 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -152.58 102.25 2.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.582 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.628 ' N ' HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -95.6 104.5 16.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.523 ' CE ' HG12 ' A' ' 28' ' ' VAL . 46.9 mmm -78.19 107.95 11.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.553 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.956 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -88.91 101.58 14.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.862 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.557 ' HD2' ' CG2' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -74.3 -168.39 0.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.072 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.42 -100.68 2.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.429 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -74.13 -69.87 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 110.736 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.577 ' ND2' ' CD1' ' A' ' 26' ' ' ILE . 0.6 OUTLIER 159.97 77.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.947 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.627 ' HB2' HD12 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -159.33 161.83 35.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.863 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.536 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -151.38 163.98 37.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.705 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -143.0 115.77 8.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.871 0.367 . . . . 0.0 111.242 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.014 HG22 HD13 ' A' ' 46' ' ' LEU . 31.2 pt -105.17 133.01 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.552 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.66 102.64 14.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.84 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.46 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -64.46 157.21 27.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.489 179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.972 ' OD1' HG23 ' A' ' 44' ' ' THR . 2.6 m-80 -68.79 -39.42 80.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.647 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -133.18 169.81 16.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.168 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.429 ' N ' ' OG1' ' A' ' 61' ' ' THR . 2.4 mp0 -73.31 -36.2 66.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.773 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -60.91 -40.08 91.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.719 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 40' ' ' PHE . . . -64.45 -49.09 72.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.46 ' HA ' ' SD ' ' A' ' 59' ' ' MET . . . -50.44 -53.23 31.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.221 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -46.49 -63.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.114 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.636 HG22 ' CD1' ' A' ' 40' ' ' PHE . 24.8 m -40.91 -46.77 2.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.309 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.703 ' SD ' HD11 ' A' ' 57' ' ' ILE . 0.9 OUTLIER -46.64 -65.01 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 -179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.736 HG11 ' CD2' ' A' ' 88' ' ' PHE . 46.1 t -70.61 -54.2 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.451 ' O ' ' OG1' ' A' ' 73' ' ' THR . 5.7 t-20 -38.75 -64.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.061 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -59.18 -31.2 68.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.013 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.485 ' OH ' ' HG ' ' A' ' 36' ' ' LEU . 14.0 m-30 -89.22 20.11 3.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.048 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 32.5 m -78.57 -22.64 46.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.841 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 74.1 m -124.34 -41.08 2.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.683 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.8 t -89.96 130.12 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.925 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.544 HG23 ' HD2' ' A' ' 77' ' ' PRO . 2.8 m -91.82 146.14 32.41 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.025 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.736 ' CG ' HD12 ' A' ' 86' ' ' ILE . 26.8 Cg_endo -95.97 138.5 0.72 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 123.262 2.641 . . . . 0.0 112.165 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.528 HG13 ' N ' ' A' ' 83' ' ' PRO . 16.9 t -125.02 154.51 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.127 0.489 . . . . 0.0 111.402 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.025 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -114.18 99.89 7.96 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.188 178.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.476 ' HB2' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER 62.24 -62.12 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.029 0.443 . . . . 0.0 110.182 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -159.45 23.86 0.3 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.371 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.447 ' C ' HG13 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -128.79 97.77 26.32 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.861 0.362 . . . . 0.0 110.693 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.528 ' N ' HG13 ' A' ' 78' ' ' VAL . 52.9 Cg_exo -55.3 106.01 0.17 Allowed 'Trans proline' 0 C--O 1.23 0.125 0 C-N-CA 122.833 2.355 . . . . 0.0 112.707 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.764 HG22 ' HA ' ' A' ' 24' ' ' LEU . 2.6 pt -107.28 107.71 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.465 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.59 ' O ' HG23 ' A' ' 21' ' ' ILE . 8.9 m-30 -65.12 142.18 58.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.63 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.736 HD12 ' CG ' ' A' ' 77' ' ' PRO . 13.5 mt -126.14 134.24 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.372 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -149.78 172.17 15.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 0.0 111.04 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.736 ' CD2' HG11 ' A' ' 69' ' ' VAL . 39.4 m-85 -65.48 -173.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.893 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.455 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 1.7 t -142.37 139.9 31.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.503 ' O ' ' CB ' ' A' ' 91' ' ' HIS . 0.1 OUTLIER -36.34 -60.93 0.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.503 ' CB ' ' O ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER 159.37 45.11 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.957 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 15.0 mmmt -88.09 73.43 9.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.929 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.435 ' C ' HD12 ' A' ' 94' ' ' LEU . 7.4 tt0 -65.47 138.63 58.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.578 ' N ' HD12 ' A' ' 94' ' ' LEU . 2.3 mp -98.12 147.64 24.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.54 145.0 25.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.915 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.34 123.59 28.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.078 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.5 t0 57.15 111.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -101.6 111.21 23.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.899 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.806 0.336 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.447 ' C ' ' HD2' ' A' ' 15' ' ' PRO . . . 82.36 102.03 0.44 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.565 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.763 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 29.3 m -124.32 24.63 0.11 Allowed Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.763 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 90.3 Cg_exo -35.43 -63.11 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.261 2.641 . . . . 0.0 112.45 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.803 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 23.4 m 36.17 63.64 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -11.7 61.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.043 HG11 ' HB3' ' A' ' 90' ' ' ASN . 12.6 p -114.12 142.79 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 68' ' ' MET . 11.4 mm -127.04 143.18 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.918 ' C ' HD13 ' A' ' 21' ' ' ILE . 7.2 t-80 -110.86 156.28 21.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.672 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.975 HD12 HG12 ' A' ' 86' ' ' ILE . 2.5 mm -128.31 106.93 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.425 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -83.61 171.22 13.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.646 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER 39.32 31.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.947 0.403 . . . . 0.0 110.354 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.929 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -102.07 107.41 52.55 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.288 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.627 ' N ' HD22 ' A' ' 24' ' ' LEU . 53.2 Cg_exo -51.98 82.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.484 2.122 . . . . 0.0 111.534 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.578 ' CD1' ' ND2' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -34.24 155.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.022 -179.297 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 25.1 t0 80.88 -3.05 1.8 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.223 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.682 HG22 ' H ' ' A' ' 29' ' ' THR . 2.0 p -54.64 -166.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.682 ' H ' HG22 ' A' ' 28' ' ' VAL . 69.8 p -100.2 144.19 29.51 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.862 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.793 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -63.74 -40.63 97.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.312 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -58.39 -28.09 61.56 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.982 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.444 ' HG3' ' OG1' ' A' ' 29' ' ' THR . 30.5 mt-10 -70.71 -64.59 0.87 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 110.361 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.673 HG12 HG21 ' A' ' 57' ' ' ILE . 46.8 t -55.2 -43.07 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.555 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.793 HD12 ' O ' ' A' ' 30' ' ' GLU . 1.6 mp -70.1 -42.81 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.5 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 3.4 t -40.3 -42.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.027 0.441 . . . . 0.0 110.138 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.604 HD22 ' OH ' ' A' ' 72' ' ' TYR . 81.5 mt -73.03 -37.89 66.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.101 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.589 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -76.49 -11.69 84.95 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.332 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.765 ' CD2' HG22 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -55.93 -61.04 7.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.818 0.342 . . . . 0.0 110.794 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.6 Cg_endo -66.12 -21.14 56.16 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.649 2.233 . . . . 0.0 111.772 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.592 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 16.3 m-30 -70.04 -28.78 65.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.626 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.3 -99.14 0.18 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.13 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.555 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 14.3 mtpt -150.63 135.89 17.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.826 0.346 . . . . 0.0 111.079 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.759 HG21 ' CG1' ' A' ' 34' ' ' ILE . 42.4 t -86.6 118.13 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.27 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 1.014 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -88.78 -8.61 54.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.698 -179.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 44' ' ' THR . 1.3 t-20 170.85 165.54 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.885 0.374 . . . . 0.0 111.275 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.88 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -139.85 113.9 8.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.883 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.611 ' CD1' HD21 ' A' ' 49' ' ' LEU . 1.3 tm? -122.75 120.44 33.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.853 ' C ' HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -108.43 145.09 35.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.91 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.853 HD23 ' C ' ' A' ' 48' ' ' MET . 2.1 mt -117.09 102.69 9.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.795 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.529 ' N ' HG21 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -72.71 136.71 45.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.4 -80.0 0.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.693 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.49 8.16 14.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 111.079 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.578 ' ND2' ' CD1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 56.89 84.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.068 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.492 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 51.8 mt-30 -159.25 123.45 3.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.398 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.576 ' HB2' HD12 ' A' ' 24' ' ' LEU . . . -109.7 170.12 8.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.527 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.538 ' CD1' ' C ' ' A' ' 55' ' ' ALA . 28.1 m-85 -148.23 143.22 26.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.01 0.433 . . . . 0.0 111.383 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.89 HD11 ' SD ' ' A' ' 68' ' ' MET . 1.0 OUTLIER -144.33 125.18 8.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.494 179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.806 ' O ' HG23 ' A' ' 44' ' ' THR . 38.3 mt-10 -93.74 127.13 39.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.258 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.502 ' CE ' ' HB1' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -99.98 146.44 26.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.164 179.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 1.014 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.1 OUTLIER -88.78 -9.22 52.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.716 0.293 . . . . 0.0 110.69 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.55 160.55 21.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.138 0.494 . . . . 0.0 111.785 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -80.84 -37.8 29.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.305 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 63' ' ' GLU . 1.1 tp10 -71.09 -23.02 62.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.061 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.502 ' HB1' ' CE ' ' A' ' 59' ' ' MET . . . -74.27 -43.29 57.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.692 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.803 ' HB1' ' O ' ' A' ' 16' ' ' SER . . . -65.46 -66.06 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.211 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -52.22 -63.2 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 71' ' ' TYR . 77.3 m -40.73 -47.72 2.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.371 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.89 ' SD ' HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -46.36 -65.26 0.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.068 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 68.0 t -68.51 -54.83 18.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.233 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 73' ' ' THR . 8.9 t-20 -46.52 -62.2 1.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.07 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.483 ' HB3' ' O ' ' A' ' 67' ' ' THR . 4.0 t80 -43.42 -48.81 7.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.153 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.604 ' OH ' HD22 ' A' ' 36' ' ' LEU . 39.6 m-85 -80.52 7.37 10.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.242 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.472 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 20.4 m -49.03 -32.39 9.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.96 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.3 m -115.36 -56.06 2.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -81.1 134.64 26.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.189 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.7 HG23 ' HD2' ' A' ' 77' ' ' PRO . 8.1 m -92.17 152.19 42.37 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.886 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.7 ' HD2' HG23 ' A' ' 76' ' ' THR . 9.6 Cg_endo -91.4 94.05 0.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.194 2.596 . . . . 0.0 112.315 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.878 ' C ' HD12 ' A' ' 79' ' ' LEU . 3.5 t -86.3 154.51 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.117 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.878 HD12 ' C ' ' A' ' 78' ' ' VAL . 9.5 mp -144.29 100.96 3.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 59.92 14.6 4.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.724 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' ' 83' ' ' PRO . . . 115.33 -3.23 22.1 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -102.71 97.72 9.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.329 . . . . 0.0 110.77 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 89.5 Cg_endo -79.11 96.78 1.09 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.8 2.333 . . . . 0.0 112.511 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.52 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 2.0 pt -100.81 107.74 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.738 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 12.1 m-85 -66.29 148.84 51.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.546 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.975 HG12 HD12 ' A' ' 21' ' ' ILE . 4.6 mt -126.27 111.88 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.473 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.434 ' OE1' ' HB3' ' A' ' 85' ' ' TYR . 3.1 mp0 -128.25 173.11 10.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.909 0.385 . . . . 0.0 111.155 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 72.7 m-85 -72.84 152.26 41.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.548 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -152.13 -174.97 5.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 1.043 ' HB3' HG11 ' A' ' 18' ' ' VAL . 0.9 OUTLIER 38.4 -162.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.955 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 92' ' ' LYS . 1.3 t-80 -105.03 -153.04 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 91' ' ' HIS . 6.1 mmtt -35.69 -64.07 0.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.406 ' OE2' ' HB2' ' A' ' 92' ' ' LYS . 0.7 OUTLIER -136.58 154.71 50.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.452 ' O ' ' OE2' ' A' ' 58' ' ' GLU . 9.3 tp -93.85 99.88 12.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.902 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.99 142.38 38.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.982 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.45 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -126.97 97.24 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 96' ' ' THR . 3.7 p30 164.57 178.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 99' ' ' SER . 12.5 m -153.31 34.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 98' ' ' SER . 2.0 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.866 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.781 0.324 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.703 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -115.29 -70.57 0.48 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.464 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -167.02 156.24 9.58 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.369 . . . . 0.0 111.153 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.7 105.45 1.11 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.77 2.313 . . . . 0.0 112.288 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.8 m -147.21 102.38 3.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.11 -53.79 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' A' ' 89' ' ' SER . 98.2 t -87.98 103.92 14.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.995 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.491 HD11 HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -87.25 134.03 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.544 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 9.3 t-160 -97.19 114.38 26.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 85' ' ' TYR . 11.2 mt -89.31 123.69 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.221 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -107.68 168.68 9.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 5.9 tmtt? 49.02 37.16 9.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.634 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.688 HD13 HD12 ' A' ' 84' ' ' ILE . 2.5 tp -120.83 126.95 26.47 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.003 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.483 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 58.1 Cg_endo -71.74 76.5 1.96 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.45 2.1 . . . . 0.0 111.449 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.954 HD11 ' C ' ' A' ' 54' ' ' GLN . 34.2 mm -34.42 155.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.837 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 24.7 t0 86.64 -4.97 0.72 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.776 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.74 HG13 ' N ' ' A' ' 29' ' ' THR . 1.8 p -59.95 -154.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.744 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.74 ' N ' HG13 ' A' ' 28' ' ' VAL . 43.8 p -105.99 144.79 32.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.184 0.516 . . . . 0.0 112.082 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.633 ' O ' HD12 ' A' ' 34' ' ' ILE . 11.2 mp0 -69.66 -35.25 74.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.517 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 35' ' ' SER . . . -53.58 -30.72 43.15 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.913 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.7 ' HG2' HD23 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -77.26 -57.88 3.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.833 0.349 . . . . 0.0 110.447 179.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 37.5 t -53.1 -43.14 47.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.977 ' CG1' HG21 ' A' ' 43' ' ' VAL . 1.5 mp -72.45 -46.87 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.589 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -38.62 -34.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.355 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 77' ' ' PRO . 18.3 mt -82.38 -39.26 22.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.51 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -72.32 -17.51 77.61 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.38 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.582 ' CD2' HG22 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -46.81 -60.67 3.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.876 0.369 . . . . 0.0 110.806 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.6 Cg_endo -66.05 -30.78 47.18 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.716 2.277 . . . . 0.0 112.11 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.618 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.1 m-30 -63.73 -40.44 96.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.597 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 64' ' ' ALA . . . 168.57 -98.78 0.14 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.395 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.456 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -151.09 142.5 23.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.719 0.295 . . . . 0.0 110.923 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.977 HG21 ' CG1' ' A' ' 34' ' ' ILE . 42.8 t -88.76 82.54 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.213 0.53 . . . . 0.0 110.687 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.991 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -66.57 -7.3 19.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.42 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 176.68 145.74 0.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.914 0.388 . . . . 0.0 111.249 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.967 HD13 HG22 ' A' ' 57' ' ' ILE . 4.9 tp -136.4 103.07 5.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.53 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 47' ' ' LEU . 3.2 tm? -105.87 105.17 15.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.3 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.6 mmm -90.5 99.61 12.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.302 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.455 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -85.64 110.92 19.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.306 -179.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.554 ' CE ' HG22 ' A' ' 26' ' ' ILE . 10.1 mmtp -62.34 -172.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.349 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . 55.22 114.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.029 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER 88.87 -21.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.914 0.387 . . . . 0.0 110.669 -179.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.484 ' HA ' HG12 ' A' ' 26' ' ' ILE . 0.8 OUTLIER 68.11 63.73 0.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.494 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.954 ' C ' HD11 ' A' ' 26' ' ' ILE . 7.2 mm-40 -136.07 126.5 26.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.758 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.781 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.75 160.12 16.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -142.32 115.91 9.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.033 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.967 HG22 HD13 ' A' ' 46' ' ' LEU . 13.8 pt -113.42 140.91 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -96.22 102.73 14.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.632 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.812 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 7.1 mmm -66.34 116.07 6.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.0 110.779 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.991 ' ND2' HG23 ' A' ' 44' ' ' THR . 4.9 m120 -33.68 -49.72 0.32 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.328 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.76 -173.01 2.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.125 0.488 . . . . 0.0 112.079 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 64' ' ' ALA . 2.1 mt-10 -72.39 -57.45 4.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.177 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -38.92 -30.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.065 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.812 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -76.63 -56.29 4.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -54.34 -55.47 28.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.382 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -56.0 -70.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.618 HG22 ' CD1' ' A' ' 40' ' ' PHE . 21.1 m -42.47 -39.34 2.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.215 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.594 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -49.17 -62.84 1.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.579 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 72.2 t -80.79 -50.42 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.308 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -45.37 -39.03 6.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.195 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 67' ' ' THR . 4.3 t80 -78.01 -57.94 3.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.19 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.503 ' OH ' HD22 ' A' ' 36' ' ' LEU . 14.5 m-85 -62.14 -12.03 17.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.14 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.2 m -39.66 -29.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.011 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 72' ' ' TYR . 10.7 t -116.81 -45.9 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.795 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.39 131.83 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.556 ' OG1' ' CE2' ' A' ' 85' ' ' TYR . 1.3 m -97.62 142.41 24.52 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.979 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.52 ' CG ' HD12 ' A' ' 86' ' ' ILE . 19.1 Cg_endo -93.86 128.93 0.62 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.022 2.481 . . . . 0.0 112.076 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.699 HG13 ' C ' ' A' ' 82' ' ' GLN . 3.3 t -115.89 149.18 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.192 0.52 . . . . 0.0 111.427 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.036 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -114.09 107.98 16.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.371 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.683 ' N ' HD22 ' A' ' 79' ' ' LEU . 5.2 mtt180 62.93 -61.33 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 0.0 110.517 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -163.64 24.84 0.19 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.455 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.699 ' C ' HG13 ' A' ' 78' ' ' VAL . 1.2 tp60 -128.05 110.04 19.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 110.563 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.616 ' N ' HG13 ' A' ' 78' ' ' VAL . 37.8 Cg_endo -66.73 96.79 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.61 2.207 . . . . 0.0 112.385 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.688 HD12 HD13 ' A' ' 24' ' ' LEU . 3.3 pt -100.63 107.94 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.767 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CE2' ' OG1' ' A' ' 76' ' ' THR . 6.4 m-85 -75.28 153.64 37.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.525 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.568 HG21 ' CG ' ' A' ' 68' ' ' MET . 5.7 mt -126.01 112.12 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.561 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 20' ' ' HIS . 9.1 mt-30 -125.45 166.27 16.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 111.1 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.579 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 74.6 m-85 -61.72 177.53 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.832 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -133.84 148.09 51.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.99 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.19 17.65 2.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.71 -153.74 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -73.49 76.23 1.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.872 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 92' ' ' LYS . 77.1 mt-10 -38.99 160.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -85.43 137.85 32.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -109.35 128.87 55.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.405 ' O ' ' CG ' ' A' ' 97' ' ' ASP . 0.9 OUTLIER -110.42 109.55 19.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.097 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 96' ' ' THR . 3.4 p30 47.16 -165.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.29 112.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.778 0.323 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.25 -147.94 5.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.459 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -128.52 114.53 19.54 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 0.0 111.064 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.64 120.73 7.32 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.675 2.25 . . . . 0.0 112.317 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 64.9 m -151.12 158.62 44.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.942 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -123.75 -47.99 1.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.504 HG21 ' H ' ' A' ' 92' ' ' LYS . 3.4 t -87.91 97.92 7.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.982 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.851 HG21 ' SD ' ' A' ' 68' ' ' MET . 37.3 mm -82.41 110.52 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.292 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' GLN . 11.1 t-80 -80.59 156.51 26.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.047 HG21 HD12 ' A' ' 24' ' ' LEU . 1.4 mt -131.13 107.84 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.404 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' HG2' ' HB2' ' A' ' 85' ' ' TYR . 2.4 ptm180 -96.38 176.03 6.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.503 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 43.52 32.94 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.975 0.416 . . . . 0.0 110.252 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.047 HD12 HG21 ' A' ' 21' ' ' ILE . 1.4 tt -118.08 99.72 51.9 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.94 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.61 ' HD2' HG22 ' A' ' 84' ' ' ILE . 29.4 Cg_endo -63.25 67.15 0.16 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.178 1.919 . . . . 0.0 111.163 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.017 HD11 ' C ' ' A' ' 54' ' ' GLN . 47.7 mm -15.28 112.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 123.987 0.805 . . . . 0.0 112.085 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.6 t70 149.41 -10.71 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.51 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 29' ' ' THR . 6.0 m -60.96 -11.91 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.287 0.565 . . . . 0.0 111.809 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 28' ' ' VAL . 3.0 p 90.64 154.16 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.991 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . 4.7 mp0 -70.38 -41.39 73.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.512 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -42.35 -35.4 1.86 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.039 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.48 ' OE2' ' HB3' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -80.51 -45.28 17.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.865 0.364 . . . . 0.0 110.581 179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 57' ' ' ILE . 16.6 t -59.32 -58.2 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.969 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.841 HG13 HG21 ' A' ' 43' ' ' VAL . 1.5 mp -64.8 -40.68 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.661 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -41.58 -43.5 2.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.988 0.423 . . . . 0.0 110.292 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.519 ' CG ' ' OH ' ' A' ' 72' ' ' TYR . 7.4 mp -72.21 -36.71 69.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.5 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -70.82 -21.31 78.03 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.43 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.457 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.8 OUTLIER -44.87 -61.31 2.3 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.74 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 39.8 Cg_endo -67.05 -41.16 10.27 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.609 2.206 . . . . 0.0 111.648 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.62 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.1 m-30 -54.39 -28.43 43.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.687 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 42' ' ' LYS . . . 154.0 -106.92 0.31 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.191 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.572 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 17.3 mtpt -150.78 142.17 23.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.0 111.002 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.841 HG21 HG13 ' A' ' 34' ' ' ILE . 42.0 t -86.71 117.82 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.5 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 1.014 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER -91.75 -6.01 52.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.437 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -172.46 155.32 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.877 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.028 ' CD2' HG22 ' A' ' 57' ' ' ILE . 2.7 tm? -151.14 113.81 4.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 47' ' ' LEU . 6.6 tt -136.5 116.81 13.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.2 mtp -95.44 139.64 31.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.469 ' O ' HG13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -125.48 91.42 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.945 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.555 ' HD2' ' CG2' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -45.02 -26.18 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.938 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.35 127.82 10.18 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.53 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.7 OUTLIER 66.89 8.3 5.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.79 0.329 . . . . 0.0 110.901 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.566 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 16.7 m120 45.88 84.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.066 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 1.017 ' C ' HD11 ' A' ' 26' ' ' ILE . 67.5 mt-30 -159.2 135.71 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.595 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.808 ' HB3' HD12 ' A' ' 21' ' ' ILE . . . -109.29 166.6 10.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.794 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.537 ' CD1' ' C ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -139.72 117.45 11.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.478 -179.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.028 HG22 ' CD2' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -127.37 152.07 34.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.618 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.47 ' HB3' ' OG1' ' A' ' 44' ' ' THR . 35.7 mt-10 -120.05 142.06 49.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.41 . . . . 0.0 111.295 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.694 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -110.74 130.39 55.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.174 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 1.014 ' CG ' HG22 ' A' ' 44' ' ' THR . 1.5 m-80 -68.56 -15.47 63.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.64 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 61' ' ' THR . 12.3 t -132.21 125.34 30.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 111.271 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -43.46 -41.94 4.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.692 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.416 ' O ' ' OG1' ' A' ' 67' ' ' THR . 8.3 tt0 -57.12 -20.82 27.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.815 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -84.47 -46.93 11.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.968 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.848 ' HB1' HD11 ' A' ' 19' ' ' ILE . . . -64.25 -49.44 71.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.042 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -64.77 -44.28 90.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.494 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.62 HG22 ' CD1' ' A' ' 40' ' ' PHE . 18.2 m -60.34 -32.74 71.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.851 ' SD ' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -58.36 -63.13 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.618 HG21 ' CE1' ' A' ' 88' ' ' PHE . 8.4 t -70.31 -51.06 41.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.07 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' O ' ' OG1' ' A' ' 73' ' ' THR . 6.8 t30 -44.06 -63.96 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.964 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 67' ' ' THR . 10.7 t80 -55.59 -35.69 66.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.574 ' CD2' ' O ' ' A' ' 68' ' ' MET . 17.8 m-85 -83.23 9.86 9.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 53.6 m -59.52 -28.37 67.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.13 -45.73 1.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.8 t -83.43 110.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.628 HG23 ' HD2' ' A' ' 77' ' ' PRO . 4.1 m -88.17 149.18 44.57 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.845 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.628 ' HD2' HG23 ' A' ' 76' ' ' THR . 18.3 Cg_endo -95.28 113.43 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.226 2.617 . . . . 0.0 112.3 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 79' ' ' LEU . 22.1 t -100.26 160.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.988 0.423 . . . . 0.0 111.167 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.948 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -156.27 133.91 10.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.713 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.547 ' HB3' HD22 ' A' ' 79' ' ' LEU . 2.0 ttt-85 37.24 30.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.94 0.4 . . . . 0.0 110.423 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 80.53 50.19 5.45 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.803 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.527 ' O ' HD12 ' A' ' 79' ' ' LEU . 1.7 mm-40 -155.2 97.68 2.41 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.05 96.56 0.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.585 2.19 . . . . 0.0 112.496 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.664 HD12 ' HG ' ' A' ' 24' ' ' LEU . 4.4 pt -95.15 111.14 25.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.67 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.509 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 4.6 m-30 -72.52 152.94 41.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.521 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 21' ' ' ILE . 6.5 mt -126.14 104.77 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.519 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -131.6 171.49 13.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 111.097 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 69' ' ' VAL . 1.4 m-85 -84.41 155.56 22.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.97 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.42 ' HB2' ' CB ' ' A' ' 20' ' ' HIS . 8.1 t -152.03 81.01 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.939 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 54.66 70.8 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.975 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.447 ' HA ' ' HB ' ' A' ' 18' ' ' VAL . 2.6 p-80 -44.77 96.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.504 ' H ' HG21 ' A' ' 18' ' ' VAL . 1.1 mtmm -128.79 90.31 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HA ' ' OE2' ' A' ' 58' ' ' GLU . 2.8 mt-10 -39.42 137.34 0.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -78.34 111.55 14.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.38 154.09 19.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 3.8 p -81.51 106.28 13.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.148 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 96' ' ' THR . 15.7 m-20 66.07 175.0 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -54.54 9.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.838 0.351 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' C ' ' HD2' ' A' ' 15' ' ' PRO . . . 74.57 93.54 0.14 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.501 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 14' ' ' VAL . 7.1 p -126.73 22.66 0.1 Allowed Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.766 ' CD ' ' N ' ' A' ' 14' ' ' VAL . 35.0 Cg_endo -65.83 157.15 60.5 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.964 2.443 . . . . 0.0 112.264 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 65' ' ' ALA . 6.5 t -175.4 146.8 0.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.89 -49.06 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.848 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.05 126.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.069 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.574 ' CG2' HG23 ' A' ' 86' ' ' ILE . 48.0 mm -101.88 112.82 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.234 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.551 ' HB2' ' CB ' ' A' ' 89' ' ' SER . 4.9 t-80 -87.49 112.89 22.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.698 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.524 HG23 HG13 ' A' ' 86' ' ' ILE . 4.8 mt -82.78 127.9 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.303 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HG2' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -114.03 151.83 31.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.66 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER 64.4 34.86 10.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.553 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.64 HD13 HD12 ' A' ' 84' ' ' ILE . 4.8 tp -119.84 129.23 25.46 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.891 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.632 ' HD2' HD12 ' A' ' 24' ' ' LEU . 73.6 Cg_endo -76.63 69.64 6.67 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.484 2.123 . . . . 0.0 111.79 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.846 HD11 ' C ' ' A' ' 54' ' ' GLN . 6.1 mm -30.64 108.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.236 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 2.2 t70 148.69 -19.48 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.673 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.68 HG22 ' H ' ' A' ' 29' ' ' THR . 1.9 p -54.69 -162.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.857 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.68 ' H ' HG22 ' A' ' 28' ' ' VAL . 39.8 p -107.91 145.79 33.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.104 0.478 . . . . 0.0 111.885 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.545 ' HB3' HD23 ' A' ' 46' ' ' LEU . 7.8 mp0 -63.07 -46.7 86.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.635 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.85 -29.36 0.17 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.782 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.581 ' OE1' HD22 ' A' ' 79' ' ' LEU . 12.8 mm-40 -81.32 -55.03 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.254 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.1 t -61.26 -57.91 9.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.64 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.581 HG23 HG21 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -53.76 -50.26 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.066 179.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.8 m -42.12 -43.43 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.39 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.593 HD22 ' OH ' ' A' ' 72' ' ' TYR . 19.9 mt -63.99 -33.91 76.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.36 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -81.62 -23.12 58.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.521 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.525 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -40.49 -58.47 2.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.0 110.826 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.1 Cg_endo -66.18 -40.28 15.83 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.616 2.21 . . . . 0.0 111.947 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.628 ' CD1' HG22 ' A' ' 67' ' ' THR . 22.5 m-30 -55.23 -30.45 60.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.575 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 156.9 -104.41 0.25 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.094 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.577 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -150.43 137.95 19.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.912 0.387 . . . . 0.0 111.03 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 34' ' ' ILE . 51.4 t -86.99 121.47 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.403 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.961 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -96.76 -0.73 47.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.574 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 44' ' ' THR . 44.4 t30 178.06 149.44 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.982 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.86 HD13 HG22 ' A' ' 57' ' ' ILE . 1.5 tp -139.91 103.17 4.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.59 HD13 ' N ' ' A' ' 48' ' ' MET . 0.5 OUTLIER -115.5 113.85 24.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.935 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.629 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.4 mmm -99.65 99.58 10.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.604 ' C ' HG21 ' A' ' 26' ' ' ILE . 14.8 tp -82.04 97.41 8.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.81 ' CE ' HG22 ' A' ' 26' ' ' ILE . 3.4 mmtp -49.0 -21.5 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.303 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -79.34 126.07 7.29 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.698 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.507 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 1.8 mttt 71.36 7.19 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.737 0.303 . . . . 0.0 111.314 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 24' ' ' LEU . 8.2 m120 49.98 62.09 2.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.035 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.846 ' C ' HD11 ' A' ' 26' ' ' ILE . 14.0 mm-40 -139.98 134.9 32.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.585 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.77 166.82 10.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.81 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -146.85 115.92 6.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 0.0 111.244 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.86 HG22 HD13 ' A' ' 46' ' ' LEU . 6.8 pt -118.03 143.04 29.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.698 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.755 ' O ' HG23 ' A' ' 44' ' ' THR . 0.5 OUTLIER -109.64 124.38 51.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.23 -179.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.523 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -91.66 138.68 31.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.351 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.961 ' CG ' HG22 ' A' ' 44' ' ' THR . 1.2 m-80 -67.25 -27.05 66.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.326 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.443 HG23 ' HB2' ' A' ' 64' ' ' ALA . 3.6 t -123.85 140.26 53.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.921 0.391 . . . . 0.0 111.377 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -54.43 -42.11 70.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.773 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -56.65 -29.28 62.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.632 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -72.04 -52.35 17.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.874 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 68' ' ' MET . . . -51.88 -60.97 2.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.08 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -44.99 -68.49 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.628 HG22 ' CD1' ' A' ' 40' ' ' PHE . 86.3 m -40.91 -36.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.979 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.968 ' SD ' HG21 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -51.67 -65.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.833 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 78.9 t -79.7 -49.26 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.172 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -41.99 -57.16 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.027 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -61.25 -50.37 73.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.053 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.593 ' OH ' HD22 ' A' ' 36' ' ' LEU . 20.2 m-30 -73.76 -0.42 15.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.259 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 69' ' ' VAL . 95.0 m -51.82 -20.68 2.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 110.931 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 t -127.21 -51.87 1.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.83 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.4 p -89.73 123.41 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.03 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.4 m -99.02 142.2 24.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.986 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.478 ' O ' HG12 ' A' ' 84' ' ' ILE . 45.6 Cg_endo -96.94 109.63 0.1 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.271 2.647 . . . . 0.0 112.292 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.992 ' O ' HD23 ' A' ' 79' ' ' LEU . 1.4 m -100.86 -179.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 111.0 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.992 HD23 ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -154.95 122.97 5.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.684 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 80' ' ' ARG . 2.8 ttp180 63.32 11.82 5.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.715 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.81 19.97 15.89 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.5 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.449 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 4.5 mm-40 -116.59 97.61 50.43 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.82 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.417 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 17.2 Cg_exo -67.24 115.41 3.65 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.969 2.446 . . . . 0.0 112.55 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.64 HD12 HD13 ' A' ' 24' ' ' LEU . 3.3 pt -122.01 107.82 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 21' ' ' ILE . 3.5 m-85 -76.03 150.75 37.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.661 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.968 HG21 ' SD ' ' A' ' 68' ' ' MET . 5.6 mt -126.11 109.67 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.341 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 20' ' ' HIS . 2.5 mt-30 -117.13 173.29 6.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.128 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.587 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 47.9 m-85 -71.73 156.12 39.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.95 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 20' ' ' HIS . 4.0 t -120.08 145.76 46.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 92' ' ' LYS . 1.9 m-20 -64.48 64.65 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.767 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.519 ' NE2' ' HG2' ' A' ' 93' ' ' GLU . 81.8 t60 38.04 -92.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.996 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.545 ' O ' ' CG ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER 51.83 80.47 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.08 0.467 . . . . 0.0 110.137 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.519 ' HG2' ' NE2' ' A' ' 91' ' ' HIS . 0.9 OUTLIER -48.4 118.43 2.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.911 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.9 mt -72.67 149.33 43.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.02 137.08 39.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.038 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 85.6 m -127.19 133.32 50.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.101 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -57.57 175.3 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 47.59 81.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.898 0.38 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.64 171.05 33.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.495 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.69 161.8 28.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 111.141 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.475 ' O ' ' HB3' ' A' ' 16' ' ' SER . 51.4 Cg_exo -52.71 -62.58 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.738 2.292 . . . . 0.0 112.316 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.565 ' OG ' ' CE1' ' A' ' 88' ' ' PHE . 42.2 t 68.53 159.01 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.943 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.401 ' HG2' ' OE2' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -166.44 -42.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 91' ' ' HIS . 21.6 t -101.94 107.94 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.109 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.815 ' CG2' HG23 ' A' ' 86' ' ' ILE . 1.4 mp -93.58 113.38 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.587 ' CD2' ' HB3' ' A' ' 54' ' ' GLN . 4.5 t-80 -84.24 117.5 23.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.361 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.758 HG22 ' HB2' ' A' ' 24' ' ' LEU . 9.9 mt -87.76 98.32 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.501 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -77.57 177.29 8.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.452 179.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER 37.19 38.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.863 0.363 . . . . 0.0 110.555 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.758 ' HB2' HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -123.65 99.94 38.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.934 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.56 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 34.6 Cg_exo -57.33 74.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.569 2.179 . . . . 0.0 111.771 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.899 HG23 ' HB3' ' A' ' 48' ' ' MET . 16.2 mm -33.23 119.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 5.1 t0 150.95 -19.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.952 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 29' ' ' THR . 6.1 m -54.99 -153.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.797 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.552 ' N ' HG23 ' A' ' 28' ' ' VAL . 40.6 p -112.05 145.7 39.23 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.06 0.457 . . . . 0.0 111.815 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.823 ' CD ' HD12 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -65.28 -56.16 14.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.545 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.89 -33.15 0.4 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.999 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.596 ' HG2' HD21 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -68.63 -58.33 4.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.476 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.02 -48.52 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.622 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.873 ' CG1' HG21 ' A' ' 43' ' ' VAL . 1.6 mp -65.08 -38.2 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.513 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -47.51 -41.44 20.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.649 HD23 ' OH ' ' A' ' 72' ' ' TYR . 8.5 mp -71.5 -33.53 69.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.2 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.597 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -69.92 -25.25 75.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.346 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.516 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 1.0 OUTLIER -41.76 -59.77 2.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 110.856 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 28.5 Cg_endo -62.87 -23.06 74.27 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.67 2.247 . . . . 0.0 111.883 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.597 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 13.7 m-30 -76.64 -38.69 54.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.507 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.13 -102.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.158 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.534 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 3.4 mtmm -150.52 146.55 26.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.777 0.323 . . . . 0.0 110.987 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.873 HG21 ' CG1' ' A' ' 34' ' ' ILE . 55.8 t -86.86 112.55 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.525 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.946 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -88.19 -13.64 40.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.202 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 170.93 119.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.051 HD23 HG22 ' A' ' 57' ' ' ILE . 1.2 tm? -123.83 117.41 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.999 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.646 ' N ' HD22 ' A' ' 46' ' ' LEU . 8.9 tt -117.84 128.55 54.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.848 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.899 ' HB3' HG23 ' A' ' 26' ' ' ILE . 9.1 mtp -106.16 139.05 41.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.708 ' C ' HG21 ' A' ' 26' ' ' ILE . 37.3 mt -120.22 103.85 9.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.642 ' N ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -55.51 -17.37 5.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . -84.08 116.52 4.27 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.439 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER 82.65 -8.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 111.059 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.56 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 25.6 m120 61.29 77.53 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.968 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.587 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 48.8 mt-30 -155.06 130.8 9.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.665 ' CA ' HD11 ' A' ' 26' ' ' ILE . . . -109.72 162.54 14.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.779 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.604 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -144.9 116.11 7.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.367 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.051 HG22 HD23 ' A' ' 46' ' ' LEU . 8.0 pt -110.19 155.04 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.815 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.761 ' O ' HG23 ' A' ' 44' ' ' THR . 0.0 OUTLIER -122.04 119.11 30.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.785 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 32.7 mmm -90.77 142.54 27.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.698 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.946 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -72.88 -23.87 60.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.912 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.5 t -130.35 137.39 49.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.229 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -48.29 -42.85 32.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.45 ' O ' ' CB ' ' A' ' 67' ' ' THR . 10.8 mp0 -53.03 -30.07 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.749 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.785 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -77.25 -47.28 20.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.988 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -65.75 -58.94 4.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.045 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 6.4 m-20 -54.68 -59.5 4.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.813 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.45 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 18.6 m -40.93 -49.0 3.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.977 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.589 ' HA ' ' CZ ' ' A' ' 40' ' ' PHE . 2.1 ttm -46.18 -63.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.82 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.773 HG13 ' HG3' ' A' ' 87' ' ' GLN . 39.1 t -68.91 -15.97 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.136 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.453 ' O ' ' OG1' ' A' ' 73' ' ' THR . 1.2 t-20 -72.82 -64.12 1.03 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 5.0 t80 -60.86 -24.4 65.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.649 ' OH ' HD23 ' A' ' 36' ' ' LEU . 24.5 m-85 -93.07 19.99 7.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.059 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 91.6 m -72.03 -31.1 65.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.8 m -118.79 -50.55 2.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.789 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.8 t -82.48 119.92 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.982 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.5 m -87.59 141.93 32.48 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.921 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.75 ' HG2' HD12 ' A' ' 86' ' ' ILE . 35.5 Cg_endo -95.81 142.88 1.08 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.081 2.52 . . . . 0.0 112.255 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' A' ' 83' ' ' PRO . 2.0 m -129.21 -179.69 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.165 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.636 HD23 ' HG3' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -141.75 108.5 5.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.636 ' HG3' HD23 ' A' ' 79' ' ' LEU . 21.1 mtm-85 61.26 14.02 5.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.502 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 113.29 7.78 20.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.361 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.453 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 6.3 tp60 -113.54 103.75 55.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.974 0.416 . . . . 0.0 110.896 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.762 ' HA ' HG12 ' A' ' 78' ' ' VAL . 24.6 Cg_exo -63.01 121.02 8.74 Favored 'Trans proline' 0 C--O 1.23 0.123 0 C-N-CA 122.943 2.429 . . . . 0.0 112.617 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.601 HG22 ' HA ' ' A' ' 24' ' ' LEU . 2.4 pt -122.34 107.56 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.513 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 21' ' ' ILE . 20.4 m-85 -62.08 141.54 58.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.036 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.815 HG23 ' CG2' ' A' ' 19' ' ' ILE . 6.5 mt -126.55 107.92 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.466 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.773 ' HG3' HG13 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -152.88 169.55 22.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 111.192 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.577 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 1.1 m-85 -74.8 137.74 42.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.554 ' HB3' ' CB ' ' A' ' 20' ' ' HIS . 3.9 t -152.39 82.56 1.24 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.882 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 89' ' ' SER . 11.5 m-80 82.51 -152.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.481 ' O ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -139.54 -58.98 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.931 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt 38.88 64.6 0.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -39.06 139.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -88.0 110.27 20.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.84 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -105.53 109.47 21.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.818 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.5 p -115.13 131.25 56.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.147 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 98' ' ' SER . 0.2 OUTLIER -72.69 90.32 1.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 59.1 p 173.74 53.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.88 0.371 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 53.04 -98.55 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.464 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.728 HG21 ' CB ' ' A' ' 62' ' ' GLU . 7.6 p -37.11 111.98 0.55 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.18 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.608 ' HG3' ' CZ ' ' A' ' 88' ' ' PHE . 55.5 Cg_endo -70.24 -47.99 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.714 2.276 . . . . 0.0 112.395 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.568 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -157.96 159.45 36.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.061 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.405 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -86.23 -24.64 25.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.887 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.477 ' O ' HD13 ' A' ' 19' ' ' ILE . 71.7 t -87.86 144.27 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.035 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.5 ' CG2' HG23 ' A' ' 86' ' ' ILE . 34.8 mm -122.4 107.89 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.213 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 87' ' ' GLN . 5.4 t-160 -78.82 121.9 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.806 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.788 HD12 HG12 ' A' ' 86' ' ' ILE . 4.3 mm -100.45 112.65 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.241 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 174.16 6.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.795 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER 45.06 44.01 7.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.675 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.777 ' HA ' HG22 ' A' ' 84' ' ' ILE . 3.2 tp -134.46 109.34 11.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.557 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 33.0 Cg_endo -64.51 74.84 0.2 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.401 2.067 . . . . 0.0 111.729 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.801 HG23 ' HB3' ' A' ' 48' ' ' MET . 15.3 mm -31.83 117.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.052 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 3.6 t70 151.16 -19.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.162 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 29' ' ' THR . 5.7 m -54.86 -155.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.881 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.538 ' N ' HG23 ' A' ' 28' ' ' VAL . 81.2 p -112.38 145.03 40.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 111.674 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.48 ' HB3' HD11 ' A' ' 34' ' ' ILE . 32.6 mt-10 -65.36 -50.6 64.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.438 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.99 -28.33 0.23 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.036 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.867 ' OE1' HD23 ' A' ' 79' ' ' LEU . 37.5 mt-10 -78.46 -52.15 8.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.945 0.403 . . . . 0.0 110.494 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 t -68.54 -57.47 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.729 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.528 HD11 HD23 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -53.14 -40.74 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 8.0 t -54.94 -43.07 73.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.698 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.554 ' CD2' ' HB2' ' A' ' 77' ' ' PRO . 6.3 mp -74.87 -11.27 60.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.761 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.65 -22.13 8.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.769 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.437 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -50.73 -52.54 55.77 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.66 0.267 . . . . 0.0 110.985 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 39.7 Cg_exo -60.01 -24.2 75.7 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.484 2.123 . . . . 0.0 111.668 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.863 ' CD2' HG22 ' A' ' 67' ' ' THR . 79.0 m-85 -82.03 7.24 13.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.035 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.13 -108.67 1.0 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.292 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.541 ' HB3' ' ND2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -150.55 146.05 26.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.101 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.453 HG21 HG23 ' A' ' 34' ' ' ILE . 55.2 t -99.81 97.04 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.955 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.937 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -87.8 22.23 2.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.302 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.9 OUTLIER 171.67 147.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.069 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.698 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -155.05 97.26 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.828 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.676 HD13 ' N ' ' A' ' 48' ' ' MET . 2.3 tm? -105.36 122.29 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.011 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.801 ' HB3' HG23 ' A' ' 26' ' ' ILE . 6.9 mtt -102.17 116.82 33.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.624 ' C ' HG21 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -88.88 101.06 13.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.605 ' CE ' HG22 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -82.03 48.13 1.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.98 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -129.57 -60.49 0.1 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.249 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -108.32 12.3 26.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.557 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 24.8 m120 62.72 64.89 0.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.914 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.585 ' C ' HD11 ' A' ' 26' ' ' ILE . 78.3 mt-30 -148.0 134.17 19.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.843 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.67 ' CA ' HD11 ' A' ' 26' ' ' ILE . . . -109.66 157.68 18.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.735 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -140.95 115.85 9.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.239 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.499 HG22 HD13 ' A' ' 46' ' ' LEU . 22.5 pt -114.91 138.18 45.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.797 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -104.6 102.7 12.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.993 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.473 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -62.9 128.31 35.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.408 179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.937 ' ND2' HG23 ' A' ' 44' ' ' THR . 0.3 OUTLIER -48.13 -39.81 21.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.31 -179.312 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.46 HG23 ' HB2' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -118.11 163.43 16.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.872 0.367 . . . . 0.0 111.238 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.728 ' CB ' HG21 ' A' ' 14' ' ' VAL . 5.6 mp0 -71.68 -44.75 63.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.828 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -55.13 -30.51 59.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.423 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -69.15 -46.51 67.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.643 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.568 ' HB1' ' O ' ' A' ' 16' ' ' SER . . . -58.12 -60.0 4.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.255 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -42.01 -58.28 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.962 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.863 HG22 ' CD2' ' A' ' 40' ' ' PHE . 22.3 m -50.81 -51.84 46.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.326 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.593 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 6.3 tpt -36.3 -60.15 0.59 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.071 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.584 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 76.3 t -79.41 -26.43 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.424 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 1.5 t-20 -58.69 -64.12 1.05 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.079 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.62 -36.22 83.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.054 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.581 ' CE1' ' HG3' ' A' ' 77' ' ' PRO . 22.4 m-85 -87.93 20.06 3.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.983 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 87.7 m -68.7 -44.57 73.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.024 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.6 t -113.62 -39.82 3.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.769 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.8 t -80.54 108.91 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.937 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.474 ' OG1' ' CE2' ' A' ' 85' ' ' TYR . 2.2 m -93.81 122.3 62.53 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.065 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.581 ' HG3' ' CE1' ' A' ' 72' ' ' TYR . 74.2 Cg_endo -96.79 120.17 0.18 Allowed 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 123.064 2.509 . . . . 0.0 112.215 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 83' ' ' PRO . 1.4 m -89.34 -179.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.235 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.974 HD13 ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -141.71 133.53 27.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.688 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.776 ' HB2' HD22 ' A' ' 79' ' ' LEU . 0.5 OUTLIER 36.25 30.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.443 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 85.57 51.98 3.5 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.871 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.552 ' HB3' ' CD1' ' A' ' 79' ' ' LEU . 1.5 tt0 -155.2 97.74 2.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.984 0.421 . . . . 0.0 110.799 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.75 ' HA ' HG12 ' A' ' 78' ' ' VAL . 52.1 Cg_exo -54.8 107.28 0.22 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.866 2.377 . . . . 0.0 112.658 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.777 HG22 ' HA ' ' A' ' 24' ' ' LEU . 7.1 pt -116.83 107.75 23.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.701 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CE2' ' OG1' ' A' ' 76' ' ' THR . 27.7 m-85 -71.28 149.08 46.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.317 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.788 HG12 HD12 ' A' ' 21' ' ' ILE . 4.5 mt -124.68 103.81 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.631 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 20' ' ' HIS . 2.8 mt-30 -125.16 172.05 9.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.883 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.608 ' CZ ' ' HG3' ' A' ' 15' ' ' PRO . 59.9 m-85 -68.88 -174.88 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.5 170.4 15.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.33 43.63 1.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -118.36 -177.83 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.57 -82.25 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.31 136.86 28.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.973 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mp -75.25 135.48 40.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.97 125.15 51.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 97' ' ' ASP . 0.9 OUTLIER -124.48 120.05 30.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.123 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 96' ' ' THR . 0.0 OUTLIER 42.99 -170.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.927 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 p -139.82 111.46 7.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.865 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.802 0.334 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 47.08 91.05 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.457 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 62' ' ' GLU . 1.9 t -63.86 130.19 94.3 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.888 0.375 . . . . 0.0 111.194 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 88' ' ' PHE . 75.1 Cg_exo -49.45 -64.68 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.731 2.287 . . . . 0.0 112.328 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.51 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 0.3 OUTLIER 165.36 156.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.986 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.512 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 15.1 ptp180 -72.04 -16.98 62.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.569 HG12 ' HB3' ' A' ' 89' ' ' SER . 87.5 t -87.92 140.88 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.669 HG21 ' HG2' ' A' ' 68' ' ' MET . 24.1 mm -127.07 109.24 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.138 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.642 ' CD2' ' CZ ' ' A' ' 56' ' ' PHE . 11.5 t-160 -78.93 110.55 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.795 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.503 HG23 HG13 ' A' ' 86' ' ' ILE . 25.7 mt -82.91 130.44 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.55 ' CG ' ' HB2' ' A' ' 85' ' ' TYR . 3.0 ptt180 -112.4 177.24 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 44.15 30.93 0.48 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.684 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.794 ' HA ' HG22 ' A' ' 84' ' ' ILE . 5.8 tp -117.59 112.85 38.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.564 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 21.9 Cg_exo -64.48 69.55 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.399 2.066 . . . . 0.0 111.391 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.796 HG21 ' C ' ' A' ' 49' ' ' LEU . 5.1 mm -33.97 111.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.371 0.605 . . . . 0.0 110.717 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 4.4 t70 150.7 -22.9 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.98 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.673 HG13 ' N ' ' A' ' 29' ' ' THR . 2.1 p -56.79 -157.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.608 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.673 ' N ' HG13 ' A' ' 28' ' ' VAL . 38.1 p -98.73 144.16 28.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.217 0.532 . . . . 0.0 112.035 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.65 -48.3 27.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.36 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.61 -31.4 0.4 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.706 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.659 ' HG2' HD13 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -79.22 -51.9 8.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 110.398 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' THR . 12.1 t -56.08 -51.09 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.775 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.823 HG23 HG21 ' A' ' 43' ' ' VAL . 1.5 mp -66.51 -50.4 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.506 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 14.9 t -44.76 -40.57 6.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.378 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 77' ' ' PRO . 13.4 mt -63.26 -42.0 99.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.43 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 40' ' ' PHE . . . -82.09 -8.99 85.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.387 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.588 HD13 HG22 ' A' ' 34' ' ' ILE . 1.3 tp -55.06 -60.05 9.16 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 110.724 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 19.7 Cg_endo -60.46 -17.85 50.34 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.611 2.208 . . . . 0.0 111.833 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.591 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 28.0 m-85 -76.99 -5.65 49.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.886 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 42' ' ' LYS . . . 141.1 -103.21 0.33 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.134 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.581 ' CB ' ' ND2' ' A' ' 60' ' ' ASN . 1.5 mmtp -150.46 138.88 20.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.851 0.358 . . . . 0.0 111.067 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.823 HG21 HG23 ' A' ' 34' ' ' ILE . 54.0 t -89.2 120.23 37.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 1.009 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -95.17 -11.98 27.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.157 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 8.7 t30 174.08 146.53 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.839 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.021 HD22 ' N ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -144.6 125.03 13.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.818 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.021 ' N ' HD22 ' A' ' 46' ' ' LEU . 7.2 tt -131.33 123.05 27.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.039 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.534 ' CA ' HD12 ' A' ' 26' ' ' ILE . 3.3 mmm -89.18 109.77 20.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.749 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.796 ' C ' HG21 ' A' ' 26' ' ' ILE . 13.6 tp -84.14 109.46 17.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.081 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.662 ' HD2' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -86.84 44.7 1.19 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.819 179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -115.84 -42.47 0.72 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.554 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 28.12 2.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 110.963 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 18.9 m120 57.93 49.18 12.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.943 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.535 ' HB3' ' NE2' ' A' ' 20' ' ' HIS . 47.8 mt-30 -134.4 140.08 46.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.363 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.559 ' CA ' HD11 ' A' ' 26' ' ' ILE . . . -109.9 172.55 6.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.65 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.642 ' CZ ' ' CD2' ' A' ' 20' ' ' HIS . 11.9 m-85 -148.01 115.71 6.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.355 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.517 HG22 HD23 ' A' ' 46' ' ' LEU . 6.6 pt -114.41 155.13 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.662 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.866 ' O ' HG23 ' A' ' 44' ' ' THR . 6.7 mm-40 -118.36 122.9 43.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.992 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.899 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 24.3 mmm -94.26 133.47 37.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.515 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 1.009 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -71.77 -24.82 61.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 110.924 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 64' ' ' ALA . 9.0 t -125.0 129.0 49.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.17 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.619 ' HB3' HG11 ' A' ' 14' ' ' VAL . 2.0 mp0 -44.68 -38.56 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.846 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -59.01 -26.45 64.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.899 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -76.38 -51.35 12.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.059 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 17' ' ' ARG . . . -57.05 -64.12 0.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.058 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.454 ' OD1' ' HG2' ' A' ' 15' ' ' PRO . 2.3 m-20 -44.73 -60.06 2.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.756 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.8 m -48.06 -35.88 12.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.034 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.669 ' HG2' HG21 ' A' ' 19' ' ' ILE . 9.4 tpt -51.52 -62.26 1.73 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.959 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.642 HG21 ' N ' ' A' ' 88' ' ' PHE . 46.1 t -77.53 -15.91 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.366 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.464 ' O ' ' OG1' ' A' ' 73' ' ' THR . 11.5 t-20 -76.46 -64.19 1.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.131 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -56.66 -38.47 72.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.128 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.526 ' CE2' ' CZ ' ' A' ' 40' ' ' PHE . 24.7 m-85 -84.72 12.78 6.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.07 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 70' ' ' ASN . 89.0 m -67.88 -34.73 77.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.11 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.22 -40.71 3.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.08 156.93 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.009 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.562 HG23 ' HD2' ' A' ' 77' ' ' PRO . 2.5 m -122.64 147.3 50.16 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.776 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.562 ' HD2' HG23 ' A' ' 76' ' ' THR . 28.9 Cg_endo -96.39 75.73 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.338 2.692 . . . . 0.0 112.386 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.603 ' O ' HD23 ' A' ' 79' ' ' LEU . 12.3 t -70.91 158.08 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.227 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.659 HD13 ' HG2' ' A' ' 32' ' ' GLU . 53.5 mt -137.63 113.44 9.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.108 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 51.64 20.23 1.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.474 ' O ' ' HD3' ' A' ' 83' ' ' PRO . . . 105.99 8.74 33.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.668 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.411 ' C ' HG13 ' A' ' 78' ' ' VAL . 5.5 tp-100 -109.27 97.5 26.44 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.829 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 81' ' ' GLY . 13.5 Cg_exo -69.93 126.75 13.55 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 123.045 2.496 . . . . 0.0 112.434 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.794 HG22 ' HA ' ' A' ' 24' ' ' LEU . 8.0 pt -135.35 107.45 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.55 ' HB2' ' CG ' ' A' ' 22' ' ' ARG . 3.3 m-85 -75.03 151.08 38.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.397 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.667 HG21 ' HG3' ' A' ' 68' ' ' MET . 4.4 mt -125.91 122.05 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.562 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.49 ' NE2' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -130.91 169.98 15.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.149 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.642 ' N ' HG21 ' A' ' 69' ' ' VAL . 58.8 m-85 -64.09 -179.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.021 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.569 ' HB3' HG12 ' A' ' 18' ' ' VAL . 87.9 p -113.76 -171.38 1.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -125.74 -39.6 2.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -68.13 -172.81 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 -43.69 3.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.5 163.28 27.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.443 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -78.98 118.41 20.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -63.44 120.58 11.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.28 135.39 54.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.112 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -101.09 51.64 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -133.23 95.74 3.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.849 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 98' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.942 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.796 0.331 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.08 63.48 0.61 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 14' ' ' VAL . 8.4 p -51.61 118.84 12.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.796 0.331 . . . . 0.0 111.123 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.48 115.89 2.5 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.704 2.269 . . . . 0.0 112.352 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.46 ' OG ' ' ND2' ' A' ' 66' ' ' ASN . 87.6 p -140.17 159.86 41.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.922 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -170.54 -45.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.917 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.609 HG13 ' HB3' ' A' ' 89' ' ' SER . 7.5 p -87.94 138.59 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.875 HG21 ' SD ' ' A' ' 68' ' ' MET . 47.2 mm -119.14 105.52 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 87' ' ' GLN . 5.0 t-160 -78.98 107.59 11.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.718 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.67 HG23 HD13 ' A' ' 86' ' ' ILE . 9.5 mt -85.22 118.52 32.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.402 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -100.73 170.08 8.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.483 179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.08 32.4 2.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.981 0.42 . . . . 0.0 110.253 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.975 HD13 HD12 ' A' ' 84' ' ' ILE . 4.2 tp -116.99 123.34 30.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.172 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' ILE . 57.1 Cg_endo -71.05 75.6 1.74 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.426 2.084 . . . . 0.0 111.597 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.957 HD11 ' C ' ' A' ' 54' ' ' GLN . 17.9 mm -30.91 148.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.117 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER 96.43 7.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.788 -178.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.571 HG21 HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -63.25 -151.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.027 179.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.637 ' O ' HG23 ' A' ' 33' ' ' VAL . 71.8 p -120.26 148.9 43.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.007 0.432 . . . . 0.0 111.749 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.544 ' CG ' HD23 ' A' ' 46' ' ' LEU . 5.6 mp0 -66.28 -66.0 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.756 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -40.05 -29.53 0.2 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.154 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.51 ' N ' ' OE1' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -82.51 -61.21 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.713 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 29' ' ' THR . 56.9 t -55.21 -53.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.851 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.971 ' CD1' HD22 ' A' ' 46' ' ' LEU . 1.4 mp -62.66 -33.99 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.279 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.563 ' HA ' HD22 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -51.07 -36.23 39.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.054 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.538 HD23 ' OH ' ' A' ' 72' ' ' TYR . 2.0 mt -70.64 -46.9 62.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.21 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.83 -13.6 82.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.281 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.84 HD13 HG22 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -48.79 -60.28 4.86 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.78 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 20.2 Cg_endo -60.77 -34.95 91.01 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.636 2.224 . . . . 0.0 111.731 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.879 ' CE2' HG22 ' A' ' 67' ' ' THR . 39.7 m-85 -63.25 -12.39 28.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.999 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.73 -106.86 0.36 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.122 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.472 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -150.61 150.22 30.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.909 0.385 . . . . 0.0 111.139 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 34' ' ' ILE . 55.0 t -102.58 121.19 53.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.307 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.778 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -102.64 8.24 39.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.513 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 171.95 153.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.831 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.971 HD22 ' CD1' ' A' ' 34' ' ' ILE . 17.1 tp -140.53 131.2 25.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.949 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 tp -136.18 137.28 40.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.597 ' HB3' HG23 ' A' ' 26' ' ' ILE . 4.9 mmm -125.09 94.77 4.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.776 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.492 ' C ' HG21 ' A' ' 26' ' ' ILE . 27.6 tp -76.43 92.9 3.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.703 ' N ' HG21 ' A' ' 26' ' ' ILE . 1.0 OUTLIER -60.65 159.23 11.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.011 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.71 -73.49 0.24 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.482 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -83.07 -8.87 59.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.788 0.327 . . . . 0.0 111.018 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 0.6 OUTLIER 68.65 47.43 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.957 ' C ' HD11 ' A' ' 26' ' ' ILE . 17.2 mt-30 -129.54 126.96 39.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.728 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.754 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.15 161.41 15.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.784 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -140.94 115.89 9.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.396 -179.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.788 HG22 ' CD1' ' A' ' 46' ' ' LEU . 7.1 pt -112.75 140.65 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.579 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 44' ' ' THR . 6.9 tt0 -103.53 102.97 12.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.27 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.456 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 2.7 mtp -74.64 147.39 41.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.122 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.778 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.2 OUTLIER -64.2 -55.13 23.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.399 -178.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -108.03 169.81 8.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 111.451 -179.094 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' N ' ' OG1' ' A' ' 61' ' ' THR . 24.1 mt-10 -71.33 -47.75 54.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.64 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -49.33 -31.6 9.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.262 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 40' ' ' PHE . . . -70.62 -51.6 27.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.769 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.456 ' HA ' ' SD ' ' A' ' 59' ' ' MET . . . -67.14 -66.1 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.315 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.46 ' ND2' ' OG ' ' A' ' 16' ' ' SER . 53.4 m-80 -37.92 -45.32 0.85 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.989 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.879 HG22 ' CE2' ' A' ' 40' ' ' PHE . 43.7 m -64.68 -53.44 47.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.141 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.875 ' SD ' HG21 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -35.36 -64.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.041 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.795 HG22 HG22 ' A' ' 86' ' ' ILE . 75.1 t -68.47 -46.69 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.286 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 67' ' ' THR . 40.5 m-20 -46.47 -64.41 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.174 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -62.11 -38.1 87.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 77' ' ' PRO . 18.1 m-85 -87.73 19.66 3.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.054 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 69' ' ' VAL . 20.3 m -83.78 -35.36 24.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.923 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 t -113.29 -40.51 3.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.9 t -75.53 138.63 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.494 ' HG1' ' HH ' ' A' ' 85' ' ' TYR . 2.4 m -90.42 112.11 51.07 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.275 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.587 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 58.8 Cg_endo -98.05 109.62 0.08 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 123.24 2.627 . . . . 0.0 112.299 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HB ' ' C ' ' A' ' 82' ' ' GLN . 0.7 OUTLIER -110.71 157.62 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 111.002 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.501 ' C ' HD13 ' A' ' 79' ' ' LEU . 3.4 tm? -107.26 100.92 10.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.523 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.404 ' HB2' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER 71.75 -58.72 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.997 0.427 . . . . 0.0 110.493 -179.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.39 24.65 0.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.417 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -129.64 104.57 17.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.717 0.294 . . . . 0.0 110.584 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 82' ' ' GLN . 28.0 Cg_endo -63.45 117.79 4.73 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.563 2.175 . . . . 0.0 112.634 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.975 HD12 HD13 ' A' ' 24' ' ' LEU . 3.4 pt -131.63 111.28 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.628 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.51 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 19.8 m-85 -77.9 165.68 23.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.442 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.795 HG22 HG22 ' A' ' 69' ' ' VAL . 39.6 mm -119.54 142.56 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.827 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' HIS . 2.1 mm-40 -141.98 170.72 15.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.06 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.586 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 32.7 m-85 -91.15 168.48 11.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.609 ' HB3' HG13 ' A' ' 18' ' ' VAL . 3.8 t -146.93 166.36 27.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.836 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.416 ' O ' ' CG ' ' A' ' 90' ' ' ASN . 25.2 t30 -178.12 49.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.84 -80.25 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.977 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -74.43 56.14 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.918 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -42.84 152.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.4 ' CD1' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -110.78 127.87 55.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.95 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -54.79 145.65 19.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 55.1 p -82.12 128.91 34.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -164.93 175.76 9.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -66.64 0.85 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.971 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.8 0.333 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.97 -97.08 2.34 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.396 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.08 132.39 23.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.894 0.378 . . . . 0.0 111.103 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 16' ' ' SER . 71.1 Cg_exo -50.55 129.62 27.21 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.729 2.286 . . . . 0.0 112.325 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 15' ' ' PRO . 0.3 OUTLIER 175.14 119.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.424 ' HD3' ' HG2' ' A' ' 93' ' ' GLU . 1.1 ttt85 -138.87 -57.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 18' ' ' VAL . 7.3 p -88.63 104.94 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.093 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.905 HG21 ' HG2' ' A' ' 68' ' ' MET . 47.3 mm -84.04 117.94 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.552 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 3.2 t-160 -82.59 153.0 25.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.899 HG13 ' HB3' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -123.31 110.54 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.083 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.46 171.0 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.871 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER 44.22 40.19 3.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.892 0.377 . . . . 0.0 110.297 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.908 HD13 HD12 ' A' ' 84' ' ' ILE . 8.1 tp -123.73 117.39 27.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.34 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.473 ' HA ' ' OD1' ' A' ' 53' ' ' ASN . 39.2 Cg_endo -67.03 74.09 0.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.299 1.999 . . . . 0.0 111.209 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.952 HD11 ' C ' ' A' ' 54' ' ' GLN . 29.1 mm -30.06 148.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.208 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.58 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 0.5 OUTLIER 100.81 10.59 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.657 -178.192 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.699 HG21 HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -67.14 -151.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.877 179.208 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.536 ' H ' HG12 ' A' ' 28' ' ' VAL . 71.7 p -124.76 145.14 49.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.978 0.418 . . . . 0.0 111.613 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.517 ' HG2' HD23 ' A' ' 46' ' ' LEU . 79.0 mt-10 -62.78 -63.73 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.57 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.69 -31.11 0.23 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.785 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HB2' ' OG1' ' A' ' 29' ' ' THR . 7.3 mm-40 -79.45 -63.73 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 110.248 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.7 t -56.77 -63.01 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.408 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.97 HG23 HG21 ' A' ' 43' ' ' VAL . 1.6 mt -46.8 -47.62 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.964 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -42.7 -50.68 5.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.376 179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.509 ' O ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 mp -57.47 -31.48 66.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.263 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 34' ' ' ILE . . . -90.45 -16.42 55.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.333 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.543 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 19.8 mt -48.96 -56.42 15.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.66 0.267 . . . . 0.0 110.986 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 31.8 Cg_endo -63.88 -18.63 64.65 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.526 2.15 . . . . 0.0 112.11 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.959 ' CE2' HG22 ' A' ' 67' ' ' THR . 37.0 m-85 -77.26 -14.67 59.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.718 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.94 -101.66 0.24 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.124 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -150.62 149.43 29.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.825 0.345 . . . . 0.0 111.09 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.97 HG21 HG23 ' A' ' 34' ' ' ILE . 55.0 t -100.08 115.85 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.343 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.798 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -96.56 2.11 52.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.522 -178.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 44' ' ' THR . 0.6 OUTLIER 170.83 142.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.937 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.023 HD13 HG22 ' A' ' 57' ' ' ILE . 39.7 tp -144.4 115.4 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.021 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.62 138.3 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.606 ' HB3' HG23 ' A' ' 26' ' ' ILE . 5.3 mmm -116.14 103.79 10.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.62 ' C ' HG21 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -89.55 91.48 8.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.812 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.803 ' N ' HG21 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -45.63 -26.87 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.887 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 52' ' ' LYS . . . -77.79 118.93 5.12 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.458 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 6.6 mtmm 85.09 -10.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 0.0 111.013 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.502 ' HA ' ' CG1' ' A' ' 26' ' ' ILE . 0.6 OUTLIER 61.89 58.75 1.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.053 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.952 ' C ' HD11 ' A' ' 26' ' ' ILE . 3.4 mm-40 -137.72 133.15 33.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.734 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.899 ' HB3' HG13 ' A' ' 21' ' ' ILE . . . -109.16 161.75 14.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.655 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -143.76 115.86 8.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.528 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.023 HG22 HD13 ' A' ' 46' ' ' LEU . 5.9 pt -109.9 154.93 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.259 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.699 ' O ' HG23 ' A' ' 44' ' ' THR . 0.7 OUTLIER -116.33 111.18 19.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.807 0.337 . . . . 0.0 111.536 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.787 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 8.5 mmm -80.14 137.42 36.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.023 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.798 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.2 OUTLIER -65.49 -41.3 93.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.419 . . . . 0.0 110.633 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -119.23 176.61 5.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.095 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.52 ' N ' ' OG1' ' A' ' 61' ' ' THR . 1.6 mp0 -73.73 -50.38 21.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.838 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -46.02 -29.32 1.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.643 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.787 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -75.94 -51.08 13.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.016 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.509 ' CA ' HD11 ' A' ' 19' ' ' ILE . . . -64.09 -61.03 2.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.099 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -44.78 -62.09 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.665 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.959 HG22 ' CE2' ' A' ' 40' ' ' PHE . 88.9 m -46.22 -51.83 13.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.98 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.905 ' HG2' HG21 ' A' ' 19' ' ' ILE . 7.1 tpt -34.63 -61.17 0.41 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.98 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.885 HG11 ' CE2' ' A' ' 88' ' ' PHE . 68.9 t -79.75 -54.59 10.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.246 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.407 ' O ' ' HB ' ' A' ' 73' ' ' THR . 20.5 m-20 -38.33 -64.18 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.305 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -60.97 -45.52 94.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.192 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 68' ' ' MET . 13.1 m-30 -73.42 -1.0 16.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.249 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 69' ' ' VAL . 46.8 m -59.16 -36.77 75.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.852 0.358 . . . . 0.0 110.817 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.7 m -112.71 -44.08 3.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.655 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.6 t -80.92 126.69 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.567 ' OG1' ' CZ ' ' A' ' 85' ' ' TYR . 3.0 m -89.31 134.94 31.9 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.07 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.48 ' O ' HG12 ' A' ' 84' ' ' ILE . 46.5 Cg_endo -97.69 80.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.982 2.455 . . . . 0.0 112.292 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.982 ' C ' HD23 ' A' ' 79' ' ' LEU . 1.4 p -92.21 158.73 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.941 0.4 . . . . 0.0 111.14 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.982 HD23 ' C ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -148.6 132.09 16.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.229 -179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.9 18.8 1.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.18 15.3 52.03 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.66 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.444 ' C ' HG23 ' A' ' 78' ' ' VAL . 74.0 mt-30 -113.68 96.78 41.95 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.054 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.29 108.7 2.05 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.903 2.402 . . . . 0.0 112.608 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.908 HD12 HD13 ' A' ' 24' ' ' LEU . 3.7 pt -117.24 110.21 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.521 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.567 ' CZ ' ' OG1' ' A' ' 76' ' ' THR . 2.4 m-85 -86.02 152.3 23.02 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.879 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.656 HG12 HD13 ' A' ' 21' ' ' ILE . 3.8 mt -126.59 140.46 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.466 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.482 ' HA ' HG22 ' A' ' 69' ' ' VAL . 2.0 pt20 -157.14 172.71 18.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 111.166 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.885 ' CE2' HG11 ' A' ' 69' ' ' VAL . 6.0 m-85 -76.0 128.8 35.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.02 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 20' ' ' HIS . 0.7 OUTLIER -152.14 179.64 8.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.75 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 55.91 -152.74 0.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.578 ' CE1' ' HG3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -92.17 -172.79 3.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.853 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -77.24 -19.91 55.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.424 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -133.72 146.65 50.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 26.2 tp -79.89 117.92 21.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.578 ' HG3' ' CE1' ' A' ' 91' ' ' HIS . 2.6 mmtp -88.32 133.87 33.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.846 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.4 m -123.03 111.26 16.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.099 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 73.19 90.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.7 p -155.98 -41.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.83 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.856 0.36 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.624 ' O ' HG23 ' A' ' 14' ' ' VAL . . . 85.15 -95.16 1.95 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.489 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.643 HG12 ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER 55.1 153.87 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.975 0.416 . . . . 0.0 111.188 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.643 ' HD2' HG12 ' A' ' 14' ' ' VAL . 33.5 Cg_exo -59.4 -67.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.776 2.317 . . . . 0.0 112.278 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 1.3 m 158.89 172.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.33 -24.98 22.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 93' ' ' GLU . 94.7 t -87.9 111.66 22.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.122 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.523 ' CG2' HG23 ' A' ' 86' ' ' ILE . 48.7 mm -97.08 105.18 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.22 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' A' ' 87' ' ' GLN . 6.6 t-160 -79.02 119.74 22.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.652 HG23 HG13 ' A' ' 86' ' ' ILE . 10.2 mt -96.72 124.53 49.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.292 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -107.69 171.2 7.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.605 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 49.01 39.36 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.167 -179.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.688 HD12 HG21 ' A' ' 84' ' ' ILE . 9.5 tp -129.16 98.27 24.02 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.555 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 39.9 Cg_exo -56.14 77.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.518 2.146 . . . . 0.0 111.519 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.724 HG22 ' HE3' ' A' ' 50' ' ' LYS . 19.4 mm -31.54 125.45 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.065 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 2.1 t70 146.31 -15.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.144 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.737 HG11 ' HG ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -55.15 -154.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.4 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.576 ' H ' HG12 ' A' ' 28' ' ' VAL . 30.4 p -124.41 146.93 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.985 0.421 . . . . 0.0 111.683 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.617 ' HB3' HD12 ' A' ' 34' ' ' ILE . 3.2 mp0 -66.67 -49.35 66.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.62 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -45.41 -36.0 5.6 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.981 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.792 ' HG2' HD21 ' A' ' 79' ' ' LEU . 2.8 tp10 -81.96 -61.05 2.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.791 0.329 . . . . 0.0 110.606 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 29' ' ' THR . 47.7 t -52.76 -59.88 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.553 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.617 HD12 ' HB3' ' A' ' 30' ' ' GLU . 33.7 mt -54.07 -40.79 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.544 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -50.92 -40.56 57.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.147 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.951 HD12 ' OH ' ' A' ' 72' ' ' TYR . 2.1 mm? -65.9 -28.34 68.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.068 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -81.22 -20.65 64.27 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.375 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.509 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.5 OUTLIER -46.11 -56.42 10.69 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.702 0.287 . . . . 0.0 110.575 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.509 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 35.4 Cg_exo -59.56 -19.98 55.07 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.385 2.057 . . . . 0.0 111.061 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.597 ' CD1' HG22 ' A' ' 67' ' ' THR . 6.2 m-30 -92.02 16.16 11.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.655 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.18 -111.14 3.02 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.034 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.463 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -150.79 154.59 37.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.883 0.373 . . . . 0.0 111.209 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.455 HG21 HG12 ' A' ' 34' ' ' ILE . 59.0 t -101.82 116.92 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.307 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.762 HG22 ' CG ' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -98.89 9.38 43.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.448 -178.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 44' ' ' THR . 8.4 t-20 175.61 144.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.887 HD13 HG22 ' A' ' 57' ' ' ILE . 5.2 tp -151.91 126.69 9.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.694 ' N ' HD12 ' A' ' 46' ' ' LEU . 3.4 tm? -141.01 107.56 5.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.713 ' HB3' HG23 ' A' ' 26' ' ' ILE . 2.7 mmm -86.29 118.87 26.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.79 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.546 ' C ' HG21 ' A' ' 26' ' ' ILE . 14.7 tp -102.02 100.36 10.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.084 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.724 ' HE3' HG22 ' A' ' 26' ' ' ILE . 1.4 mmtp -53.83 -19.05 3.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -37.68 -96.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.696 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -100.94 48.1 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.328 . . . . 0.0 110.981 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.555 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 25.6 m120 39.93 73.33 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.605 ' C ' HD11 ' A' ' 26' ' ' ILE . 5.0 mt-30 -151.05 133.24 15.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.64 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.554 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.6 165.33 11.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.744 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.542 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -143.87 115.9 8.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.308 -179.543 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.887 HG22 HD13 ' A' ' 46' ' ' LEU . 15.0 pt -119.52 139.26 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.675 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 44' ' ' THR . 0.4 OUTLIER -108.0 103.84 13.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.256 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 65' ' ' ALA . 0.9 OUTLIER -69.84 146.21 51.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.248 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.762 ' CG ' HG22 ' A' ' 44' ' ' THR . 0.2 OUTLIER -66.22 -47.0 75.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.329 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.95 168.94 9.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.426 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.5 ' HB3' HG11 ' A' ' 14' ' ' VAL . 5.6 mp0 -72.05 -47.21 53.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.682 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -50.53 -26.93 5.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.408 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 40' ' ' PHE . . . -74.39 -52.41 12.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.852 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 68' ' ' MET . . . -53.89 -58.43 7.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.197 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 70' ' ' ASN . 1.7 m-20 -46.54 -64.71 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.597 HG22 ' CD1' ' A' ' 40' ' ' PHE . 19.9 m -40.83 -55.43 2.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.784 ' SD ' HG21 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -36.12 -63.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.037 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.639 HG22 HG22 ' A' ' 86' ' ' ILE . 65.2 t -83.37 -58.47 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.257 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 66' ' ' ASN . 21.1 t-20 -37.6 -36.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.486 ' HB3' ' O ' ' A' ' 67' ' ' THR . 2.1 t80 -78.19 -52.73 8.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.991 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.951 ' OH ' HD12 ' A' ' 36' ' ' LEU . 13.4 m-85 -65.89 -9.1 26.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.054 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 72' ' ' TYR . 28.6 m -38.1 -36.66 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.936 0.398 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 t -110.32 -56.62 2.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.739 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.43 120.91 31.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.5 m -94.3 141.47 23.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.263 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 76' ' ' THR . 58.2 Cg_endo -98.43 137.6 0.36 Allowed 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.436 2.757 . . . . 0.0 112.311 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -122.91 179.94 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.948 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.792 HD21 ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -140.92 118.73 11.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.85 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 47.33 24.28 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.536 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.51 15.38 23.11 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.412 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.456 ' C ' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -120.3 97.9 48.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.599 ' HA ' HG12 ' A' ' 78' ' ' VAL . 39.6 Cg_exo -57.3 129.06 32.13 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.976 2.45 . . . . 0.0 112.802 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.688 HG21 HD12 ' A' ' 24' ' ' LEU . 5.3 pt -133.45 109.33 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.203 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.602 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -80.4 146.57 31.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.086 -178.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.784 HG21 ' SD ' ' A' ' 68' ' ' MET . 5.9 mt -126.4 108.75 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.412 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.534 ' HA ' ' CG1' ' A' ' 69' ' ' VAL . 30.0 mt-30 -140.39 166.09 25.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 111.366 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -74.03 120.38 19.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.656 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 20' ' ' HIS . 0.6 OUTLIER -151.52 141.62 22.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.046 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 91' ' ' HIS . 1.5 m-20 69.39 -76.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.977 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 90' ' ' ASN . 6.7 m80 85.72 -13.57 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.799 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 93' ' ' GLU . 6.2 mttp -55.26 89.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -41.47 168.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.831 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.5 mt -67.64 100.23 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -138.94 162.04 35.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.959 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 73.2 p -91.9 102.23 14.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.093 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER 160.99 -61.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.26 80.17 8.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.937 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.967 179.933 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.838 0.351 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.78 -98.81 2.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.5 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.88 145.58 58.36 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 111.139 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.11 95.46 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.755 2.303 . . . . 0.0 112.223 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.582 ' HB3' ' CE1' ' A' ' 88' ' ' PHE . 3.1 m -141.35 137.6 32.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.987 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.07 -49.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.85 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.471 ' HB ' ' OG ' ' A' ' 89' ' ' SER . 7.3 t -88.03 100.43 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.04 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.82 HD11 ' HB1' ' A' ' 65' ' ' ALA . 37.4 mm -81.21 105.7 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.239 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.692 ' CD2' ' CE2' ' A' ' 56' ' ' PHE . 10.2 t-160 -84.65 107.58 16.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.837 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.549 HG23 HG13 ' A' ' 86' ' ' ILE . 1.7 mm -82.86 119.35 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.187 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.97 173.42 6.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.685 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 84' ' ' ILE . 3.1 tmtt? 43.22 41.99 3.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.536 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.814 HD12 ' HD2' ' A' ' 25' ' ' PRO . 6.3 tp -127.79 130.45 23.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.814 ' HD2' HD12 ' A' ' 24' ' ' LEU . 73.6 Cg_endo -76.49 74.75 4.62 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.592 2.194 . . . . 0.0 111.742 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.89 HD11 ' C ' ' A' ' 54' ' ' GLN . 15.0 mm -32.83 110.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.143 0.497 . . . . 0.0 110.659 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.567 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 6.3 t70 146.69 -17.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.539 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.69 HG22 ' H ' ' A' ' 29' ' ' THR . 1.7 p -51.19 -168.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.373 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.69 ' H ' HG22 ' A' ' 28' ' ' VAL . 45.2 p -105.77 145.91 30.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.12 0.486 . . . . 0.0 111.808 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.9 mp0 -62.08 -46.12 90.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.672 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -39.64 -36.77 0.76 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.085 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.442 ' OE1' ' HB2' ' A' ' 79' ' ' LEU . 91.9 mt-10 -75.12 -51.18 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 110.454 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.3 t -64.07 -61.74 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.02 HG23 HG21 ' A' ' 43' ' ' VAL . 1.1 mt -50.82 -46.82 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.097 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 3.7 t -45.62 -45.12 13.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.583 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.511 HD22 ' OH ' ' A' ' 72' ' ' TYR . 68.6 mt -69.16 -21.27 64.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.539 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.592 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -87.1 -28.37 25.76 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.526 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.493 ' CB ' ' HD3' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -40.86 -53.14 6.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.805 0.336 . . . . 0.0 110.698 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 38' ' ' LEU . 19.6 Cg_exo -65.71 -34.33 41.27 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.718 2.279 . . . . 0.0 111.786 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.596 ' CD1' HG22 ' A' ' 67' ' ' THR . 15.6 m-30 -65.83 -39.3 90.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.833 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.521 ' O ' ' CD ' ' A' ' 42' ' ' LYS . . . 165.68 -98.52 0.15 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.42 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -150.48 141.64 23.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.79 0.328 . . . . 0.0 110.94 179.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.02 HG21 HG23 ' A' ' 34' ' ' ILE . 55.5 t -88.68 86.49 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.908 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -80.62 7.44 10.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.322 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 170.75 137.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.027 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.976 HD23 HG22 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -147.92 98.4 2.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.545 ' N ' HD22 ' A' ' 46' ' ' LEU . 6.5 tt -97.88 149.16 22.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.816 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.812 ' HB3' HG23 ' A' ' 26' ' ' ILE . 8.2 mtt -125.21 110.65 14.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.148 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.645 ' C ' HG21 ' A' ' 26' ' ' ILE . 6.0 tp -88.42 96.4 10.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.751 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.714 ' CD ' HG22 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -74.73 0.56 14.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.255 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.63 -9.03 36.07 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.404 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -160.46 -64.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.778 0.323 . . . . 0.0 111.001 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER 155.08 43.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.551 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.89 ' C ' HD11 ' A' ' 26' ' ' ILE . 63.8 mt-30 -130.44 133.09 46.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.11 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.766 ' N ' HD11 ' A' ' 26' ' ' ILE . . . -109.81 163.06 13.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.715 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.692 ' CE2' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -148.0 115.78 6.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.134 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.976 HG22 HD23 ' A' ' 46' ' ' LEU . 22.0 pt -112.18 137.18 45.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.78 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.73 102.67 14.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.731 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.855 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 17.7 mmm -67.02 124.02 21.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.645 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.908 ' ND2' HG23 ' A' ' 44' ' ' THR . 2.8 m120 -35.69 -33.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.78 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -144.67 176.78 9.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.971 -179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.512 ' N ' ' OG1' ' A' ' 61' ' ' THR . 1.2 mp0 -72.88 -44.76 60.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.95 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -50.25 -24.55 2.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.947 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.855 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -83.47 -49.72 9.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.82 ' HB1' HD11 ' A' ' 19' ' ' ILE . . . -65.41 -31.2 72.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.369 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -70.09 -54.49 12.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.596 HG22 ' CD1' ' A' ' 40' ' ' PHE . 24.1 m -56.62 -22.63 35.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.269 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.585 ' SD ' HD11 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -69.03 -65.01 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.066 -179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.581 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 21.6 t -67.97 -48.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.277 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -52.77 -40.47 63.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.037 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.428 ' CB ' ' O ' ' A' ' 67' ' ' THR . 3.5 t80 -67.81 -44.53 77.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.511 ' OH ' HD22 ' A' ' 36' ' ' LEU . 41.0 m-85 -85.84 12.48 9.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.445 ' OG1' ' HA ' ' A' ' 70' ' ' ASN . 54.1 m -66.26 -13.84 61.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.2 m -127.77 -39.8 1.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.832 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.76 138.74 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.484 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 1.3 m -103.33 142.56 24.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.01 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.761 ' HG2' HD12 ' A' ' 86' ' ' ILE . 30.2 Cg_endo -95.24 145.08 1.4 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 123.103 2.535 . . . . 0.0 112.097 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' HB ' ' C ' ' A' ' 82' ' ' GLN . 0.7 OUTLIER -133.29 166.28 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 0.0 110.994 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.793 ' C ' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -107.88 107.63 18.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.406 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER 28.92 34.53 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.327 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . 115.93 36.24 1.16 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.559 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.548 ' CB ' ' HG ' ' A' ' 79' ' ' LEU . 2.5 tt0 -151.34 97.18 3.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.076 0.465 . . . . 0.0 110.613 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.406 ' N ' ' HB ' ' A' ' 78' ' ' VAL . 38.7 Cg_exo -61.16 126.2 18.86 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.004 2.47 . . . . 0.0 112.959 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.487 ' O ' HG13 ' A' ' 84' ' ' ILE . 9.4 pt -137.73 107.7 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.273 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -68.85 146.88 52.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.99 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.761 HD12 ' HG2' ' A' ' 77' ' ' PRO . 6.5 mt -126.31 103.75 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.203 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' HIS . 4.1 mt-30 -126.64 174.27 8.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.899 0.381 . . . . 0.0 111.142 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.582 ' CE1' ' HB3' ' A' ' 16' ' ' SER . 71.4 m-85 -71.27 167.44 19.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.816 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.528 ' CA ' ' HB2' ' A' ' 20' ' ' HIS . 1.1 p -108.3 176.23 5.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.792 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.87 42.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.0 34.59 13.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -75.5 76.0 2.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -52.26 138.86 25.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.4 mt -48.2 114.47 0.95 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.49 154.73 23.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.84 123.55 25.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -67.23 138.68 57.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.3 -20.34 19.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.957 179.961 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.862 0.363 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.78 70.63 1.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.451 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.1 156.72 48.15 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.919 0.39 . . . . 0.0 111.141 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.43 87.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.713 2.275 . . . . 0.0 112.334 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.0 p -143.74 95.25 2.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 58' ' ' GLU . 3.5 mtm180 -137.22 -42.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 89' ' ' SER . 9.6 t -87.91 133.81 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.582 HG21 ' HG2' ' A' ' 68' ' ' MET . 4.8 mm -115.61 102.42 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.395 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.518 ' CD2' ' HB3' ' A' ' 54' ' ' GLN . 4.7 t-160 -79.08 113.98 17.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.598 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.911 HD12 HG12 ' A' ' 86' ' ' ILE . 4.1 mm -82.83 127.03 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.347 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -108.79 171.33 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.671 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HG2' ' CZ ' ' A' ' 85' ' ' TYR . 1.9 tptp 43.66 33.17 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.27 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.772 HD13 HD12 ' A' ' 84' ' ' ILE . 2.2 tp -115.46 110.66 44.74 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.103 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.568 ' HA ' ' ND2' ' A' ' 53' ' ' ASN . 43.8 Cg_endo -68.22 61.69 1.04 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.277 1.985 . . . . 0.0 110.991 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.913 HD11 ' C ' ' A' ' 54' ' ' GLN . 37.5 mm -8.5 105.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.468 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.622 ' CB ' ' O ' ' A' ' 26' ' ' ILE . 24.6 t70 129.18 24.91 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 O-C-N 124.408 1.067 . . . . 0.0 111.325 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.731 ' C ' HG23 ' A' ' 29' ' ' THR . 5.2 p -85.23 8.38 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.376 0.607 . . . . 0.0 111.031 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.731 HG23 ' C ' ' A' ' 28' ' ' VAL . 3.0 p 90.29 146.82 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.976 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -74.92 -40.19 60.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.228 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 35' ' ' SER . . . -53.86 -25.9 31.65 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.96 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.807 ' HG3' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -80.39 -50.31 10.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.719 0.295 . . . . 0.0 110.551 179.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.402 ' HB ' ' CD2' ' A' ' 46' ' ' LEU . 12.4 t -62.29 -51.26 74.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.748 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.32 -41.51 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.442 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 1.9 t -49.74 -33.3 15.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.181 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.849 HD13 ' CZ ' ' A' ' 72' ' ' TYR . 6.6 mt -75.43 -34.9 61.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.456 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.552 ' HA2' ' CD2' ' A' ' 40' ' ' PHE . . . -70.03 -26.09 74.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.464 ' N ' ' HD2' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -37.87 -61.23 0.81 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.367 . . . . 0.0 110.723 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 38' ' ' LEU . 37.2 Cg_endo -65.87 -22.51 56.16 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.57 2.18 . . . . 0.0 111.626 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.59 ' CE2' ' HA ' ' A' ' 68' ' ' MET . 13.1 m-30 -80.77 0.45 34.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.976 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.8 -101.69 0.85 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.375 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' CB ' HD21 ' A' ' 60' ' ' ASN . 5.7 mtpm? -150.32 145.56 26.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 111.481 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.679 HG22 HD11 ' A' ' 57' ' ' ILE . 54.7 t -89.51 122.58 41.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.651 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.931 HG22 ' OD1' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -99.15 -14.32 19.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.211 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.1 t-20 172.88 142.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.676 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' PHE . 5.3 tp -148.52 95.93 2.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.998 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 47' ' ' LEU . 7.1 tt -95.33 127.48 41.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.66 ' HB3' HG23 ' A' ' 26' ' ' ILE . 27.9 mtp -94.59 137.03 34.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.971 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.471 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.2 tp -124.06 101.82 7.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.784 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.675 ' HE3' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -59.6 -13.86 11.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.21 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 50' ' ' LYS . . . -35.15 -95.36 0.01 OUTLIER Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.619 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 63.8 mmtt -104.03 44.11 1.04 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.914 0.388 . . . . 0.0 110.774 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.568 ' ND2' ' HA ' ' A' ' 25' ' ' PRO . 4.9 m120 48.76 75.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.912 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.913 ' C ' HD11 ' A' ' 26' ' ' ILE . 21.8 mt-30 -157.65 138.42 13.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.619 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.691 ' HB3' ' CG1' ' A' ' 21' ' ' ILE . . . -109.28 167.97 9.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -139.55 115.66 10.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.283 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.679 HD11 HG22 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -127.56 144.03 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.655 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.523 ' N ' HG12 ' A' ' 57' ' ' ILE . 15.5 mt-10 -121.53 133.14 55.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.895 0.379 . . . . 0.0 111.106 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.869 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 27.9 mmm -92.09 151.28 20.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.589 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.931 ' OD1' HG22 ' A' ' 44' ' ' THR . 0.4 OUTLIER -68.65 -26.73 65.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.952 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.619 HG23 ' H ' ' A' ' 64' ' ' ALA . 4.8 t -131.17 138.22 49.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.091 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.39 -21.02 2.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.821 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -73.59 -36.59 65.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.869 ' HB3' ' HB3' ' A' ' 59' ' ' MET . . . -67.43 -49.87 61.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' A' ' 19' ' ' ILE . . . -55.78 -56.91 14.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.208 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -41.97 -68.48 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.986 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.566 HG22 ' CD1' ' A' ' 40' ' ' PHE . 19.4 m -40.93 -49.83 3.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.114 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.59 ' HA ' ' CE2' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -38.4 -64.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.977 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 88' ' ' PHE . 54.1 t -77.09 -59.0 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -41.88 -27.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.056 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.423 ' CB ' ' O ' ' A' ' 67' ' ' THR . 10.7 t80 -85.46 -45.43 11.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.948 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.849 ' CZ ' HD13 ' A' ' 36' ' ' LEU . 19.2 m-85 -82.9 9.12 10.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 m -70.13 -23.63 63.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.05 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.9 t -116.65 -34.2 4.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.788 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 2.7 p -113.8 126.82 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.989 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.523 HG21 ' CE1' ' A' ' 85' ' ' TYR . 2.0 m -97.6 131.26 27.37 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.151 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.575 ' HG3' ' CE1' ' A' ' 72' ' ' TYR . 72.5 Cg_endo -98.33 120.87 0.14 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 123.178 2.585 . . . . 0.0 112.411 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.677 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -95.07 -179.96 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.856 179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.807 HD12 ' HG3' ' A' ' 32' ' ' GLU . 2.4 mm? -139.96 115.53 10.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.951 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.07 21.41 1.02 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.728 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.42 15.72 16.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.488 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.524 ' O ' HG23 ' A' ' 84' ' ' ILE . 18.7 mm100 -122.83 97.98 43.33 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.027 0.441 . . . . 0.0 110.956 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 22.2 Cg_exo -64.91 105.9 0.71 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.974 2.449 . . . . 0.0 112.746 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.772 HD12 HD13 ' A' ' 24' ' ' LEU . 1.6 pt -119.9 112.39 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.371 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.641 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -76.71 156.03 32.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.94 -178.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.911 HG12 HD12 ' A' ' 21' ' ' ILE . 7.7 mt -126.15 104.27 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.327 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -113.84 175.3 5.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 111.346 -179.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.583 ' CZ ' ' HB ' ' A' ' 69' ' ' VAL . 44.3 m-85 -73.1 -178.45 2.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.041 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.468 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 41.8 t -117.03 164.06 15.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.81 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -114.3 41.09 2.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.016 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -144.22 152.41 40.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -58.86 3.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -115.46 160.73 19.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.943 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 94' ' ' LEU . 11.5 tp -62.77 132.32 51.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -55.96 111.34 0.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.843 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 p -111.78 137.68 49.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.105 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -94.29 -21.36 19.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.956 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.33 40.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.882 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.927 179.958 . . . . . . . . 0 0 . 1 stop_ save_